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Background: Melanoma incidence continues to rise worldwide but mortality rates remain 
stable, meaning ever more patients require support. However, there is currently little 
research on the support needs of melanoma patients and their carers.  
 
Aim: To explore the experience/support needs of melanoma patients and their carers over 
time.  
 
Methods: Using a Constructivist Grounded Theory 17 melanoma patients, 11 carers and 11 
healthcare professionals (HCPS) were recruited. Concurrent data analysis, theoretical 
sampling and constant comparison informed a longitudinal, emergent research design 
capturing experiences over time.  Data were collected from patients and carers using 
interviews and diagramming over 2 years and from HCPs on 2 occasions.  
 
Results: A substantive theory emerged highlighting four key phases in the melanoma 
experience: pre-diagnosis, diagnosis and initial treatment, surveillance and advanced 
disease, and for some, death. The overall experience was captured by the metaphor ‘Riding 
the Rollercoaster’ reflecting the ‘ups’ and ‘downs’ participants experienced at each stage in 
their ‘roles’, ‘routines’ and ‘relationships’. Changes were mediated by the ways in which 
patients and carers ‘recognised’ and ‘responded’ to their situation and the ‘resources’ that 
they could draw upon. Key processes including ‘sharing’ and ‘hiding’ impacted in particular 




The ‘relationships’ forged with HCPs during diagnosis were crucial as HCPs were a major 
‘resource’ providing expertise, information and emotional support. Some patients forged 
close and trusting ‘relationships’ with HCPs but others had less positive experiences. The 
support needs of carers were given limited attention.  
 
Conclusions: Melanoma has ongoing effects on the lives of patients and carers. HCPs play 
a pivotal role as part of a broader support network but not everyone received the help that 
they needed.  If HCPs are to improve the melanoma experience they need to systematically 
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1 CHAPTER ONE: SETTING THE SCENE 
This brief introductory chapter sets the context for the thesis. It starts by highlighting my 
motivation to undertake the study. This is a key element of reflexivity that, as I will describe 
fully later, is an essential part of the methodology used (Constructivist Grounded Theory). 
Subsequently the structure of the thesis is presented in the form of a brief chapter by chapter 
account of its content.   
 
1.1 WHAT MOTIVATED ME TO EXPLORE THE SUPPORT NEEDS OF PEOPLE LIVING 
WITH MELANOMA AND THEIR CARERS?  
Before starting this study I worked as a Research Nurse for 9 years supporting patients taking 
part in clinical trials including those with melanoma. My main responsibilities were taking 
consent and ensuring the safety of patients taking part in clinical trials. I would record side 
effects and collect data on Quality of Life (QoL) and patient outcomes such as pain. During 
the process I spent a lot of time talking to patients and building a relationship with them. I 
realised that the safety data and outcomes that I was collecting did not reflect the full patient 
experience. This became particularly apparent when the side effects of new drug therapies 
began to emerge (see next chapter for more detail). For example, one young woman had 
developed blistering to her feet but the grading system I was using did not capture the 
difficulties the blisters imposed on her actively engaging with her daughter to create happy 
memories. She felt that these activities were a vital legacy that would comfort her daughter 




During this time I also completed a MMedSci in advanced practice, with the dissertation 
examining Quality of Life in patients with kidney cancer. This involved a literature review 
focusing primarily on measures of Health Related Quality Of Life (HRQOL), which further 
reinforced the inherent limitations of such approaches. I became increasingly convinced that 
these measures missed important dimensions of the patient experience: the potential impact 
of the melanoma on their family or their work. Furthermore, there was no Clinical Nurse 
Specialist (CNS) support available in the hospital at the time so patient concerns could not be 
picked up via that route. 
 
My growing realization that melanoma patients potentially had several unmet needs led me to 
explore their support needs as the dissertation component of my second Master’s degree 
(MSc Clinical Research). This was a small retrospective Grounded Theory study during which 
I interviewed 11 patients diagnosed with melanoma. While the participants were disease free 
following treatment they all had a high risk of developing further melanoma. As part of the 
study I worked with a member of the local consumer research panel whose wife had died from 
melanoma in 2005. He could still vividly recall the experience of caring for his wife, with limited 
professional support. Keen to improve this experience for others, he helped with the 
development of my questions and patient information material. While I will discuss the results 
of this study in more detail in the literature review chapter, a major insight to emerge was the 
realisation that melanoma had serious consequences, not only for the patient but also their 
close family. This further reinforced the narrow perspective of the trial data that I was involved 
in collecting as carers’ needs were not considered at all.  
 
The above factors were instrumental in motivating me to develop a research proposal for a 
PhD study that would explore not only the experiences of patients and their carers but also 
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the part played by the healthcare professionals with whom they came into contact. To achieve 
this it was necessary to seek funding for such a study. 
1.2 FUNDING THE STUDY 
Funding was obtained through a successful application for a National Institute for Health 
Research Clinical Doctoral Research Fellowship. The scheme, having a clinical element, 
enabled me both to undertake a PhD and develop my clinical role with cancer patients, with a 
focus on melanoma. The scheme also covered a clinical and academic training package 
incorporating a visit to leading melanoma treatment centres in Australia and New Zealand. 
The application process commenced in May 2012 and was supported by a study management 
group whose role was to ensure that participants’ rights were met and that the study was 
conducted ethically. This comprised three consumer representatives from the Yorkshire and 
Humberside Consumer Research Panel (one being the same person involved in my Masters 
study) and two CNSs from different hospitals within the region. My supervisors and the study 
management team reviewed the application prior to submission. Following a successful 
application I was able to commence the Fellowship in June 2013 while continuing to work as 
a part-time Research Nurse.  
 
1.3 THESIS STRUCTURE 
This initial chapter has considered my motivation for undertaking the study upon which this 
thesis is based. I now provide a brief overview of the remaining chapters.   
 
Chapter Two: Presents an introduction to melanoma, the biology of the disease, epidemiology 
and treatment options. I also describe the local clinical context, issues related to survivorship, 
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living with or beyond melanoma, palliative and terminal care. The chapter concludes by 
considering the current understanding of the support needs of melanoma patients and their 
carers.  
 
Chapter Three: Discusses the role of extant knowledge within a Grounded Theory study, 
including my prior experience, sources of patient and carer knowledge and sources of 
professional knowledge/research, as well as the published literature. Analysis and synthesis 
of these sources identifies a number of themes: Quality of Life, psychosocial wellbeing, 
financial impact, information and educational need, support service use, supportive 
relationships, gender related differences and behavioural responses to melanoma. These 
themes underpin the sensitising concepts and foreshadowed questions providing initial 
direction for the study.  
 
Chapter Four: Explores why Grounded Theory methods were chosen for the study, 
specifically Constructivist Grounded Theory.  The application of Constructivist Grounded 
Theory methods to the study and issues related to ethics, rigour and reflexivity complete this 
chapter.  
 
Chapter Five: Provides details of the participants in the form of a short biography.   
 
Chapter Six: Introduces the results of the study and the mid-range theory produced from the 
data. It then focuses on the diagnostic process and how patients and carers reacted to it. This, 
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and subsequent chapters explore the impact of melanoma on three main areas: roles, 
relationships and routines.  
 
Chapter Seven: Taking a temporal perspective the focus now turns to the stage of 
surveillance, where patients are monitored for new or recurrent disease and may require 
further surgery. The experience of patients and carers is again explored in terms of roles, 
relationships and routines.   
 
Chapter Eight: Goes on to explore the experience of being diagnosed with metastatic disease 
and the transition to palliative care. It also provides a brief exploration of the experience of 
carers after the death of the patient with melanoma.  
 
Chapter Nine: The discussion begins with a summary of the overall research then addresses 
its limitations as well as issues of rigour and reflexivity. It also introduces literature published 
since the commencement of the study. The implications of the findings for future research, 
practice and education are considered. 
 
1.4 A NOTE ON NOMENCLATURE 
Throughout the thesis the following terms are used: 
Patient: Refers to an individual with a diagnosis of melanoma. The various interpretations of 
the term ‘patient’ are explored at differing points in the thesis.  
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Carer: Refers to the individual who provides the main social, psychological and /or physical 
support for a person with melanoma.  
Participant: Refers to any individual who participated in the study, whether they are a patient, 
carer or healthcare professional.  
The use of ‘patient’ and ‘carer’ were discussed in detail with participants and whilst they were 
not seen as ideal no better terms were suggested.   
Healthcare Professional (HCP): Refers to Healthcare professionals as a general term whether 




2 CHAPTER TWO: AN INTRODUCTION TO MELANOMA 
 
2.1 WHAT IS MELANOMA? 
Malignant melanoma is the deadliest form of skin cancer. Most commonly, it starts as a 
changing mole on the skin surface that may subsequently spread to the lymph nodes and 
other organs, becoming fatal if left untreated. In some instances it is easily curable whereas 
in others, despite rigorous treatment, it progresses to a fatal metastatic form. Patients may 
require multiple treatments that can include disfiguring surgery, surveillance visits and drug 
therapies. To have some appreciation of this diversity it is important for the non-specialist 
reader to have at least a broad understanding of the condition, how it manifests itself, the 
various treatment options and their associated outcomes.  
  
2.2 BIOLOGY   
Melanin is a substance found in different parts of the body but is most obvious as the pigment 
in the skin. Melanoma is a cancer of melanocytes, the cells that produce melanin. The skin is 
therefore the most common site for melanoma but it can also develop in the eyes and other 
organs. Melanocytes are found at the junction between the two layers of the skin: the 







Figure 2.1 – Melanocytes within the structures of the skin and initial formation of a melanoma. 
Image from: Science Learning Hub (2014) 
 
Melanocytes produce melanin to protect the body against damage due to Ultraviolet (UV) light 
exposure. The development of melanoma is not fully understood but may occur when chronic 
exposure to growth stimuli (such as UV light) causes DNA damage to the melanocytes leading 
to a cancerous state where the damaged cells replicate in an uncontrolled manner (Busam, 
Barnhill & Piepkorn 2014). Melanoma typically grows horizontally, before spreading vertically 
and eventually metastasising via the lymphatic and/or vascular systems if not treated. See 







Figure 2.2: Melanoma development in relation to staging and image of a melanoma skin lesion 
  
Image from: Health, Medicine & Anatomy Pictures (2013) 
 
The stage of the disease largely determines a patient’s prognosis and appropriate treatment. 
Melanoma occurring in the eye or mucosal tissue is considered a sub-type. The initial DNA 
damage leads to mutations in the BRAF gene which produces the B-RAF protein involved in 
cell signaling and growth. This mutation occurs in 50% of melanoma cases and influences the 







There are over 15,000 cases of malignant melanoma per year and over 2,000 associated 
deaths in the UK with this incidence continuing to rise (Cancer Research UK (CRUK) 2017). 
Whilst melanoma is rare when compared to other cancers its incidence has increased more 
than any other cancer over the last 30 years across all age groups. Like many cancers, it is 
more common in older patients but for those aged 25-49 it is the second most common cancer 
in women and third most common cancer in men (CRUK 2017). In contrast to many cancers, 
it commonly affects younger, working-age adults. The incidence of melanoma is increasing 
faster in men, who are typically diagnosed in older age and more likely to die from melanoma 
(National Cancer Intelligence Network 2012a).  
 
While incidence is increasing, mortality rates remain relatively stable in the UK, Australia and 
parts of the USA, probably due to early diagnosis and curative excision (Bataille & de Vries 
2008). However such success means that more patients require follow-up and active 
surveillance.  
 
Risk factors for melanoma primarily relate to skin type and exposure to the sun or UV light, 
which has increased due to intermittent sun exposure during foreign travel for those living in 
less sunny countries compared to chronic exposure in sunnier climates (Godar 2011).  
Exposure during childhood and teenage years when the skin is more sensitive increases risk 
for younger people, as does cumulative exposure for older adults (CRUK 2015a). The trunk, 
head and neck in men and lower and upper limbs in women are the most common sites for 





The majority of patients present to their General Practitioner (GP) after noticing changes to an 
existing mole. CRUK (2015b) list the following changes that patients should look out for:  
• getting bigger 
• changing shape, particularly becoming irregular  
• changing colour – getting darker, patchy or multi shaded 
• loss of symmetry  
• itching or pain 
• bleeding or becoming crusty 
• looking inflamed/red 
 
Unfortunately patients often delay seeking help until they perceive any changes as being 
potentially significant (Hajdarevic et al. 2010).  
 
GPs should refer a suspected melanoma within two weeks to a dermatologist or plastic 
surgeon, who undertake a biopsy/excision to obtain a histological diagnosis if a malignancy is 
suspected. The clinical and histological details are then discussed by the Specialist Skin Multi-
disciplinary Team (MDT) (comprising of dermatologists, plastic surgeons, oncologists, 







Treatments for melanoma have changed significantly in recent years following advances in 
surgical techniques and drug therapies. Patients may need multiple treatments for disease 
recurrence over months or years. The prognosis for metastatic disease has been historically 
poor. In 2010 one-year survival ranged from 33% to 62% (Balch et al. 2009), with no systemic 
therapy extending survival significantly (Marsden et al. 2010). Since then new targeted and 
immune therapies have increased survival rates but come with significant side effects (fatigue, 
skin reactions, diarrhoea and endocrine problems) requiring careful management (Chapman 
et al. 2011, Hodi et al. 2010).  
 
These new treatments became available for some patients during the data collection period 











Figure 2.3: Treatments for melanoma in the UK by the National Institute for Health and Care 
Excellence (NICE) approval date 
 
The available treatments are now considered in greater detail. 
 
2.5.1 SURGERY 
Surgery is the gold standard for primary melanoma as complete removal may result in cure, 
particularly for patients with stages 0 to 2 (Figure 2.2 above), with around 90% of patients at 
stage I surviving more than 10 years (Balch et al. 2009).  
Chemotherapy
1st immunotherapy 
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Immunotherapy for 
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amenable to surgery
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Tissue from every surgery is examined to ensure all the melanoma is removed with a margin 
of normal tissue surrounding it. Patients may therefore require further surgery to obtain a clear 
margin.  
 
When melanoma spreads locally to subcutaneous tissue or lymph nodes, surgery remains the 
primary treatment and may also be considered in single deposit metastatic disease (NICE 
2015). Patients may therefore have multiple surgeries, for example, for a primary melanoma 
on a limb, further surgery for melanoma on the same limb and then surgery to remove distant 




Following potentially curative treatment for melanoma at any stage regular surveillance is 
offered to detect new disease early. Until 2015 this included full skin and lymph node 
examination but following the publication of updated guidance, imaging via CT and MRI scans 
were included for patients with stage IIC melanomas and above (NICE 2015). This change 
was driven by the approval of new drug treatments which are more effective when given 
earlier.  
 
Patients with a low risk of recurrence are discharged after one year, and those with 
intermediate risk after five years. Some patients may have ongoing surveillance depending on 





Melanoma does not respond to chemotherapy as well as some cancers and there has been 
less success in treating metastatic disease or preventing recurrence after surgery. For more 
than thirty years the chemotherapy dacarbazine was the mainstay of metastatic melanoma 
treatment, with about 10% of patients experiencing a response to treatment with the average 
survival being 9 months (Patel et al. 2011). In rare instances chemotherapy is still used for 
metastatic melanoma when targeted therapy or immunotherapy are not suitable.  
 
2.5.4 TARGETED TREATMENT 
The first targeted treatment for melanoma was approved by NICE in 2012 (NICE 2012a) and 
works by targeting changes to the BRAF gene present in approximately 40-50% of melanomas 
(Eiglentler et al. 2016a). Response to targeted treatments can be dramatic with visible lesions 
reducing in size within days and patients living longer compared to chemotherapy (Chapman 
et al. 2012, Long et al. 2015, Ascierto et al. 2016). However such gains come with potentially 
major side-effects that require careful management. The most challenging side-effects are 
arthralgia, myalgia and photo-sensitivity (Chapman et al. 2011, Dummer et al. 2012, Larkin et 
al. 2015, Ascierto et al. 2016). Despite this the survival benefit is usually considered to 
outweigh the burden of side-effects, and use of targeted therapies has increased. (Hauschild 
et al. 2012, McGettigan 2014, Robert et al. 2015a, Grob et al. 2015).   
 
2.5.5 IMMUNOTHERAPY 
Immunotherapy has been shown to be effective for metastatic melanoma (Hodi et al. 2010, 
Weber et al. 2015, McDermott et al. 2014, Robert et al. 2015b) but the side-effects can be life-
threatening and include diarrhoea, colitis, hepatitis, endocrinopathies as well as skin rashes 
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and fatigue (Ascierto et al. 2014). Experience within my clinical setting suggests that these 
side-effects are more severe than those reported in clinical trials (Dearden et al. 2015). Careful 
monitoring and early reporting of immune related side-effects are therefore required to avoid 
life-threatening complications (Weber at al. 2013).   
 
Newer immunotherapies cause similar problems but these tend to be less severe (Eigentler 
2016b) leading to better Health-Related Quality of Life outcome measures (Schadendorf et al. 
2016), however direct comparisons between immunotherapies have not been made. 
Combinations of immunotherapy improve survival but at a cost, with twice as many patients 
experiencing severe toxicity (Postow et al. 2015). Data on long term effects is limited but some 
such as hypothyroidism or endocrinopathies are not reversible and require ongoing treatment.  
 
2.5.6 RADIOTHERAPY 
Radiotherapy is a localised rather than systemic treatment, recommended for the control of 
local disease and local recurrence (NICE 2015). Radiotherapy is administered following the 
removal of lymph nodes for patients with stage III melanoma with the main side effect being 
lymphoedema (Sanganalmath 2016). Other side-effects that patients may experience include 
fatigue and sore skin.  
 
In metastatic disease radiotherapy may be used for symptomatic control in any site of the 





2.6 SURVIVORSHIP AND LIVING WITH AND BEYOND CANCER  
Survivorship concerns living beyond or with cancer. Patients with melanoma may achieve a 
cure or may require multiple treatments and/or experience recurrent disease but continue to 
live with their cancer under control.  Melanoma survivors may be of any age and background 
and therefore have varying needs which have historically not always been officially 
recognized, with the care pathway for all cancers including survivorship, subsequent 
treatments and palliative care (NHS Improvement 2010), not reflecting the complexity 
experienced by melanoma patients. Developments in the National Cancer Survivorship 
Initiative (Great Britain. Department of Health, Macmillan Cancer support & NHS Improvement 
2010) promoted a change in emphasis from measuring clinical activity to capturing the patient 
experience to reduce the number of people reporting unmet physical or psychological support 
needs (Great Britain. Department of Health 2011). As a result of the National Cancer 
Survivorship Initiative (2013) the Recovery Package led by Macmillan Cancer Support (2013) 
was developed focusing on ‘living with and beyond cancer’. In practice this meant that CNSs 
were mandated to carry out holistic needs assessment on all cancer patients. Within the local 
skin cancer context however, assessment tools were chosen for their brevity as CNSs were 
worried that in-depth tools that asked patients about financial difficulties, psychological 
problems, fear of dying or sexuality could cause additional worry, particularly if they had been 
cured. In-depth assessment therefore focused on patients with metastatic disease or 
additional psychological problems. The level of support available to patients taking part in the 
study was therefore unclear when it commenced.  
 
Survivorship approaches however did not always take into account the growing number of 
people living longer with metastatic disease owing to targeted treatments and 
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immunotherapies. As some of the participants in the study benefited from these new 
treatments, the supportive relationships they experienced were explored during the study.  
 
2.7 PALLIATIVE AND TERMINAL CARE  
Historically patients with metastatic melanoma entered the terminal phase of their illness, 
necessitating palliative care, in a matter of months. Newer treatments have extended the time 
that patients live with metastatic disease and the timing of the terminal phase of disease has 
become harder to predict. This has created new challenges regarding the optimal point for 
palliative care services. Prior to 2010, patients who did not respond to chemotherapy would 
enter a reasonably predictable phase of decline so referrals to local palliative care services 
were made early to ensure a smooth transition. However, early referral became difficult for 
patients who were still on treatment and not deemed to be in the terminal phase. As services 
became busier referrals were only accepted for specific, complex care needs. A change in the 
transition from treatment to palliative care therefore occurred during my data collection, the 
effects of which I needed to consider.   
 
 
2.8 THE CLINICAL PATHWAY AND LOCAL CONTEXT  
Help for a suspected melanoma involves a patient pathway comprising, at a minimum their 
GP and local dermatology department, but may also include referral to specialist services such 
as plastic surgery and oncology. Patients will therefore have a combination of the following 
people involved in their care:  
• GP for assessment of lesion and referral to hospital 
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• Dermatologist (at a local district general hospital or teaching hospital depending on 
location) for primary surgery 
• CNS for support including: teaching of self-examination, coordination of hospital visits 
and information provision (if more than one hospital is involved then patients may have 
more than one CNS) 
• Plastic Surgeon for larger skin surgery, skin grafts or lymph node surgery 
• Oncologist for surveillance, radiotherapy and systemic therapies 
• Other surgeon eg Opthalmologist if ocular melanoma, colorectal surgeon if mucosal 
melanoma, head & neck surgeon for specific surgeries 
• Palliative care specialists in the hospital or community setting for symptom control and 
complex end of life care 
• Voluntary services such as those attached to hospital or hospice care. These can 
include information, counseling, complimentary therapy or volunteer transport 
services. 
Patients therefore follow potentially diverse pathways and may have varied experiences. 
Patients within the geographical area used within this study are no exception.  The specialist 
cancer centre receives referrals from other departments as well as five surrounding district 
general hospitals and from further afield for specialist care (eg mucosal or ocular melanoma). 
Melanoma patients with early stage disease are often treated at their local hospital but may 
require referral to the teaching hospital for specialist treatment.   
 
Variation also exists within the voluntary services available depending on where patients live, 
for example some areas have voluntary driver services to help patients get to the cancer 
centre. Complementary therapies are available near the cancer centre and in some district 
20 
 
general hospitals or hospices but the level of service provision is not consistent across all 
geographical areas.  
 
Public perceptions of melanoma are also an important consideration, with the majority of 
people not really being aware of what melanoma is, nor how potentially fatal it may be. Such 
considerations also apply within cancer services. So whilst local cancer services are improving 
patient pathways and care, this applies mostly to lung, breast, colorectal and prostate cancers 
(South Yorkshire, Bassetlaw & North Derbyshire Cancer Alliance 2017). While all areas of 
cancer are anticipated to benefit from additional investment, it remains the case that resources 
and publicity are often targeted at the most common cancers. Melanoma, although no longer 
considered a rare cancer still does not receive the same attention as other cancers. For 
example, there is no melanoma specific support group.   
 
2.9 SUPPORT NEEDS 
Supporting patients with melanoma is complex as diagnosis, curative treatment and palliative 
care may be required in quick succession. Such support is currently provided by CNSs based 
in dermatology, surgery or oncology as recommended by NICE (2006a) guidance. However 
there has been very little research exploring the support needs of melanoma patients (NICE 
2006b). In a small qualitative study investigating the role of the Skin Cancer CNS McGarr 
(2008) found that the majority of time was spent with melanoma patients, who were prioritised 
over those with Basal Cell Carcinomas or Squamous Cell Carcinomas. For melanoma patients 
the CNS was seen to provide information, advice and support. However, services are 
inconsistent across the country, particularly the availability of Nurse Specialists (Melanoma 
Task Force 2011).  For example, within our locality there is no defined budget for psychological 
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services for patients with skin cancers. Patients therefore often rely on voluntary counselling 
services usually funded by charities such as Macmillan. This variation in service is unfortunate 
as having a named CNS has been shown to make a positive difference to patient outcomes 
(Great Britain. Department of Health 2012).  
 
The needs of carers of melanoma patients have received even less attention as highlighted 
by my own small study for my Master’s degree. Whilst there is growing awareness of the 
needs of carers for people with cancer, support remains limited especially in areas such as 
melanoma. For example approximately 38% of carers for patients living with cancer reported 
providing more than 30 hours of care per week which can cause physical, emotional and 
financial burden (Macmillan Cancer Support 2008) but their needs often go unrecognised. 
National initiatives such as Living With and Beyond Cancer (National Cancer Action Team 
2012) incorporating the National Survivorship Initiative (Great Britain. Department of Health, 
Macmillan Cancer support & NHS Improvement 2010) still focus primarily on the needs of the 
patient. At the time my study commenced very little work focused on carers, despite their need 
for recognition and support being great (Cancer 52 & National Cancer Survivorship Initiative 




This chapter considered the nature and treatment of melanoma so that readers can better 
understand the condition and its potential impact on patients/carers to better appreciate the 
context for my study. The following chapter considers the role that the literature and other 
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forms of prior knowledge played in shaping the initial direction of the study and the 





3 CHAPTER THREE: THE ROLE OF THE LITERATURE AND 
OTHER FORMS OF PRIOR KNOWLEDGE 
 
3.1 INTRODUCTION  
Undertaking a review of the existing literature is a widely accepted part of healthcare research. 
For Bryman (2012) it serves a number of useful purposes enabling the researcher to: 
determine what is already known about the topic, to understand what concepts/theories exist 
and what research methods have been used to study it, to identify any controversies about 
the topic, and to recognise the key contributors. Within the traditional healthcare research 
paradigm such ‘key contributors’ are generally held to be other researchers and/or the 
policy/practice literatures. Moreover, methods are often viewed hierarchically, with the 
experiment or randomised controlled trial being at the top. Other forms of knowledge are seen 
as being anecdotal/lower quality, as are many other methods. 
 
This is not necessarily the case in qualitative studies, especially those such as my own (see 
later for rationale) that adopt a constructivist approach, in which all forms of knowledge are 
equally valid (Rodwell 1998). However, the role of the literature and other extant knowledge 
in qualitative research is contested, especially in methodologies such as Grounded Theory. 
The purpose of this chapter is to explain and justify the part existing knowledge played in 
shaping the present study. 
 
The role of existing knowledge, including published literature, in Grounded Theory is not 
universally accepted. Early advocates argued that the literature should not be consulted until 
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after data collection and analysis had been completed. Glaser and Strauss (1967) warned 
against ‘forcing’ data into pre-existing categories and advised against contaminating the 
analysis, arguing that the literature should only be consulted after the theory had emerged. 
However, as Grounded Theory evolved so too did debates about the role of the literature. 
Corbin and Strauss (2008) acknowledged that “Researchers bring to the inquiry a 
considerable background in professional and disciplinary literature” (p134), and that the initial 
research question might be shaped by a variety of sources including the literature and the 
personal/professional experience of the researcher. Therefore, as no researcher can truly 
enter the field naively it is important to acknowledge anything that may have influenced the 
study. This was also recognised by Charmaz (2014) who concluded that an initial literature 
review forms part of a Constructivist Grounded Theory Study but that the purpose of this and 
its relationship to other forms of knowledge needs to be made clear.  
 
Within a constructivist study the primary role of prior knowledge is to identify ‘sensitising 
concepts’ that help to shape the initial ‘foreshadowed questions’ (Rodwell 1998) that guide the 
study at the outset. Charmaz (2012) describes sensitising concepts as a broad term that 
captures the influences that inform, but not determine, the initial direction of a study. Such 
concepts do not provide a theoretical framework that is imposed upon the data, but they may 
be drawn upon in later analysis. Sensitising concepts may be derived from the published 
literature, but also from a wide variety of other sources, including the researcher themselves 
(Charmaz 2012). As her writings exerted a considerable influence on my thinking I felt it 
essential to make clear any role that my own prior knowledge/experience played. Furthermore, 
‘reflexivity’ is now widely recognised as a key component of any constructivist study (Gentles 
et al. 2014) and a more detailed discussion of its role within this study can be found in the 
methods and discussion chapters. 
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Moreover, in the current social and healthcare context patients and carers are not seen as 
passive recipients of care but rather as active players in shaping their own experience. 
Therefore, any patient and carer knowledge that might influence the study also needs to be 
considered. It was this inclusive approach to prior knowledge that informed this study.  
The initial overview of the existing knowledge in this chapter therefore not only included the 
above sources but also the published research and professional literature. For the purposes 
of this study sources of professional and research knowledge were seen to emanate from 
published papers, textbooks, policy documents and the grey literature.  Patient and carer 
knowledge were held to come primarily from leaflets produced by healthcare organisations or 
charities concerned with their condition but other potential sources such as websites, blogs 
and online support groups were also included. A description of the way in which these sources 
were identified is provided later.  
 
Having stated my position on the definition and role of existing knowledge, attention is now 
turned to the various forms of knowledge that played a part in shaping the initial direction of 
the study, beginning with my own. 
 
3.2 SOURCES OF MY PRIOR KNOWLEDGE AND THEIR POTENTIAL INFLUENCE 
The sources of my own prior knowledge are varied and arise from both professional and 
personal experience.  Probably the most influential were those arising from my professional 
background and prior studies for two Master’s degrees. This was described briefly in the 




My knowledge of melanoma arises primarily from my experience of working with patients. This 
informed me that melanoma brings uncertainty to professionals and patients alike as it may 
behave aggressively or be relatively benign, may respond to treatment or not. Although 
patients look to healthcare professionals (HCPs) for knowledge and expertise we cannot 
always provide the definitive answers and reassurance that patients seek. In my role as a 
Research Nurse I often spent time talking to patients and carers and this led me to question 
whether their support needs are always acknowledged. Moreover from my experience 
members of the skin cancer MDT often seemed to hold pre-conceived ideas about patients 
that may influence their views on the type and amount of support required.   
 
Such emerging concerns influenced the development of my second Masters dissertation 
focussing on the support needs of melanoma patients and how these could best be met. The 
literature review preceding that study indicated that there was little prior work in this field with 
most advice being drawn from the literature on cancer generally.  
 
At the heart of the findings from my study was the core category entitled ‘Melanoma related 
worry’. This highlighted a number of the concerns of melanoma patients, particularly in the 
early stages about death and later about the possibility of recurrence.  My study suggested 
that three factors could reduce such worries. These were: 
• The extent to which patients’ concerns were acknowledged and responded to, 
especially at the pre-diagnostic stage, with a good GP being vital  
• Someone to share their worries and support them. This was most often a partner but 
a relationship with their CNS was also important  
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• Patients’ efforts to try and avoid recurrence. These revolved mainly around sun-
avoidance and self-examination. 
Building on my professional experience and my findings I increasingly realized that melanoma 
was rarely a solitary experience. Rather others, especially family members and HCPs, play a 
key role. The extent to which patients’ concerns were acknowledged and addressed seemed 
to turn largely on the quality of their relationships with others.  
 
Such themes also emerged from the published literature and played an important part in 
shaping the initial foreshadowed questions for my study. 
 
Whilst my professional experience clearly influenced my thinking, personal experiences of 
contact with the health care system, both in relation to myself and my father also played a 
part. 
 
Shortly before starting my PhD I had urgent investigations and treatment for suspected thyroid 
cancer. A partial thyroidectomy was carried out but the worst part was awaiting the results of 
the biopsy and final histology. Time seemed to stand still and days felt like months, causing 
me considerable anxiety. To minimise concern amongst family and colleagues during this 
period I played down my own fears using humour. This reinforced for me the difficulties that 




Supporting my mother caring for my father (who had a cardiac condition over a 15 year period) 
was far more protracted and further reinforced my increasing belief that the role and support 
needs of carers are not fully recognised in the current health care system.  
 
Having highlighted the part played by my own prior knowledge/experience I now consider 
sources of patient and carer knowledge. 
 
3.3 SOURCES OF PATIENT AND CARER KNOWLEDGE  
Given the active role now accorded patients, and to a lesser extent carers, within the health 
care system, I was clear that these groups should play an active part in my study. It also 
seemed likely that before I interviewed them, my participants would have been exposed to 
various forms of knowledge that may have shaped their understanding of melanoma. I 
therefore wanted to explore major sources of such knowledge for potential sensitising 
concepts.  
 
Patients and carers probably gain much of their knowledge from information leaflets provided 
by HCPs after diagnosis. Leaflets relating to melanoma from prominent UK healthcare 
organisations and charities were therefore seen as important. Newspapers are also a common 
source of information and so efforts were made to explore how melanoma is portrayed in the 
popular press. Patients also increasingly turn to the internet for advice and the popular search 
engines Google and Yahoo were searched using the term ‘melanoma’. These three searches 





3.3.1 PATIENT INFORMATION LEAFLETS 
All patient and carer information booklets produced by Cancer Research UK (CRUK), 
Macmillan Cancer Support (MCS), the British Association of Dermatologists (BAD) and 
National Health Service (NHS) Choices were included up to June 2013. Leaflets from Cancer 
Bacup, the leading provider of cancer patient information in the UK until 2008 when it merged 
with MCS, were also included. In 2011 the local teaching hospital stopped producing and 
updating its own patient information for cancer in favour of using the resources produced by 
MCS. The most prominent source of information was therefore MCS who have produced six 
separate guides for patients with melanoma. Information sources regarding other cancers, 
general effects of cancer or non-melanoma skin cancer were excluded from the search. 
Information from BAD may have been given to patients by Skin Cancer CNSs working in 
peripheral dermatology clinics. These were therefore included. Patients would most likely 
access CRUK and NHS choices information via the internet owing to their predominantly 
electronic format. These sources were therefore included in the internet search to avoid 
duplication. The main patient information leaflets/booklets included were therefore those 
produced by MCS and BAD as listed below with examples in Appendix 1.  
MCS: 
• Understanding melanoma  
• Understanding melanoma: treatment with local surgery 
• Understanding melanoma: lymph node assessment and treatment  
• Understanding melanoma: adjuvant treatments after surgery 
• Understanding melanoma that has come back in the same area 






• Stage 1 melanoma 
• Stage 2 melanoma 
• Stage 3 melanoma 
• Stage 4 melanoma 
 
3.3.2 NEWSPAPERS 
The British Newspaper Archive did not yield any results after 2000 so was not used as recent 
articles were not available.  Individual popular national newspaper archives were therefore 
searched for the term ‘melanoma’ for the previous 10 years (2003-2013) to see how melanoma 
was presented in the popular media. Publications included The Daily Mail, The Independent, 
The Guardian, The Sun and The Telegraph as these were the newspapers with the largest 
readership (Hollander 2013). Searches of individual newspaper archives using the term 
‘melanoma’ revealed articles from 1999.  The content was scanned backwards chronologically 
from the most recent in 2013 to the oldest and the decision made to stop retrieval at January 
2003 when no new information was forthcoming. Articles not relating to melanoma were 
excluded. Where the terms ‘melanoma’ and ‘skin cancer’ were used interchangeably articles 
were read carefully to determine whether melanoma or non-melanoma skin cancers were 
being referred to. Articles discussing both melanoma and non-melanoma skin cancer were 
included but those discussing non-melanoma only were excluded. Articles relating to 
melanoma were then screened to focus on those reporting the patient or carer experience. 
Those that only concerned tanning behaviour, melanoma prevalence or risk, detection 
methods, research into melanoma development or research into new treatments were 
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excluded. Data were extracted from personal accounts of having melanoma to discover 
themes relating to the experience. The Guardian, the Times, the Sun and the Telegraph did 
not have searchable archives that were free to use so articles found from the Daily Mail, the 
Independent and the Express were used as a representative sample of newspaper headlines 





Figure 3.1: Selection of Newspaper Articles  
 
3.3.3 INTERNET SEARCH 
The popular search engines Google and Yahoo were searched for information published in 
the UK between January 2003 and June 2013 mirroring the dates of the newspaper search. 
While UK versions of the search engines were used and UK sources specified in the search, 
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some international results were returned by the search engines. These were therefore 
included as patients may have accessed them. To make the search manageable, results were 
then considered for the first two pages only as the majority of internet users do not go past 
the first page (Chitika 2013, Petrescu et al. 2014). Websites rather than webpages were 
considered as the unit of analysis for extract data. All pages relating to melanoma in humans 
were included with those relating to melanoma in animals being excluded.  A description of 
the websites included can be found in Appendix 2.  
 
How these sources were analysed is considered later in this chapter. I will now consider 
professional sources of knowledge. 
 
3.4 SOURCES OF PROFESSIONAL KNOWLEDGE 
Professional knowledge was held to come primarily from the published research literature, 
textbooks and the grey/policy literature. There is no widely accepted ‘core’ text on skin 
cancer/melanoma so the National Institute for Health and Care Excellence (NICE) guidelines 
were used. These are therefore considered below. 
 
NICE published guidelines for the care of patients with skin cancer in 2006 following a review 
of the extant literature (NICE 2006a). This revealed a dearth of evidence on the needs of this 
group and a qualitative survey was therefore commissioned (NICE 2006b). The review 
identified twelve studies including one systematic review of good quality, nine observational 
studies of fair quality, one observational study of poor quality and one expert review of fair 
quality. Of these papers five focused on melanoma. Overall the quality of the evidence was 
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found to be poor, based on the presumption that RCTs provide the most robust evidence. The 
conclusion reached was that patients with skin cancers have diverse needs that differ from 
those of patients with other cancers (NICE, 2006a). However,  the needs of melanoma patients 
were not considered separately and the needs of carers were not considered at all. Reviews 
on patient information needs, the needs of patients with disfigurement, psychological 
interventions, patient satisfaction surveys, clinical trial participation, protocol driven care and 
palliative and supportive care were undertaken separately, reflecting how HCPs view patients’ 
needs individually rather than holistically.  
 
As the above review represented a comprehensive consideration of the, admittedly limited, 
literature up until 2006 I only considered work after that date until the start of the study (June 
2013). Separate searches were performed to find papers published on 1) the experience and 
needs of patients with melanoma 2) the experience and needs of the carers of patients with 
melanoma. Details of the databases and search terms used can be found in Appendix 3.  
 
Studies identified were then screened via the title and those that appeared to meet the criteria 
detailed in Appendix 4 were screened via the abstract. Full text versions of the relevant studies 
were retrieved to ascertain whether they met the requirements of the review.  As this was not 
intended to be a systematic review but rather a broad conceptual overview of the main ideas 
about melanoma, influential studies were not excluded on the basis of ‘quality’ using tools 
such as the Critical Appraisal Skills Programme checklists (CASP 2017). The selection of 
papers can be seen in Figure 3.2.  
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Figure 3.2: Selection of professional papers 
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As indicated in the figure above, on completion of the search and application of the selection 
criteria 55 papers were included in the review. A table of study characteristics can be found in 
Appendix 5.  
 
The majority of the studies were descriptive rather than testing an intervention or determining 
causality. Most used a cross-sectional survey design where measurement tools were self-
completed by respondents. Fifty-eight separate tools were identified, including measures of 
HRQOL, cancer symptoms, melanoma specific measures, psychological coping or distress 
and information need.  The literature reviews included in the review also heavily relied on 
these measurement tools to capture patient outcomes. The quality of the measurement tools 
varied with some being validated in international melanoma populations (such as the FACT-
M) to those that had not been validated in a melanoma population. Some of the original 
versions had been modified but not subsequently tested for internal consistency, others had 
been translated but not validated with the target population. Such issues limit the interpretation 
of the results of these studies.  
 
Five qualitative studies provided the most detailed first-hand accounts of the experience of 
melanoma. Two papers based on the same study of perceptions of GP-led follow-up in 
Scotland considered patients’ perspectives (Murchie et al. 2010) as well as those of GPs 
(Murchie et al. 2009).  The third paper explored the risk perceptions and coping mechanisms 
of a high risk population after surgery for melanoma in Australia (McLoone et al. 2012). The 
fourth explored the experience of carers of cancer patients in France, but included 17 
melanoma patients (Mancini et al. 2011) and the fifth explored the impact of non-metastatic 
melanoma on QOL in a British population (Burdon-Jones et al. 2010).   
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Overall the extant research literature when the study commenced was mainly limited to 
deductive approaches reducing the patient experience to quantifiable data to enable 
comparison between groups.  Whilst this indicated the symptoms patients experience and the 
efficacy of interventions, it does not necessarily reflect the issues that are most important to 
patients and carers as all the measures used were designed by researchers.  
 
Grey literature included NICE guidance and evidence review (NICE 2006a, NICE 2006b) and 
an unpublished dissertation (McGarr 2008). The NICE guidance and evidence review has 
been described earlier in the chapter. The dissertation (McGarr 2008) was a small qualitative 
study involving 11 Skin Cancer CNSs that explored their perspectives of their role. The study 
included a literature review on the needs of skin cancer patients concluding that despite 
differences to other cancers, patients diagnosed with skin cancer experience similar emotional 
and psychological responses to their diagnosis as patients with other cancers and have similar 
needs. 
 
The searches of professional sources of knowledge also revealed two patient accounts of 
melanoma. One was a first person account of having melanoma written by a nurse (Griffin 
2011) and the other was a book about melanoma published by a patient (Welsh 2011). Sally 
Welsh (2011) used her own experiences of melanoma to produce ‘A Melanoma Patient’s 
Survival Guide’. 
 
3.5 ANALYSIS AND SYNTHESIS 
Thematic analysis of all sources retrieved was undertaken. Each source of information was 
read and re-read while notes were taken to identify themes. The patient information booklets 
available at the time focussed primarily on disease/treatment so did not greatly influence 
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themes related to the patient and carer experience. Web searches and a link written in a 
newspaper article led to first-person accounts of melanoma on the internet. These included 
written accounts, such as an American photographer who took daily photographs of his life 
including his diagnosis and treatment for melanoma and a video diary of an American man 
and his wife as he is treated for melanoma. The purpose of the photographs was artistic, but 
the purpose of the video diary was to warn people about the dangers of tanning. In examining 
the photographs I took notes on their meaning as I looked through them, recording what they 
seemed to represent.  As I watched the videos I also took notes about what was being shown 
and its meaning. Some videos or sections were re-watched when I felt I needed to check my 
interpretation.  
 
Following detailed reading/viewing initial themes were identified from these patient accounts 
and synthesised with those emerging from my own personal/professional knowledge. In 
combination these indicated that:  
• Melanoma is a source of considerable worry/concern that patients want to be 
recognised and responded to.  
• Such concerns relate primarily to fear of death, especially in the earlier stages and 
later to fear of recurrence. My own brush with cancer highlighted how difficult it can be 
to share concerns without ‘burdening’ those close to you. 
•  The desire to share concerns highlighted the importance of close and supportive 
relationships, often with a partner or other family member but also with a trusted health 
care professional. 
• Both my professional and personal experience strongly suggested that living with 
melanoma (or other health related worry) is rarely an individual experience but that it 
involves and impacts on others, especially family members. The extent to which family 
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members for people with melanoma can be seen as ‘carers’ in the more widely 
accepted sense has not been explored and their needs had, to date, received little 
attention. 
• Melanoma is likely to result in behavioural change by the patient, such as sun 
avoidance and/or self-examination. 
 
Newspaper articles, while sometimes based on patient reports, were stylised to fit the agenda 
of the journalists (to sell news) often resulting in sensationalised, emotive accounts. Websites 
also tended to be written for specific purposes including disease information and fundraising. 
However, when sources were considered together clear themes emerged. These related 
primarily to:  
• Not knowing about the dangers of tanning  
• Wanting to warn others about melanoma and the dangers of sun exposure 
• Avoiding sun exposure and using preventative measures 
• The value of supportive relationships 
• The effects on the family 
• Feeling lucky having survived melanoma 
• Worrying about the melanoma coming back 
• Financial issues following a diagnosis of melanoma 
 
There were notable temporal variations within the newspaper searches in that during 2006 
and prior to that the articles talked about skin cancer and did not differentiate between sub-
types. After 2006, however, melanoma was specifically mentioned with it being referred to as 
‘the most deadly/aggressive form of skin cancer’. This change in public or journalistic 
perception of the disease coincided with the discovery of new treatments for melanoma, so 
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may have arisen from research related publicity, pharmaceutical publicity and/or a public need 
to differentiate skin cancers owing to treatment changes. 
 
Analysis of the research and grey literature revealed several themes. These were identified 
as: QOL, psychological wellbeing, gender, sun avoidance, supportive relationships, 
information and education, financial issues, and support services.  
An overview of how these were described in the research literature is provided below. Rather 
than describe individual studies in detail the ways in which each of these themes was 
‘represented’ in the research literature is the primary focus here. 
 
Following analysis of all three forms of prior knowledge (my own personal/professional, patient 
and carer sources and the research literature) the themes emerging were then synthesised 
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Figure 3.3: Development of themes from the existing knowledge  
 
Each of these major themes is now described below. 
 
3.5.1 QUALITY OF LIFE  
‘Quality of life’ (QOL) or ‘Health Related Quality of Life’ (HRQOL) are terms that appeared in 
numerous studies concerning the impact of disease and illness and/or their treatment. More 
often than not these concepts are captured using measures devised primarily by researchers 
and intended to provide a summary score that can be used in complex multi-variate analyses. 
This was certainly the case in the research literature relating to melanoma with such measures 
being used extensively to provide an indication of, for example, the value of additional life 
added by new treatments or the relative cost of those treatments. Almost 60 different 
instruments were found in the studies I identified exploring varying dimensions of ‘Quality of 
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Life’ such as: physical functioning, mental functioning, anxiety, depression, as well as 
melanoma-specific symptoms or behaviours. These were often used to compare a group of 
melanoma patients to a ‘normal’ population or other cancer patients. There are numerous 
problems associated with such an approach. The most obvious of these limitations is that 
many of these instruments have not been validated with melanoma patients and therefore 
may not be sensitive enough to detect changes specific to melanoma (Cornish et al. 2009). A 
more fundamental question might be ‘do quantitative measures devised by researchers 
actually capture the impact of melanoma as experienced by patients themselves?’  
 
Notwithstanding these limitations studies suggest that melanoma does impact on patients’ 
QOL in varying ways at differing points in time. Al-Shakhli et al. (2006) found that patients’ 
QOL was reduced during the diagnostic period but others found that this impact was not 
sustained over time (Schubert-Fritschle et al. 2013). Indeed, in some cases melanoma 
patients had better QOL ‘scores’ than the general population (Holterhues et al. 2011, Zucca 
et al. 2012, Noorda et al. 2007). 
 
These findings of improved QOL reflected patient accounts of melanoma found in the 
newspaper reports, first-hand accounts on websites and in books written by melanoma 
survivors. Having one’s mortality threatened through a melanoma diagnosis but surviving 
appears to give people a new appreciation for life. Sally Welsh (2011) states that:  
“Beautiful things happen in the minds, hearts and bodies of melanoma patients. Priorities 
change. Words that might never have been spoken are suddenly spoken. Faith grows. Beauty 
that was unseen is now seen. Lived life can become life lived abundantly!!” (P1)  
        
However in metastatic disease QOL can change dramatically. For instance, Cashin et al. 
(2008) found that patients’ condition deteriorated quickly in almost all areas of QOL.  The full 
emotional impact of this has not been systematically studied but website entries such as the 
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video diary of Eric Sizemore (Sizemore 2011) illustrates his dramatic physical deterioration 
over time. Most studies of QOL have focussed on the patient but the video diary of Eric 
Sizemore was filmed by his wife and reveals the physical and emotional effects on her. 
 
It is clear therefore that living with melanoma is likely to impact on QOL, although this may 
change over time and perceived QOL can improve when treatment is successful. However, 
such studies have been largely quantitative and often instruments not designed to assess 
QOL in melanoma. There have been very few qualitative studies on patients’ QOL nor has the 
experience of carers been explored. 
 
A closely related concept in the research literature was psychosocial wellbeing. 
 
3.5.2 PSYCHOSOCIAL WELLBEING 
As with QOL several areas of psychosocial wellbeing can be impacted by melanoma in 
differing ways over time, such as anxiety and depression, especially around the time of 
diagnosis.  Indeed the initial appointment may cause more anxiety than awaiting the results 
(Al-Shakhli et al. 2006). In a review of the research literature, Kasparian et al. (2013a) found 
the diagnostic period to be the most stressful time of all with patients expressing fears about 
death and suffering, as well as concerns about the emotional well-being of significant others 
such as family and friends.  This is reflected in patient accounts.  For example Rebecca Smith 
(2012) was 'consumed by anxiety' worrying that she would not live to see her daughter's 
wedding the following year and Sally Welsh (2011) described her diagnosis as ‘grief upon 
grief’.  
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 Kasparian et al. (2012a, 2009) found that melanoma has significant emotional, social, and 
psychological consequences, particularly anxiety and depression, with women (Vurnek et al. 
2008) or younger patients with lower education, unemployment and limited social support, 
being most at risk (Kasparian et al. 2012a, 2009). Poor psychological well-being is 
compounded for those with greater physical deterioration; negative cognitive appraisals of 
melanoma, passive or avoidant coping styles, and a lack of confidence in one's ability to cope 
(Kasparian et al. 2012a, 2009). 
 
Body image is another area of concern, but again varies, for example by personality type with 
Lichtenthal et al. (2005) finding that patients with compulsive personality characteristics 
express more concern, as do women and those with more histrionic personality features.  
 
Whilst the time around diagnosis appears a particularly stressful period anxiety often reduces 
upon diagnosis (Al-Shakhli et al. 2006) as many patients experience a process of adjustment 
(Murchie et al. 2010, Bird 2011). However such findings are not universal and Hamama-Raz 
et al. (2007) found that neither the stage of the cancer at diagnosis nor time since diagnosis 
predict either well-being or distress, with the impact of such being contested. However, fear 
of recurrence or metastatic disease can last for years after treatment is completed (Kasparian 
et al. 2012b, McLoone et al. 2012) with uncertainty about the future being an on-going concern 
(White et al. 2012), irrespective of the actual risk (McLoone et al. 2012, McLoone et al. 2011).  
 
However, in response to this uncertainty some melanoma patients can develop a more 
positive outlook on life (Oliveria et al. 2013) by making the most of the time they have, 
spending more time with family and doing the things they enjoy (Bird 2011). When compared 
to patients with other skin cancers those with melanoma seem significantly more likely to 
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mention a sense of relief ⁄gratitude following treatment and ⁄or a commitment to enjoy life more 
(Burdon-Jones et al. 2010), for example being grateful to watch their daughters grow up 
(Bucay 2007).  
 
Feelings of psychological distress are likely to extend to carers and families but this was not 
considered in the literature.   
 
Given the potential emotional impact of melanoma the literature indicates that many patients 
would like more emotional support (McLoone et al. 2012, Kasparian et al. 2009) but that this 
is not always provided (McLoone et al. 2012). Ironically patients with other dermatological 
conditions are more likely to be referred for psychological support than those with melanoma, 
even though melanoma has a far greater impact (Korner & Fritzsche 2012). This is despite 
the fact that interventions such as education, behavioural/skills training, social support and 
psychotherapy appear to improve psychosocial outcomes for melanoma patients (Kasparian 
et al. 2013a). However, to date studies have only targeted patients with a high risk of 
recurrence.  
 
As with QOL it seems that melanoma can have a negative impact on psychological well-being 
but that this may vary depending on factors such as coping styles or personality traits, as well 
as gender or age. Furthermore, any negative impact may vary over time, decreasing in those 
who are successfully treated, although fear of relapse and/or metastatic disease may last for 
several years.  However, the impact of melanoma need not be negative with some patients 
appearing to reappraise their priorities and take a different outlook on life. Again the research 
on QOL studies exploring psychological well-being have been nearly all quantitative.  
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Another area in which melanoma may have an impact is on the patient’s financial situation. 
 
3.5.3 FINANCIAL SITUATION 
Melanoma patients may experience financial problems that can vary by age.  Economic 
concerns appear far more prominent amongst younger melanoma survivors, whose ability to 
work may be affected (Oliveria et al. 2013). Irrespective of their employment situation patients 
reported difficulty in obtaining health insurance/life insurance (Holterhues et al. 2011, Oliveria 
et al. 2013), travel insurance (McArdle 2012), disability insurance or mortgages (Holterhues 
et al. 2011). For instance, McArdle (2012) found that 7 of 10 leading insurance companies 
would decline an application for insurance within 5 years of diagnosis, after 5 years patients 
faced an increased premium.  
 
With a range of potential problems facing melanoma patients it is important to consider what 
support can be most helpful. The provision of education/information is one of the most 
frequently cited in the literature. 
 
3.5.4 INFORMATION & EDUCATION 
The literature clearly indicates that melanoma patients value information (Constantinidou et 
al. 2009) but frequently do not get as much as they want (Al-Shakhli et al. 2006, Husson et al. 
2010. Hetz & Tomasone 2012, Schlesinger-Raab et al. 2010), especially those with metastatic 
disease (Passalacqua et al. 2012, White et al. 2012). Husson et al. (2010) suggest that patient-
tailored information can improve satisfaction but recognise that time and resources may be 
barriers to this.  
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In a literature review Rychetnik et al. (2013) found the main sources of information patients 
use are: doctors, nurses and books/magazines. HCPs are therefore the primary source of 
information for patients and my own personal experience and observations suggest that the 
CNS has a central role to play in this regard.   
 
The Internet is also increasingly used as an important source of information with Ludgate et 
al. (2011) finding that the majority of skin cancer patients see using the Internet as a positive 
experience yet were wary of some content on the available websites, with a third of melanoma 
patients experiencing anxiety as a result of their Internet search. My own search revealed that 
the majority of information for melanoma patients is produced by charities or healthcare 
organisations and written by HCPs for patients, carers and the public. The information 
booklets produced by MCS (2011a, 2011b, 2011c, 2011d, 2011e, 2011f) and CRUK (2012a, 
2012b) have the most detail about melanoma and its treatment.  
 
However, simply providing written information may not be enough. From my experience of 
talking to patients about melanoma, particularly during my Masters dissertation, I found that 
patients needed help to relate any information to their own circumstances. This is important 
as some groups of melanoma patients may have greater information needs than others. For 
example, individuals without secondary education were found to have greater information 
needs but were paradoxically less able to ask questions of their medical team (Hetz & 
Tomasone 2012). Husson et al. (2010) also discovered an association between level of 
education and satisfaction with the information provided. The need for information may also 
vary dependent on the stage of disease or risk of recurrence (McLoone et al. 2011, Husson 
et al. 2010) with patients who have later stage disease or low risk of recurrence being more 
satisfied with information provision. Gender may also be a factor with Clarke et al. (2006) 
   
  48 
concluding that men are more likely to access written information whereas women prefer oral 
sources providing they have faith in the provider (Passalacqua et al. 2012).   
 
Content of information may also be important. From my analysis of websites containing patient 
stories of melanoma tended to be cautionary in nature, as were some of those generated by 
various charities. For example while the American Cancer Society (2008, 2011, 2013) devotes 
one section of it’s website to stories of hope, the content predominantly focuses on warnings 
to people who might develop melanoma. Newspaper articles also contain predominantly 
‘warning messages’. Messages of encouragement, survival and feeling lucky or thankful are 
secondary.  It therefore appears that much of the information potentially available to 
melanoma patients says relatively little about how to live with the condition other than 
avoidance or the prevention of recurrence and that an ‘information gap’ about living positively 
with melanoma exists.   
 
On the basis of my reviews it therefore seems that: 
• Many melanoma patients have a high need for information that is not always met 
• There is an informational gap about the experience of having and living with melanoma 
• Subgroups may have additional information needs and those with lower educational 
levels are potentially less well served 
• Men and women may have differing information needs  
 
As noted above information is often obtained from HCPs and access to these and other forms 
of support is also an important consideration.   
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3.5.5 SUPPORT SERVICE USE 
Access to support services is likely to vary at differing times. The diagnostic period can be a 
particularly stressful one but this may not run smoothly. Many patients describe experiences 
of missed diagnosis and being told that a mole or lesion was ‘nothing to worry about’ only for 
it to later be diagnosed as malignant. Others describe having to make repeated visits to their 
GP, of not being taken seriously and of having to ‘insist’ on a referral for specialist opinion.  
This was a major finding in my MSc dissertation (Bird 2011) where the initial contact with GPs 
was pivotal to subsequent trust in the system more generally. 
 
On-going treatment often necessitates contact with several differing HCPs, including 
dermatologists, primary care providers and nurse practitioners (Bowen et al. 2012). In clinical 
practice I have observed CNSs, oncologists and plastic surgeons performing clinical 
examinations. Such visits can in themselves cause anxiety if there are concerns about 
recurrence (Oliveria et al. 2013) but may also be viewed positively if they allow patients to feel 
in greater control of their situation (McLoone et al. 2012). Location of follow-up may also be 
important with logistical difficulties such as transport inhibiting attendance (Rychetnik et al. 
2013). Conversely GP-led melanoma follow-up is more convenient for some, especially if they 
perceive their appointment to be less rushed, the atmosphere to be more pleasant and having 
better continuity of care (Murchie et al. 2010).  
 
Continuity of care enables a trusting relationship to be built between the patient and HCP. 
Hamama-Raz & Solomon (2006) found that melanoma survivors at high risk of recurrence 
particularly valued ‘expert care’ that was readily accessible and delivered with continuity.  
Expertise of the person conducting an examination is important, particularly if patients have 
lost trust in a HCP (Oliveria et al. 2013, McLoone et al. 2013), with trust appearing to vary by 
the type of practitioner. For example, Murchie et al. (2010) found that some patients are 
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concerned that most GPs have less experience of melanoma than hospital specialists but also 
worried about the expertise of junior doctors who were perceived to have poor knowledge. 
Rychetnik et al. (2013) suggests that perception of expertise is a social construction, often 
based on the nature and quality of the relationship between patient and HCP. 
 
Given the psychological impact of melanoma best practice should include protocols for the 
management of depression and anxiety, including referral to psychosocial specialists as 
appropriate (Hamama-Raz & Solomon 2006). However, as noted previously there is much 
room for improvement, with McLoone et al. (2012) finding that no patients in their study 
received professional emotional support.  Similarly, the review conducted by Schlesinger-
Raab et al. (2010) found that almost half of all study participants indicated that their doctors 
did not ask about their ability to cope with their disease.  
 
Melanoma patients appear to access the majority of professional support during routine follow-
up appointments rather than from additional support services. Winzer et al. (2009) found that 
patients who were younger, male and who had no partner were more interested in accessing 
a specialist support programme. There may therefore be specific sub-groups with limited pre-
existing social support who would benefit from support services.  
 
Studies exploring what HCPs think about providing support are very limited with a small 
qualitative study of nine CNSs by McGarr (2008) finding that they saw the provision of 
information and support as being a major part of their role and was something that patients 
valued. No other studies relating to melanoma could be found. 
 
   
  51 
From a consideration of the literature on access to professional support it appears that:  
• Support provision may not match patient need and that the limited amount provided is 
available later in the trajectory but a great deal of anxiety is experienced during 
diagnosis 
• The majority of support for melanoma patients is given during surveillance visits 
making continuity of care important 
• The relationship between the patients and HCP is key to enabling patients to voice 
their concerns 
• Different types of support may be appropriate for differing groups of melanoma patients  
• There appears to be no literature regarding the support needs of carers 
 
Despite the availability of formal support much of the help that melanoma patients receive 
comes from their close relationships 
 
 
3.5.6 SUPPORTIVE RELATIONSHIPS 
Social support within close relationships is the most frequently used coping strategy amongst 
people with melanoma (Lehto et al. 2005, Mancini et al. 2011). Such relationships are often 
with family members, especially partners, but can also come from the patient’s wider social 
network or HCPs (Lehto et al. 2005). Gender differences in the source of social support have 
been found with women being significantly more likely to be supported by their friends, and 
men by their close family (Schlesinger-Raab et al. 2010). Older patients have been found to 
receive less support than younger ones (Lehto et al. 2005) suggesting that there may be 
groups of melanoma patients with unmet needs. 
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Given the importance of supportive relationships it is surprising that the needs of carers are 
not considered in the research literature, despite the significant feelings of grief and loss that 
are described in the press upon the death of a patient (Sizemore 2011). Moreover carers may 
also have to support other family members such as children, something that often causes 
additional stress (Griffin 2011).  
 
Faith is another source of support for some patients and carers and a diagnosis of melanoma 
may strengthen a person’s relationship with their religion or spiritual beliefs. But again this is 
not considered in the research literature with accounts being confined largely to the popular 
press (Sizemore 2011, Welsh 2011). 
 
Despite the importance of close supportive relationships being widely recognised, the nature 
of such relationships and the impact that melanoma has upon them has not been widely 
studied. 
 
3.5.7 GENDER RELATED DIFFERENCES IN EXPERIENCING MELANOMA 
As noted in a number of the themes above, gender appears to influence the ways in which 
people experience melanoma. However the impact of gender reported within the research 
literature varies depending upon the measures used. For example Ludgate et al. (2011) found 
no correlation between levels of anxiety and gender at initial consultation whereas Lehto et al. 
(2005) found that newly diagnosed females reported greater psychological symptoms and 
depression than males. Later in the disease trajectory Hamama-Raz (2012) found that distress 
was significantly higher among female than male melanoma survivors although Vurnek et al. 
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(2008) found no differences between men and women in QOL or coping styles. Amongst 
patients with advanced melanoma women want significantly more involvement in treatment 
decisions, clearer information, and more dialogue with HCPs (Passalacqua et al. 2012).  
 
The nature and extent of gender differences are therefore inconsistent but on balance 
melanoma appears to have a more negative impact on women than men. Differences between 
men and women may not be specific to melanoma patients as White et al. (2012) studied a 
number of cancers and found that overall women had greater concerns than men about: the 
cancer returning, the cancer spreading, the impact of cancer on those closest to them, their 
lack of energy and tiredness, and not being able to do the things they used to do. 
 
Gender differences in behavioural responses to melanoma are just as unclear, with Korner et 
al. (2013) finding no differences in self skin examination (SSE) and sun avoidance behaviour 
whereas Manne & Lessin (2006) reported that men were less likely to engage in SSE, sun 
avoidance or use sun protection. The reasons for this were not explored but newspaper 
articles suggest that this might be due to the ‘macho’ attitude of men. Holterhues et al. (2011) 
found that women were more worried about the effects of sunlight on both their skin and on 
their spouses and children and so sought shade and/or used sunscreen more often than men. 
These findings suggest gender differences related to anxiety, perceived risk or a greater 
concern with body image and appearance (Lichtenthal et al. 2005).  
 
The literature also suggests that there may be gender differences in how people seek 
information and support. Women have been found to be more likely than men to use the 
Internet to search for information about their diagnosis (Ludgate et al. 2011) while a different 
study found that men had significantly more interest in a support programme than women 
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(Winzer et al. 2009). It may be that women have social networks in place to assist coping 
whereas men rely more on support groups. Women express a greater willingness to talk to 
family members, other cancer patients, nurses or non-medical staff (Schlesinger-Raab et al. 
2010). This may be because women feel more comfortable discussing their emotions with 
their wider social network than men, who tend to rely more on close family members 
(Schlesinger-Raab et al. 2010). My own study found that there may also be gender differences 
in people’s preference for the gender of the HCP that they develop relationships with, one 
man stating that he could not ‘pour his heart out to a woman’ (Bird 2011). This may be because 
men tend to rely more on their own resources with some studies suggesting that men see 
themselves as being better able to cope than women (Hamama-Raz 2012). 
 
For women of childbearing age, a melanoma diagnosis can have very specific effects 
regarding family planning. Some women decide not to get pregnant because they have been 
informed that hormones may accelerate melanoma development or they are worried about 
passing the risk of melanoma to their children (Oliveria et al. 2013). This concern was 
expressed in the popular press.   
 
Therefore whilst the picture that emerges varies it seems that gender does exert an influence 
on the experience of melanoma in respect of 
• The degree of anxiety or worry reported  
• Behavioural changes with regard to sun avoidance and protection 
• Perceptions and use of social support networks  
• Women of childbearing age experience specific decisions regarding family planning 
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3.5.8 BEHAVIOURAL RESPONSES TO MELANOMA: PREVENTION 
The most commonly reported behavioural responses to a diagnosis of melanoma relate to 
SSE, sun avoidance and/or protection. Reports are especially prevalent in newspaper articles 
and patient accounts on the internet which all warn of the dangers of sun exposure and many 
include statements about sun protection measures (Sizemore 2011, David Cornfield 
Melanoma Fund 2011). 189 newspaper articles, excluding those detailing personal accounts 
of melanoma, were found to relate to sun protection and the dangers of tanning often using 
emotive headlines such as “My TOWIE tan gave me skin cancer!” (Satherley 2011) and 
“Sunbeds almost wrecked my face” (Donnelly 2012).  
  
Within the research literature a diagnosis of melanoma is portrayed as a ‘teachable’ moment 
where patients could improve sun protection and SSE habits owing to increased perception 
of risk and distress (Manne & Lessin 2006) with melanoma survivors becoming more aware 
of sun avoidance and protection measures (Burdon-Jones et al. 2010, McLoone et al. 2012, 
Oliveria et al. 2013). However, the frequency of SSE has been found to increase only with 
perceived benefit and not perceived risk or skin cancer-worry (Kasparian et al. 2012a). 
Different patient subgroups seem to have varied knowledge, readiness for change, and 
receptiveness to medical advice regarding SSE, suggesting that an individual’s psychosocial 
characteristics need to be considered (Korner et al. 2013). My dissertation project (Bird 2011, 
Bird et al. 2015) found that some patients perform SSE for reassurance to mitigate melanoma 
related worry. Others have also found that worry about sun exposure can lead to lifestyle 
changes in some melanoma patients that may affect their daily activities and choice of leisure 
pursuits or holidays (McLoone et al. 2012, Mols et al. 2010). While the majority of melanoma 
patients continue outdoor activities while using sun protection measures, being outdoors 
without sun protection can be a cause of anxiety (Oliveria et al. 2013, Mcloone et al. 2012). 
This is not the case for all melanoma survivors though as the use of specific sun protection 
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behaviours within the melanoma population has been shown to vary. For example, Bowen et 
al. (2012) found that 59% wore long-sleeved shirts, 80% wore long trousers or skirts, 45% 
used sunscreen with SPF 15+, 35% wore something to cover their head, 16% wore a wide 
brimmed hat, 46% wore sunglasses, 36% stayed in the shade and 20% avoided peak hours 
of sun. However in one study of patients with primary melanoma in the USA, SSE and the use 
of sun protection measures (with the exception of sunscreen use) was not greater than that of 
the general population (Mujumdar et al. 2009). There are therefore groups of melanoma 
patients with differing needs relating to sun protection.  
 
Once again women are more likely to worry about sun exposure than men (Holterhues et al. 
2011) and are more likely to engage in sun protection activities such as seeking shade, 
wearing sunscreen, having fewer holidays to sunny destinations and wearing long sleeves 
and trousers (Holterhues et al. 2011 Bowen et al. 2012). However, men report nearly seven 
times more usage of hats, caps or scarves than women (Bowen et al. 2012). 
 
The effect of the diagnosis on the families of melanoma patients may depend not only upon 
patient factors, but also the perceptions of individual family members and the interactions 
between patients and their families. Women have been reported to be more worried about 
their spouses and children being exposed to the sun than men (Holterhues et al. 2011) and 
caregivers of melanoma patients have reported a decrease in their own sun-related activities 
(Mancini et al. 2011). During my MSc dissertation some patients discussed their families 
adopting sun protection behaviours but this was not explored with carers themselves who 
were not part of the study (Bird 2011).  
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The professional literature strongly promotes patient education although this is not always 
applied in practice, which may partially explain why not all melanoma patients adopt 
preventive behaviours. Within my clinical experience medical consultations are short and do 
not leave much time for discussion about sun protection behaviours. The focus of surveillance 
visits is to detect new or recurrent melanoma and discussion about sun protection may not 
occur. Where discussion does occur it varies depending on professional background; with 
dermatologists holding differing views on sun protection to oncologists, plastic surgeons or 
CNSs.  
 
The literature suggests that the increased use of sun protection and SSE may be driven by a 
combination of the perception of risk held by patients, carers and HCPs. Better understanding 
of the social processes involved in patient education and how perceived information is 
translated into behaviour is therefore needed, as is awareness of individual differences in 
response to melanoma. Some patients may experience excessive anxiety related to sun 
exposure whereas others may not engage in consistent sun protection behaviour. A balance 
needs to be struck to ensure that patients understand the risks related to sun exposure but do 
not worry excessively. Gender differences again emerge with women being more likely to 
engage in sun protection behaviours than men, although men are more likely to protect their 
head. As with most aspects of melanoma the impact on the behaviour of carers has not been 
widely explored.   
 
3.6 IDENTIFYING THE SENSITISING CONCEPTS AND FORESHADOWED QUESTIONS 
Despite variations in terminology, there was a strong element of overlap and consistency 
between the main themes emerging from my personal/professional experience, patient and 
carer knowledge and the varying forms of knowledge that professionals might draw upon. In 
seeking to develop a succinct overview that brought these various themes together it 
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appeared that they could be conceptualised as falling into a number of thematic categories 
that might serve as sensitising concepts, as outlined below: 
• One relates to the potential impact that melanoma has over time on various aspects 
of the patient’s life such as: QOL, psychological well-being, worry/concern and 
financial implications. Such an impact is generally described in negative terms. 
However, many of these concepts such as QOL and psychological well-being have, to 
date, been largely professionally defined and explored primarily with patients rather 
than patients and carers. There is clearly a need for further work that considers the 
impact of melanoma on both patients and carers, over time, and that focuses on their 
perceptions and experiences rather than the use of standardised measures 
• Another relates to factors that might, in some way, improve the patient experience, 
such as supportive relationships, information and education and the use of formal 
services. Once again most of the work to date has focussed only on the patient 
experience with little attention having been given to carers. Nor has there been prior 
work that has explored what HCPs see as their role in supporting patients/carers. 
Another factor that might in some way differentiate the patient experience is that of 
gender. Whilst statistical differences may have emerged from prior work few studies 
have sought to explore qualitative differences between genders. 
• The third sensitising concept to emerge suggests that melanoma patients might take 
action themselves in response to melanoma. This emerged strongly from all three 
forms of knowledge and to date the focus has been on behaviours such as sun 
avoidance and self-examination. These are important but there may well be other 
changes that both patients and carers might make as a result of melanoma. This is an 
area worthy of further exploration.  
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The above three areas were the primary sensitising concepts that emerged from my 
consideration of existing forms of knowledge and these clearly influenced the foreshadowed 
questions as outlined below.  
 
From the outset my primary aim in undertaking this study was to explore the changing 
experiences and support needs of patients with melanoma and their carers throughout the 
disease trajectory. By doing so I hoped not only to add to our understanding but also to 
generate insights that had the potential to improve the melanoma experience especially, but 
not exclusively, by informing professional practice. In addition to the sensitising concepts 
described above two other overarching concepts lie at the heart of the study.  
• Firstly that the experience of melanoma cannot be considered as a solitary one and 
that the nature of interactions and relationships with others, especially family members 
and trusted HCPs, is central to a full understanding.  
• Secondly that the melanoma experience is a temporal one, likely to change over time 
and that these changes may not coincide with traditional medical/professionally 
defined pathways. It was therefore considered essential that my study actively involved 
patients, carers and HCPs and that it followed their experiences over time.  
These two factors, together with my desire to generate insights that had potential practical 
application strongly influenced my methodological decisions, as will be highlighted in the next 
chapter. Building on all of the above the foreshadowed questions outlined below formed the 
initial direction for my study that will explore these questions from the point of view of all 
parties. 
• How do patients and carers experience melanoma, and what impact does it have on 
various aspects of their lives such as QOL, psychological well-being, their worries and 
concerns and their financial situation? 
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• Do these experiences and impacts vary over time? 
• Do patients and carers make changes to their lives as a result of melanoma?  
• Are patient and carer experiences and impacts influenced by factors such as gender, 
information and education, the nature of supportive relationships and the support 
services accessed? What are their experiences of the latter? 
• Do the experiences and perceptions of patients, carers and health care professionals 
vary? 




This chapter has considered how my personal and professional experience motivated me to 
explore the experience of patients with melanoma and their carers, particularly relating to: 
• Melanoma related worry 
•  Supportive relationships 
• The impact on family members  
• Behavioural change after a diagnosis of melanoma 
Information from patient and public sources then revealed the following themes about the 
experience of having melanoma: 
• Patients and their family felt that they did not know enough about melanoma and 
wanted to warn others about the dangers of sun exposure 
• They also valued supportive relationships 
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• Melanoma survivors felt lucky that the melanoma had been removed but worried about 
it coming back and may start using preventative measures 
• Patients may also experience financial difficulties as a result of their diagnosis and 
treatment 
 
Examination of professional literature revealed further themes related to QOL, 
information/education, gender related differences, psychological well-being, support service 
use and HCP-specific issues.  
 
In combination these three sources of knowledge served to identify the sensitising concepts 
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This chapter begins by describing how and why I came to choose Constructivist Grounded 
Theory Methods to explore the experience and support needs of melanoma patients and their 
carers, and considers this decision in the context of the study aims. It goes on to provide 
details of the study design and how it was conducted including reflections on ethical issues, 
rigour and reflexivity. 
 
The preceding chapter described how the sensitising concepts and foreshadowed questions 
emerged and identified the relative lack of attention currently given to:   
• The potential impact of melanoma over time on various aspects of patients’ and carers’ 
lives 
• The actions that melanoma patients/carers might take in response to this condition 
• Factors that might, in some way, improve the patient/carer experience: especially in 
relation to supportive relationships, information and education, and the use of formal 
services 
• The role of HCPs in the melanoma journey 
As already noted a key motivation in my intent to explore such issues was my desire to 
generate new insights that would reflect multiple perspectives and have the potential for 
practical application.  
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Having identified the need for further study, a key question then concerned how best to 
address the issues identified above.   
 
4.2 PLANNING THE STUDY  
 
4.2.1 THE NEED FOR A QUALITATIVE APPROACH 
My consideration of the existing knowledge about melanoma drew attention to gaps in 
understanding about the experiences and support needs of melanoma patients and their 
carers. The existence of such gaps, and the over reliance on quantitative approaches within 
most previous studies, suggested that a qualitative methodology would be beneficial. 
Reaching this conclusion was helpful but still left several decisions to be made, for as Ormston 
et al. (2013) note qualitative methods comprise a very ‘broad church’.  Despite this Denzin 
and Lincoln (2011) identify several shared characteristics underpinning qualitative approaches 
and they describe qualitative methods as:  
‘… a set of interpretive, material practices that make the world visible. These practices 
transform the world. They turn the world into a set of representations…..qualitative 
researchers study things in their natural settings, attempting to make sense of or interpret 
phenomena in terms of the meanings people bring to them.’ p3 
 
 I particularly wanted to adopt an approach that would encourage participants to freely express 
their personal experiences and to play an active role in ‘making sense’ of these experiences. 
This was driven by my dissatisfaction with the reliance on QOL measurement tools as a proxy 
for the impact of melanoma and my belief that the ‘scores’ on such scales did not reflect real 
life experience.  I therefore decided at a fairly early stage that an interpretivist stance was 
required. My rationale for deciding to adopt a constructivist Grounded Theory methodology is 
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described below. Prior to this I consider some of the ontological, epistemological and 
methodological debates that shaped my ultimate choice. 
 
 At the most abstract level decisions as to which research approach to adopt reflect the 
ontological, epistemological and methodological assumptions that underpin varying research 
paradigms (Lopez & Willis 2004).  According to Guba and Lincoln (1994) paradigms are best 
understood as representing a ‘world view’ that summarises the overarching beliefs upon which 
particular research approaches are built. A paradigm is shaped by three sets of questions. 
Ontological questions are concerned with the nature of ‘reality’ that each paradigm holds, 
epistemological beliefs reflect how knowledge is perceived and methodological questions 
capture the ways in which each paradigm believes that such knowledge can be apprehended. 
Debates about paradigms are complex and numerous approaches have been identified. Table 
4.1 provides an overview of one widely used classification proposed by Guba and Lincoln in 
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Table 4.1: Basic beliefs underpinning alternative inquiry paradigms   
Item Positivism Postpositivism Critical theory  Constructivism Participatory 
Ontology Naïve realism – 
“real” reality but 
apprehendible 
Critical realism – “real” 




Historical realism – 
virtual reality shaped by 
social, political, cultural, 
economic, ethnic and 
gender values; 
crystallised over time 
 




Participative reality – 
subjective-objective reality, 
co-created by mind and 
given cosmos. 












Critical subjectivity in 
participatory transaction 
with cosmos, extended 
epistemology of 
experiential propositional, 











of hypotheses; may 
include qualitative 
methods 
Dialogic/ dialectical Hermeneutical/ 
dialectical  
Political participation in 
collaborative action 
inquiry; primacy of the 
practical; use of language 
grounded in shared 
experiential context.  
 
Lincoln, Lynham & Guba (2011 p100) 
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Given my aims and assumptions, positivism, post-positivism and critical theory approaches 
were not appropriate so I came to the study from a constructivist paradigm.  
 
According to Ormston et al (2013) constructivism involves efforts to ‘construct meaning and 
interpretations based on those of participants where reality is affected by the research 
process’ (p12) therefore acknowledging interaction between participants and the researcher.  
This basic tenet was consistent with my own aspirations. The most influential recent exposition 
of the underlying assumptions of constructivism has been that provided by Guba and Lincoln 
(2013) who identify the following characteristics. They describe constructivism as having: 
• A ‘relativist’ ontology in which the world is comprised of multiple realities which are 
constructed by individuals in a given context 
• A ’transactional subjectivist’ epistemology in which knowledge is co-created during the 
interactions between researcher and participants  
• A ‘hermeneutic’ methodology involving an iterative dialectic process between researcher 
and participants to uncover meaning 
•  A belief that the values of the inquirer, research participants and stakeholders need to 
be made transparent 
Once again these precepts seemed consistent with both my goals and my beliefs and 
accepting these required me to acknowledge the following points:  
• The existence of multiple realities   
• That events may be interpreted in differing ways by various participants  
• That understanding is constructed through interaction with participants  
• That the researcher cannot adopt a neutral position but rather their own beliefs and 
insights influence the research process and outcomes in fundamental ways   
However there are a number of methods that may, to a greater or lesser extent, claim to meet 
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some or all of the above conditions. The most widely used of these, especially in nursing and 
health care research, are phenomenology, ethnography and Grounded Theory (Parahoo 
2006). In deciding upon the most appropriate method I needed to consider which of these 
options would best address my aims.   
 
4.2.2 WHY I CHOSE GROUNDED THEORY  
From the range of potential qualitative approaches that were available Grounded Theory was 
thought to have several advantages including its emphasis on exploring social processes and 
how these may change over time, as well as its goal of providing new theoretical insights that 
seek to have practical application in the real world. However, although Grounded Theory was 
the approach that was ultimately used, others such as phenomenology and ethnography were 
considered as alternative methodologies. Whilst either of these approaches could have been 
used I felt that they would not have necessarily been the best way to address the 
foreshadowed questions that this study sought to explore.  
 
Part of the challenge in deciding which methodology to use was how to interpret what each 
approach claims to do. Making this decision was not helped by the ways in which various 
terms are used. For as Crookes and Davies (1998) note the terms Phenomenology, 
Ethnography and Grounded Theory are each sometimes used as synonyms for qualitative 
methods. In reality however each is a distinct approach with its own particular set of goals and 
assumptions. 
 
Crookes and Davies (1998) describe the goal of phenomenology as being to investigate 
‘everyday experience from the perspective of those living that experience’. They go on to 
argue that its ability to identify key issues from the perspectives of service users is 
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advantageous. According to Adams and van Manen (2008) phenomenology provides an 
interpretation of the ‘lived reality’ of participants to identify the ‘essence’ of that experience. At 
first sight these characteristics seemed consistent with my own goals but a closer look 
suggested otherwise.  
 
Balls (2009) asserts that nurses are drawn to phenomenology because, like nursing, it 
considers the whole person and values their experience. Phenomenology could have been 
applied to my study as it is concerned with ‘lived experience’ and may have identified different 
dimensions of that experience (Richards & Morse 2007). However, as Parahoo (2006) 
contends, the goal of phenomenology is essentially to provide an in-depth description of the 
individual experience of a specific phenomenon. As such I did not feel that it would be best 
suited to explore, what I already knew to be, the complex, multi-faceted and often shared 
experience of living with melanoma.  Moreover, as Galvin & Holloway (2015) note the results 
generated by phenomenology often do not have the potential for direct practical application. 
This was central to my aims and therefore phenomenology was not considered the ‘best fit’ 
methodology.  
 
According to Charmaz (2014), ethnography, as a method, is primarily about: 
‘….recording the life of a particular group within a given milieu, requiring detailed knowledge 
of the multiple dimensions of life within the given milieu in order to understand taken for 
granted assumptions’ (p35). 
 
For Streubert (2011) ethnography is particularly suited to exploring how individual experiences 
are connected to, and can be understood through, membership of a given group or culture. 
Consequently, as Parahoo (2006) contends ‘ethnographers are interested in how the behavior 
of individuals is influenced or mediated by the culture in which they live’ (p67). This overriding 
emphasis on group membership and culture did not seem particularly appropriate for my 
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study. From my own experience melanoma affects a diverse cross section of the population 
who are unlikely to be members of a specific cultural group. Therefore, as with 
phenomenology, ethnography was not seen to provide a ‘best fit’ with my own aims, therefore 
this left Grounded Theory.   
 
4.2.3 THE EVOLUTION OF GROUNDED THEORY AND CONSTRUCTIVIST 
GROUNDED THEORY 
 
4.2.3.1 The development of Grounded Theory 
Grounded Theory was initially developed by Glaser & Strauss (1967) during their research 
into death and dying within an acute hospital context. In exploring this experience they wished 
to employ an alternative to the then dominant quantitative paradigm, which was essentially 
theory testing and deductive. In doing so they devised a ‘new’ approach to research that was 
theory generating, with the emerging theory being rooted in the data. Furthermore, rather than 
the emphasis being placed on developing a ‘grand’, overarching theory (which aims to explore 
and explain the widest set of phenomena possible) their goal was to produce a substantive 
‘mid-range’ theory that explored a given phenomenon in a certain context (death and dying in 
an acute hospital in their case and melanoma amongst recently diagnosed patients and carers 
in mine). They called their approach ‘Grounded Theory’ and philosophically it was firmly rooted 
in Pragmatism and Symbolic Interactionism (Stern & Porr 2011). Both of these philosophies 
are underpinned by the idea that knowledge, rather than being universal and constant, is 
context related and is primarily influenced by the actions, interpretations and interactions of 
people in a given setting. The classic description of this belief was captured by Blumer (1969), 
who when describing the basis of symbolic interactionism wrote that:  
“Human beings interpret or define each other’s actions instead of merely reacting to each 
other’s actions. Their response is not made directly to the actions of one another but instead 
is based on the meaning which they attach to such actions” (p.19) 
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Knowledge, and subsequent action, is therefore based on peoples’ interpretations, which may 
change over time. Consequently Grounded Theory stresses the importance of the context in 
which people function and how they share and construct their social world (Holloway & Galvin 
2015).  
 
The original Grounded Theory methodology as envisaged by Glaser & Strauss (1967) had 
three basic precepts: theory generation; theoretical sampling; and constant comparative 
analysis, with these elements being considered as integral and mutually reinforcing.  The 
descriptions of the method provided by Glaser & Strauss (1967) were intended to be a guide 
for systematically gathering and analyzing data to form theory. However, despite being offered 
as an alternative to quantitative approaches early Grounded Theory was still rooted in a largely 
‘objectivist’ world view in which the views and interpretations of the researcher were dominant. 
Paradoxically, therefore, whilst arguing that people constructed their world through their 
interactions with others, for Glaser and Strauss (1967) the interactions between researchers 
and participants were not held to be influential.  Rather, the researcher was seen to be ‘value 
neutral’ and, in order to avoid ‘bias’ all forms of prior knowledge were to be put to one side. 
So for example Glaser and Strauss (1967) advocated ignoring any existing literature until after 
fieldwork had been completed. Participants were seen primarily as ‘providers’ of data, having 
no other part to play. For Glaser and Strauss (1967) establishing rapport with participants was 
a time-consuming, but necessary, aspect of data collection.  
 
  As Williams and Keady (2012) note, whilst classical grounded theorists recognized the need 
to ‘interact’ with participants, such interaction was kept to a minimum and it was the 
researcher’s role to interpret the data and produce the theory. Glaser (Glaser & Holton 2004) 
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always remained true to what he described as ‘Classical Grounded Theory’, emphasizing the 
systematic but flexible nature of its methods but still prioritising the researcher’s role. 
 
Since its original publication, however, Grounded Theory methods have been taken in differing 
directions including Strauss & Corbin’s (Strauss and Corbin 1998, Corbin & Strauss 2008) 
approach that focused primarily on analytic techniques and Charmaz’s (2006) Constructivist 
Grounded Theory.  Strauss began working with Corbin to produce their own version of 
Grounded Theory methods (Strauss and Corbin 1998, Corbin & Strauss 2008) to clarify the 
analytic processes involved and make them more accessible to students. They therefore 
concentrated primarily on the techniques of Grounded Theory, especially data analysis. While 
starting from a classical, objectivist foundation, over time their methods evolved to take on a 
more constructivist approach with Corbin (2008) stating that her initial position as an ‘authority’ 
on healthcare changed to that of a ‘negotiator’ or co-creator of care with her patients. 
Eventually Charmaz (2014) recognised this change in Corbin and Strauss’ (2008) standpoint 
with both sets of authors openly acknowledging the position of the other.  
 
However, Charmaz (2000, 2006) had long argued for a more radical interpretation and 
application of Grounded Theory in which the interactions between participants and researcher 
were not simply acknowledged but actively encouraged. She called this ‘Constructivist’ 
Grounded Theory.  
 
4.2.3.2 Constructivist Grounded Theory 
From the outset Charmaz (2000, 2006) challenged the objectivity advocated by Glaser & 
Strauss (1967), and to a lesser extent Strauss and Corbin (1998), making a clear distinction 
between objectivist and constructivist Grounded Theory. In proposing a new version of 
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Grounded theory Charmaz’s (2000) goal was to develop an approach that resulted in the 
‘mutual creation of knowledge’ between participants and researchers, in which both parties 
played a full and active role. She argued that existing Grounded Theory principles could be 
used by researchers in many ways and that the methods employed represented a flexible 
‘toolkit’.  Almost in anticipation of Charmaz’s arguments, Rodwell (1998), when providing an 
overview of objectivist methods more generally, referred to using Grounded Theory 
techniques as part of constructivist research (even if the end product was not a Grounded 
Theory, see later), and as Charmaz (2000) was to do a couple of years later, Rodwell (1998) 
emphasised the importance of co-construction with participants. Both Rodwell (1998) and 
Charmaz (2006) describe variations of Constructivist Grounded Theory research that share 
the same epistemological standpoints, which reflect those outlined earlier.  
 
Therefore while the methods used in the differing iterations of Grounded Theory are often 
similar, it is the ways in which these methods are applied, and in particular the interactions 
between the researcher and the participants, that sets them apart. Mills et al. (2006) offer a 
methodological spiral on which all variations of Grounded Theory sit, depending upon their 
epistemological underpinnings, describing the constructivist paradigm as evolved Grounded 
Theory.  
 
However the arguments outlined above have not been accepted uncritically and writers such 
as Bertero (2012) criticise those researchers who claim to have used Grounded Theory while 
only paying lip service to its central tenets. Bertero (2012) contends that for any approach to 
be called Grounded Theory it must contain the following essential elements:   
• Simultaneous data collection and analysis  
• Theoretical sampling leading to theoretical saturation 
• Hierarchical coding processes 
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• The Identification of a core category 
 
However even these elements seem to be open to interpretation with Hallberg (2006) 
suggesting that the following are required: simultaneous data collection & analysis; intensive 
interviewing, open followed by theoretical sampling, hierarchical coding processes, categories 
emerge from data rather than preconceptions, identification and verification of relationships 
between categories, identification of a core category, detailed memo writing and theoretical 
saturation of categories. Based on the writings of several authors (Glaser & Strauss 1967, 
Corbin & Strauss 2008, Charmaz 2014, Birks & Mills 2015, Bertero 2012, Hallberg 2006, 
Urquhart 2013) the common elements appear to be:  
• Theory generation rather than verification 
• Theoretical sampling 
• Constant comparison 
• Simultaneous data collection and analysis 
• Hierarchical coding procedures 
• Memo writing  
• Theoretical saturation of categories and their properties  
 
Whilst there is obvious congruence between many of these processes and a constructivist 
approach what sets the latter apart is the importance it accords to the relationships formed 
between participants and researchers and the belief that acknowledging and building on all 
forms of prior knowledge is central to reaching a shared understanding, in marked contrast to 
the position advocated by Glaser and Strauss (1967). Therefore, constructivist Grounded 
Theory rejects the notion of a value-free observer, and explicitly recognizes that the 
researcher’s personal, professional and disciplinary perspectives are influential in shaping the 
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initial foreshadowed questions, data collection and subsequent analysis (Charmaz 2014). I 
have already sought to make my own influences as clear as possible. Consequently reflexivity 
is an essential element of any study and a fuller description of my approach to reflexivity will 
be provided later.  
 
Other differences in emphasis between variants of Grounded Theory also emerge. Glaser and 
Strauss (1967) and Strauss and Corbin (1998) argue for the need to identify a ‘Core Category’ 
and a ‘Basic Social Process’ that lie at the heart of a Grounded Theory. Charmaz (2006), on 
the other hand, contends that this position is too reductive and that in complex social situations 
a number of categories and processes are likely to interact to shape the experiences of those 
living with, for example long term conditions.  
 
From the above it is clear that there is no universally accepted approach to Grounded Theory 
and therefore it is essential that each researcher makes their own position clear.  In order to 
provide transparency I will therefore state my own interpretation of constructivist Grounded 
Theory methods and how they were used to carry out this study. 
 
4.3 THE APPLICATION OF CONSTRUCTIVIST GROUNDED THEORY TO THIS 
STUDY 
Consistent with the central elements of Grounded Theory described above my study aimed to 
generate rather than test theory and the processes of data collection and analysis were to be 
conducted simultaneously. Therefore whilst for ease of interpretation I describe the methods 
I used in separate sections these were, in reality, largely undertaken simultaneously. With 
these caveats in mind my study was underpinned by the following principles and unfolded as 
described below.   
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4.3.1 THEORY GENERATION RATHER THAN VERIFICATION  
Authors writing about Grounded Theory and constructivist research often refer to the 
generation of theory as being their primary goal, but this is not always the end product. The 
result may sometimes be largely descriptive rather than theoretical or based on data that might 
have been ‘forced’ with the resultant theory not being adequately ‘grounded’ in the data. In 
such cases it is questionable whether the study was truly Grounded Theory (Glaser & Strauss 
1967). In constructivist research more generally, Rodwell (1998) considers that whilst 
Grounded Theory ‘techniques’ (such as constant comparison) may be used the end result is 
typically a detailed ‘case report’ often in the form of a case study. As noted above writers such 
as Charmaz (2006) highlight the importance of theorizing but do not accept that a solitary core 
category is always adequate to capture the complexity of real-life events and see the 
insistence upon identifying only one core category as a legacy of the objectivist tradition. 
Therefore, whilst all proponents of both Grounded Theory and constructivist research agree 
that the final product must be shaped by the data, universal agreement on the nature of that 
final product remains elusive.  
 
My goal was to co-construct with my participants a ‘theory’ of their experience of living with 
melanoma that, as far as possible, captured the key stages and processes that occurred over 
time, with particular reference to support needs. My desire to have a temporal dimension 
meant that a longitudinal study involving several interviews with the same participants would 
be required. My intent to gain as complete a picture as possible from a number of perspectives 
meant that I needed to include people with melanoma, their carers (where there was one) and 
at least one health care professional. The ultimate goal was that the insights provided would 
have potential practical application to improve the melanoma experience for all parties. As 
with all Grounded Theory studies certain essential elements were required, key to which are 
theoretical sampling and constant comparison. 
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4.3.2 THEORETICAL SAMPLING  
In qualitative studies, and especially in Grounded Theory, sampling techniques differ from 
those applied in quantitative studies. In quantitative studies the goal is ‘representation’ and 
random sampling is seen as the ‘gold standard’. In qualitative studies purposive or selected 
sampling is most frequently adopted. This may start off as a convenience sample, in which 
participants known to have a view on the subject of interest are selected. Sampling is usually 
then refined over time as new participants are identified, often by previous ones. Grounded 
Theory studies may start in this way but as the study unfolds theoretical sampling takes 
precedence. The primary purpose of this is to build the emerging theory and to do so both 
participants and data are selected explicitly to explore emerging ideas and maximise 
opportunities to refine these (Corbin & Strauss 2008).   
 
Consequently, according to Draucker et al. (2007) theoretical sampling is central to Grounded 
Theory and evolves over time. Typically, at the start of the study individuals or groups who are 
known to have knowledge of the topic under study are selected (convenience sampling). 
However as data collection and analysis are concurrent early analysis helps to identify either 
other participants and/or ideas that can be developed in future interviews.  Theoretical 
sampling is therefore used to identify either participants or data that will elaborate upon and 
refine previously identified categories until these begin to become saturated (see below). 
 
Although sample size is not a primary consideration in qualitative research it is still a topic that 
is the subject of debate, therefore it is briefly considered below.  When considering sample 
size Charmaz (2006), for example, agrees with Glaser (2002) that there is value in looking at 
a ‘many cases’ as this will strengthen the researcher’s grasp of the participants’ world. 
Unfortunately she does not then define what she means by ‘many cases’. Rather she states 
that enough material is needed to both anchor the participants’ experiences and identify 
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differences between and amongst participants with sufficient confidence to connect them to 
their social context. This is rather vague and instead of citing a number of participants many 
authors rely on the idea of ‘saturation’, which is considered later.  However, despite not being 
tied to sample size qualitative writers nevertheless ponder the question: What is too small?   
 
Morse (2000) suggests that a Grounded Theory study with two to three unstructured 
interviews per person may need twenty to thirty participants (so therefore fourty to ninety 
interviews) depending on the scope of the study, the nature of the topic and the study design. 
On the other hand Stern & Porr (2011) caution against collecting too much data as it can 
become unmanageable and for them thirty to forty interviews or hours of observation are 
generally adequate to reach theoretical saturation.  
 
The situation is often further complicated for students undertaking a PhD who may be 
restricted as to the number of interviews they can undertake by resource and time constraints. 
In reviewing sample sizes across a number of published PhD studies Mason (2010) found an 
average of thirty-one interviews per study but her review excluded designs that were 
longitudinal or involved repeated interviews. As interesting as such musings are ultimately the 
sample size (which in this context does not just refer to the number of participants but also the 
number of interviews) should be enough to provide some confidence that the issues in 
question have been explored sufficiently to provide credible answers. Approximately twenty 
patients and twenty carers were estimated to sufficiently explore emerging issues through 
repeated interviews over three years. Along with Healthcare Professional interviews, this 
allowed for interactions within triads to be analysed. Previous work had shown this number to 
be sufficient (Hellstrom, Nolan & Lundh 2007) and thus provided an estimated number of 
participants required for ethical approval. Consideration of what constitutes a ‘credible’ 
Grounded Theory will be considered later. Constant Comparison is another central element 
of Grounded Theory. 
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4.3.3 CONSTANT COMPARISON 
In Grounded Theory the constant comparative method is central to the analytic process and 
goes hand in hand with theoretical sampling, with one informing the other. Constant 
comparison occurs in some form at all stages of data collection and analysis. Initially data are 
compared with data, within and across interviews, to help in the identification of early codes. 
These early codes then help to inform theoretical sampling, either of new participants and/or 
of additional topics, with this process occurring in an iterative fashion. Consequently Charmaz 
(2014) sees constant comparison as being applicable at all stages of analysis and theory 
generation and, as with Birks & Mills (2015), describes a number of comparisons that may be 
made including: statements within the same interview, between interviews, later interviews 
compared to earlier interviews, between participants, between codes, between incidents and 
codes, between codes and categories, between categories. However, it is when categories 
begin to emerge that constant comparison is most fully employed.  
Glaser & Strauss (1967) provided detailed procedures for constant comparison and described 
four overlapping stages:  
• comparing incidents applicable to each category 
• integrating categories and their properties 
• delimiting the theory 
• writing the theory 
These stages are not conducted in a strictly sequential way, but are often simultaneous, 
highlighting the interdependence between analysis, theoretical sampling and theory building 
as the researcher must remain open to new ideas while forming the theory. Such new ideas 
then inform subsequent sampling decisions, the focus of interviews and analysis.  As 
comparisons are made throughout the analytic process, indeed until the writing of the final 
theory, Glaser & Strauss (1967) stress that insights may emerge late in the process. This, as 
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will be described below, has implications for deciding when theoretical saturation has 
occurred.  
 
4.3.4 SIMULTANEOUS DATA COLLECTION AND ANALYSIS 
The central role that this plays in Grounded Theory has already been considered. 
 
4.3.5 HIERARCHICAL CODING PROCEDURES 
Hierarchical coding refers to the way in which the researcher sequentially uses open, axial 
and selective coding to develop categories and establish links between them. Differing stages 
of coding have been suggested. Glaser & Strauss (1967) describe the coding of incidents, 
then coding for categories, by using notes and memos. Similarly Charmaz (2014) suggests 
using initial then focused coding, but she does not advocate axial coding as she prefers an 
emergent rather than a procedural approach. Theoretical coding is meant to interrelate 
categories and move them to a more abstract level (Charmaz 2014). The position I adopted 
with regard to coding will be discussed further below.  
 
4.3.6 MEMO WRITING  
Memo writing is seen as an essential part of the analytical process with memos of various 
types being used to record the researcher’s thoughts and processes as they develop links 
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4.3.7 THEORETICAL SATURATION OF CATEGORIES AND THEIR PROPERTIES 
As noted above theoretical saturation is taken to be the point at which data collection ceases 
and whilst data analysis may still continue it too is often largely complete by this stage. 
However, defining the point of theoretical saturation is somewhat ambiguous for as Glaser & 
Strauss (1967) state new insights may emerge at any point.  Therefore, as the quote below 
suggests ultimately an element of informed judgement is required. 
“Saturation is a critical concept in Grounded Theory and is based on a subjective decision: 
actually, you can never know if further interviewing would give more information.”  
 (Hallberg 2006 p144) 
 
Given my desire to fully involve my participants I felt that the point of theoretical saturation 
should not be decided by myself alone but agreed with participants. Saturation would only be 
reached when they felt that their ‘story’ had been told fully. I anticipated that not everyone’s 
‘melanoma journey’ would be complete when data collection ended, as for some participants 
their life with melanoma would extend beyond the duration of the study. Despite this they 
needed to be satisfied that a full account had been rendered up until that point in time. 
 
Having described the main tenets underpinning the interpretation of Grounded Theory that 
informed my study issues of data collection are now considered. 
 
4.3.8 DATA COLLECTION  
As indicated earlier Charmaz (2006) argues that Grounded Theory methods should be seen 
as a set of flexible tools that can be used as suits a particular study but she also advocates 
that to be successful the tools selected must be the most appropriate to answer the questions 
posed. The choice as to ‘how’ the data were collected will therefore have a significant impact 
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on the quality of the result (Charmaz 2006). Given my desire to engage with participants over 
an extended period of time, and to allow them every opportunity to contribute fully to the study, 
interviews seemed the obvious choice of method.  Indeed, Charmaz (2014) states that 
‘intensive’ interviews fit Grounded Theory methods well because they allow in-depth, open-
ended exploration of an area in which the interviewee has substantial experience.  
 
Whilst some researchers talk of undertaking an ‘open’ interview, it has been argued that this 
is in fact a misnomer and that in the context of research an ‘open’ interview is a meaningless 
concept (Whyte 1982). Whyte (1982) argues that in agreeing to take part in a study, 
participants have been invited to talk about something and have a reasonable expectation that 
this is what will be addressed.  Furthermore, as already discussed, my study was guided by a 
set of sensitising concepts that gave initial direction to data collection. It therefore seemed that 
semi-structured, but flexible interviews were the most appropriate method to use. According 
to Tod (2010), semi-structured interviews have several advantages in that:  
• They permit the researcher to identify a range of issues (shaped by the foreshadowed 
questions) to be explored. These issues are usually formed into a rough interview 
‘guide’ 
• They are flexible and the order in which issues are addressed is not important. This 
allows participants a degree of freedom to explore those aspects that they feel are 
important   
• The interview guide can evolve and change in content and emphasis as new issues 
emerge. This latter characteristic is essential to both theoretical sampling and 
constant comparison 
 
The flexibility of semi-structured interviews is particularly valuable when participants are 
interviewed on more than one occasion to allow the focus of investigation to change and 
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evolve over time. This attribute reflected my intention to explore experiences as they emerged 
after a melanoma diagnosis, suggesting that longitudinal interviewing would be appropriate. 
This was reinforced when I considered the potential advantages and disadvantages of 
longitudinal interviews as shown in in Table 4.2. On the basis of these it seemed apparent that 
the advantages outweighed any potential disadvantages.  
 
 




Longitudinal qualitative research can achieve 
depth, quality, and variety of understandings 
related to the trends and processes of change 
Vogt (2002). 
 
 Qualitative longitudinal methods are 
particularly suited to exploring many 
dimensions of health and illness including: 
symptoms, patient expectations, understanding 
how changes and adaptations result from 
particular traumas, events or interventions, the 
significance of timing and timeliness, the 
impact of health inequalities & the impact of 
caring (Holland et al 2006). 
 
Through repeated contact a more nuanced 
understanding of phenomena as they evolve 
through time, especially those with an 
unpredictable trajectory can be captured. This 
is particularly relevant for a better 
understanding the experience of illness 
(Carduff et al 2015). 
 
Longitudinal approaches recognise that human 
actions and participant perspectives might 
change during the course of a study, and seek 
to capture these (Saldana 2003). 
This is anticipated and the study aims to 
uncover these changes. 
Where the aim is to observe change, 
the researcher must be prepared that 
change may not be seen during the 
period of study (Saldana 2003). 
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Data collection and quality 
Repeated contact over time may have benefits 
for the quality of the data, the relationship 
between researcher and participants and the 
quality of the data outputs (Holland et al 2006). 
Continuity of researcher can lead to a 
loss of objectivity and an accumulation 
of a partial perspective (Holland et al 
2006) but this is not a concern within a 
constructivist study. 
Repeat interviews allow for flexibility of 
sampling, methods, units of analysis, and 
theorisation. (Holland et al 2006). Flexibility of 
the interview schedule can help to capture 
change as it happens over time (Carduff et al 
2015) but the timing of data collection should 
be considered to anticipate changes where 
possible (Calman et al 2013). 
The research focus and topic guide 
evolve over time so may vary from the 
original aim of the research (Calman et 
al 2013). This again is not a concern in 
a constructivist study. 
 Attrition can be problematic in 
longitudinal research but may be 
countered by regular contact, good 
engagement with participants and 
efforts to maintain involvement (Carduff 
et al 2015). This proved to be the case 
with most of my participants. 
Analytic quality 
Analytic quality requires ongoing commitment 
of time and contact. This is aided when there is 
consistency of researcher(s) which allows 
rapport to be built with respondents and 
analytic insights to be accumulated. (Holland et 
al 2006). 
A small sample can give rise to a large 
and complex data set which can be 
analyzed in multiple ways from different 
perspectives (Calman et al 2013). 
Quality analysis of such a large amount 
of data is time consuming (Holland et al 
2006). 
The rich data from longitudinal interviews 
provide detail and density enhancing the 
likelihood of developing categories (Calman et 
al 2013) and enhancing analytic quality. 
Analysis is often complex and 
multidimensional and, as noted above is 
usually time consuming (Calman et al 
2013). This proved to be the case in my 
study but I feel that the quality and 
depth of the resulting product made the 
effort worthwhile.  
 
 
There are also specific ethical concerns related to longitudinal qualitative interviewing that 
will be discussed later in this chapter, 
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Longitudinal, semi-structured interviews were therefore suited to the aims of the study and the 
primary method of data collection. Having made this decision I also wanted to identify the best 
way of enabling participants to take a full role in the process. Whilst the need to engage 
participants as equal partners in the research process lies at the heart of constructivist 
methods little is written about how best to achieve this, especially when the topic to be 
addressed may be sensitive or difficult. In discussing this issue with my supervisors my 
attention was drawn to the use of diagramming as a means of engaging with research 
participants over time as suggested by Keady and Williams (Keady et al. 2007a,b, Williams 
and Keady 2012). Diagramming in Grounded Theory is most often associated with data 
analysis. According to Charmaz (2014) diagrams have the advantage of being able to provide 
‘visual representations of categories and their relationships’ (p218) and several authors 
(Strauss and Corbin 1998, Clarke 2003, Corbin and Strauss 2008) see the use of diagrams 
as being intrinsic to Grounded Theory analysis. They suggest that a variety of diagrams 
including maps, figures and charts both assist in teasing out relationships in the data and in 
representing these relationships in the findings. 
 
Whilst diagrams are advocated for use during analysis by Keady and Williams (Keady et al. 
2007a,b, Williams and Keady 2012), these authors also see them as a key element of data 
collection. In using diagrams as a means of data collection the authors offered a new approach 
to co-constructed inquiry which facilitated engagement with people living with long-term 
conditions (dementia in their initial study) over time. They used diagramming as a way of 
working with the participants to create their own ‘personal theory’ of their experience (Keady 
et al. 2007a,b) This new approach was based on a life story model and comprised several 
sequential ‘stages’ which are seen as representing a series of ‘acts’. The aim was to address, 
amongst other things, the question of ‘how’ to achieve the ‘mutual creation of knowledge’ and 
which techniques might enable researchers to forge meaningful relationships with participants. 
They were particularly interested in identifying ‘what’ and ‘who’ participants saw as being 
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‘centre stage’ (most important to them) as things developed over time. According to Charmaz 
(2014) the authors: 
‘….offer ‘center stage diagrams’ as a way of advancing constructivist Grounded Theory. Over 
time, they co-construct these diagrams with participants about their lives through adopting 
participant’s language and visual representation of his or her subjective 
experience……Williams and Keady find that center stage diagrams enable participants to 
move forward with the researcher…’ (p219). 
 
The use of such diagrams seemed to offer considerable potential and was a strategy that I 
was keen to try. As will be explained later, I did not use diagrams in exactly the same way as 
the original authors nor was my goal to adopt a life story approach. However diagramming 
played a key role in both data collection and analysis. A consideration of how this was used 
in a longitudinal fashion is something that will be discussed later. 
 
I also wanted participants to be involved in bringing their individual data together into a 
collective theory. To facilitate this I planned to use focus groups as a method of data collection 
with patients and carers towards the end of the study so as to enable them to discuss their 
experiences collectively. Birks & Mills (2015) view focus groups as an extension of the 
standard interview and see them as being useful in Grounded Theory research as a way of 
eliciting potentially shared perspectives. Goodman & Evans (2015) advocate that a focus 
group held at the end of a study allows participants to respond to findings and offer alternative 
interpretations, thereby allowing people to modify their initial thoughts if they wish. This was 
my goal in using focus groups as I wanted to provide an opportunity for participants to review 
the ‘final’ version of the theory, and to identify commonalities and differences. One limitation 
of focus groups is their potential susceptibility to researcher manipulation and bias (Goodman 
& Evans 2015). To try and avoid this reflexivity was employed as discussed later in this 
chapter.  
 
   
  86 
Having stated my interpretation of constructivist Grounded Theory and the methods I intended 
to employ, I will now provide a detailed account of how the study was conducted.  
4.4 STUDY DESIGN 
When planning a study there are several things to consider including the need to gain the 
necessary approvals to access research participants, especially within a healthcare setting. 
Certain actions were therefore required prior to sampling and data collection. These included 
selecting the study site and groups to study and deciding at what point in their melanoma 
journey to invite people to take part in order to capture the breadth of their experience (Corbin 
& Strauss 2008). 
 
The nature of melanoma and its trajectory suggested that those patients likely to experience 
relapse or disease progression would do so within the first two years of diagnosis. A three-
year study period was therefore planned to capture the majority of patient and carer 
experiences.  My previous study (Bird 2011) employed a cross-sectional design, focusing on 
the retrospective experience of patients. The present study was designed to prospectively 
capture not only their experience, but also those of carers and health care practitioners to 
identify both short and long-term impacts in a contemporaneous way. In keeping with 
Grounded Theory methods, sampling, analysis and theory generation were to be conducted 
simultaneously. This is illustrated in Figure 4.1 below. How this timeline unfolded is now 
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Figure 4.1: Study timeline 
 
4.4.1 PARTICIPANT RECRUITMENT & SELECTION CRITERIA 
Initially patients were to be included if they met the following selection criteria: 
• Over 16 years of age 
• Able to understand what the study involved and be able to give consent 
• Histological diagnosis of melanoma 
• Diagnosed within the previous 3 months 
 
The last criteria of being diagnosed within the previous three months was removed in an 
amendment shortly after the study opened as it became apparent that the complex referral 
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Carers were included if they met the following selection criteria: 
• Over 16 years of age 
• Able to understand what the study involves and be able to give consent 
• Were nominated as their main carer by someone with a histological diagnosis of melanoma 
  
Healthcare and other professionals who might be nominated were eligible for inclusion as 
described below.  
 
Patients were initially identified through oncology and dermatology clinics within a large, 
regional teaching hospital. Including oncology as well as dermatology allowed for patients with 
differing experiences to be recruited such as those diagnosed with metastatic disease or no 
known primary melanoma. Recruitment commenced by identifying patients with a new 
diagnosis of stage II (thicker primary melanomas) or III (lymph node involvement) melanoma, 
as described in Chapter 2, who were approached at outpatient appointments. As newly 
diagnosed melanoma patients are seen at three monthly intervals it was anticipated that 
several patients could be identified in a relatively short time. Later, as theoretical sampling 
occurred, recruitment widened to include patients diagnosed with different stages of 
melanoma (low risk and metastatic disease) to enable comparison of differing experiences.  
The low risk group are treated by dermatologists alone whereas the moderate to high risk 
groups are treated by a range of people including dermatologists, plastic surgeons and 
oncologists. Patients diagnosed with metastatic disease are often referred directly to an 
oncologist. The service patients receive therefore varies for these differing groups and 
consequently their experiences are likely to differ too.  
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Approximately half of all patients approached agreed to take part in the study. Patients 
refusing to participate stated reasons such as that they wanted to forget about the melanoma 
or felt that the commitment to repeat interviews was too great. This meant that the group 
participating was self-selected to an extent. During the latter stages of recruitment, when it 
became clear that the majority of patients taking part were generally older and had high-risk 
disease, specific efforts were made to recruit patients who were younger and/or with earlier 
stage disease to explore potential differences in their experiences. This was only partially 
successful, for a variety of reasons. For example younger patients with a new diagnosis were 
not available in great numbers during the recruitment period and those with earlier stage 
disease were only accessible through referral from a single dermatology clinic, thus limiting 
their participation. Reflections on the impact of such sampling limitations will be considered in 
the final chapter. Details of consent processes and ethical issues are provided later.  
 
Carers were approached with patients where they were in attendance or patients passed the 
information sheet to the person that they identified as their main carer. Patients could 
participate without carers but owing to the need to maintain patient confidentiality, carers could 
only participate with the consent of the patient. Patients were also asked to nominate a HCP 
who they felt had been particularly helpful. This was done 6 months following the patient’s 
initial recruitment to allow exposure to differing professional groups. Therefore the HCP could 
have come from within primary, secondary or tertiary care or voluntary sector and from any 
discipline. HCPs were invited to participate by letter, followed by a maximum of 2 telephone 
calls or emails to gain their reply.  
 
A biographical description of each participant and those that that they nominated to take part 
in the study, including HCPs is provided in the first results chapter.  
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4.4.2 DATA COLLECTION  
Demographic data was collected from patients’ case notes and verbally from carers and 
HCPs. This was used to describe the participant group as outlined in the next chapter.  
 
In keeping with Grounded Theory methods, data collection and analysis took place in parallel 
(as shown in figure 1). However they are described separately here for ease of presentation. 
A separate reflexive account of my own part in data collection is provided later.  
 
 Participant Interviews 
As described earlier the primary method of data collection employed in this study was in-depth 
interviewing augmented by the use of diagramming (see below for fuller description). 
Interviews were carried out face-to-face and participants were offered a choice of setting: half 
chose the research centre and half their home. Patients and carers were given the option of 
being interviewed together or separately and in almost all instances they chose to be 
interviewed together. Where they were interviewed separately (3 occasions) this was due to 
carers’ work commitments. Interviews lasted between 15 and 90 minutes, with most interviews 
lasting around an hour.  
 
The first interview took place as soon as possible after the participant or carer had provided 
their consent (see below). After the initial contact further interviews were planned to take place 
at months 3, 6, and 12 respectively and then six monthly, with an additional interview if there 
was a new cancer episode. This allowed for data to be collected for patients who experienced 
recurrent disease. Interviews were planned to take place over a minimum period of one year. 
It was anticipated that those recruited early in the study would be followed up for the full three 
years, but that not all subsequent participants would reach the three-year time point.  A 
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maximum of 10 interviews with any one patient and/or carer were planned but six proved to 
be the maximum number. This strategy was anticipated to allow enough opportunity to clarify 
concepts as they emerged and generate a robust theory as shown in figure 4.2. 
 
Figure 4.2: Using interviews to generate theory 
 
Interviews with HCPs took place after patients nominated them (6 months after the patient 
was recruited) and once at the end of the patient’s data collection period to explore any 
changes in the relationship that may have taken place.  
 
With permission the interviews were audio recorded for accuracy and to enable me to focus 
my attention on my interactions with participants. Charmaz (2014) advocates recording 
interviews as taking notes may interfere with the flow of the interview and are likely to fail to 
capture subtle nuances.    
Collective 
experience 
Initial and final interviews 
Initial interview Personal experience Melanoma story 
Patients &  nominated carers  
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The first interview usually took place within a week of information about the study being 
provided. At this point consent was obtained and the purpose and the structure of the study 
were discussed again along with related issues of confidentiality. The consent form was 
completed prior to the interview being undertaken. This interview was relatively unstructured 
and open questions were used to allow participants to freely express their experiences. No 
formal interview guide was used but participants were asked to talk about their experience, 
starting wherever they wanted to. The interview evolved from there but a list of topics I wanted 
to address included: how the melanoma diagnosis impacted their daily life, what the term 
‘support’ meant to participants, who participants sought ‘support’ from, emotions and 
experiences as a result of the melanoma diagnosis and sun-related behaviours. Later in the 
interview probes or prompts were used to clarify issues if required. On starting the interview I 
would say something like “Please start where you want to. Just say what has happened and 
how you have felt” (JB, Interview with P02). Charmaz (2014) suggests that often one question 
may be all that is needed, and for some participants this proved to be the case. Participants 
naturally wanted to talk primarily about how the melanoma had affected various aspects of 
their life. Ultimately what emerged was therefore a ‘melanoma story’ in contrast to the life story 
approach adopted by Keady et al (2007). Elaborating upon this ‘melanoma story’ was aided 
considerably by the use of diagramming, and many participants found this very useful as 
described below.  
 
Diagramming has been used in various ways by grounded theorists to develop and elaborate 
their theory, but often at the stage of data analysis. As with Keady et al (2007) in addition to 
using diagrams during analysis I also used them with patients and carers during the interviews 
to enable them to engage more fully with the process of theory generation. Diagramming in 
the context of theory analysis will be discussed later, here I will discuss the data collection 
aspect of diagramming.  
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During the first, second or occasionally third interviews (owing to the staggered time frame of 
participant recruitment), participants were asked if thinking about their experiences in a ‘visual’ 
form, as a diagram or picture, would help. Paper and pens were available to aid exploration. I 
didn’t suggest ways that they might do this so as not to influence them initially. Some 
participants were able to provide a visual representation, whereas others were not. Some 
participants thought this a good idea, whereas others did not. However, even those who felt 
that creating a diagram might be helpful did not feel confident to begin to draw one. Therefore, 
whilst by no means skilled myself, I offered to start the drawing off if they described what they 
wanted it to look like and told me where lines started and stopped. One of the participants Phil 
(see later) readily described his experience as being like an ‘avalanche’, beginning with a 
‘snowball’ and then rapidly escalating:  
"First there was the mole and then the operations and here we are on a mountainside. It was 
a little snowball and as it’s gone downhill it’s increased in size and speed. Very steep hillside. 
Little snowball was my mole. Under my arm, I wasn’t concerned about that. And then the next 
one was the groin and that’s quite big now. I don’t want to go any further. Unless it starts going 
up again it’s going to come to an inevitable conclusion. I want it to start going back up." Phil 
(Patient M06) 
 
Based on this description we began to try and represent his experiences as a diagram, as 
shown in figure 4.3. 
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Figure 4.3: Avalanche developed by Phil, initial drawings from the interview (names blanked 
out for confidentiality) 
 
At the next interview with Phil and his wife Kate, we discussed changes that had happened 
since the last interview and how his avalanche analogy had developed. Things had improved 
so the ‘avalanche’ turned into a ‘rollercoaster’. This was thought to be a better metaphor as a 
‘rollercoaster’ has both ups and downs whereas an ‘avalanche’ only goes in one direction, 
downhill. Phil describes this below: 
"If I equate it to a rollercoaster, obviously it’s a long ride with ups and downs, I want to be on 
the peak not in the trough. It’s a rollercoaster now because I can see the other side. I’m in a 
carriage because I haven’t got any control. I know there will be twists and turns on my 
rollercoaster but I don’t know what they will be. I can only say what I’ve experienced up to 
now.” Phil (Patient) 
 
The original drawing we produced to try and capture this is presented in Figure 4.4. 
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Figure 4.4: Rollercoaster developed by Phil at subsequent interview  
 
 
Phil was not the only participant to refer to their experiences as being like a ‘rollercoaster’. , In 
Tony’s initial interview, he had referred to an ‘emotional rollercoaster’ and we tried to capture 
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Figure 4.5: Rollercoaster developed by Tony during the study (names blanked out for 
confidentiality) 
 
As all the participants had in one way or another talked about the ‘ups’ and ‘downs’ or ‘highs’ 
and ‘lows’ of their journey the idea of a using the metaphor of a ‘rollercoaster’ to capture this 
was introduced and everyone thought that it worked really well.  Some sought to draw their 
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Some of the initial descriptions of the melanoma experience were very powerful but neither 
participants nor myself possessed the talent to capture these as well as we would like visually. 
With participants approval I therefore commissioned an artist, Amy Martindale to create visual 
images from a selection of quotes. The rollercoaster she produced can be seen in Figure 4.7. 
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These images were then shared with participants during the focus groups and were very well 
received, stimulating yet more discussion and helping to create a shared visual image of their 
experiences.  
 
Figure 4.7: Rollercoaster picture created from participant quotes 
 
Having considered the process of individual data collection, I now consider the focus groups. 
 
4.4.2.1 Focus Groups 
Focus groups were initially planned for patients and carers but one also took place with HCPs. 
These were conducted towards the end of data collection and analysis to aid saturation of the 
data (which had been reached following a joint decision between myself and the participants) 
and refine the final version of the theory, having already presented it to participants 
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individually. I anticipated that group discussion might enable participants to further explore the 
meaning of the theory and allow possible modification following discussion with others who 
had been through a ‘melanoma journey’.   
 
In July 2016, two years and nine months into data collection, remaining patients (those who 
had not withdrawn or died) and remaining carers (those who were continuing to take part with 
a patient and those who had decided to continue participation after the death of the patient) 
were asked if they were willing to participate in a focus group to discuss the developing theory. 
Nine patients and eight carers were approached to take part in a focus group. Two dates were 
selected at appropriate venues away from the hospital. All those who were approached agreed 
to take part. Logistical difficulties restricted attendance but six participants were present. Five 
participants (three patients and two carers) attended the first focus group for patients and 
carers, and unfortunately only one patient was involved in the second planned focus group 
owing to three patients being unable to attend on the day. The focus groups lasted 110 and 
25 minutes respectively.  
 
The interaction between participants in a focus group provides valuable data in most 
instances, but is somewhat dependent upon establishing rapport between the researcher and 
participant group (Birks & Mills 2015). Conducting focus groups at the end of the study meant 
that rapport had already been established with individual participants and they had already 
been engaged in the study and development of the theory. This meant that they were able to 
focus on the theory while providing additional detail to explore their experiences with each 
other. The discussion flowed easily with little prompting from me, as participants were keen to 
share their experiences with others who were living with melanoma. Prior to the discussion 
copies of the developing theory were made available to participants and I provided a verbal 
explanation of each element. Participants then began to consider the dimensions of the theory 
  
  100 
drawing on examples from their own experience. I also used the opportunity to discuss the 
terminology used in the theory to ensure that they made sense to the participants.    
 
 A focus group for HCPs was not originally planned as I anticipated it being difficult for them 
to be released from work commitments. However, CNSs were the HCPs nominated by most 
patients and in February 2016, two and a half years into the study, an opportunity to hold a 
focus group with Skin Cancer CNSs involved in the study presented itself after one of their 
regular meetings. In view of this I felt that replacing the planned second individual interview 
with a focus group would enable me to gain data that would enrich and refine the theory (Birks 
& Mills 2015). Six skin cancer nurse specialists took part in the focus group over 60 minutes. 
As they were already known to each other and I knew them through my clinical role, rapport 
had already been established so discussion flowed without much prompting. Copies of the 
theory were provided at the beginning of the discussion with a verbal explanation. Participants 
were then asked to share their thoughts on the theory, which they did while providing further 
examples from their own experiences.  
 
All the focus groups were recorded with permission from participants. This was particularly 
important to enable me to manage the meetings as having multiple participants meant that full 
concentration was needed to follow the conversation. 
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4.4.3 DATA ANALYSIS USING THE CONSTANT COMPARATIVE METHOD TO 
DEVELOP THEORY 
Audio recordings were transcribed and anonymised to maintain confidentiality. I transcribed 
the first two interviews myself to aid familiarity with the data. Subsequent interviews were then 
transcribed by a professional service. While transcripts were used to aid analysis, the original 
recordings were also listened to enabling better engagement with the data. Listening to the 
recordings, as Charmaz (2014) notes, helped me to get a better feel for the tone, tempo, 
silences, form and flow of the conversation. 
 
Sections of data may refer to more than one category and it was anticipated that the interviews 
would produce large amounts of data, particularly as repeat interviews were planned. NVivo 
(QSR International Pty Ltd 2012) computer software was therefore initially used to aid 
analysis. Some authors consider it more efficient than manual analysis (Polit et al. 2001) and 
as data were to be analysed iteratively, in parallel with data collection, time was considered a 
significant issue. Urquhart (2013) cautions that a software package may have embedded in it 
a particular view of how the analysis should be done and so advocates familiarising oneself 
with the basic concepts of coding prior to using packages such as NVivo. Having used 
Grounded Theory methods for my Masters dissertation I was familiar with the basic techniques 
of coding and had prior training using Nvivo. In addition I attended a two-day course on the 
use of NVivo to refresh and update my skills. However, when coding the first two interviews 
using NVivo I found the process more time consuming than anticipated and it also generated 
an excessively long list of codes. An additional barrier was created through the available 
equipment; I worked on an Apple laptop to enable backup through the local network in my 
department but at the time NVivo was only developed for Windows computers. This meant 
connecting to a virtual computer on the departmental server to access the software. However, 
this method generated a large number of codes that were not leading to categories. Having 
coded paper transcripts in the past, I realised that carrying a large number around would be 
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impractical, so an electronic form was required. Driven by the need to move my analysis on 
and collect further data, I re-coded the transcripts in the form of a Word document which 
proved to be a more natural process. An example of open coding of a transcript can be found 
in Appendix 6, along with the steps taken through focused coding and category formation to 
diagramming and theory formation. Using this method there were still a large number of initial 
codes but not as many as previously and these were both more manageable and more 
conceptually dense.   
 
Continued coding enabled new concepts to emerge through induction (Donovan & Sanders 
2005). It was anticipated that coding could occur chronologically, running alongside further 
interviews to aid constant comparison and theoretical sampling (Polit et al. 2001). This is 
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Figure 4.8: Development of coding alongside interviews 
 
 
By comparing data between participants, potential categories emerged and I began to use 
focused coding (See example of focused coding in Appendix 6) while still allowing new ideas 
to emerge as changes over time experienced by participants began to unfold. Charmaz (2014) 
states that one goal of focused coding is to determine the adequacy and conceptual strength 
of the initial codes. This was true as some codes were not carried forward or were modified to 
reflect the ongoing data analysis.  To incorporate memos into focused coding I created 
separate files for each focused code to include the data and memos. This enabled me to move 
the analysis forward. Where ideas emerged when I wasn’t directly working at my computer, I 
would write paper notes to be included later.  
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Applying the constant comparative method, all data were compared: patient to patient, carer 
to carer, HCP to HCP, patient to carer, patient to HCP and carer to HCP. This process 
commenced from the first interview which contained data from both a patient and carer. By 
the second interview I had data from two patients and two carers to compare as well as being 
able to compare incidents within the interviews. Shared meanings were evident for some 
categories but tensions began to emerge where understandings were not shared. The first 
interview I conducted stood out as ‘being positive’, although it took more interviews for me to 
realise that this was the patent’s and carer’s way of giving meaning to the melanoma by 
trivialising it in comparison to other life events. The second patient talked at length about his 
roles in life, as a self-employed tradesman, a husband, a father, a friend and a brother. He 
related his experience of having melanoma through these roles. While there were similarities 
in the interviews, it wasn’t until comparing the fifth interview (section available in Appendix 6) 
that aspects of the processes of ‘hiding’ and ‘sharing’ of information began to emerge. As 
analysis progressed and codes became categories ‘hiding’ and ‘sharing’ became part of the 
category that I termed ‘relationships’. The emergence of the category ‘relationships’ is 
illustrated in Table 4.2 as an example of category development within the study. 
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Table 4.2: Example of category development  
Initial Codes Focused codes Initial categories Final category  




Keep going for the family 
Withdrawing 
Choosing when to cry 
Being strong for others 
 
 
Talking to people 
Being straight with them 
People being there 
Reciprocal support 
Friends and family sharing cancer 
experiences 
 
HCPs support by giving information 
Receiving information/ Eyes open 
 
Being able to ask people for help 
Knowing who to contact 
A “good” HCP 
Belt & braces 
 
Expectations not met 
Diagnosis not immediate 
Having to ask for help rather than it 
being offered 

























































It was through the act of comparing seemingly different experiences that I began to build ideas. 
However, coding was not performed in isolation as there came a time where I had many 
categories and was still generating some open codes without moving easily to a theoretical 
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4.4.4 THEORY GENERATION THROUGH DIAGRAMMING 
All authors advocating Grounded Theory and constructivist research agree that the final 
product must be shaped by the data, so a vision of the final product cannot be preconceived.  
The first step towards theory building is attaining theoretical sensitivity. I already had a degree 
of this owing to my previous personal and professional experiences but this was enhanced 
when considering the role of other forms of knowledge, as described in Chapter Three. While 
Glaser & Strauss (1967) advocate ignoring the literature initially, they also state that the ability 
to theorise will depend upon the researcher’s ability to have theoretical insight into the area of 
research. Charmaz (2006) states that to gain theoretical sensitivity, it is important to consider 
the subject under study from multiple vantage points, and then use existing insights and those 
gathered from the data to make comparisons, follow leads and build upon ideas. Corbin & 
Strauss (2008) state that in essence it is the researcher’s ability to compare and question the 
data that is central. As I was using a constructivist approach I also wanted my participants to 
engage in this process. Diagramming was one way to achieve this as described earlier but it 
also played a key role in data analysis. I found that comparing and questioning data wasn’t 
enough to move to a more theoretical level. To explore how categories were interrelated, I 
used diagramming and then shared emerging theoretical relationships with the participants. 
An example of how the rollercoaster metaphor and diagramming process was introduced to 
Sarah can be seen in Appendix 6. This was the stage where, in conjunction with participants, 
final categories forming the final theory were determined as patients and carers drew and 
discussed their own ‘rollercoasters’. Patients and carers who were interviewed together were 
able to discuss each other’s’ ‘rollercoasters’ and in some cases drew their own visualization 
of the other person’s ‘rollercoaster’ before seeing what the other person had drawn for 
themselves. This led to elaboration of the key phases and transition points. 
 
  
  107 
Diagramming was therefore central to theory generation and development as categories and 
their properties were explored. Corbin & Strauss (2008) advocate using diagramming and 
memos to aid conceptualization. Charmaz (2014) also promotes the use of diagrams and 
maps at all stages of analysis but provides few examples of how they might be used. However 
she argues that the boundary between data collection and data analysis becomes increasingly 
blurred and this was evident during my interviews where I shared various iterations of the 
developing theory with participants to gain their views. Those who had adopted diagramming 
found this very useful at that point. As I returned to participants I explored my initial categories 
alongside their individual quotes and provided short summaries (either textual or in 
diagrammatic form) to facilitate discussion and further develop ideas and the relationships 
between categories. Examples of the diagrams shared with participants to prompt their 
thoughts can be seen below in Figure 4.9. As the diagrams developed, categories and 
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Figure 4.9: Example of category development diagrams shared with participants during 
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4.4.5 MEMOS 
Charmaz (2014) describes the value of memos in the following way: 
Memo-writing is the pivotal intermediate step between data collection and writing drafts of 
papers. Memo-writing constitutes a crucial step in Grounded Theory because it prompts you 
to analyse your data and codes early in the research process.  
(Charmaz 2014 p162) 
 
During my study memo writing took a number of differing forms. Charmaz (2014) suggests 
that a methodological journal can accomplish multiple purposes including: taking a step back 
from the data so as not to become too immersed, providing a means of capturing emerging 
ideas and feelings by reflecting on a recent interview, and bringing together potentially 
disparate ideas and moving them towards a higher conceptual level. Through using a 
reflective journal to record methodological decisions and analytic processes I was able to keep 
a contemporaneous account of the theory as it emerged over time. I often recorded my initial 
reactions to an interview immediately afterwards and returned to these later for further 
consideration.   
 
Analytic memo writing also began early for me and such memos were recorded in a separate 
document.  As the potentially more abstract and complex categories began to emerge, I then 
created separate documents for each category containing sections of data and accompanying 
theoretical insights. Through regular meetings with my supervisors, in which we discussed the 
analysis and emerging theory, supervision records also captured the various methodological, 
analytical and theoretical decisions made during the study. An examples of a theoretical memo 
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4.4.6 THEORETICAL SATURATION 
Data collection and analysis needed to end within the planned timeframe of the study for 
logistical reasons. However, it naturally came to a close as interviews were repeated and new 
data was not forthcoming. There came a point in the third year of interviews where participants 
who were likely to experience recurrent disease had done so, and those that wanted to 
withdraw had. Patients diagnosed with metastatic disease had died, along with others who 
had experienced recurrence and carers had chosen whether to continue with the study or not. 
Data collection was then centred around patients who were having ongoing surveillance, their 
carers and the carers of patients who had died. At the same time the evolving theory had been 
taken to participants in its various iterations and fewer changes were being made. At that 
point, it seemed reasonable to use the focus groups to finalise the theory. During the focus 
groups, the theory did not change significantly. Wording was altered slightly after discussion 
but the content remained the same.  
 
4.5 ETHICAL CONSIDERATIONS 
Biomedical ethics are often considered using the four sets of moral principles set out by 
Beauchamp & Childress (2013): respect for autonomy, non-maleficence, beneficence and 
justice. Within healthcare research particular attention is also given to the rights of research 
participants including the issue of consent as originated in the Nuremburg Code (1947). Within 
the UK, healthcare research is also governed by the Research Governance Framework (Great 
Britain. Department of Health 2005).  The priorities of the Research Governance Framework 
include the need for ethical review, informed consent, data protection, the reduction of risk to 
participants and that the dignity, rights, safety and well-being of research participants are 
upheld at all times. The priorities of the Research Governance Framework are congruent with 
the moral principles of Beauchamp & Childress (2013) in that:  
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• Informed consent respects autonomy  
• Data protection, risk reduction and safety uphold aspects of non-maleficence  
• Upholding patient rights relates to justice  
• The need for ethical review ensures that the research has been peer reviewed to 
consider ethical principles  
 
The study was reviewed by an NHS ethics committee prior to commencement of the study. 
Copies of ethics and other approvals can be found in Appendix 8. The Research governance 
framework recommends participant involvement at all stages of the research process. 
Through the involvement of members of the Yorkshire and Humberside Consumer Research 
Panel in the development of the funding application, study protocol, related documents and 
ethics submission, only four questions were asked by the ethics committee at the meeting. 
These are detailed in the letter from the Ethics Committee found in Appendix 8. The majority 
of ethical issues had been addressed prior to submission.  
 
Within this study respect for the autonomy of participants was upheld through the informed 
consent process. All participants were given written and verbal information during their clinic 
appointment and given a minimum of one day to consider the information as they were then 
telephoned to see if they wanted to take part and arrange an interview or to reflect further 
before making a decision. Participants’ decisions to take part or not were respected and not 
questioned. The consent process was ongoing throughout the study. Participants could 
withdraw at any time and if they did they were given the option for their data to be withdrawn 
from analysis. They were assured that their treatment would not be affected whether they 
participated or not. 
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Non-maleficence with respect to upholding participants’ wellbeing, safety and confidentiality 
were all considered. It was anticipated that patients and carers who took part might 
subsequently have further questions or additional support needs and concerns that were 
highlighted by the interviews. During the consent process, participants were advised that the 
research may not be of direct benefit to them personally, but might improve care for future 
patients. However, if any participant experienced distress as a result of this research, owing 
to issues that are raised, with the permission of the individual, their clinical team would be 
informed and two CNSs, from differing hospitals, on the advisory committee for the study were 
available for support. Participants were not excluded if they became terminally ill, but were 
reminded that they could leave the study at any point and the demands of continuing to take 
part in the study discussed with them. Such discussions were conducted on a case by case 
basis and the decisions of patients and carers respected. These occasions are detailed later, 
in the participant biographies. Participants could also access support from the Cancer Support 
Centre and were signposted there. The dignity of all participants was respected at all times 
and interviews were conducted sensitively. When entering patient homes, common courtesies 
were respected. The safety of the researcher was considered and lone-worker policies were 
adhered to.  
 
The Data Protection Act (Great Britain 1998) and patient confidentiality require researchers to 
ensure that all patient details are kept confidential and individuals cannot be identified from 
the data collected.  Permission was obtained from patients to access their notes to record 
demographic data. As the main data collected was qualitative it was especially important that 
confidentiality was maintained so that patients felt comfortable and happy to discuss their 
views, feelings and experiences and without fear of any repercussions on their treatment. 
Patients were therefore assured that identifiable data was not seen by anyone outside of 
essential members of the research team. The process of transcription and analysis was 
explained to them prior to consent and where an external transcribing company was used, 
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specific ethical approval was gained after including the company’s confidentiality policy in an 
amendment shortly after the study opened to recruitment (See Appendix 8). In transcripts and 
quotes, participants were given an alias. This was felt to be in keeping with a constructivist 
methodology rather than providing a participant number. This also applied to healthcare 
professionals. Identifiable places and names were therefore removed from transcripts and 
quotes.  Recordings of interviews were stored on a secure server and kept until the 
transcription and checking process was completed including the initial analysis then deleted. 
Recording equipment was kept in a locked cupboard in the Cancer Clinical Trials Centre 
(CCTC) (which can only be accessed by authorised personnel) throughout the study. Where 
interviews took place in the patient’s home, the digital recordings were immediately returned 
to CCTC for appropriate storage (related risk assessment can be found in Appendix 8). 
Transcriptions were anonymised for analysis and stored on a secure, backed-up server, 
protected by a strong password and encryption.  
 
Justice and patient rights were upheld through the other principles. Their rights to 
confidentiality, autonomy and access to care were respected. Patient needs were placed as 
more important than the study at all times. This was particularly important when patients were 
too physically ill to take part in interviews. Where a carer wished to continue participation this 
decision was respected. Patient consent for this would have been obtained where appropriate, 
but in the cases where carers continued participation, it was after the patient’s death. 
 
Some potential benefits of participation were anticipated as some patients and carers, or 
HCPs, may have found the process of talking about their experience helpful. In later interviews 
and focus groups with patients and carers, the effect of the research process was discussed 
and will be considered within the section on reflexivity.  
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Specific ethical issues considered during the study were those related to longitudinal 
interviewing and the development of the researcher-participant relationship. These include:  
• Recruitment and consent shortly after significant diagnosis (Calman et al 2013, Yates 
& McLeod 1996). 
• Confidentiality & anonymity (Yates & McLeod 1996),  
• Developing a research relationship that can lead to blurring of boundaries potentially 
resulting in intrusion, dependency and distortion of life experience through repeated 
contact. Therefore the physical and psychological safety of the researcher and 
participant must be planned for, particularly where the focus of the study has an 
emotional element (Carduff et al 2015, Holland et al 2006, Yates & McLeod 1996). 
• There may be difficulty in closing the research relationship and this must be planned 
for, particularly where there is the potential for patients to become unwell or die 
during the study (Holland et al 2006, Carduff et al 2015). 
• Participant fatigue in interviews should be avoided by avoiding repetition and 
including emerging topics in subsequent interviews (Carduff et al 2015). 
 
Table 4.4 shows the ethical issues anticipated prior to the commencement of the research, 
including those related to longitudinal interviewing as detailed in the section above as well as 
those addressed during the conduct of the study. 
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Table 4.4 Specific ethical issues addressed throughout the study  
Timepoint Ethical Issue Action taken 
Approach to participate following 
diagnosis 
Participants given the choice to 
take part in research and not 
coerced at a vulnerable time after 
receiving bad news. 
Suitability of potential participants was discussed with the 
medical team prior to being approached and the medical team 
asked if they were happy to be approached by the researcher. 
Participants given a verbal summary of the research and asked 
if they would like to hear more. If they did not want to hear more 
or take part then their decision was respected. 
Consent  Participants should be given 
enough time to consider the 
information given to them before 
deciding whether to take part. 
Participants were given at least 24 hours to read the study 
information and were provided with opportunities to ask 
questions over the telephone and face-to-face before the first 
interview. 
Withdrawal/continued consent Participants have the right to 
withdraw from research at any 
time without giving a reason or 
their care being affected.  
Ongoing consent was gained from participants verbally prior to 
the start of every repeat interview. Some interviews were 
delayed or omitted if participants did not want to be interviewed 
at that particular time. One participant withdrew from the study 
and was given the option for data already collected to be 
retained or destroyed. 
Confidentiality of participants and 
third parties identified during 
interviews. 
Participants should feel free to talk 
without their care being affected 
and should not be identifiable from 
their data. 
Interview recordings were kept on an encrypted laptop and 
transferred to a secure, encrypted server. Transcriptions were 
then anonymised by the researcher so that people and places 
could not be identified, whether interview participants or third 
parties discussed during interviews such as non-participating 
HCPs 
Identification of participant support 
need during interviews and 
prevention of blurred boundaries 
within the research relationship. 
During interviews some patients 
and carers asked questions about 
their care, but as the researcher it 
was not my place to answer these.  
With their consent, patients and carers were referred to their 
allocated CNS to discuss any concerns they had. Prior to the 
study commencing two CNSs at differing hospitals had agreed 
to support study participants independently if they had issues 
that they did not want to discuss with their own clinical team. 
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This service was not utilised as the two patients requiring 
referral were happy to be contacted by their own team. 
Study completion and closure of the 
research relationship.  
Following repeat interviews, it was 
anticipated that participants and 
the researcher would build a 
relationship and the closing of this 
relationship would need to be 
mediated.  
The Consumer Panel involved in the study were involved in 
discussions surrounding study completion prior to its start to 
ensure appropriate planning, although it was recognised that 
this would need to be handled on an individual basis.  
Some patients completed the study early owing to disease 
progression or death. Carers were given the option for further 
interviews, to be sent a summary of the research or to have no 
further contact.  
Some carers completed the study early owing to changes in 
their relationship with the patient and their participation/contact 
necessarily ended there.  
For those patients and carers completing the study, the Focus 
groups provided an appropriate way to end study involvement 
and the relationship between participants and the researcher.  
Following analysis a summary of the results was sent to all 
participants with my contact details, should they have any 
questions. Two participants (one carer and one patient) 
telephoned to say that they had found taking part in the study a 
positive experience and that it had helped them to get through a 
difficult time.  
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4.6 RIGOUR 
The issue of how to gauge rigour in all qualitative research, including both constructivist 
research and Grounded Theory is contested. In terms of Grounded Theory the original criteria 
proposed for judging the quality of the theory itself by Glaser and Struass (1967) were: Fit 
(referring to how well the theory aligns with the data), Work (considering the extent to which 
the theory provides a usable explanation of the topic under study), Grab (which relates to the  
degree to which the theory provides an explanation that readily ‘grabs’ the imagination of the 
reader) and Modifiability (whether or not the theory provides an explanation that appears 
readily applicable, albeit with suitable modifications as needed, to other like contexts). As 
might be expected Charmaz (2006, 2014) suggested an alternative model that she thought 
was more relevant for constructivist Grounded Theory. 
 
Therefore in considering the rigour of a Constructivist Grounded Theory, Charmaz (2006) 
advocated moving beyond the positivist stance of Glaser & Strauss (1967) and proposed an 
alternative set of criteria that she termed Credibility, Originality, Resonance and Usefulness. 
For Charmaz (2006) these address the issues listed in Table 4.5: 
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Table 4.5: Charmaz criteria for considering the quality of a Constructivist Grounded Theory 
Credibility • Is the researcher familiar with setting and topic? 
• Are the data sufficient to merit the claims? Have 
systematic observations been made between 
categories? Do the categories cover a wide range of 
observations? 
• Are there strong links between the gathered data and 
the argument and analysis? 
• Is there enough evidence for the claims to allow the 
researcher to form an independent assessment and 
agree with the claims? 
Originality • Are the categories fresh and offer new insights? 
• Does the analysis provide a new conceptual rendering 
of the data? 
• What is the social and theoretical significance of this 
work? 
• How does the Grounded Theory challenge, extend 
current ideas and practices? 
Resonance • Do the categories portray the fullness of the study 
experience? 
• Have taken for-granted meanings been revealed? 
• Where the data indicate have links been drawn 
between institutions and individual lives? 
• Does analysis offer participants deeper insights about 
their lives and worlds and does the theory make 
sense to them? 
Usefulness • Does analysis offer interpretations people can use in 
their everyday worlds? 
• Are there any generic processes within the categories 
and if so, have they been examined for tacit 
implications? 
• Does the analysis spark further research in other 
substantive areas? 
• How does the work contribute to knowledge? How 
does it contribute to making a better world? 
Charmaz (2006) 
Whilst the above framework considers the ‘quality’ of the Grounded Theory that emerges from 
a study it does not address the extent to which the study engaged with the participants and 
allows them to play an active role. This is an important consideration in a constructivist study 
such as mine. For such studies, whether they generate a Grounded Theory or other output 
such as ‘case report’ (as discussed earlier), Rodwell advocates the use of the authenticity 
criteria developed by Guba and Lincoln 1989).  
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With regard to constructivist studies the most widely cited, and applied, model for judging the 
quality of a study, is that proposed by Guba and Lincoln (1989). This framework has been 
adopted by many authors as an overarching one that may be applied to qualitative methods 
across the board. 
 
Just as Glaser and Strauss (1967) wanted to devise a new approach to qualitative research, 
which they called Grounded Theory, Guba and Lincoln (1989) sought to develop and apply a 
new approach to the evaluation of services. They termed this ‘fourth generation evaluation’. 
They deemed such a development necessary in order to overcome the deficiencies that they 
saw within previous approaches to evaluation. They viewed existing models as being 
dominated by a positivist paradigm with the right to define what was ‘working’ being vested in 
powerful interest groups, either those closely associated with the ‘service’ that was being 
evaluated (educational initiatives in the case of Guba and Lincoln), or those conducting the 
evaluation or both. Their fourth generation model was based on the need to seek the views of 
all those with an interest in the service (termed ‘stakeholders’) with the aim of achieving 
agreement (consensus) on the criteria to be applied in determining if the service had indeed 
‘worked’. If consensus could not be achieved following several interactions then multiple 
reports should be produced that would ensure that the voices of each stakeholder group were 
heard. Whilst constructivist Grounded Theory is not necessarily concerned with the evaluation 
of services the need to actively engage with all interested parties lies at the heart of both 
Fourth Generation Evaluation and Constructivist Grounded Theory. 
 
The model advocated by Guba and Lincoln (1989) for considering the quality of their new 
approach was, in many ways, a radical departure from existing approaches to evaluation and 
they were concerned that it might be rejected by the ‘scientific elite’ who largely decided which 
studies were funded. Guba and Lincoln (1989) therefore proposed two sets of criteria for 
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deciding upon the rigour or quality of a study. One was termed the ‘parallel’ criteria and these 
they viewed as being comparable to the tradition scientific canons of generalizability, reliability 
and internal and external validity. They named these the ‘trustworthiness’ criteria and they 
included dependability, confirmability and transferability.  
 
However Guba and Lincoln (1989) were also aware that these ‘parallel’ criteria did not 
consider the extent to which the study had been able to engage with all participants and ensure 
that their voices had been heard. They therefore suggested a second set of criteria that they 
termed the ‘authenticity’ criteria which comprised: Ontological authenticity (the extent to which 
participants’ understanding of their own position has changed as a result of taking part in the 
study), Educative authenticity (the extent to which participants better understand the position 
of other groups as a result of taking part in the study), Catalytic authenticity (the extent to 
which the results of the study provide a stimulus for change) , Tactical authenticity (the extent 
to which the results of the study provide the means to achieve change) and Fairness (the 
extent to which the study captured the voices of all participants). According to Guba and 
Lincoln (1989) it was these latter criteria that most adequately reflected the degree to which a 
Fourth Generation Evaluation had been true to the principles upon which it was based. 
 
However although the ‘authenticity’ criteria were developed with the aim of ensuring 
participants were fully engaged in the study Nolan et al. (2003) were concerned that the 
language used to describe them was overly complex and might not be readily understood by 
participants who did not have an academic background. Therefore, when building a model to 
engage multiple groups of participants concerned with services for older people (older people, 
family carers, practitioners, politicians and researchers) in Sweden, Nolan and colleagues 
(Nolan et al. 2003), whilst keeping the rationale underpinning the authenticity criteria renamed 
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them to make them more readily understandable to the wider group of participants that they 
were working with.  This was as follows: 
• Fairness became Equal Access 
• Ontological Authenticity became Enhanced Awareness of our own position 
• Educative Authenticity became Enhanced Awareness of the position of others  
• Catalytic Authenticity became Encourage Action and  
• Tactical Authenticity became Enable Action 
 
Collectively these became known as the ‘EA’ criteria and they have since become widely 
adopted by both other researchers and practitioners/service providers. In addition to renaming 
the criteria Nolan et al. (2003) also argued that the framework should be applied not just at 
the end of the study but at all stages, as illustrated in table 4.6:  
 
Table 4.6: Modified Authenticity Criteria applied throughout the study 
Criteria Planning Process Product 





   
Encourage Action    
Enable Action    
 
The extent to which my study met the criteria of Charmaz (2006, 2014) and Nolan et al. (2003) 
will be considered in the discussion. Attention is now turned to the question of reflexivity.  
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4.7 REFLEXIVITY 
As noted earlier while reflexivity has been seen as an essential element of many qualitative 
approaches it has only recently been recognised as being central to constructivist Grounded 
Theory, as described by Charmaz (2014) below:   
“What we bring to the study influences what we can see….Researchers and research 
participants make assumptions about what is real , possess stocks of knowledge, occupy 
social statuses and pursue purposes that influence their respective views and actions in the 
presence of each other. Nevertheless, researchers, not participants, are obligated to be 
reflexive about what we bring to the scene, what we see, and how we see it. “  
Charmaz (2014) p27 
 
The researcher’s potential influence on the research process is evident at all stages, from 
planning through to writing the final theory. Corbin & Strauss (2008) note that this influence is 
most apparent during data collection and analysis as researchers react to participants’ 
accounts and participants react in turn to the researcher, usually on a subconscious level. 
While reflexivity has become a part of Grounded Theory Methods, its exact use is hard to 
pinpoint within the literature. To try to achieve consensus on its use in Grounded Theory 
Gentles et al. (2014) reviewed the existing literature. They concluded that whilst the notion of 
reflexivity is widely promoted most researchers fail to explicitly define what they mean by it 
and which approach they are adopting. As a result of their reading they suggest that reflexivity, 
at least in Grounded Theory, should address four issues:   
• Types of researcher interactions that may influence the research 
• Researcher influence during all stages of the research process 
• How researcher influence is handled 
• How researcher influence is viewed.  
In keeping with these suggestions I will now consider how I may have influenced the study at 
its various stages and how such influence was addressed.   
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4.7.1 RESEARCHER INFLUENCE ON RESEARCH DESIGN AND DECISIONS 
My influence on the choice of research topic has been addressed in Chapters 3 and 4. As a 
PhD student the influence was not mine alone and the views of my supervisors also played 
an important part in the methodological decisions that were made.  The other important 
influence on the design was the study advisory group which included patient representatives 
and specialist nurses who commented on the research protocol, associated documents and 
ethics submission to ensure that they were suitable for participants. 
 
4.7.2 RESEARCHER-PARTICIPANT INTERACTIONS DURING DATA COLLECTION  
The foremost influence on researcher-participant interaction was my professional role. I did 
not hide this from participants as I worked in the clinics that some participants attended and 
so they might have at least seen me in passing. To try to hide my nursing role may have 
inhibited the development of trust with participants, especially if they already knew of it or 
found out at a later point in the study.   
 
As I had in effect a ‘dual’ role for many participants (as a researcher and a nurse) this 
influenced my interactions with them. Some cast me in the nurse role and asked advice or 
questions about their melanoma and its treatment. When this happened I usually referred 
them to their CNS. However, I also ensured that I always checked out participants’ meanings 
and what they understood about their condition in case they were assuming that I already 
knew because I was a nurse. I was also concerned that participants may not like to pass on 
what could be considered as potentially ‘critical’ comments about their experiences in case I 
knew the person they were talking about. However, this did not appear to be the case. An 
advantage of my nursing background was that participants seemed able to talk about 
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potentially personal effects of their melanoma because I was unlikely to be embarrassed by 
their accounts.     
 
In building rapport with participants, I capitalised on the skills gained in clinical practice where 
a trusting relationship needs to be built within the confines of the clinic. I observed common 
courtesies when visiting participants’ homes and offered hospitality such as refreshments and 
an appropriate environment when they visited the research centre to participate in interviews. 
When visiting participants’ homes, while dressing smartly, I would dress more casually than I 
would in a work environment to separate my research persona from my clinical persona and 
to avoid appearing in any position of power, so I quite often wore jeans and a shirt. Such attire 
was not possible in the research centre where I had to adhere to the appropriate dress code 
for the work environment. However, this did not appear to hinder the conversation, possibly 
because everyone else was dressed in a similar fashion. With each repeated interview, my 
relationship with participants became more familiar and relaxed with the majority very willing, 
indeed often eager, to share their story. The rapport and trust that had built up during the 
interviews also enabled the participants to engage readily in the focus groups.   
 
4.7.3 RESEARCHER INFLUENCE ON THE ANALYSIS  
During data analysis my potential influence on how the theory might emerge became clearer. 
Even though I tried to make explicit the part that my prior professional and personal experience 
had played in both my motivation for undertaking the study and the foreshadowed questions 
that I wished to study it became apparent that other, more latent, processes were at work. As 
a result of my clinical experience I became aware that I held some preconceived ideas about 
what the ‘melanoma journey’ should look like. These were influenced by the traditional 
‘medical model’ trajectory and the clinical pathways that myself and colleagues used to frame 
our work. I became aware that whilst participants might use a similar framework to describe 
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their experiences that it should not be imposed upon them.  I therefore worked hard to ensure 
that participants were encouraged to describe and chart their experiences over time using the 
milestones and key junctures that were most meaningful to them. I always checked meanings 
and returned to participants with my interpretation of their story at the next interview. This was 
a distinct advantage of repeated, longitudinal interviews.   
 
4.7.4 RESEARCHER INFLUENCE ON THE WRITING OF THE THESIS/THEORY  
The ways in which the results of research are written and presented is very important if they 
are to reach as wide an audience as possible. For Charmaz (2006), Constructivist Grounded 
Theory should be written in a style and language that can be easily understood by all the 
participants. For Nolan et al. (2003) this key aspect to ‘equal access’, as even if participants 
can physically access research findings they are of limited use if they cannot subsequently 
understand the language used.  This presents something of a dilemma for a PhD student 
writing a thesis. The thesis has to be ‘examined’ and this may bring with it certain expectations 
as to how it is written and presented. Whilst in reality it is unlikely that many of my participants 
will read my thesis I still wanted the theory itself to be written in a language and to use terms 
that would be easily understood. I therefore always checked that participants were happy with 
the way that the ‘theory’ was describing their experiences and this was one of the main aims 
of the focus groups. Based on their responses I feel happy that this was achieved. However it 
is not just the participants that need to be able to understand the ‘theory’ and if it is to be of 
wider use other people living with melanoma, their carers and practitioners need to be able to 
relate to it. It will be for future readers of this thesis and subsequent publications to decide if I 
have achieved this.   
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4.7.5 INFLUENCE OF THE RESEARCH ON THE RESEARCHER  
The influence of the research on me became apparent in my clinical work as I was better able 
to empathise with patients and carers and began to notice issues that were important to them 
that had also been raised in the research. I was then able to explore those issues.  
The other issue was that of the relationship built with participants during the course of the 
research. With repeated contact over three years, a relationship was built with each participant 
over time. During conversations before or after interviews I would often share details about 
myself. For example one participant mentioned a band that they were going to see and as I 
had seen the same band a few years before, we shared a common interest. With another 
participant, I shared an interest in photography and with other participants I shared the 
experience of having dogs as pets.  
Building ongoing relationships over time also meant that I needed to ensure that that these 
were brought to a close appropriately. This was firstly done while arranging the focus groups 
but for a final written theory to be shared with participants. These opportunities enabled me to 
ensure that participants were left without ongoing issues and that I had the opportunity to 
thank them for their participation. These opportunities also provided an end to the relationship 
from my perspective as relationships built over years, even in the name of research, are not 
one sided.  
 
 
4.7.6 THE INFLUENCE OF THE RESEARCH PROCESS 
Charmaz (2014) states that research participants can use interviews to make sense of their 
situation. This was the case in my research and the research process itself had an effect on 
participants’ experiences. This will be discussed in detail in the results and discussion 
chapters.  
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Given the longitudinal element of the design, the influence of time on the research, researcher 
and participants must be considered. Saldana (2003) asserts that time should be considered 
as a social construction, rather than something that is experienced equally by all people at all 
times. In section 3.2 I have described the experience of time standing still while waiting for 
results and in this respect, participants may feel time differently at various points in their 
experience of melanoma. Saldana (2003) considers time to be data but to capture the 
complexities of a journey the researcher should use the concept of from-through rather than 
the more discrete events occurring ‘from’ one time point ‘to’ another. This is in keeping with 
the aim to identify social processes within Grounded Theory methods. Saldana (2003) also 
links the concept of change to time stating that this should be considered prior to the 
commencement of a study, for example change could be defined as differences, events, a 
process or continuous events or motion. Using Grounded Theory methods the final product or 
type of change identified cannot be anticipated although it can be argued that the process 
used to identify change is the constant comparative method whereby change is identified 
through differences between and within interviews and the examination of negative cases. 
Saldana (2003) asserts that change, like time, is contextual and may therefore change during 
a longitudinal study as it depends upon time and social processes that can be experienced 
differently. The final constructs of time and change and their influence on the researcher, 
research and participants within this study will be considered further in the discussion chapter. 
  
4.8 SUMMARY 
This chapter has provided insight into the methodological decisions made including why: 
• Qualitative methods were chosen 
• Grounded Theory was considered the most appropriate as it allows the development 
of mid-range theory with practical application 
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• A constructivist approach Grounded Theory, influenced by Charmaz (2014) was 
chosen 
The essential elements of Grounded Theory methods have been highlighted including: theory 
generation rather than verification, theoretical sampling, the use of constant comparison, 
simultaneous data collection and analysis, hierarchical coding, memo writing and theoretical 
saturation of categories and their properties. It has also described how these were used in my 
study. In particular it has shown how diagramming was used with patients and carers to involve 
them in data collection and analysis to form the final theory.  
 
While the principles of rigour and reflexivity have been explored, these will be fully elaborated 
on in later chapters. I now turn attention to the results, beginning with an introduction to the 
participants.   
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5 CHAPTER 5: AN INTRODUCTION TO THE PARTICIPANTS 
This study adopted a Constructivist Grounded Theory approach in which an active role for the 
researcher and participants was integral. Using brief ‘pen portraits’ this chapter introduces the 
primary participants in the study, people living with melanoma and where one was nominated, 
their carer/supporter, together with the HCP nominated as being the most influential. It is 
hoped that this will bring these individuals ‘to life’ for the reader. Pseudonyms are used and 
care has been taken not to provide any information that would allow participants to be 




5.1 ANNE & ALAN 
Anne and Alan were a retired couple, both in their late sixties. They had worked hard to build 
their farm business which they sold and retired to the local village. Their melanoma journey 
began when Anne ‘noticed’ a ‘mark’ on the back of her hand. She attributed this to a working 
injury but when she realized that it wasn’t going away, she sought help from her GP, who 
referred her for a specialist opinion. Anne did not see herself as a ‘sun worshipper’ and did 
not recognize the sun exposure as part of her occupation as a risk. She was surprised that 
after the ‘mark’ had been removed, it was found to be melanoma.  I met Anne when she was 
diagnosed with a further melanoma on her arm which she described as ‘a different animal’. 
There had been a three-month delay in her being referred to oncology as the letter hadn’t 
arrived. Alan had also recently been diagnosed with prostate cancer so they were both familiar 
with the oncology department and its systems. This meant that Anne knew that she needed 
to ‘chase up’ her appointment. Anne also had fibromyalgia, which was a greater concern to 
her than the melanoma. 
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Anne and Alan viewed the melanoma diagnosis stoically as they had overcome what they saw 
as greater challenges in the past. For example while visiting family their party was involved in 
a traffic accident that caused the deaths of three family members and friends. They had also 
lost contact with their grandchildren, owing to the breakdown of their son’s marriage, 
something seen as being of far greater concern than the melanoma. When nominating a HCP 
for the study, Anne chose the CNS at her local hospital as she had built a relationship with her 
after the initial diagnosis.   
 
Anne and Alan took part in four interviews over the course of fourteen months. The fifth 
planned interview was postponed as Anne had a stroke and her rehabilitation took priority. 
With agreement, I kept in touch with Anne and Alan via telephone and three months later Anne 
was diagnosed with metastatic melanoma. At this point both withdrew from the study as Anne 
was too unwell to continue and Alan’s time was taken caring for her. She died four months 
later.   
 
5.2 TONY & LIZ 
Tony was a sixty-six-year-old retired fire-fighter, who was working as a plumber at the time of 
study entry. He was in the merchant navy in his youth and as a result of chronic sun exposure 
had a twelve-year dermatological history, including removal of several basal cell carcinomas.  
Consequently, he had built a good relationship with the Skin Cancer CNS at his local hospital 
and nominated her to take part in the study. The latest lesion removed from his upper back 
turned out to be melanoma. At that time Tony was living with his wife Liz and they both had 
two adult children from previous relationships who did not live with them. Liz only took part in 
one interview before withdrawing from the study when they separated and subsequently 
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divorced, although she gave permission for the data from that interview to be used as they 
remained friends.  
 
Soon after the initial melanoma, Tony was diagnosed with another in his right axillary lymph 
nodes which required further surgery followed by radiotherapy. I met him as he was recovering 
from surgery, prior to having his radiotherapy. 
 
During the interviews, Tony had further investigations but he remained disease free. The 
combination of surgery and radiotherapy, however, left Tony with reduced power in his 
dominant arm and he didn’t feel able to work anymore. He decided to retire and took a job 
delivering medication for a pharmacy.  
 
Tony was very sociable, being secretary to a motorcycle club and regularly arranging fund 
raising events for a variety of charities. He conducted a lot of the club’s administration via 
social media, and was in regular contact with numerous people during his recovery. He 
therefore had good social support and he discussed his experiences with club members who 
had been treated for other cancers. He also had support from his brother who was a 
professional counsellor.  
Towards the end of the study Tony became involved with a new partner and withdrew when 
they moved just before the focus groups started.   
 
5.3 WITHDREW 
The third patient I recruited took part in the initial interview but then withdrew from the study 
and did not wish the data to be used. No reason was given, as was their right. 
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5.4 PHIL & KATE 
Phil and Kate were in their early sixties and had worked for the same company, having met 
when Phil replaced the light fittings in Kate’s office. Kate had stopped work to have a family 
but at interview was working part-time having gone back to work as their children got older. 
Phil was now retired but passionate about his hobbies of watching football and photography.  
 
Phil had a melanoma removed from his chest followed by a wide local excision. During his 
three monthly checks he found a lump under his left arm while having a shower. This required 
lymph node surgery and I met him just before his radiotherapy. Phil had avoided finding 
information about melanoma until it had spread to his lymph nodes. At this point he became 
very proactive, searching for all the latest information. When he was diagnosed with metastatic 
disease, he was keen to take part in any clinical trials available. He was supported by his CNS 
in oncology and regularly contacted her using email. He did not hesitate in nominating her for 
this study. Kate was very supportive of Phil and organsied his appointments like a ‘secretary’. 
They were also close to friends/neighbours, some of whom had experienced other cancers. 
This provided a good support network for them.  
 
Phil had the opportunity to try Vemurafenib, then a new treatment for melanoma. He was keen 
to share his experience with the clinical team so that this knowledge might help other patients. 
Phil became too unwell to take part in the later interviews and died shortly after, at which point 
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5.5 SARAH, PAM, LYNN & AMY 
Sarah was a twenty-eight year old single parent of three children aged between twelve months 
and eight years old. Although her parents were divorced she saw both of them regularly along 
with her sister and her aunt. Sarah had a melanoma diagnosed during her most recent 
pregnancy so her daughter was also under surveillance. When I met Sarah she has just been 
diagnosed with recurrent disease to her right groin which required surgery and radiotherapy.  
Initially her mother, Pam, agreed to take part in the study as a carer. Unfortunately their 
relationship later broke down, as did her contact with many of her friends. Subsequently her 
Aunt Lynn took on more caring responsibilities and participated in later interviews.  Sarah’s 
sister, Amy, also took part in the final interview. While many HCPs were involved in Sarah’s 
care she nominated her practice nurse as the most influential. They had a long standing 
relationship which pre-dated her melanoma and was based around her children’s contact with 
the practice.   
  
Sarah was always cheerful and well presented, attending to her hair and make-up throughout 
her treatment, possibly as a result of her having been a hairdresser prior to her illness. 
Maintaining her appearance was very important to Sarah, because she didn’t want to ‘look 
poorly’ for her children, who she tried to shield from her illness as much as possible.   
 
 During the first interview Sarah had asked me about whether she could get help with childcare 
costs while she was attending radiotherapy appointments, so I referred her to the CNS and 
Cancer Support Centre for advice.  
 
The combination of surgery and radiotherapy left Sarah with lymphoedema to her right leg. 
This meant that she tired quickly and could not play with her children as much as she wanted 
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to. Having to avoid sun exposure also had an effect on their family leisure time. Towards the 
end of the study Sarah was diagnosed with localized but inoperable spread of the melanoma. 
She was faced with a choice of treatments including immunotherapy as well as the new 
targeted therapies. Despite such difficult choices her main concern was what would happen 
to her children if she died.  Sarah took part in interviews to the end of data collection and 
wanted to take part in a focus group but problems with childcare meant she could not attend. 
 
5.6 IRENE & SUE 
Irene was an eighty-two-year-old lady with no children but was close to her niece, Sue, whose 
own children were now in their late teens/early twenties. Irene enjoyed gardening and 
spending time with friends. She went on holidays around the UK but less frequently since she 
had been diagnosed with angina. She now struggled when walking uphill so her small dog 
was now walked by a neighbour. 
 
 Investigations for ‘polyps’, thought to be side-effects of her heart medication led to her being 
diagnosed with mucosal melanoma. The diagnostic process was complicated for Irene as she 
was not seen via the usual dermatology route. Her case was discussed at a Gastro-intestinal 
multi-disciplinary team (MDT) meeting, resulting in delays in her being referred for 
investigation to the skin MDT. Her GP felt some responsibility for this and so acted to ensure 
an urgent oncology appointment was made.  
 
Sue had been made redundant shortly before her Aunt was diagnosed with inoperable 
melanoma but upon hearing the news she decided to care for Irene rather than actively seek 
another job.  Irene had always been very caring towards friends and family and Sue felt she 
deserved her support. Having both mucosal melanoma and angina meant that Irene’s 
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treatment options were limited so interventions were delayed until she was symptomatic. Irene 
was stoical about this, with three of her sisters having died of other cancers.  She spent time 
with Sue sorting out her affairs and passing on family history. Unfortunately, when Irene 
became symptomatic, she deteriorated quickly and died within 6 months of the start of the 
study. Sue wanted to remain involved after Irene’s death to ensure that their story was 
complete. Sue believed in spiritualism and took comfort from the fact that Irene was going to 
meet her sisters who had pre-deceased her.  
 
When nominating a HCP to take part in the study, both Irene and Sue chose Irene’s GP who 
had been supportive throughout.   
 
5.7 TOM & EDNA 
Tom and Edna were both in their eighties. It was their second marriage, each having been 
widowed more than twenty years before. Tom was a retired mining engineer and Edna was a 
retired office worker. They enjoyed cruises and holidays and would go away for the weekend 
whenever they could. Their families visited regularly but Tom and Edna were very 
independent.  
 
Tom’s melanoma on his right heel needed several surgeries to obtain clear skin margins. 
Although his mobility was severely impaired they adapted their lives to accommodate this, for 
example by purchasing a scooter, wheelchair and crutches to minimise the impact on their 
lifestyle. They aimed to carry on as normal, tolerating the numerous hospital appointments.  
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They both had a lot of faith in the plastic surgeon as they had seen him at every appointment 
and if they had a problem, could easily get an appointment through his secretary. They felt 
that the surgeon was the person who knew all about Tom’s care so nominated him for the 
study.  
 
5.8 JOHN & ESTHER 
John was a farmer and Esther an art teacher. They lived in a bungalow on the edge of the 
farm and were both in their mid sixties. They had two adult sons and grandchildren, one of 
whom lived in Australia. John and Esther had another house in Austria that they visited 
regularly. Ten years ago John had seen his GP with a mark on the right side of his face, and 
was reassured that it was nothing to worry about. A short time afterwards, while skiing in 
Austria, a friend advised him to get his mark checked as he had had something similar 
removed. John saw his GP again and was found to have a pre-malignant lesion.  
 
I met John who, after investigations for a persistent cough, had recently been diagnosed with 
metastatic melanoma. This came as a shock and John’s disease then progressed very quickly 
with the transition between hospital and community care not being as seamless as it should 
have been, so that Esther did not know who to turn to for help and information as the 
melanoma spread to John’s brain. She was therefore glad to get support from the Macmillan 
nurse once they were referred. John was eventually admitted to the local hospice and he 
decided not to have any treatment. He found it very difficult to talk to anyone about his 
condition and became withdrawn, not really communicating with Esther. He only really opened 
up during the first interview for the research study. John’s sons visited as their father’s health 
worsened and helped Esther to care for him and supported her subsequently.  
 
   
  138 
John died within three months of his interview so data from him were only collected once. 
Esther took a break from work while John was ill but was able to return to part-time teaching 
after his death. After John’s death Esther continued to participate in two interviews and one of 
the focus groups. She felt that this helped her to deal with her, at times, overwhelming grief.  
Owing to John’s quick deterioration, the nomination of a HCP was made by Esther, who chose 
the Community Macmillan Nurse with whom she had established a strong relationship in a 
very short period of time. 
 
5.9 KAREN & LAURA 
Karen, fourty-seven, was a nurse working as a senior clinical manager. She had three 
daughters and was divorced from their father. The eldest daughter, Laura, was a mental health 
nurse.  The two younger, twin daughters were finishing college. Karen’s mother also lived 
nearby. Karen was diagnosed with recurrent melanoma after being mis-diagnosed 10 years 
earlier with a benign lesion. When a ‘new’ lump appeared on her ear, she was busy with work 
and put off seeing her GP as she did not expect it to be anything sinister. Subsequently Karen 
had multiple surgeries and eventually her ear had to be amputated. She joined the study while 
under surveillance but was soon diagnosed with metastatic disease.  
 
At this time the new therapies for melanoma were not available so Karen decided to take part 
in a clinical trial. She initially attended clinics alone and only passed on the information she 
wished to her family.  Once in the trial, Karen sometimes brought Laura to her appointments. 
Laura was very angry about the previous mis-diagnosis. Although Karen had been offered 
treatment closer to home she built a trusting relationship with the oncology department and 
did not want to be treated elsewhere.   
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During the interviews, Laura felt that she was ‘becoming like a Mum’ as she looked after Karen 
and the rest of the family. As a nurse, Laura had a better understanding of what was happening 
and relayed this to her sisters. While supporting her Mum, Laura re-evaluated some of her 
own relationships, discarding friends who did not understand why she was spending so much 
time with Karen. Karen and Laura planned short breaks and days out to create happy 
memories.  
 
After Karen’s death I had no way of contacting Laura directly as Karen had arranged the 
interviews and so her involvement in the study stopped and no HCP was nominated. 
 
5.10 HELEN 
Helen was fourty-six and worked at a local supermarket. She had a very cheerful disposition 
and enjoyed interacting with her customers.  She was single, but lived near her mother who 
she kept in close contact with. She also had a large group of friends and went out with them 
regularly.  
 
Helen ‘noticed’ an ulcer on her lip that was not healing and went to see her GP, who gave her 
some cream. When things did not improve, Helen was referred to the head and neck surgeons. 
Helen was surprised when she was diagnosed with melanoma and enlarged lymph nodes 
which required surgery. I met Helen when she was recovering from surgery and considering 
radiotherapy.  
 
As her sister had died from breast cancer a few years earlier, Helen had not immediately told 
her mother about her diagnosis. When I met Helen, her mother still did not know. 
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Consequently Helen didn’t name her as her carer. Neither did she want to impose on a close 
friend who accompanied her to appointments as she had a young family of her own.  
 
After having radiotherapy to her neck, Helen found eating very difficult and was limited to a 
liquid diet. She lost a lot of weight and not wanting to impose on her family/friends had built a 
trusting relationship with the Head and Neck Macmillan Nurse who would telephone to check 
on her after treatment. This was the HCP that Helen nominated to take part in the study.  
 
Helen slowly regained her ability to eat. Although she was still not able to eat socially she 
would still go out with friends, and have a drink whilst they ate. When she felt able, Helen 
would also still cook for her friends, but have some soup herself. Eventually she was able to 
eat soft foods but it was a long recovery. The radiotherapy also left Helen with a dry mouth so 
she carried a bottle of water with her wherever she went.  
 
Helen decided to tell her Mum about the melanoma before she started radiotherapy and found 
her Mum to be supportive, helping with meal preparation. Helen stayed with her Mum for a 
few days after her treatment. However, her Mum did not trust Helen to tell her everything once 
she knew that information had initially been withheld.   
 
Helen completed study participation, including a focus group and was being followed up by 
the oncologists and surgeons at the end of data collection.  
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5.11 LUKE 
Luke was fourty-two, recently divorced and living with his mother. His father had died from 
bowel cancer the previous year.  Luke enjoyed photography, walking and growing his own 
vegetables. He had a manual job in a warehouse, which kept him fit, and he enjoyed being 
active. He did not have many friends, only mentioning a co-worker in the interviews. He didn’t 
feel he needed a ‘carer’ and so did not nominate one. He was very independent and liked to 
deal with things himself.  
 
After his father had died, Luke had focused his attention on his Mum, so he hadn’t immediately 
noticed the mole on his back changing. Its position made it difficult to see and he only ‘noticed’ 
it by chance in the mirror one day. He saw his GP who had said that she was ‘very concerned’, 
but did not elaborate any further. The subsequent feeling of not having enough information 
stayed with Luke throughout the study. I met him after his surgery and although he now knew 
his diagnosis he still had many unanswered questions. He had not been in touch with the CNS 
so, with permission, I asked the team to contact him. Despite this Luke did not develop a 
relationship with any HCP in particular as he had not seen the same person twice. He therefore 
did not nominate anyone.  
 
When we met, Luke was still recovering from surgery and had not gone back to work yet due 
to the physical demands this placed on him. Luke had rarely missed a day’s work so was keen 
to get back. He filled his time by going for long walks, taking photographs along the way. As 
he improved he managed to do some limited gardening and negotiated a return to work on 
light duties. Luke found this a little boring and preferred to be more active but realized that he 
wasn’t yet able to do the heavy lifting required. When he did return to full duties he struggled 
as the promised support was not provided. However, following an occupational health review 
additional help was made available.  
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Luke didn’t require any treatment beyond surgery but attended follow-up appointments for a 
year. He was then diagnosed with metastatic disease during a routine scan. Luke took part in 
one interview just after this but was then transferred to the hospice and died within weeks.  
 
5.12  FRED 
Fred was in his seventies but still worked at the local supermarket. He was a widower with 
four children and numerous grandchildren. He couldn’t name an individual carer as he found 
it difficult to choose between his children who all shared his care. He would see one of his 
daughters for a meal each weekend and whilst his sons lived further away, they took their turn 
in taking him to his hospital appointments. His eldest teenage granddaughter would do his 
housework once a week for pocket money. Fred had a springer spaniel that he walked around 
the local park every day and he also spent time in his garden or with his friends in the pub.  
 
Fred noticed a ‘mark’ on his right cheek that did not look quite right so he went to see his GP 
who sent him to dermatology to have it removed. The histology result was indeterminate but 
thought to be low risk, so he was discharged. A year later another black spot appeared on his 
cheek, but as he had previously been discharged he needed another referral from his GP. 
After minor surgery Fred was given an appointment to get his results but received a worrying 
telephone call asking him to attend earlier. The result showed that, while the lesion had been 
completely removed it was a metastatic melanoma deposit rather than the primary lesion. He 
therefore had a skin examination, a CT scan and ophthalmological examination to identify the 
primary melanoma. However, one was not found; not uncommon in melanoma where the 
primary lesion can regress even after metastatic deposits have left the primary site.  
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Fred continued to have follow-up examinations every three months. At one appointment, a 
further black ‘mark’ on his cheek caused concern, but it turned out to be a stitch that had not 
dissolved and had worked its way to the surface. During his investigations Fred spent time 
with the new CNS, who had taken an interest in his case. It transpired that her daughter and 
his granddaughter were friends at school and they had formed a close relationship. Fred had 
only needed to contact the CNS twice but he knew that she would always get back to him and 
trusted her to do whatever was needed. He therefore named the CNS for inclusion in this 
study. 
 
Fred told his family and friends of the melanoma but did not make a ‘big deal’ out of it. As he 
recovered from the melanoma, his hip became problematic and was a greater priority until he 
had a total hip replacement. Fred participated in all interviews and a focus group. At the end 
of the study he was attending for routine surveillance without any further problems.  
 
5.13  MATT 
Matt, at twenty-eight, was one of the youngest participants. He had a difficult childhood with 
an alcoholic mother and had some problems with addiction himself in the past. He had moved 
to a new area to ‘start afresh’ and was trying to stay in work and mix with people who might 
be a ‘better influence’ on him.  His brother had been more successful at finding a career and 
he wanted to emulate him. He was still in contact with his mother, though they had a difficult 
relationship.  
 
Matt’s girlfriend at the time had ‘noticed a mark’ on his back so he went to see his GP who 
referred him to dermatology to have it removed. I met Matt after he had found out that it was 
melanoma that needed a wide local excision. This meant that Matt had to take some time off 
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work and he was worried that too much free time might lead to old habits returning, so he 
wanted to start work again as soon as possible. Fortunately, as he worked in a call centre, he 
was able to return to work within a couple of weeks.  
 
Matt turned to the internet for further information about melanoma. He discovered that the 
actor Hugh Jackman had been diagnosed with skin cancer in the past, and took comfort in 
knowing that someone he admired had been through something similar. Having moved to a 
new area, Matt had few friends and split up with his girlfriend before receiving the diagnosis. 
He noticed that he was becoming snappy at work and felt angry. This lead to his boss calling 
him into her office to find out why. When he explained what had happened, she was 
sympathetic as she had had treatment for a different cancer in the past. Matt subsequently 
shared his experience with another colleague who was having treatment for cancer. Matt’s 
mood and working relationships improved. The experience of having melanoma made him 
think about his spiritual beliefs. Matt thought that it was a sign from God to ‘watch his back’ 
and look after himself. This reinforced his resolution to improve his life.  
 
Matt continued to have regular follow-up but did not require any further treatment. As most of 
his contact had been with his plastic surgeon he nominated him as his HCP. However he did 
not respond to the invitation to take part and so could not be interviewed.  
 
5.14  RUTH 
Ruth worked as a care assistant in a nursing home. She was in her sixties, divorced with adult 
children and grandchildren. Her granddaughter would usually be at the house when I visited 
and her daughter or a friend would accompany her to hospital appointments. Ruth had enjoyed 
sunbathing on holidays in the Mediterranean for many years and ‘noticed’ a change in a mole 
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on her lower right thigh so went to see her GP. After having the mole removed Ruth was told 
that it was melanoma. I met her following the surgery from which she had recovered quickly.  
 
While wanting to take part in the study, Ruth tried to deny the melanoma. She was resolute 
that she would not think about it and stated that she didn’t listen during clinic appointments. 
During the interviews she would answer questions as briefly as possible, and whilst stating 
that she didn’t think about it she had evidently paid attention to some of the information given 
to her. Ruth didn’t feel she had a carer but this may have also have been because she didn’t 
want to admit that there was something wrong. Ruth confided in one particular friend she 
trusted not to say anything to anyone else. It was important to Ruth that she controlled who 
knew about her diagnosis. 
 
Ruth attended routine surveillance for six months and nominated the plastic surgeon that she 
had seen to take part in the study. Unfortunately the surgeon did not respond to the invitation 
letter or the follow-up telephone call. During surveillance Ruth had planned another holiday 
abroad with her usual group of friends but didn’t think that it was the same now that she 
couldn’t sunbathe.  Shortly after returning from holiday, Ruth was diagnosed with metastatic 
disease. She started a new targeted therapy and asked if we could do the next scheduled 
interview after the first cycle. Unfortunately during that time, Ruth was admitted to hospital and 
diagnosed with brain metastases so further interviews were inappropriate. She died a few 
weeks later. After her death, Ruth’s family took the opportunity to meet the clinical team and 
ask questions about her treatment, possibly a reflection of the fact that Ruth had not shared 
much information with her family.  
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5.15  MARK & SANDRA 
Mark was an outdoor worker in his forties. His wife Sandra was a care assistant at the local 
hospital, who had been treated for breast cancer ten years earlier. They lived in the country 
with their two German Shepherd dogs and were renovating their cottage. Mark had a ‘spot’ on 
his right ear that had started to bleed and was not healing. Sandra was having to regularly 
wash his pillow case so insisted that he went to the GP to get it checked, who referred him to 
the hospital for tests. When they went to receive the results Sandra realized that something 
was wrong when there were a lot of people in the room, including a nurse wearing a Macmillan 
name badge. Mark, not having worked in healthcare, did not pick up on these cues. After the 
initial melanoma diagnosis, Mark was left with a large piece of his ear missing so a prosthesis 
was made to disguise it. I met him at that point. Owing to the complex surgery to his ear, he 
felt as though the plastic surgeon had the most involvement with his care so nominated him 
for the study. However the surgeon did not respond to the invitation letter or follow-up 
telephone call. 
 
The cancer diagnosis had shaken them both, despite Sandra’s experience a decade before. 
Mark enjoyed his job but the constant sun exposure caused Sandra worry, particularly in the 
summer months. She wanted him to take a job where he was less exposed and ‘nagged’ him 
to use sun cream. At first Mark also felt strongly about this and spoke to the Health and Safety 
Officer at work to make sun cream available to all outdoor workers in the company. However, 
as time went on and he returned to his normal routine, he admitted to forgetting to use it 
sometimes. This caused a degree of tension between them. They both realized how serious 
melanoma could be and so Mark wanted to accelerate his plans for renovating the cottage so 
that everything was in place for Sandra should he become unwell. He also wanted to make 
sure that there was enough money put aside for her, so he would work any overtime offered. 
However, Sandra saw this as putting himself at risk owing to the additional sun exposure.  
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While they were a source of support for each other, Sandra felt that Mark did not open up 
enough to her. She had the support of her friends and he had support from his friends and 
colleagues but this was not always obvious. For Mark, having colleagues telephone to see 
how he was, was enough support. He would joke about the songs that he would have played 
at his funeral and if anyone made a comment when he wasn’t wearing the prosthesis, he 
would tell them what had happened, adding a warning that there are consequences to not 
using sun protection. While Mark was attending for follow-up, another colleague had a lesion 
removed that was diagnosed with a less serious form of skin cancer, and Mark was happy to 
provide support.  
 
During the study one of their dogs died from cancer, which Mark found particularly hard. Mark 
and Sandra took part in interviews to the end of data collection and wanted to take part in the 
focus group but Mark was unable to take the time off work.  
 
5.16  JACKIE & NICK 
Jackie and Nick were in their fourties. Jackie worked as a secretary in a hospital and Nick was 
a transport manager. The long hours that Nick worked meant that arranging an interview was 
difficult so he only participated in one interview towards the end of the study, whereas Jackie 
was allowed time off work to attend the research centre. They had no children, having tried 
IVF in the past and as they both worked long hours, they made the most of their leisure time. 
They enjoyed regular holidays abroad and Jackie had used sunbeds in the past, believing that 
it would prevent her from getting burned. She had fair skin with freckles and red hair.  
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Jackie had a melanoma removed ten years earlier and had been discharged. Nick had recently 
‘noticed’ a freckle on the same arm as the earlier melanoma that seemed to be changing and 
urged Jackie to go to the doctor. When the diagnosis of melanoma was made Jackie was a 
little shaken but only took a couple of days off work for the surgery as it did not affect her ability 
to perform tasks. She shared the diagnosis with one close colleague and her family. This 
caused some tension as her mother blamed her love of the sun for the melanoma. Nick 
identified himself as her carer as he was meeting her emotional needs as well as ensuring 
she did not stay out in the sun too long. 
 
After the first melanoma Jackie had used higher factor sun creams and sunbathed less. Her 
family would tell her not to lie in the sun and these reminders became more frequent after the 
second melanoma. Jackie now felt the need for more information, actively searching the 
Macmillan website. Jackie took part in the study until the end of data collection but was not 
able to attend one of the focus groups. She had no further episodes of melanoma during the 
study. She did not feel able to nominate one particular HCP to take part in the study.  
 
5.17  JACK & CAROL 
Jack and Carol were in their early sixties and were retired. They had been married for many 
years and had two adult children. Jack had been a miner and Carol was a home help. They 
had spent much of the previous year caring for their elderly parents who had now died. Their 
daughter, a nurse, had recently bought a house with her partner so Jack was helping with the 
renovations. In previous years Jack had been a keen runner, including marathons, but now 
preferred walking. They had both enjoyed holidays around the world including Thailand and 
China but would rather see the sights than lie on a beach. They became grandparents during 
the study and started to spend some of their time looking after their grandson.  
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A lump appeared on the right hand side of Jack’s cheek which he didn’t think anything of, until 
his son repeatedly suggested that he went to the doctor. When Jack saw his GP, he was 
reassured that it wasn’t anything to worry about but Jack went back a second time to see 
another GP who referred him to dermatology. The dermatologist suspected a basal cell 
carcinoma, but the diagnosis revealed that it was melanoma so a wide local excision was 
undertaken.  After surgery Jack was concerned about how it might look, as the dressing was 
larger than he expected but he was pleased with the result. I met Jack and Carol after his 
second surgery.  
 
During the first interview Jack and Carol revealed that they had not spoken to each other 
during the journey home after being given the diagnosis, and had rarely discussed it since, 
not wanting to upset each other. When I met them, they were waiting for his CT scan to be 
reviewed as there was a suspicious area in his right lung. A further scan showed this to be 
benign.  
 
Jack continued to attend for regular surveillance visits and had no further episodes of 
melanoma, but he was more cautious in the sun, wearing a hat and regularly using sun cream. 
He participated in the interviews and one of the focus groups, but Carol could not attend the 
focus group as she was recovering from foot surgery. Jack did not feel able to nominate a 
HCP to take part in the study as he did not think he had seen the same person twice during 
his care. Jack’s diagnosis prompted his sister to have a suspicious mole removed which was 
subsequently diagnosed as melanoma.  
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5.18  JEAN & BOB 
Jean, fifty, was partly home based as an area manager for a large company and Bob, fourty-
nine, her partner, was a long-distance lorry driver so travelled a lot. Jean had no children but 
Bob had children and grandchildren from a previous relationship. They had daily contact with 
members of their families but said very little about their social lives outside of the family. They 
both worked long hours but enjoyed regular holidays abroad. Jean was surprised when a mole 
that been assessed by a GP ten years earlier as benign began to change. She went to see 
her new GP as she had moved house since the last assessment and after referral to 
dermatology and surgery, found that it was melanoma. The size of the wide local excision 
meant that Jean needed to have a skin graft, which was taken from the back of her thigh. The 
response from her new GP that resulted in a quick referral for treatment and the support that 
he provided afterwards prompted Jean to nominate him to take part in this study but upon 
trying to contact him, I learnt that he was off work on sick leave. 
 
Jean was keen to get back to work but the position of the skin graft made travelling difficult so 
she took extended time off. It was during this time that I met Jean and Bob. Jean was very 
independent and preferred to go to appointments alone as Bob didn’t get paid if he took the 
day off work to go with her. When needed, Jean had asked her elderly parents to take her to 
the hospital but her father’s driving made her nervous so she arranged for hospital transport 
after a couple of visits. Bob wanted to be more involved in Jean’s care, but she resisted this 
as she admitted to trying to deny the melanoma to herself. This caused some tension between 
them as Bob wanted to support her more, but Jean wanted to get back to normal rather than 
dwell on the melanoma.  
 
During the study Jean was admitted to hospital with costochondritis. This became more of a 
concern than the melanoma for a time. During surveillance visits for the melanoma Jean had 
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a further lesion removed from her right thigh as a precaution but this was benign. Jean’s 
surveillance visits were eventually managed from her local hospital once she had been 
discharged from plastic surgery. She took part in the interviews until the end of data collection 
as well as one of the focus groups. Bob could not take part in the focus group owing to work 
commitments.  
 
5.19  SUMMARY 
Hopefully the descriptions above have enabled the reader to begin to ‘get to know’ the 
participants in the study. In the following chapters I chart their ‘melanoma journeys’ 
highlighting the main timeframes they identified and the major processes that captured key 
elements of their experiences. Together these aspects comprise the mid-range theory to 
emerge from the study, one that was agreed individually by participants and those who took 
part in the focus groups. This theory charts the ‘ups and downs’ that the participants 
experienced and these are reflected in the metaphor ‘Riding the Rollercoaster’ that was briefly 
introduced in the methods chapter. The next chapter begins with a brief overview of the theory 
before describing the early stages of the participants ‘melanoma journey’.     
 
  
   
  152 
6 CHAPTER 6 LIVING WITH MELANOMA: RIDING THE 
ROLLERCOASTER 
6.1 INTRODUCTION AND THEORY OVERVIEW  
The primary aim of the study was to better understand the experience of living with melanoma 
from the perspectives of patients, their primary carer and the HCP that they identified as being 
the most influential. It was intended that the insights gained would result in the development 
of a mid-range substantive theory that had the potential for practical application in order that 
the melanoma ‘journey’ could be improved for those who might embark on it in the future. In 
order to do so a constructivist Grounded Theory method was adopted that employed a 
longitudinal design involving multiple sequential interviews with participants. The intended 
result was a temporal account of living with melanoma that highlighted key points in the 
participants’ ‘journeys’ and when help and support might be provided most effectively. 
 
The extensive volumes of data collected revealed a complex and multifaceted picture, with 
each ‘journey’ having both shared and unique elements. To develop a theory that captured 
such complexity, but could also be easily understood by multiple audiences, some of this 
individual variation was necessarily lost. Such a compromise is inevitable in all such 
undertakings. Nevertheless I believe (as did the participants) that what follows provides a 
faithful yet simplified rendering of the major milestones experienced by those living with 
melanoma and the impact that it had on them. Furthermore, as was explained in the Methods 
chapter, I sought as fully as I was able to allow participants to play an active part in the co-
construction of the theory. The extent to which this might be considered successful will be 
explored further in the discussion. 
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I begin with a brief overview of the theory as a whole, followed by an account of the early 
stages of participants’ ‘journeys’. The later stages will be explored in subsequent chapters. 
This overview will provide readers with a ‘route map’ to follow the relationships and interactions 
between the various stages and processes that marked the melanoma ‘journey’ as it unfolded 
over time. 
 
Consistent with a temporal approach the theory comprises a number of stages or ‘moments’ 
in the melanoma journey, the overall effects of which, as suggested in the preceding chapter 
are captured by the metaphor ‘Riding the Rollercoaster’. This reflects the various ‘ups and 
downs’ that participants experienced during their ‘journeys’, and whilst the nature of these 
understandably varied, as did the final outcome (for example between participants with fatal 
metastatic disease and those who remained melanoma free), all those who took part 
experienced both ‘ups and downs’. These are explored in the following chapters.  
 
Based on an analysis of their accounts the melanoma experience can be considered to 
comprise of the following key ‘moments’. These are captured below using, where appropriate, 
both everyday language and their more medicalised equivalent: 
• What’s that mole?: Pre-diagnosis   
• The Melanoma journey begins: Diagnosis and early treatment 
• Ups and Downs: Surveillance  
• The ‘Bombshell’: Advanced Melanoma, and for some, death  
Clearly not all participants experienced all stages (for example metastatic disease and death) 
but all were experienced by some. In working through these various stages participants’ lives 
underwent a number of changes brought about by the impact of the melanoma, and the nature 
of the interactions between patients and carers and their contact with the health care system. 
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These changes and the processes that accompanied them are captured in the theory by using 
an alliteration of ‘R’s, which reflect the impact of the melanoma on the participants:   
• Routines of daily life 
• The Roles that they fulfilled, and 
• Their Relationships with each other and the health care system  
These impacts were mediated by the ways in which participants Recognised and Responded 
to the challenges that they faced and the Resources that they could draw upon in so doing. 
The participants’ experiences are described below highlighting the ways in which these core 
elements of the theory interacted with each other at the differing stages of the melanoma 
journey, beginning with stage one, ‘What’s that mole?’ 
 
6.2 WHAT’S THAT MOLE?: PRE-DIAGNOSIS 
‘Well it probably started last year when I noticed me mole on me back’. Luke 
 
Many of the participants first became aware of what would later turn out to be a melanoma 
when they, or someone close to them, ‘noticed’ something unusual, such as a mark or 
discolouration on their skin. Participants often referred to this as a ‘mole’ but differing 
manifestations presented themselves. In order to provide a ‘shorthand’ for such diversity the 
term ‘lesion’, although rather medicalised, will be used in the account that follows unless, when 
using verbatim quotes, participants used a differing term. 
  
This process of ‘noticing’ often occurred by chance, and might involve the patient seeing 
something unusual for the first time, or the lesion being brought to their attention by others, 
usually, but not always, family members who ‘noticed’ it themselves. At this point many saw 
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no reason for concern and their ‘response’ was to ignore things. This tended to continue, either 
until there was a change which meant that the lesion could no longer be ignored or someone 
‘nagged’ the patient to do something about it. This is described by Mark and Sandra: 
 
“Well basically it was just a lump, a small lump on my ear, I did think it was a spot really.  
Typical bloke, you know, so it was left and left and left …… maybe up to a year afterwards, it 
just started losing a little spot of blood every now and again…. but Sandra (wife) was getting 
fed up of washing the pillowcases every other day, so she said ‘You'd better go’ (to the 
doctor).” Mark 
  
“The only reason why he went to the doctor was because I were nagging him because there 
were blood on the pillowcases all the time, and I said ‘This is not normal’.” Sandra 
 
For Luke the situation was somewhat different. His lesion was in a less visible place and his 
attention was drawn to it by chance. Although he ‘kept his eye on it’, other seemingly more 
important life events intervened and as with Mark, it was some time before he became aware 
of his ‘mole’ again: 
 
“Well it probably started last year when I noticed me mole on me back.  It were only because 
I’d lowered the mirror in bathroom. So I kept me eye on it, nowt really changed, and then me 
Dad got ill again (with cancer) and I sort of forgot all about that (mole).  And then come 
separation with me wife, …  I were just one day I were getting dressed (and) I caught it (mole) 
with me nail, and it started bleeding.  I thought that’s strange.  After about two weeks it never 
healed, and that’s when I went to the doctors.” Luke 
 
In Matt’s case it was his girlfriend who first ‘noticed’ a new ‘mole’, but, consistent with the 
others above, Matt ignored it until more radical changes occurred. As this point he started 
searching for more information, using the internet, until he became convinced that something 
‘dodgy’ was happening, a realisation that prompted rapid action: 
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“I didn’t notice until my girlfriend at the time saying ‘oh, what’s that’, I said oh, ‘it’s nothing, just 
a mole’,  ..I didn’t really think anything of it, until it turned really, really funny.  I thought ‘that’s 
just not right, this, just looks dodgy’.  Just got bigger, colour went darker, started itching a bit. 
I started Googling it on the internet, and the Google images looked similar to what I had on 
my back.  So I thought yeah, this could be dodgy, I thought I need a professional opinion. Well 
he  (doctor) said  ‘oh, that looks dodgy, I'm going to refer you’.  And I got referred to clinic, 
then the hospital, quite quick.” Matt 
 
Others, upon ‘noticing’ something unusual, looked for an explanation that meant it could be 
seen as ‘normal’. This continued until further changes occurred and/or ‘nagging’ from family 
members resulted in a professional opinion being sought. For Tom and Edna below the news 
that Tom had a melanoma came as a shock, as it was something they had never heard of:  
 
“I had what I thought was a birth mark, on the side of my foot.  After a while, it started to show 
signs of roughening up and being painful…… and the upshot was that eventually with a bit of 
pressure from my wife, I went to the doctors with it.” Tom 
“Yeah, you didn’t think it was melanoma when you went initially.” Edna  
“No, I didn’t think it was melanoma when I went.  Well to be honest, I didn’t know what 
melanoma was.” Tom 
 
As Tom and Edna had seen the lesion as a ‘normal’ birth mark, they initially ‘discounted’ it.  
Similarly Anne also explained away the mark on her skin as being caused by gardening or 
feeding the chickens, resulting in a delay before seeking advice. This ‘normalising’ meant that 
the lesion could be ‘discounted’, resulting in delays before help was sought. As a result, by 
the time she joined the study Anne had more than one melanoma:  
“The first Melanoma sat on the back of my hand just like a tea leaf. I did have it there for a 
while, longer than I should have had it there really but I felt that I had knocked my hand in the 
garden… or when I was feeding the poultry and I just really didn’t take any notice of it.” Anne  
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However, others, upon ‘noticing’ a change to their skin did not ignore or normalise the situation 
but sought professional advice quickly, only for the professionals themselves to ‘normalise’ 
things. This happened to Jean, and John and Esther, as they describe below.  
 
“About 10 or more years ago, I went to the doctors because I had a very dark, very flat circular-
ish thing on the back of my calf.  The doctor said that he wasn’t worried but that I should take 
photographs of it so that I would be able to identify if it ever changed.   And so I did. But I 
totally trusted that first doctor, but just keep an eye on it in case it changes.  And it never did, 
it sat there for, got to be at least 10 years.  It weren’t until something happened to it and 
because it was so dark and about the size of a 5p piece, (that) a few people had said to me 
that doesn’t look good, you should get it checked out..” Jean 
 
“Well I think it started probably (about) nine years ago, I got a small black patch on the side of 
my face.  Esther (wife) said ‘I think you should go to see the doctor about that’, and the GP, 
they said ‘is it flush with the skin?’, I said ‘well yes it is’, he said ‘well there’s nothing to bother 
about then’.  (Years later) We were over in Austria and the skiing instructor’s wife said ‘you 
should go and get that seen to, because Otto has just had one of those removed’.  So I came 
back, went to the GP.” John 
  
“Yes, and that was the thing.  When originally you had it checked, you went twice to him, twice 
he said it was okay, (we left it) ages, (but then) it just didn’t look right … and it was really this 
friend of ours who said you go and get it properly checked.” Esther 
 
In the above cases it was several years before further help was sought, often at the suggestion 
of others. In Jean’s case the doctor had advised ‘monitoring’ the lesion, which she did for a 
decade or more, until further changes happened and others urged her to seek advice. In John 
and Esther’s case no active ‘monitoring’ was suggested and it was only a chance encounter 
whilst on holiday that prompted them to seek another opinion. The seemingly innocuous 
nature of the lesion and the reassurance of their GP resulted in a lengthy delay. Sadly in this 
case the melanoma rapidly became metastatic and John died three months after joining the 
study. However, his wife Esther chose to continue and we will hear more from her later. 
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An exception to those ‘noticing’ a skin lesion, Irene ‘noticed’ bleeding that she attributed to 
haemorrhoids. She sought help from her GP immediately, who initially reassured her that the 
cause had been identified causing some delay in her diagnosis but when there was no 
improvement he referred her for investigations.  
 
 
So far participants have described the events surrounding the discovery of a new ‘mole’ or 
similar change. These participants did not ‘recognise’ the need to act and so usually 
‘responded’ by ignoring their ‘mole’, often for many years. For others however the onset of 
their melanoma was preceded by years of experiencing skin problems. Consequently because 
of this Helen and Phil were able to ‘recognise’ that something wasn’t right quickly and their 
‘response’ was to seek a professional opinion rapidly:  
 
“I noticed a mole which seemed a little bit abnormal. I've had moles forever, but this particular 
one seemed to be not behaving the same as the rest of them.  So I went more or less straight 
away to see the doctor, and she agreed and things progressed from there.” Phil 
 
“It didn’t look right to me. I've had mouth ulcers before, it wasn’t a mouth ulcer like that. I just 
got a funny feeling that something wasn’t quite right, and I went to the doctors the beginning 
of January. And then she referred me.” Helen 
 
Tony was having regular skin checks as he had numerous Basal Cell Carcinomas removed 
over a twelve year period, when one was found to be a melanoma: 
“Then I found one or they found one on my back which didn’t seem untoward in its size, shape 
or anything else. That one came back as malignant.” Tony 
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Things were rather different for Karen and her daughter, Laura. Karen had surgery for a benign 
skin lesion over a decade earlier, followed by further minor procedures. She had ‘monitored’ 
the situation for many years but was able to ‘discount’ and ‘normalise’ subsequent minor 
changes.  Even when more pronounced changes occurred Karen did not suspect anything 
serious. When a melanoma was diagnosed it came as a genuine shock to both Karen and 
Laura, heightened because they were both experienced nurses: 
 
I’d had a lump on my ear going back to 2003 that was removed.  (It) came back in 2008, and 
they did sort of a shave, tidied it up, absolutely fine. After that I've always had a little bit of a 
lump so thought nothing of it. And then it started to grow quite large, in two areas… one that 
was a very big bluish vascular lump.  So completely bizarre I’ll go to the doctors, I thought 
‘well it’s been nothing in the past, it’ll be nothing this time’.  And I suppose lucky for me in a 
way he (doctor) said ‘I've got no idea what it is, but I’ll put you on the fast track cancer referral’.” 
Karen 
 
“Well as long as I can remember basically my mum’s always had a lump on her ear and then 
when she told me obviously it was melanoma,  I thought  what if we’d have noticed this sooner, 
what if my mum would have stopped saying ‘oh it’ll be fine’ and gone (to the doctor), rather 
than just leaving it and leaving it, and what if we’d have pushed?”  Laura 
 
From the above accounts of the pre-diagnostic period two broad patterns have emerged. In 
the first the melanoma appeared as a ‘new’ lesion and in the second it was part of a much 
longer history of skin-related problems. The ways in which the melanoma was ‘recognised’ 
and ‘responded’ to in these scenarios tended to differ, but similar patterns can be seen.  
The lesion needed to be ‘recognised’ as being something out of the ordinary, so that it could 
no longer be ignored, ‘normalised’ and ‘discounted’, before participants ‘responded’ to it.  For 
Mark and Sandra, Luke, and Matt their story began with them ‘noticing’ a new skin lesion but 
their initial ‘response’ was to largely ‘ignore’ this (although Luke did ‘keep an eye on it’ 
(monitor) for a while until a more significant (and potentially worrying) change occurred and/or 
until they were prompted to act by others. It was only upon ‘recognising’ what they perceived 
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to be a worrying change or the pressure to act from others became strident enough that they 
‘responded’ by seeking professional advice. 
 
Other participants with a new lesion (Tom and Edna/Anne) did not ignore it but rather 
‘responded’ by finding a ‘normal’ explanation that meant any worries could be ‘discounted’.  
Once again it was not until there was ‘recognition’ of a more significant change or because of 
‘nagging’ from others that they ‘responded’ by seeking professional help. In both these 
scenarios lengthy delays ensued. 
 
A third group of participants (Jean/John and Esther) ‘recognised’ the need to act quickly and 
so ‘responded’ by seeking professional help very soon after ‘noticing’ their skin lesion. In their 
cases however the professional they contacted reassured them that their lesions were not a 
cause for concern and so any worries were ‘discounted’. Although Jean was advised to 
‘monitor’ the situation, because no major changes were noted, further action was not taken. 
As with all the participants so far it was only when more major changes were ‘recognised’ 
and/or others advised action that further help was sought. This again resulted in lengthy 
delays. 
 
Two participants with a long history of skin lesions (Phil/Helen) were able to ‘recognise’ when 
a new lesion was a cause for concern and ‘responded’ by seeking professional help rapidly. 
Tony’s melanoma, however was recognised by a HCP during a routine examination. For 
Karen and Laura the situation was slightly different in that it was the same lesion that had 
been treated over many years (and was ‘monitored’ by Karen during this period) that 
developed into a melanoma. Despite Karen and Laura being experienced nurses this came 
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as a shock to them both and caused considerable guilt for Laura who blamed herself for not 
‘monitoring’ the situation more closely. 
 
6.2.1 SUMMARY 
Even at this first stage of the melanoma ‘journey’ many of the processes that would occur 
repeatedly had already emerged, although the relative emphasis was to change as the 
‘journey’ progressed and the impact of the melanoma became more pronounced.  
 
During the pre-diagnostic stage the processes of ‘Recognising’ and ‘Responding’ and a variety 
of related processes, (‘Ignoring/Normalising’ and ‘Discounting/Monitoring’) were apparent and 
these will, to a greater or lesser extent, re-surface throughout the ‘rollercoaster’, with some, 
especially ‘monitoring’ gaining greater prominence. 
 
At this point the impact of the melanoma on the participants’ ‘routines, roles and relationships’ 
was relatively minor, nor had participants as yet had to draw on many ‘resources’. However 
what was quite clear at this early stage was that for the majority melanoma was not a solitary 
journey and it is already apparent that significant others played a major part both in 
’recognising’ the initial lesion and in prompting a ‘response’ by the patients. Moreover, all the 
participants, sooner or later, had contact with HCPs, and their ‘responses’ either in rapidly 
referring on or suggesting no further treatment was needed, were crucial. As will become clear 
it is these sets of ‘relationships’ (with significant others and HCPs), together with ‘routines’ and 
‘roles’ that will achieve greater prominence as the melanoma ‘rollercoaster’ continues. 
Furthermore whilst up until now the participants had not drawn on major ‘resources’ 
(relationships aside), apart from the use of the internet by Matt, the importance of access to 
‘resources’ will emerge as being significant later.  
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Having described the pre-diagnostic stage of the melanoma ‘rollercoaster’ and started to 
elaborate upon some of the main processes at play, attention is now turned to the next major 
juncture that marked the start of the melanoma ‘rollercoaster’ proper: Diagnosis and initial 
treatment. 
 
6.3 THE MELANOMA ‘JOURNEY’ BEGINS: DIAGNOSIS AND INITIAL TREATMENT 
“It’s really strange that one word can alter your life and, if you let it, destroy it.” Tony 
 
This section considers participants’ experiences during diagnosis and initial treatment. It will 
highlight ways in which the melanoma ‘rollercoaster’ unfolded upon diagnosis and how 
participants ‘responded’ to the news. Following the temporal approach that characterises 
Grounded Theory we begin with the diagnostic process. However, this often merged into the 
initial treatment and efforts are made to capture this overlap so as to reflect the sometimes 
confusing sequence of events.  
 
The first necessary step to obtaining a diagnosis was to ‘recognise’ the need for action and to 
seek a professional opinion. Within the UK health care system entry to expert medical opinion 
is via a GP. When they decided to seek advice one crucial factor was the ‘reaction’ they 
received from their GP. In the best cases GP’s were seen as highly approachable and had 
genuine concern for their patients. 
“My doctor’s really nice and friendly, I would feel quite at ease going and saying ‘I don’t feel 
like there’s something quite right’.  She said I will send you to the hospital, fast track you 
….And then she even phoned me up at half past nine at night… So yeah, she’s a lovely 
doctor.”   Helen 
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“I’m just glad that she’s (his wife Jean) changed to my doctor, he’s an absolutely fantastic 
doctor.  And she was only with him two weeks and he got her in (and) he’s rung her up to see 
how she is.  She’d been with her other doctor 10 years and he hasn’t done anything.”  Bob 
 
Fred was also pleased with the speed with which his case was dealt with but there is a hint 
that perhaps his doctor’s ‘bedside manner’ was perceived as less than optimal: 
“I mean don’t get me wrong when I did get to see [my GP] about this, the spot, he did do it 
(refer to hospital) promptly.  I got an appointment through very quickly, two or three days 
probably.  I mean he didn’t hang around.  But they’re a bit remote, you know.” Fred 
 
Following referral the quality of the participants’ first contact with the specialist hospital teams 
and especially the way in which their diagnosis was relayed was a significant event. For some 
their first contact was very positive and this usually set the tone for what was to follow.  Once 
again it was the ‘human face’ of the practitioners with whom participants came into contact 
that was often crucial: 
“The way the hospital fast tracked everything gives you peace of mind to be honest, that the 
hospital and everybody else are doing everything they possibly can do to help you.  10 out of 
10 to them for the way they told me, the doctor I saw, unbelievable, his knowledge, but you 
could still talk to him as a day to day person and ask him anything and he would come back 
with information, what is going to happen and they just relaxed you and reassured you about 
things that lay ahead for you.” Tony 
 
Therefore, from the outset the ‘relationships’ between participants and HCPs was of central 
importance and practitioners often became a major ‘resource’ which many participants would 
draw upon. Indeed, as diagnosis moved into initial treatment the importance of a good 
relationship with a HCP became even more apparent, as Karen makes clear below. However, 
her quote also reflects the feeling of being caught in a ‘whirlwind’, something that characterised 
the initial experience of many participants, as will be highlighted later:  
“I have to say the registrar, I don’t know what her name is.  But she’s been absolutely amazing, 
that continuity with her has been really good.   But from a negative point of view you’re just in 
a bit of a vortex and whirlwind and don’t quite know whether you’re coming or going.” Karen 
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For Tony continuity of contact was central and he describes the positive effect this had on how 
he ‘reacted’ to his early treatment: 
 
“In fact you get quite a good rapport going with the regular doctors you see each time and it 
used to be quite entertaining; one doctor, it was quite a highlight to go in there lie on the table 
and hear the conversations about what they had done all weekend, he would be totally relaxed 
with you while snipping and cutting… You just feel so relaxed.  I know at the end of it people 
in the hospitals are doing a job but it seems a lot more to me. They just talk to you and ask 
how you are, what you’re doing, how you are feeling, it just lifted you so much, it really did.” 
Tony 
 
Sadly, not everyone’s first contact with specialist services was as positive and Luke felt let 
down: 
“I saw this doctor and she said we’ll send you to dermatology, they might take a biopsy and 
have a look at it. So this other doctor come up, and she just turned round and said I’m very 
concerned, we need to get you in straight away.  There were no explanation about what she 
thought it were, I just felt like I were being pushed away and I left with more questions (than 
answers).” Luke 
 
Some people had to proactively ‘chase up’ their initial referral before further action occurred:  
“(The oncologist) said he would send a letter out for him to come for a scan the next week. So 
we expected it… So then the fortnight came and went, nothing.” Kate 
“And they'd lost my paperwork.” Phil 
“So you actually phoned up, didn’t you?  And spoke to a receptionist at radiology… And she 
just said oh, we seem to have bypassed you or missed you.”  Kate 
“And I only really did that because I was prompted by your other friend, wasn’t I?” Phil 
“Yeah, somebody, actually my uncle phoned up to see how you were, and he said no, he 
should have had his appointment before now.” Kate 
“Because his wife had just gone through breast cancer, so they knew the basic… You don’t 
expect having to press people, you expect things to happen.” Phil. 
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Skin cancer seemed an unlikely cause of the bleeding that Irene ‘noticed’ so she was referred 
to a colorectal surgeon and seemed to get ‘lost in the system’ which concerned both Irene and 
her GP: 
 
“So it was a long while when nothing was happening, or I mean nothing's happening now, but 
I am getting feedback from my doctor and [the oncologist] and [the surgeon].  So I do feel a 
bit more as if I'm in the system.  Whereas I felt that maybe they'd forget me, because I'd got 
lost somewhere en route.” Irene 
 
‘Recognising’ that there had been a delay in getting a diagnosis, Irene’s GP made telephone 
calls to speed the process up and get her seen by an oncologist as he was unhappy about 
the delays and felt he “owed it to her”: 
 
“Because I think all of the MDT involvement was radiological and, you know, theoretical and 
academic. So they were making decisions about her care without needing to explain that to 
patients.  And it keeps us very honest having to explain our mistakes or delays or whatever to 
patients sitting right in front of us.” Henri, GP 
 
Receiving the diagnosis, no matter how expertly given, was a major shock for many 
participants, even those with years of experience of skin-related lesions. Tony was ‘amazed’ 
that after having numerous moles removed over many years it was the ‘last small one’ that 
turned out to be malignant. He described his reaction to the diagnosis as follows: “It is hard 
when we both walked into that office and she said I had skin cancer. Doesn’t matter how 
strong you are.”  Most participants, such as Anne, were ‘surprised’ by the diagnosis and it 
even came as a shock to Karen who, despite being a nurse, left the consultation confused:  
“So even though you’re from a clinical background, I’m not in oncology, and to me melanomas 
were a mole, oh that’s a bit of a big lump, chop it off, and I knew very little else about the 
disease …and went home knowing just I've got melanoma, it’s on my ear and they’re going to 
chop it off.” Karen 
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The shock that participants felt was heightened for those, such as Jack and Carol, who had 
initially been led to believe that there was nothing to be concerned about: 
“Yeah, it was the fact that we was led to believe it was nothing by our own doctor and also the 
dermatologist, and when we went back down we thought [he] was just going to have it checked 
to make sure everything was all right.  And then when we sat down in there and they said that 
it was a melanoma and it was a stage two.” Carol 
 
At this point many participants wanted some degree of certainty with respect to the diagnosis 
and what the future might hold but it was not always possible for practitioners to provide such 
reassurance. This uncertainty added to the fear that many initially felt: 
“But they can't tell me (what will happen) because they really don’t know, do they?  But 
sometimes you expect them to know.  The first doctor I saw, he said it were middle, then when 
I went to [oncology], they said it were high. Yeah.  When they said middle, I thought oh well 
middle’s not as good as low but better than high, but then [oncology] said high. More scary.” 
Ruth 
 
HCPs ‘recognised’ this and wanted to provide patients with “a plan” but also ‘recognised’ the 
difficulty in imparting information at that time: 
“So I think part of it is providing information in a way that they can digest… And then, rather 
than simply leave them with a diagnosis and without a plan for the future, but there being a 
clear plan for their future.” Ashley, Surgeon 
 
The feeling of being ‘A bit shell shocked, to be honest’ voiced by Fred succinctly summarised 
the reaction of many, but for some, although the diagnosis could hardly be described as 
welcome news it nevertheless provided a sense of knowing what they were facing.  
“And obviously it’s the waiting that’s the worst I think.  I think once you know what you’re faced 
with and there’s something can be done, I think that you have a bit of a sigh of relief then” 
Helen 
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It was upon being given the diagnosis that the need for information became a central concern 
for many, even for those with clinical knowledge. However, the data revealed a paradox in 
that at the point of diagnosis, when information was seen as crucial, most patients were not 
able to process what they had been given: 
“Because it is only after you walk away you think oh I should have asked about this. So if there 
was one thing, I think it would be information, you know.  But I think the problem with it is on 
that, at that precise moment (being given the diagnosis), I don't think you're actually capable 
of processing the information, even though that's what you need.” Mark 
  
Even when patients were given considerable amounts of information what they could 
meaningful assimilate was often limited: 
“And I left with several pamphlets and cards and telephone numbers. (But)I needed somebody 
to spell something out to me. I mean I even remember coming out and reciting the words, it’s 
a level 2 and there’s four grades to it. And I even remember getting home and thinking well 
what’s the worst grade? Is it one or is it four?” Jean 
 
Others noted that immediately after being given the diagnosis, anything that followed ‘went 
out of the window’. For example, Jack ‘did not take anything in’, and for Mark the doctor might 
as well ‘have been talking a different language’. Even Karen, who in her professional capacity 
must have been used to relaying bad news, upon hearing the word ‘melanoma’ described how 
although she was aware that the doctor was speaking anything he said became ‘all muffled’.  
Clearly strategies to assist patients at this point are needed and one such was described by 
Esther who was advised to tape record the consultation. Whilst she valued this advice she felt 
that it would have helped if she had been provided with a list of questions to ask beforehand:  
“They did say that you could record conversation. We really needed to have that tape 
recording and perhaps a list of questions, the right questions to ask. Because it was so 
dramatic, you’ve no time to sort of (take in), the enormity of it.” Esther 
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Some HCPs ‘recognised’ that patients had a limited ability to take in information after being 
given their diagnosis but were sometimes still surprised by patients’ lack of understanding 
after the event: 
“The person that took him to clinic was a Greek Cypriot nurse and they had a chat about 
Cyprus and that’s the only memory he’s got of the consultation.  We know that patients only 
retain a certain amount, but that was very interesting, I thought, because actually if we hadn’t 
have investigated that a little bit further or pushed him a little bit further he might not have 
turned up for his radiotherapy, because he had no knowledge that it had been arranged for 
him.” Jackie, CNS 
 
CNSs tried to mitigate this for example by ringing patients some time later or ‘tailoring’ how 
information was given so that it suited different patients’ preferred means of contact:  
“I’ll try and ring every patient after they’ve had a melanoma diagnosis a week later, 
regardless… Because I think a week is a good length of time for them to assimilate 
information… And they often have questions that they won't have (asked) at the time.” Lou, 
CNS 
 
“We set up the email from quite early on, and that appealed to his way of preferred 
communication.  And he’s been very good at using it, and we've been able to respond back 
quickly.  So I think that’s helpful for him because it has given him less time to be concerned 
or anxious. So he’s been able to articulate those particular problems, and then we can solve 
the problem and then get back to him pretty promptly really.” Les, CNS 
 
These examples of communication after diagnosis demonstrate ‘best’ practice that had a 
positive impact on patients’ and carers’ experiences, but not everyone had access to such 
individualised services as some participants still had unmet information needs. For Mark his 
ability to take in information would have been much improved if the language used had been 
tailored more to his ‘lay’ understanding: 
“After that (being told the diagnosis) we went into the room with a Macmillan nurse and she 
said you're not saying a great deal Mark, and I just said I don’t know what’s happening.  Maybe 
its big medical words if it were in layman’s terms it might be easier… She said you’ve got 
cancer.  Right, so that’s a six letter word I can deal with.  I know what that is, as opposed to a 
malignant melanoma.” Mark 
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The technical nature of the information given to Irene by hospital consultants meant that her 
GP became a valuable ‘resource’ helping her to understand her situation.  
“She had lots of me explaining hospital consultant's opinions and hospital letters, so I think - 
there was still not a lot of great communication.” Henri, GP 
 
Nick, as a carer, who accompanied his wife, Jackie, to the consultation felt that he was in a 
better position to ask the necessary questions and absorb any information that was given, 
highlighting the important ‘role’ played by carers:  
“Jackie got quite upset understandably and didn’t know where her head was, I was asking the 
consultant straightforward questions.  Can it be dug out? Is it easily treated?  I think Jackie 
can’t see all the answers that’s coming towards her, or can’t pay full attention to what’s coming 
in.  So I just act as the information sponge.” Nick 
 
Some HCPs did not always ‘recognise’ the ‘role’ of carers and focussed their attention on the 
patient. Others however acknowledged that carers also had a crucial ‘role’ to play:  
“Obviously the patient is always going to be my focus, but I’ll try and bring in the carer as much 
as I can.  But a lot of the initial questions and how they feel and checking their understanding 
to start with, more with the patient.” Lou, CNS 
 
“[Carers] need to know as much information as the patient does.  Sometimes they want to 
know more… I think you need the same amount of support as the patient does.  Maybe in a 
different way because the patient's going to go through treatment and it's affecting them and 
they’re anxious about it.  The relative is anxious about it but they're not going to have to go 
through surgery or treatment or investigations.  But I think they probably need the same 
support.” Alex, CNS 
 
The importance of good information as a ‘resource’ was reaffirmed as initial treatment began. 
For many this happened quickly:  
“It happened so quickly (getting treatment).  It were like a roundabout.  Went through one 
room, waited in one room and had surgery, what I thought was just a minor operation, you 
know, in this big operation theatre.” Mark 
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 For others treatment was complex and could involve multiple sequential stages, which 
increased the uncertainty participants felt: 
“I need to have a skin graft, I need to have skin cut out around the mole so I'm just taking one 
step at a time really.  I mean that’s going to take two weeks, to talk to a plastic surgeon, then 
another of couple of weeks to get that took out, then another couple of weeks to get my results, 
so looking at two months.  So waiting for two months, basically, see if it’s better or not, you 
know.” Matt 
 
The degree of uncertainty was not helped when participants did not know what to expect of 
their treatment: 
“People kept asking me do you have any questions, and I really was struggling to think of any, 
really didn’t have any - because I didn’t know the questions to ask!” Jean 
 
HCPs recognised that some patients did not know what to ask but couldn’t always anticipate 
the information that they needed: 
“But I think there’s a lot of patients that, they don’t know what questions to ask, and they’ll say 
that, I don’t know well what should I be asking?” Jackie, CNS 
 
“Because at the end of the day it’s about the individual patient it’s not about the group of 
patients because if you’re an individual patient you want to know what affects you and you’re 
the only person who’ll know what to say what affects you.” Ashley, Surgeon 
 
For some a lack of basic information resulted in avoidable delays to their treatment: 
“In this system, there are things that you need to know, and if you don’t know, you flounder.   
When I first went to the doctor, now you can choose where to see people, so I said well the 
closest one.  They didn’t tell me there was any pitfalls and the main pitfall was the surgeon’s 
only there twice a month, so I ended up waiting and waiting weeks… Unnecessarily long gaps 
in between, when I could have, if only the doctor had have said well [go to another hospital] 
because he’s there nearly every day.” Phil 
 
Moreover, because of the multidisciplinary nature of melanoma treatment participants could 
get information from multiple sources, some of which seemed contradictory: 
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“But you see I have a dilemma, because in the literature from the dermatology, it says only 
wear very light things, cotton or silk preferred, but you see the things that she’s (lymphedema 
specialist) they’re tight, and it’s elastic, and the idea is it holds everything tight.  So which do 
you do, who do you believe?  And then there’s [the surgeon] in the middle with what he wants, 
so.  And they all have slightly different views, they’re looking after what they’re covering, but 
whether they ought to be looking after the whole body itself, I don’t know.” Tom 
 
Despite ‘recognition’ by some HCPs clearly improvements to the ways in which patients and 
carers are informed both about their diagnosis and their initial treatment could potentially make 
a big difference to their melanoma ‘journey’ and this is something that will resurface again. 
How such improvements could be made will be addressed in the discussion chapter.   
    
As has already been noted for most participants melanoma was not a solitary ‘journey’ and 
family members/friends, were, for many, to become an increasingly important ‘resource’. 
However, upon being given the diagnosis it was HCPs who were the first point of contact and 
who played a key role in giving information and providing support.  
 
6.3.1 HEALTH CARE PROFESSIONALS AS RESOURCES 
“It’s quite nice to have that one person just to phone and ask anything really.” Helen  
 
Most participants were shocked upon receiving the diagnosis and in the period immediately 
following this it was HCPs who, in the best cases, would prove to be a vital source of 
information and support. Once again how accessible and approachable the professional was, 
both in terms of being easy to contact and crucially their ‘human face’ were key factors in 
forging a ‘relationship’. For Edna it was the approachability and willingness of her surgeon to 
provide support that was important:   
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“Well, [the surgeon] has told us that if we have any problems to get in touch with his secretary, 
which we did a few weeks ago, because there was something Tom wasn’t very sure about.  
And they made an appointment for us straight away.”  Edna 
 
For the majority however, such as Tony, Helen and Fred, the Macmillan Nurse or the CNS 
was the key person, with accessibility, approachability and reliability being essential qualities: 
“As we were walking through [the hospital] I saw the Macmillan nurses and I said ‘the wife’s 
coming down in a minute for a word’ and it was absolutely no problem at all. When Liz arrived 
we were ushered into a little room on our own, and it wasn’t as though you had to book an 
appointment it was there instantly.” Tony 
 
“It’s nice to have your Macmillan nurse, just to ring up if you think of something, or sometimes 
when they’re telling you stuff as well, I think sometimes you only take half of it in... then it is 
nice having a Macmillan nurse just to ring up, and she always rings me straight back if I leave 
her a message.” Helen 
  
“And the time or two I’ve rung [the nurse specialist] ...… if they’ve not been there I’ve just left 
a message and they’ve rung me back, you know.  So it’s, everybody’s been lovely.” Fred 
 
The opportunity to talk to somebody outside the family who could ‘tell you how it is’ was valued 
and as Sarah, who had three young children described, for her it was the health visitor who 
fulfilled this important role: 
“The doctor sent the health visitor out to me, and she came and spoke to me.  She’s due to 
come back I think it’s this week to see me.  So I've got, and I've got support there….at the end 
of a phone…. Because it’s alright having your family, but it’s like you need somebody out of 
the family who doesn’t know you, to basically tell you how it is.” Sarah 
 
HCPs also ‘recognised’ that patients and carers needed them to be accessible and to provide 
information that was easily understood, they therefore tried to ‘tailor’ support to individual 
preferences: 
“I went every day while she was in, just touched base with her, made sure she was all right. 
Because I think she felt that she’d dropped into a black hole, and I think having a specific 
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person who is going to be working on your behalf to make sure that you’re not forgotten is 
quite important for patients when they’re scared.” Pat, CNS 
 
“I mean ideally when you meet somebody at diagnosis, you do tend to get a feel for what 
somebody wants.  Some people may be happy for you just to have the card and they'll ring 
you if there's any questions, whereas with others you might get a sense that oh ‘will you be 
there at that next appointment?’”  Max, CNS 
 
Unfortunately not everyone’s experience was so positive and Sarah also described how the 
promised support of a CNS did not materialise leaving her feeling disappointed and losing 
trust in the system: 
“She’s a lovely woman [the CNS], but when I had me operation she said she were going to 
come and see me that day or the day after to make sure I'm alright. Well I didn’t hear nothing, 
there were no contact, and then I had to go for a check-up and I saw her again, (and she said) 
‘like if you need me, ring me’.  But it’s like you told me you were going to come.”  Sarah 
 
 
It would become clear throughout the data that such trust was vital and had to be earned. 
Once lost however it was very difficult to regain, something that HCPs interviewed 
‘recognised’:  
“And then it's just kind of, if you say you're going to do something, to do it.  I always find with 
my patients if I say I'm going to ring you, they trust that I will ring them.  If you start breaking 
that then that trust breaks down a little bit.” Chris, CNS 
 
As highlighted earlier it was often the information, advice and support that HCPs provided that 
participants particularly valued, especially once the initial shock of the diagnosis had subsided. 
However, as noted above, simply providing information was not sufficient as it needed to be 
timed correctly and tailored to people’s level of understanding. The situation was made more 
complex by the fact that people varied as to the amount of information they wanted, and for 
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some too much information was just as problematic as too little.  For example, Jackie, clearly 
valued information and often actively searched for it using the internet as a ‘resource’:  
“Well, he told me [the dermatologist] that it was Breslow’s thickness of 0.8.  So I thought I’d 
have a look to see what that entailed, on Cancer Research thing.  It’s quite good to look at 
that, I found it quite interesting.  Because I’d got it into my head it was worse than it actually 
was.” Jackie 
 
Phil, on the other hand, kept away from the internet, and several others such as Tom and 
Jean really did not want to know too much about what the future might hold. The quote from 
Edna below captures the need to achieve the appropriate ‘balance’ when providing 
information. This is clearly a skill that HCPs need to master, and this is something that will be 
returned to in the discussion. 
“You have to be careful sometimes. When I was at the hospice they gave me a card, a 
pamphlet for the lymphoedema association in London so I sent for this information, and I’m 
not kidding, there’s enough in there to worry you to death.  You’d never sleep for a year if you 
read it all.” Tom 
 
“I think you have to take a balanced view of all the information that you’re given, rather than 
dwell either on just the good bits or the bad bits.   I think that’s the way I look at it.” Edna 
 
The value of building a ‘relationship’ with the patient and carer at diagnosis in order to be able 
to relate to their needs later was also ‘recognised’ by HCPs: 
“The longer relationship you have, the better really… when you're planning things for the 
future, go back to the diagnosis” Les, CNS 
 
The benefits of such ‘relationships’ were not one way, as HCPs got a sense of “satisfaction” 
from knowing that they had done “a good job”: 
“His daughter says he loves you, you know.  So it does and it makes the job worthwhile I think, 
because sometimes it can be a thankless job and, you're in it for the patients, but it is quite 
nice to get a little bit of self-satisfaction back when you know that you've done a good job and 
you get told you've made a difference.” Max, CNS 
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The important role of HCPs was clear in the data but family and friends were to play an 
increasingly important role as time went on. 
 
6.3.2 FAMILY AND FRIENDS AS A RESOURCE 
“Well I mean the support I’m getting really is from my family….”  Fred  
 
For some participants, such as Fred, family support, at least in the early stages, was a 
continuation of long-established patterns. Fred, although still working in his 70’s, had four 
children who had supported him for a number of years:  
“The support I’m getting now is no different from before.  I go to their houses for meals at the 
weekend.  I go to one daughter on Friday, I go to the other daughter on Sunday.  (My son) is 
probably once every three or four weeks. And so the support really that I’m getting now is 
absolutely no different from what it’s been for the last three years.” Fred 
 
For others such as Irene, and her niece Sue, melanoma brought about, at least initially, a 
modest increase in the ‘role’ that Sue was to play. It is clear that such support was not only 
freely given by Sue but much appreciated by Irene:  
“Well she ferries me about, takes me to the hospital, takes me, well wherever I need to go.” 
Irene 
 
“It's just what I do, be there really. They say things happen for a reason sometimes don't they? 
I lost my job in October and I've not been able to find anything suitable since.  And I've got all 
the time in the world to help Auntie Irene.” Sue 
 
For many participants family support, if not taken for granted, was at least, in part, taken as a 
given: 
“Yes, we can call on (the family) for support.” Edna  
“We can call on them (family) any time, day or night, so yeah.” Tom 
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Others, in addition to their family, could rely on friends. This reinforced the importance of 
friendship: 
“I’ve found as I’ve been very active with this club. The amount of support I’ve had from these 
people has been amazing, which has helped me through. It’s made me realise how many true 
friends I’ve got actually and having their support has given me a lot of strength.” Tony  
    
Following treatment some participants experienced difficulties with routine tasks of daily life 
so family or friends lent a hand. Sarah, who had three young children to look after, was 
particularly fortunate in the amount of support her family provided. Indeed her sister made 
financial sacrifices in order to help Sarah:  
“Like me sister’s been, she’s like me nurse (and) she’s like me second mum.  From me coming 
out of hospital, she did all me dressing, she’s changed me, she bathed me, she took me kids 
to school, picked them up. She’s knocked her hours down too so she can do the school runs, 
and the money just like went from up there to down there.  She said it’s not important, as long 
as you're alright.  So I have had some good support around me.  Me mum, me dad, me sister.” 
Sarah 
 
Others found tasks such as shopping difficult and again family and friends provided support:  
“I had to get friends and family to go out and giving them shopping lists.  And then paying the 
bills, the things that you had to deal with.  Yeah, and they’re still bringing me shopping, 
because I’m still not driving.” Jean 
 
However, not everyone was so well supported, a fact acknowledged by some participants. For 
example Anne, who felt well supported by her husband, recognised how difficult living with 
melanoma might be for those without close support, such as Luke who could turn to just one 
person, and only then in a limited capacity:   
“I’m lucky in a way, Alan’s lucky in a way that we’ve got each other to look after each other. 
We wouldn’t get depressed about the situation because we’ve always had each other to talk 
to. But if I was on my own…” Anne 
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“I talked to me friend at work about it, but you don’t go into detail.  He’s probably the only 
person I've really talked to about it, but you don’t go deep into it.” Luke 
 
However if family, friends and others were to provide support they needed to be aware of the 
diagnosis and this was one of the first dilemmas that participants faced, how much information 
to disclose and to whom.  
 
6.3.3 TO TELL, WHAT TO TELL AND WHO TO TELL: HIDING AND SHARING AS 
PROCESSES:  
“I don’t go round advertising it, you know.” Phil 
 
Participants’ were initially shocked on receiving their diagnosis but once this had begun to 
subside one of the first decisions to be made was who to tell about their melanoma and how 
much detail to divulge. For some this had been a concern even prior to the formal diagnosis 
when they had been undergoing ‘tests’. In this context the ‘hiding’ or ‘sharing’ of information 
became important processes, once again highlighting that information, of various types, was 
a key ‘resource’.   
 
Many chose not to say anything until a diagnosis was certain so as not to cause any 
unnecessary concern: 
“But I didn’t tell my mum and dad, because at 80 and 81 I didn’t want to worry them until I 
thought they had to worry.  So when I actually got the confirmation from the doctor that’s when 
I told them.” Jean 
 
Decisions came with their own challenges:  
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“It was a bit stressful last year because I didn’t tell my mum either.   I thought I’ll wait until I get 
everything in, all my results and everything, because she’s not very good at handling things.  
So I kept that from her, so that was a bit awful.” Helen 
 
For many it was only when a confirmed diagnosis had been given that this information was 
‘shared’ with others. However, who it was shared with and how much was shared varied. Phil, 
for example, was selective with whom he shared information, focussing primarily on family 
and friends. Others, as will be described below, felt it was important to share their diagnosis 
with people at work as well. 
“As soon as I got to know for definite myself then it’s not something I kept secret.  I don’t go 
‘round advertising it, you know, I haven't told like work people and stuff like that, but certainly 
friends and family.” Phil 
 
‘Sharing’ the diagnosis reflected the degree of ‘trust’ within a family, as openness was 
essential if appropriate support was to be offered and accepted: 
“They [sons] feel we’d hurt them if we didn’t share it.  It would be a sign of a lack of trust, so 
we do.  So they are with us every step of the way and they are wonderful, very supportive, 
and feel devastated too.” Esther 
 
However, the amount of information given was often ‘tailored’ according to who was getting it: 
“But I've always been a great believer in trying to be as straight as possible.  So what I've 
always done with them is tell them as soon as I know, and then make sure I have one evening 
with each of them alone, because they all ask completely different questions.” Karen 
 
Fred made decisions about how appropriate it was for his grandchildren to know, based 
primarily on their age: 
“I’ve got ten grandchildren. Some 18, 16, 14, 15 and 13, and the elder ones all know about it. 
Then I’ve got younger ones who we haven’t even discussed it with them, I mean I’ve got one 
who’s four, one who’s two, one who’s seven, and we haven’t discussed it with them.” Fred 
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Sarah possibly had the most difficult decision and chose to share the fact that she was ill with 
her three young children, but a degree of ‘hiding’ was apparent. Sarah’s children were a great 
comfort to her, reinforcing the vital ‘resource’ that ‘relationships’ provided at various levels:   
“The boys can come home from school, they’ve made me a card, so they know I'm poorly, but 
I don’t think they like to ask a lot of questions, in case it upsets me but they sometimes ask 
questions and it’s like ‘are you going to be alright mummy?’, and ‘you're never going to leave 
me’?,  and you think you’re eight year old this shouldn’t be happening. But I can honestly say 
it’s down to them, me children.  If I'd not have got them, then I think I'd be more at rock bottom.” 
Sarah 
 
Concerns about how much and what to ‘share’ were also recognised by HCPs: 
“Often it's just getting down to, getting to know them as a person because they might not be 
worried about actually the surgery, they might be worried about other things.  And if you can 
help them with them other things, they'll do a lot better and them other things might be money, 
they might be a holiday that's booked in two weeks… How am I going to tell my children?” 
Chris, CNS 
 
Moreover, where HCPs were aware of a patient’s decision to ‘tailor’ the information given to 
particular family members, such as children, these decisions were respected. Sarah’s Practice 
Nurse ‘recognised’ that she needed to offer support at the right time to be effective as Sarah 
wouldn’t have had the conversation in front of her children: 
“If she’s on her own then I’ll sort of ask her a bit more gently how things are really going, that 
kind of thing, but if her daughter’s with her it’s not appropriate.” Charlie, Practice Nurse 
 
‘Sharing’ with the close family was something most participants did but the amount of ‘sharing’ 
that took place with wider networks varied. Some, such as Phil, did not raise the issue at work, 
whereas others did and found that this openness helped, as Mark and Matt describe below:  
“Work’s been very understanding, I can't fault work, they phone me on a regular basis, how 
are you, are you alright, have you got any more appointments that we need to book in?  Lots 
of work colleagues just ring up out the blue, just nothing to do with work, just how are you?” 
Mark 
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“When I talked to the manager about it.  They could tell there was something on my mind, I 
was snapping at people and quiet, more quiet than usual really, yeah… Once I told her, then 
it just went better.” Matt 
 
Inevitably the diagnosis had some impact on the family.   
 
6.3.4 IMPACT OF THE DIAGNOSIS ON THE FAMILY:  
“Cancer’s a bit like throwing a stone into a mill pond…..and the ripple hits everybody you know, 
friends, family and everything outside.” Mark 
 
For most participants the ‘shared’ nature of living with melanoma emerged early in the data, 
but its impact varied.  At almost an existential and abstract level were concerns voiced by 
those with children, such as Anne and Tony who were worried that melanoma might have a 
genetic element putting their children at increased risk:  
“At the back of my mind I’m a little bit worried about the boys. We’ve got three boys and with 
both of us having cancer I’ve already said to them, you’ve got to be aware of this,  if there’s a 
problem with me and there’s a problem with their father. I mean eventually in their life will they 
get cancer?” Anne 
 
Patient’s concerns about family members were ‘recognised’ by HCPs, as Tony’s CNS 
describes below:  
“We’ll have talked a little bit about implications for other family members, because I made a 
note of the fact he’d got two children, and there was, it obviously got a little bit complicated, 
the family, but I've got that he’s got a brother and, who was obviously the brother with the 
other melanoma, and mapped out his family tree a little bit here.” Lou, CNS 
 
For Sarah such fears were far more immediate as she had actually been pregnant with her 
youngest child when the melanoma was diagnosed. 
   
  181 
“What hit me most is they said I'd already had the cancer while I were carrying [my daughter].  
They told me this afterwards.  She hasn’t got it she got all clear, luckily, but to think I had it 
while I were carrying her and she could have had it, then things probably could have been 
worse then.” Sarah 
 
In addition to concerns about cancer in the family the emotional impact of the diagnosis itself 
was ‘recognised’. For example Laura (Karen’s daughter) felt guilty when she could not 
accompany her mother to her hospital appointments and Sarah’s Mum, Pam, was so upset 
that she needed counselling: 
“I feel very guilty when I don’t come with her here (to the hospital), like when I have to work or 
when I've got other commitments and things, and I don’t like it when my sister comes because 
she doesn’t understand, she doesn’t get it at all.” Laura 
 
“Well I am having counselling, and I have started the counselling when I found out that me 
daughter had got cancer.  And obviously it threw me because you don’t expect to like find 
something out like that…. I have to go every two weeks it’s like a relief to me, you know, 
because I'm talking to someone who knows about this kind of thing.” Pam 
 
Pam’s experience highlights the importance of emotional support being available to the family 
as well the patient and yet as the literature review highlighted very little attention has routinely 
been given to the support needs of carers of people with melanoma. This is something that 
will be returned to later. 
The emotional impact of the diagnosis could also have an effect on the ‘relationships’ between 
family members: 
“I dread him coming home every night, what kind of mood’s he going to be in, because when 
work don’t go right it’s getting him down and I think he needs somebody else to talk to because 
I don’t feel that he talks to me how he should, but I think it’s because he knows I get upset.” 
Sandra 
 
Bob also noted his wife’s mood changes and the fact that she was trying to ‘hide’ the emotional 
impact that the melanoma was having on her. Such ‘hiding’ was a sign of potentially more 
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damaging effects of the melanoma on their relationship for despite Bob desperately wanting 
to ‘share’ his wife’s melanoma ‘rollercoaster’ she was, in his view at least, keeping him at a 
distance: 
“I’ve had to coax her into telling me what’s gone off.  For some reason she didn’t want me at 
hospital, I don’t know why but she just didn’t want me there.  We couldn’t have proper 
conversations about it, because she just didn’t want to talk about it.” Bob 
 
HCPs also ‘recognised’ the psychological impact of a melanoma diagnosis and as we will see 
in the next chapter, aimed to reduce this impact over time: 
“I suspect that for a lot of people there’s been new diagnosis of cancer of a sort that may or 
not come back is a kind of sword of Damocles hanging over them, and that comes with some 
significant psychological sequelae in some patients and the question I suppose is how do they 
deal with that?” Ashley, Surgeon 
 
Forging relationships with patients who had similar experiences was seen as a potential 
strategy to overcome some of the anxieties that patients experienced at diagnosis but not all 
HCPs felt confident to facilitate this. 
“You see at [oncology] particularly people will be sitting on the corridor, and you know that 
they’ve got similar diagnosis and similar complexities, but obviously you can’t say would you 
two like to meet and introduce them in terms of. And I’m sure that a lot of patients would benefit 
from knowing that there are other people around.” Les, CNS 
 
This section has further reinforced the importance of ‘relationships’ as a key ‘resource’ and 
started to highlight the impact of the melanoma on these ‘relationships’, some positive, others 
less so. It is paradoxical that at a time when family relationships and support were becoming 
ever more important that in some cases the melanoma began drive a wedge between people.  
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6.3.5 THE IMPACT OF THE MELANOMA ON ROLES:  
“You know, I’m just trying to keep things as normal as possible.”  Mark 
 
Following their initial treatment participants had to adjust to the effects of this both physically 
and psychologically. Physically, there could be side effects caused by the radiotherapy or 
the excision of the melanoma. These could impact on activities such as eating or sleeping:  
“Obviously the radiotherapy doesn’t make you feel very well.  Because with it being on your 
throat and what have you, and the eating and stuff, that’s not too grand.  It’s mainly my 
mouth, how your mouth feels, it’s horrible. You like get yellow saliva that is also difficult to 
swallow because you’ve got a sore throat, and you can’t brush your teeth properly.” Helen 
 
“But it’s (the excision) healed, the thigh’s just a little bit tender now but that’s much improved.  
And as long as I’ve got something soft to sit on, I can wander around all day safely in the 
house and be happy that it’s okay, I’m not going to bang into anything…..   (but) I’m still 
nervous about getting into bed without any protection on it.” Jean 
 
Such effects meant that some participants had to cancel planned events, such as holidays 
which was an additional cause of stress:  
“Well we did book for last May, Menorca, but this kicked off, so we had to cancel it.” Jack 
 
 As already described family and friends often helped out with daily activities but despite this 
the melanoma began to have an impact on the ‘roles’ that participants had. For those of 
working age maintaining employment was important and could serve as a form of diversion, 
stopping them dwelling too much on the potential longer impact of melanoma: 
“I work in the [supermarket] and I have to serve customers, so you’ve got to be smiley and 
happy when they come up to your till, you can’t be all miserable and sad really.  So that sort 
of helps. It’s just nice, it’s just nice to just talk about everyday things really, and not talk 
about...(the melanoma)…  just to have a bit of a normalish day like you would have.  So 
yeah, that helped really.” Helen 
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HCPs also ‘recognised’ the importance of maintaining occupational roles for patients, both 
for financial reasons as well as a way of ‘keeping busy’ and where possible tried to facilitate 
this: 
“Even though when I'd rung the week after (diagnosis), his wife said he was really anxious, 
his anxiety level was quite low, and it was just things like practical concerns about his work, 
because he was still working, worry, anxiety, and he’d got some tingling in his hands.” Lou, 
CNS 
 
Indeed for many of the melanoma patients in particular ‘keeping busy’ seemed to be their 
main strategy to try and ensure that things remained, ‘as normal as possible’. For those still 
in employment, work provided a major diversion, even if patients chose not to share their 
diagnosis with work colleagues:    
“Highest priority is staying in work. So keep, just keep myself busy.” Matt 
 
“But while I’m at work occupied I don’t tend to think about it as much.  It’s still there, but you 
see I’m not telling people at work as well about I don’t want people to know my business 
really, so I’m just putting on a front at work a bit as well.” Jackie 
 
For family carers, such as Laura, work was also an important way of trying to keep her mind 
off the situation. However she had also started to think about what the future might hold with 
regard to her caring role:  
“It’s weird, because I think I've just literally thrown myself into work, because I love my job 
and I've just focused on that, like I literally will just work and then when mum’s really, really 
poorly and I have to look after her and things and she needs help and she needs driving 
places, she needs her hair washing, things like that, like it just, I think I push it to the back of 
my mind that she’s my mum and I just go along with it.” Laura 
 
Some had to give up work temporarily as they recovered from the immediate effects of their 
treatment, and this could be a novel experience: 
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“The last time I was sick from work and I had two days off in 2004 when I was 40.  And then 
it’s taken 10 years to have any more time off at all sick.” Jean  
 
Whilst initially this was something to enjoy, boredom could soon set in and for some this was 
the biggest impact of melanoma at this early stage: 
“The first week you’re happy as Larry, you’ve got a week off work.  And then day after day it 
just gets more monotonous.  There’s only so many news websites you can read or films you 
can watch.  It’s not too bad now because I can go out in garden and help me mum a bit, no 
digging but she gets me potting all the plants up.  It’s not too bad, it’s just boredom.” Luke 
 
Those not in work sought other ways to ‘keep busy’: 
“Yeah, I mean he (Jack) has kept himself busy, because our daughter and son-in-law, 
they're moving, and the house needs modernising. So he’s kept himself busy like that, and I 
think that’s helped.  Because if you're not busy, you ponder and think.” Carol 
 
Several others tried not to think too much about their melanoma and this seemed to be a 
major cognitive coping strategy. This was described by Mark as ‘putting it in a box’ and can 
be seen as another manifestation of ‘hiding’ behaviour, in this case the purpose of which 
was to allow participants to maintain a sense of ‘normality’ for as long as possible:  
“I’m a very busy person as well, I’m not very often sat down.  I’m always doing something.  
Yeah, sort of takes your mind off it, especially when you’re waiting for results and stuff as 
well, just trying to be busy and just doing your normal things really rather than sitting there 
mulling things over in your head.  I do try to be positive, but when you’re laid in bed at night 
and stuff like that you’re thinking oh God.” Helen  
 
“I don’t really think about it to be that honest.  I try not to, because like I say it’s one of them 
things that you’re powerless to do anything about, so it’s just trying to get back and lead a 
normal life. No, I just take it as it comes.” Luke 
 
However, ‘putting the melanoma in a box’ did not mean completely ‘burying your head in the 
sand’ and even at this early stage some participants had started to plan for a possibly less 
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than rosy future. But, as Mark implicitly pointed out, this was being realistic rather than 
nihilistic, and for him at least actually served to reduce a source of stress:  
“We have like made preparations for, you know, I mean a lot of the financial stuff was in my 
name, and I know how difficult it is dealing with banks and what have you.  So I thought we’ll 
do it now.” Phil 
 
“I'm just trying to do as much as I can, just in case the worst happens, that Sandra’s looked 
after.  We've gone through all the policies, we've gone through everything we can claim 
against.  We've had the mortgage paid off, the insurance has paid out, so all that’s done, 
that’s one worry off my mind for Sandra.” Mark 
 
For others the melanoma meant having to give up work and take unexpected retirement. For 
Tony this raised fears that he might ‘dwell’ on things too much, something he tried to avoid 
for his family’s sake: 
“That was the hardest part because I had to retire and I had no intentions of retiring. Then I 
had this big fear of being sat at home sad and alone or not being with people all the time, 
that I would dwell on it but I haven’t mainly for the family.” Tony 
 
Despite the challenges they faced most participants at this early stage wanted to try and 
keep things as ‘normal’ as possible, but this meant some changes to their routines of daily 
life were inevitable.  
 
6.3.6 CHANGING ROUTINES:  
“Still do the same routine, get up, get the kids to school, go and do me shopping, do 
whatever I need to do, so I just leave it like that still as though I'm just still doing the same 
routine.” Sarah 
 
Routines add structure to peoples’ lives and help to shape and mark the passage of time. As 
noted by Sarah trying to keep to the same routines was an important indication that things 
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were still ‘normal’. Despite this however some people were unable to maintain routines 
and/or activities that they valued. For Tom this meant giving up both gardening and his 
walking club, things he clearly missed. But despite this he tried to be philosophical:   
“There’s one thing I’ve had to do, and that’s get a gardener, and it’s not the same when 
somebody else has done it, you don’t get that same pleasure (and) I used to belong to a 
walking club on a Tuesday… but I can’t do that now, you see, I can’t walk, so that has 
changed.  But it would have probably changed anyway, because of my age.  I mean some of 
these things are changing not from melanoma, but because I’m going on towards 90.” Tom 
 
But as noted earlier for many having to curb or even relinquish either valued roles, daily 
routines or both meant that boredom often ensued. Finding new routines or roles could help 
to alleviate this. For Jean even attending the hospital clinic took on significance that she 
couldn’t have imagined earlier and became something to look forward to:  
“I work full time normally, and I’m out and about, so I think that was just frustration.    I’d get 
excited about the day out to the (clinic). I got to the stage where I was looking forward to it 
because it was the only time I was leaving the house in the initial stages.” Jean 
 
For many having melanoma meant that as well as needing to adjust their usual ‘routines’, 
new ones were added. The most obvious changes that participants made to their daily 
‘routines’ (or long term behaviours) at this stage, were in their ‘relationship’ with the sun. 
While HCPs aimed to help patients and carers maintain their usual ‘roles’, they actively 
encouraged changes in their ‘routines’ related to sun exposure: 
“Our plan is for them not to burn in the sunshine. To get that across, that some sunshine is 
necessary for vitamin D but be careful not to burn and do it safely to protect their skin. So in 
that respect if that’s not something they’ve been doing before we actually need to change 
what they do.” Pat, CNS 
 
Some had been life-long ‘sun worshipers’ and had built holidays over many decades around 
following the sun. Jackie was one such person. Whilst she was not prepared to give up 
   
  188 
sunbathing entirely, even after being diagnosed with melanoma, she did at least modify her 
habits and take greater precautions:  
“Well I’ll probably not sunbathe as much, peak time between twelve and even four (and) I 
started using a higher factor I am now going to wear factor 50 at all times now, well, when I 
go away, and I am a bit wary of when I went for a walk even in the UK I’d put a bit of suntan 
lotion on if it was quite hot.” Jackie 
 
Anne, who had never sunbathed seemed taken aback that she had developed melanoma, 
when her friend who had ‘roasted’ herself for years had not. However, as her husband Alan 
pointed out both their work as farmers and their hobby as keen gardeners meant that they 
had experienced considerable exposure to the sun over many years. As with Jackie, Anne 
now made sure that she was covered up whenever she went into the garden: 
“I mean I’ve, I do wonder why it’s come. We don’t sunbathe, we don’t go on holidays where 
we lie roasting in the sun at all. My good friend who I’ve had all my life, she goes abroad on 
holiday and roasts literally roasts and gets away with it and she’s never had anything like 
this.” Anne 
“We’ve always been very exposed to sunlight. Arms out gardening. We’ve always worked 
outside. So we’ve always had our sleeves rolled up, actually had an awful lot of exposure to 
sunlight without laying down in it.”  Alan 
 
The problem of occupational exposure to the sun was more immediate for Mark and Sandra. 
His outdoor occupation meant that Mark was often exposed to the sun. His diagnosis with 
melanoma had resulted in his employer looking at the firm’s policy with respect to protecting 
their employees from excessive sun exposure. However his wife Sandra was not particularly 
impressed with their efforts to date and one of her main worries was that Mark continued to 
spend long hours in the sun, despite the fact that he had recently started to take the need to 
apply sun protection far more seriously:  
“I've always nagged him to put creams on his face with working outside, and he never has, 
the skin nurse has said even in winter he needs to wear an SPF... I'm a bit annoyed with his 
work. They have been good with him, but they did say that they were going to send an email 
out and try and bring some barrier cream in for the men that are working outside, and there’s 
nothing happening there.” Sandra 
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‘Recognising’ the need to be aware of the deleterious effects of the sun and taking 
precautions were an early manifestation of ‘protecting’ behaviours. In addition some took to 
‘monitoring’ themselves, as Sarah describes:  
“So it’s like if I'm constantly looking at myself all the time, I do sit there in the bath and I’ll 
look at them, what I can see, I do check all me, like me groins and things like that, If I 
worked that out in that doctors the very first time with me mole, I might not have been here 
now because it were already in the second stage, they told me.” Sarah 
 
Both ‘protecting’ and ‘monitoring’ were to become far more frequent as the melanoma 
‘journey’ progressed. 
 
6.3.7  SUMMARY  
For all of the participants the diagnosis of melanoma came as a ‘shock’. It was during the 
diagnostic period that many of the participants had their first sustained contact with the 
health care system and the quality of this contact and the nature of the ‘relationships’ that 
they forged with HCPs at this time often proved crucial to their on-going ‘journey’. Some had 
a positive experience, others less so. As we have seen a number of HCPs were attuned to 
patients, but not always carers’ needs. For those patients who had a positive first contact 
and forged good relationships, often with one HCP, their subsequent experiences were often 
more positive, even if the prognosis was not. In this sense, and at this point, HCPs became 
an important ‘resource’ for many participants.  
 
Furthermore, most participants knew little about melanoma and information was therefore 
another vital ‘resource’, with HCPs often being the main source. However, the situation was 
complex and diverse. Some participants struggled to get enough information, others were 
given too much or what they were given was too complex. Even those participants who 
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received information often could not ‘take it all in’, following the ‘shock’ of their diagnosis. 
Some participants wanted lots of information and actively sought it via the internet and other 
sources. Others wanted to know little and preferred to ‘ignore’ their melanoma. But what 
participants most valued at this point was continuity of contact with an approachable and 
accessible ‘expert’ in the form of a HCP who could guide them through the diagnostic period 
and beyond, into their initial treatment. 
 
The nature of participants’ initial treatment varied considerably depending upon the type of 
melanoma they had and the stage at which it had been diagnosed. For some treatment was 
relatively straightforward but for others it was far more involved. It was during treatment that 
the impact of the melanoma on their ‘relationships’ with family and friends, and their ‘roles’ 
and ‘routines’ began to emerge.  
 
One of the first decisions participants had to make was whether to ‘share’ their diagnosis or 
to ‘hide’ it from family, friends and colleagues. This was important as it was not until people 
were aware of the diagnosis that they could potentially offer support. It was usually at this 
point that family became an important ‘resource’ offering both practical and emotional help. 
From a practical perspective early treatment often meant that daily, and previously taken for 
granted, ‘routines’ such as shopping became potentially problematic. Most participants 
wanted to keep things as ‘normal’ as possible but often had to turn to close family for help. 
For those with more complex and prolonged treatments ‘routines’ could be considerably 
disrupted and melanoma began to impact on their ‘roles’ such as employment or treasured 
leisure activities. Here the ‘role’ of family members also began to alter as some took on a 
more overt ‘caring’ role.  However the needs of such carers went unrecognised by the health 
care system.  
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Paradoxically at this point some patients found it hard to ‘share’ their emotional ‘responses’ 
to melanoma with those closest to them and this ‘hiding’ of emotions could cause 
‘relationship’ difficulties, just when such ‘relationships’ were more important than ever. 
 
Living with melanoma also meant introducing new ‘routines’, especially in participants’ 
‘relationship’ with the sun and a number of protective behaviours were adopted. In addition 
more overt ‘monitoring’ of their treatment and its effectiveness was practiced by many 
participants. Several of the ‘responses’ described above were heightened as participants 
moved beyond early treatment and entered the ‘surveillance’ phase.  
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7 CHAPTER 7: SURVEILLANCE – UPS AND DOWNS 
In this chapter we explore the experiences of participants who, after having the melanoma 
removed, attended regular clinic visits for surveillance. The purpose of surveillance was to 
detect any new melanoma early so that it could be treated as soon as possible, something 
that patients and carers were aware of and that caused a significant amount of worry. Some 
participants experienced recurrent disease during this time and had further surgery. This part 
of their ‘rollercoaster’ is captured in the phase termed ‘ups and downs’. In creating their 
rollercoasters some participants used ‘downs’ to represent low mood caused by events related 
to melanoma with the ‘ups’ representing their mood improving as the incident resolved. Others 
used ‘ups’ to represent the anxiety that they felt related to the melanoma with the ‘downs’ 
representing improvement of the situation. Despite these seemingly opposite descriptions they 
both capture the varying, often emotional, impact of the melanoma over time heightened by 
the fear, experienced by many, that the melanoma might recur. 
 
7.1 IT MIGHT COME BACK 
“I’ve always had that hope that perhaps this time it’ll not come back, but it does come back, 
but I deal with it, so.” Tom 
 
Patients and carers were aware one of the main reasons for surveillance was to detect 
melanoma if it returned. This was something that everyone hoped would not occur, but it was 
nevertheless a latent anxiety, with Sarah noting that it was ‘always on my mind’ and Anne 
‘recognising’ that ‘nobody can give you 100% guarantee’ of cure. Many participants therefore 
held on to the ‘hope’ that they would be one of the ‘lucky ones’ and often kept their fears to 
the back of their minds, frequently using ‘black’ humour to do so:   
“A couple of the lads just ring me up on a regular basis, I keep telling them well you’re not in 
my will… But again that’s me just making a joke of it.” Mark  
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Knowing that the melanoma might return and potentially mean a shortened life-span motivated 
participants to ‘live life to the full’ and many re-considered their priorities such as reducing their 
working hours as Jackie noted ‘life’s too short’ or as Helen decided ‘not putting off until 
tomorrow things you can do today’. 
 
Concerns about recurrence tended to lessen overtime, especially as patients began to be 
discharged, or ‘fired’ as Jean put it.  But despite this many still maintained their ‘routines’ of 
‘monitoring’ and inevitably some found new changes themselves: 
“I was just feeling round and I found this lump, and I didn’t really think nowt of it because I 
thought it might be something to do with the stitches… But he said no, he says I’ll have to cut 
it and get it out again.” Ruth 
 
Sometimes suspicious lesions or lumps were found during routine examinations by HCPs, and 
this was reassuring for many participants. New lesions were frequently excised and for both 
Fred and Tony this became part of their surveillance ‘routines’. Many of the lumps and lesions 
that were removed after the first melanoma were benign which Fred described as ‘false 
alarms’. Some were unfortunately another melanoma. This possibility was something that, as 
Kate noted, was ‘always at the back of your mind’ but it understandably came as a major blow. 
Despite this participants’ prior experience seemed in some way to help prepare them for this:  
“In my language oh bloody hell, not again.  But I think this time round we both suspected that’s 
what it might be.  So we were probably a lot more prepared for it. But when we went and she 
got the diagnosis, oh Jesus not again.  I just felt awful for Jackie, and I thought oh here you 
go, just be as supportive as you can.” Nick 
 
This was one of the main ‘downs’ of the rollercoaster, and was something that HCPs 
recognised as potentially having a ‘devastating impact’ on people’s lives:   
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“And recurrence when everything’s been stable, and then you hit a bump in the road, it brings 
it all back again, and that’s quite difficult. And then recurrence can mean different things can’t 
it, because it can just mean something as simple as a bit more surgery, but it can have other 
more devastating impacts on patients’ lives.” Pat, CNS 
 
To mitigate their fear that the melanoma could come back meant that patients and carers 
adopted new ‘routines’ of ‘monitoring’ and ‘protecting’.  
 
7.2 NEW ROUTINES: MONITORING AND PROTECTING 
“Because I'm always looking.  Every day I look.  It's just, from my perspective, I just want to 
make sure that there's nothing there.” Fred 
 
Patients and carers became more aware of new changes to their skin and ‘monitored’ these 
by, for example, checking the treatment site for signs of healing, or any changes that they 
might consider suspicious. Those patients who had extensive surgery or radiotherapy 
‘monitored’ themselves for a longer period (beyond eighteen months) alongside signs of new 
melanomas. Carers also ‘monitored’ any psychological ‘responses’ to the melanoma as well 
as physical symptoms: 
“I mean some days I come and she’s just full of life… And then you can come again and she’s 
like just sat there… she’s just feeling so down and low and tired, drained… and it’s hard.” Pam 
 
‘Monitoring’ for signs of a new melanoma could be overt or covert. Patients and carers might 
conduct ‘monitoring’ together as a ‘shared routine’ for the reassurance it brought. In some 
cases though patients would not admit to carers how much they engaged in ‘monitoring’ or 
carers would take opportunities to look for changes without the patient being aware as they 
did not want to cause each other to worry. This is another way in which information or the 
melanoma experience was ‘hidden’ or ‘tailored’.  Tony and his wife photographed his moles, 
openly monitoring them together with their children. For Kate and Phil monitoring together 
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became a “ritual”. For those who lived alone ‘monitoring’ was difficult without someone to 
assist: 
“I wouldn’t say I have a set routine but this week I’ve probably done it twice…. just have a 
quick look in the mirror.  It’s a pain in the backside seeing spots - I’ve got two, two wardrobe 
doors with mirrors on so I have to sort of put them at different angles and turn round.” Luke 
 
John did not share his ‘monitoring’ with Esther who nevertheless did this covertly herself, so 
as not to worry her partner:  
“I checked it without (him knowing)… because to go on about something is to make matters 
worse, and they make you more worried.” Esther 
 
Sandra also adopted a similar approach:   
“I try to do it without him knowing but when he’s in bath or he’s undressed I can see me visually 
scanning, x-raying his body to see if I can see anything new… I’m consciously doing it; I am 
looking to see if I can see any changes.” Sandra  
 
If their monitoring efforts were to be effective patients and carers needed to know what to look 
for. This might be quite obvious in respect of a visible lesion but checking for things such as 
enlarged lymph nodes was not so easy: 
“Press as deep as you can under your armpit and look for a grain of rice. That was entirely 
wrong, entirely wrong information.” Phil 
 
Over time if there was no recurrence patients and carers began to worry less and relaxed their 
‘monitoring’  but this could take many months. For instance, 12 months after diagnosis Fred 
and Matt still checked themselves every day, but six months later they had relaxed their 
‘routines’ with Matt only checking every six months and Fred almost stopping, as for him it 
was a case of ‘out of sight out of mind’.  
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Even if there was no recurrence the melanoma was never far from some peoples’ minds as 
the surgical scars served as permanent reminders for some. For Jackie the worry never 
completely went away as she had ‘a reminder of it always there’. 
 
There were however psychological benefits to ‘monitoring’ and as participants became more 
skilled they were confident that they could detect any changes at an early stage. However this 
was not infallible and Sarah was dismayed to be told that she had a new lesion by her surgeon. 
This knocked her confidence:   
“But it’s like this time I didn’t notice that on my leg what obviously the surgeon did and he was 
really concerned over it, but to me it didn’t look like nowt… I didn’t feel no different or notice 
owt if I’m being honest.” Sarah  
 
This sort of episode reinforced the value of ‘expert’ opinion with patients and carers continuing 
to see HCPs as an important ‘resource’ and their ‘relationship’ with them continued to be a 
central factor in the melanoma experience. Participants who experienced ongoing effects from 
surgery or new skin changes often wanted to be reassured that their own interpretation of any 
changes was correct:  
“I don’t know whether it’s one of them… Tags yeah, you’ve got one or two of them there.  But 
I don’t know… it does need checking out.” Carol  
 
Regular follow up appointments were an opportunity for face to face contact and gave patients 
and carers access to the expertise of HCPs:  
“I mean it’s a safety valve really isn’t it, coming and having it checked.” Anne 
 
For many surveillance was an integral part of the melanoma journey which often involved 
frequent attendance for tests, scans and physical examinations. This added a further ‘routine’ 
to participants’ daily lives which brought its own anxieties and/or moments of ‘good news’ 
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which added to the ‘ups and downs of the rollercoaster’ and provided participants with a sense 
of their own potential futures, as Edna describes below:    
“I think apprehension after the first operation… it brings it back just a little bit each time (you 
attend the clinic)… But when we’ve been to the hospital and… you get an all clear, in my diary 
it goes down as a red letter day, so that marks a point where, and you can move forward 
again.” Edna 
 
For some, such as Anne, having examinations that proved negative were a source of 
reassurance that allowed her to ‘live her life’ relatively free of worry. For Luke however they 
were a reminder that the melanoma could recur at any point. HCPs recognised the 
combination of anxiety and relief that participants could experience:   
“Even if there’s nothing going on I’ve had patients say that they get worried and don’t sleep a 
few nights before the appointment, because they’re worried that something will have cropped 
up that they hadn’t noticed… and then after the appointment there’s that sense of relief that 
you’ve said everything’s fine.” Pat, CNS 
 
Scans caused anxiety but also provided reassurance, creating some of the ‘ups’ and ‘downs’ 
of the rollercoaster: 
“In between you having your test and getting your results, that’s when you’re in no man’s land.” 
Jack  
 
“They do want the scans. But then we’ve got all the waiting… So I think that’s quite 
significant… there’s a level of relief once they’ve had those results.” Les, CNS 
 
Mark and Sandra found that surveillance seemed to lack structure compared to the treatment 
and follow-up that Sandra received for breast cancer. They understood that treatment was not 
available at the time but felt they should be doing something to prevent the melanoma coming 
back. Matt, however found the lack of intervention as a positive sign that his treatment had 
been successful. 
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“I thought is this it, is that it?  They just checked my glands, the scar, that were it, see you in 
four months’ time.  Yeah, it felt a bit quick… Must be a good thing.” Matt 
 
Patients and carers also began to ‘monitor’ their sun exposure, ‘recognising’ it as a risk to their 
health. This led to them adopting new ‘protecting’ routines to limit UV exposure. 
“I've kept my shirt on when I've been out in the sun, worn a hat and slip slap slop, as they 
say.” Phil 
 
Protecting themselves and others from the detrimental effects of sun exposure became a new 
‘routine’ for patients and carers as their ‘relationship’ with the sun changed, especially for 
those who had not previously understood the risks involved or the importance of taking 
protective measures. Three months after his diagnosis and on finding more information about 
melanoma, Fred considered changing his habits: 
“Until I started reading about it I didn’t really associate walking in sun and being in garden in 
sun was a danger. I’ve never put sun cream on when I’ve been walking the dog or when I’ve 
been working in the garden. Perhaps I should start.” Fred 
 
Similarly Jackie, and Jean who had been using sun cream, decided to use one with a higher 
protection factor.  
“So normally I would have taken 30 for the first week, and 15 for the second… Well now it’s 
50 the first week and 30 the second.” Jean  
 
For Tony, the effect of the melanoma extended to his family: 
“She (daughter) has gone totally the other way now, whereas she would lay on the beach all 
day long, she won’t anymore, so something is rubbing off, which can’t be a bad thing.” Tony 
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These new ‘routines’ both affected and were influenced by the participants’ ‘relationships’ and 
‘roles’. The dynamic between these three factors was in flux throughout the melanoma 
‘rollercoaster’. Below we consider the impact at this stage on participants’ roles. 
 
7.3 THE IMPACT OF MELANOMA ON ROLES 
“And I'm back at work, that's quite nice to be back at work, bit of normality.” Helen 
 
After their initial treatment patients and carers aimed to return to their usual roles as soon as 
possible. How quickly they achieved this depended upon the nature of their treatment. This 
varied considerably, for example, Jackie only needed to take a few days off before she could 
return to her usual activities following a small operation whereas Tony struggled with the 
physical demands of his job, making the decision to retire. Leisure, social and family roles 
were also affected although participants aimed to maintain their normal roles and activities as 
much as possible. These sometimes required modifying to accommodate the after effects of 
treatment, which for some only emerged over time. For instance, Sarah coped well throughout 
surgery and radiotherapy, only noticing the full effects after treatment finished when she 
struggled with the tiredness caused by her lymphoedema. This affected all aspects of her life 
as a mother and a partner. Consequently she continued to rely on family members to help her 
care for her children: 
“But obviously I’ve got three kids to look after.  I’m just constantly tired and drained and finding 
it really hard.  If I didn’t have my auntie here or my sister, they stay with me until teatime-ish, 
they’ll help me bath them,… make sure they’ve had their tea… then I can just go and lay in 
bed until I wake up the next morning.” Sarah 
 
In marked contrast Fred and Jackie returned to work with minimal disruption, while others 
needed to modify their work patterns. Luke received help from his firm’s occupational health 
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department and worked between the office and warehouse, while Jean who could not do any 
physical activity could work from her computer at home until she was able to travel: 
“Sitting was a problem… Getting in the car and driving, being on the road, having to think 
about getting on a train and maybe travelling a couple of hours and having to sit and things 
like that.  But because I could go back and sit in (the bedroom) and not move all day while I 
caught up, I could do it.” Jean 
 
For many such as Helen, returning to work was a sign of recovery and she was assisted to do 
so by her nominated HCP: 
 
“Helen was quite adamant to keep things normal at home and was really keen to get back to 
work. And I know when I saw her recently in clinic she was like yeah I’m back at work and, 
you know, quite buzzing with life really and that was always her focus.” Chris, CNS  
 
Some, such as Tony, could not modify their work and had to make the decision to retire from 
their job. However, Tony found alternative employment that gave him a meaningful role: 
“September I started, delivering pharmacy three hours a day and it’s just nice, because most 
of my patients are seniors and it’s more than just dropping the stuff off.  You have a little chat 
with them.” Tony 
 
HCPs recognised the importance of maintaining valued roles for ‘patients to be healthy 
mentally and physically’.  Of course not all participants worked and so maintaining leisure and 
social roles were equally important. However even with modifications this was not easy with 
Tom and Edna, for example, having great difficulty getting holiday insurance. Despite help 
from their CNS they still struggled and so modified their plans by getting mobility aids, such 
as a scooter and having a ramp fitted. They made the most of their limitations and still felt that 
they had a good life: 
“Well, what we’ve tried to do is just to make it that we can live as normal life as possible 
because we’ve got the facilities and there’s not an awful lot we can’t do is there?” Edna 
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“I suppose some of the things that I’m not doing is just because… I wouldn’t be doing them 
because of my age I don’t think. I am nearly 90. I’ve been cutting the hedge this morning so I 
can’t say there’s anything I don’t do.” Tom  
 
Others too made modifications. We have already noted that some people, such as Helen, who 
could not eat solid food in the early stages, still went out with her friends (although would not 
eat in public) or invited them to her house instead. This went on for eighteen months after her 
treatment finished. Others, such as Sarah, curtailed activities, such as taking her children 
swimming as she struggled to come to terms with her body image. This caused her 
considerable guilt: 
“I feel like everybody’s just like looking at me because they’ll see my scar down my leg, and 
then that leg’s a lot bigger than that one… But then it’s like the kids are missing out because 
of me, so then that makes me feel bad.” Sarah 
 
The need to adopt new ‘routines’ to protect themselves and others from the sun also had a 
long-lasting effect on patients’ and carers’ leisure and social ‘roles’. Some changes were 
minimal, for example Helen continued to go on holiday to the sun but her friends adopted 
protective behaviours to ensure that she did not have too much sun exposure. Others made 
similar changes, some were more extensive and might involve cancelling holiday plans:   
“I was worried about the sun…. I didn’t find it easy… It’s just that we’ve always sunbathed, 
we’ve always had like a routine and this time, I mean I said to [my friends], you just do the sun 
business, I’ll get under the umbrella or I’ll just shop.” Ruth 
 
“I turned down a holiday in Spain because I know like when I get drunk all responsibility goes 
out the window and I'll just end up getting really badly burnt… I'm going to Holland in 
September and the climate's quite temperate there so should be all right there.” Matt 
 
HCPs also ‘recognised’ the effect of the melanoma on patients’ leisure ‘routines’: 
“Then you get the odd person that is so worried about it that they stop going away on holiday 
abroad… they’re almost hiding from the sun.” Lou, CNS 
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For some having the melanoma motivated them to get as much out of life as possible. For 
instance, Matt applied himself to his job, sought promotion and tried ‘to do the best I can in 
life’. Sarah and Tony spent some of their leisure time fundraising for cancer charities, so that 
‘something good’s come out of it’. In their efforts to keep things as normal as possible 
participants tended not to see themselves as ‘patients’ and as the physical demands often 
diminished for many, partners and close family members were less likely to identify 
themselves as ‘carers’, seeing what they did more as  ‘helping out’, ‘being there’ or 
‘organising’. This however was still an important role that patients valued.  
Jean, for instance, arranged for her parents to take her to hospital appointments as her partner 
Bob would not have been paid if he took time off work. While Bob initially felt that the 
melanoma brought them closer as a couple, during surveillance he felt as though Jean was 
doing everything “on her own” and he was being “kept out” of her melanoma treatment. He 
did not ‘buy into’ the cost argument: 
“We're supposed to be a team partnership and it just doesn't seem to be that way.  But if it 
were me that were going through it, it'd be a different ballgame… And if cost is the argument, 
it's not a very good argument as far as I'm concerned.” Bob 
 
The potential for close ‘relationships’ to suffer in this way was not unique and we have already 
noted that Sarah’s relationship with her mother gradually became more strained as her mother 
could not accept the diagnosis and failed to fulfil the caring role that Sarah was expecting. 
This caused tensions in the rest of the family:  
“It’s my sister.. I’ve always said, if it was my daughter going through this then I’m sorry I’d have 
to be there 24 hours, well, do whatever I could.  When she comes, yeah, she does her ironing 
and that, and this, that and the other, but she’s always got an excuse.” Lynn 
 
The importance of ‘relationships’ was often heightened during the surveillance period, with 
‘hiding’ and ‘sharing’ playing a key role. 
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7.4  RELATIONSHIPS AS A RESOURCE: SHARING AND HIDING 
“Sometimes it helps when somebody’s got a problem and you’ve got a problem and you just 
talk.” Jack 
 
As patients and carers began to recover from the initial treatment and settle into their new 
‘routine’ of surveillance the importance of their ‘relationships’ with others became increasingly 
apparent. The practical help received from their social network often continued for some time 
and was evident in changes to ‘roles’ and ‘routines’ as these elements of the experience 
continued to interact. However, as their physical recovery progressed, the provision of social 
support depended upon whether information or experiences were ‘shared,’ ‘tailored’ or 
‘hidden’. The degree of ‘sharing’ or ‘hiding’ that took place was a key factor. Couples in 
particular valued each other as a source of support as they talked about the melanoma and 
‘shared’ their feelings about it. In addition to the emotional support that their relationship 
brought, other benefits were seen. For example, having someone to accompany them to 
appointments which, for Tom and Edna, meant that they could both listen to any information 
given. Other couples felt that the experience brought them closer:  
“I think it’s brought us a bit closer actually, because now she’s sharing things with me that she 
wouldn’t have done before.” Bob 
 
“It does change you.  It’s either going to fetch you closer together or it’s just going to push you 
apart.  Sandra always says to me, she says I’ve had a breast off, most blokes would run a 
mile, and I say but I’m not most blokes.  We were strong enough at that point, but I think now 
that we’re going through it again the other way around you understand more.  I think it’s 
brought us closer together again.” Mark 
 
Even though Tony had divorced his wife during the study, they remained in contact and he 
realised it still had an emotional effect on her, noting  “It’s as much a rollercoaster for the 
partner as it is for the patient.”  
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During surveillance wider family and friends also provided practical and emotional support for 
patients and carers. Sarah’s support came mainly from her sister who reduced her working 
hours to make herself available. Tony was fortunate that his brother was a counsellor and as 
he stated ‘when I’m down, he’s the one that can lift me back up’. Tony’s brother was himself 
diagnosed with melanoma eighteen months later so Tony was able to repay the support he 
had received. 
 
Anne and Alan shared their diagnosis with their sons, but as they lived some distance away, 
they relied mainly on their friends for immediate help, describing them as a ‘support network’. 
Rather than a network Ruth turned to a particular friend, who knew her well enough to let Ruth 
talk about things in her own time.  
Patients particularly valued support from others who had experienced a cancer diagnosis, 
recognising the shared experience: 
“I was talking to him (friend), and he’d had exactly the same treatment as I’d had and he was 
two years down the line.  It’s like a little club.  It’s amazing how you find people and you 
suddenly have that bond because you’ve been in the same situation.” Tony 
 
Sarah struggled to come to terms with her altered body image and wanted to talk to someone 
who had been through a similar situation but did not know where to start:  
 “I've got really good support… it’s just now I think I need to talk to somebody who’s been 
through it… see their scars and see how they deal with it.  If they like love their self, how did 
they get to that point? …I need to learn to accept myself again.” Sarah  
 
HCPs recognised that some patients would need help to deal with the disfiguring effects of 
surgery: 
“Will all the men down the pub pick on me because I look different?  You know, those kind of 
things really. For the ladies… and they get used to looking the way they do, like the make up 
   
  205 
and the hair doing and things like that.  And it's just helping them through that process.” Chris, 
CNS 
 
When the physical effects of the melanoma and treatment reduced, the need to ‘share’ the 
experience to gain support lessened: 
“When I were diagnosed with it initially. I did maybe, talked about it more then, but now I feel 
like I’m more or less back to normal.” Jackie  
 
‘Sharing’ the experience of melanoma like this had a notable effect on participants’ 
relationships with friends and family. Whilst most of these were positive and brought people 
closer together some relationships unfortunately broke down. For example, Matt, Sarah and 
Mark were all disappointed at the lack of support offered by their mothers. Sandra, Mark’s 
wife, felt that his family did not understand how serious melanoma was, thinking of it ‘only as 
skin cancer’, conversely Sarah’s Mum realised the seriousness of the condition but couldn’t 
handle the implications. She tended to limit contact with Sarah so that her sister and aunt took 
on greater support roles. Matt’s relationship with his mother had been fragile before his 
diagnosis so when she was not able to offer him any support he did not make the effort to 
keep in touch with her.  
 
An inability to ‘handle’ the diagnosis was not confined to close family and Sarah decided to 
reduce contact with those friends who she felt had ‘abandoned’ her at her time of need:   
“They can’t be bothered to come and see me when I’m at my worst and I’m down.  I get odd 
texts off her but it’s not like, you’re supposed to be my friend, you live on my road.. what’s ten 
minutes to come up for a cup of coffee and a little chat.  To me that would mean the world to 
me, so I’ve pushed quite a few people out.” Sarah  
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Conversely, some relationships changed for the better after ‘sharing’ the melanoma diagnosis. 
Matt, for example reflected on the threat that the melanoma posed to his life, and this prompted 
him to re-build his relationship with his father.  
“It does put things in perspective more, you know what I mean, you just feel like how fragile 
life is… finally got in touch with my dad after nearly 20 years. That went well.” Matt  
 
Whilst relying on family and friends, patients were also aware of the emotional impact that 
providing support had and so tried to mitigate this. For instance, Fred realised that ‘sharing’ 
the cancer diagnosis with his daughter caused her worry so he made a point of focussing on 
any good news with her after his clinic visits.  
 
The need for patients and carers to ‘share’ their experiences tended to reduce with time. 
Although melanoma as something that was ‘always there’ many people were able to put it “at 
the back of my mind”. Keeping busy was a key strategy but despite this at certain times, such 
as when results were due, concerns tended to resurface again. This was the nature of the 
‘rollercoaster’.  However, with time even major psychological concerns, such as body image 
tended to subside as people began to accept their new reality: 
“So I’ve accepted that it’s (scar) there, I’ve been reasonably comfortable in the bikini and the 
shorter frocks.  And I just ignore it, and to be honest other people seem to have ignored it.” 
Jean  
 
For others it was not so easy. Jack was aware of the scar on his cheek but took a stoical view, 
knowing that he would not be entering into any new relationships. However, Sarah had 
rejected the possibility of a new relationship as she had not been able to accept the way she 
now looked:  
“He wanted to be with me and everything and be with my kids, you’d think I’d be the happiest 
woman alive.  But I don’t feel comfortable in myself, I don’t like myself, and it’s horrible because 
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I can’t be happy with anyone because I’m not happy in myself because of my leg and my 
scars.” Sarah 
 
Sarah’s case illustrates how people reacted differently to melanoma. In this section we have 
considered the potential benefits of ‘sharing’ but not everyone was comfortable with this idea. 
For instance, Jean had not told many people about her diagnosis before she had surgery and 
subsequently found it difficult to ‘share’ the news afterwards, feeling that it tended to end 
conversations: 
“It’s almost like a bereavement.  Are you all right?  No I’ve got cancer.  Cut off, end of 
conversation.  What do they say, they ain’t got a clue.  It’s a bit like - are you all right?  No, my 
mother’s just died.” Jean  
 
Some participants continued to ‘hide’ certain aspects of their condition just as they did at the 
time of diagnosis. Consequently not all of the information available to participants was openly 
‘shared’ but such decisions were reviewed as new information was available. For example, 
Jack and Carol waited to tell their adult children about the melanoma until a follow-up scan 
was available three months later to confirm all the melanoma had been removed. Helen had 
also delayed telling her mother about the melanoma but because of this her mother now made 
frequent contact with Helen to check on her progress:   
“My mum likes to see me now.  Whereas before she’d go a few days with not seeing me…But 
she phones me up and I’ll say are you all right?  She’ll go no, are you all right?” Helen  
 
 
Even if they ‘shared’ information patients and carers still often did not ‘share’ their true feelings 
with everyone as they did not want to cause undue worry. This could even happen with close 
couples such as Jack and Carol, which paradoxically caused more rather than less worry for 
the non-affected partner:   
“Jack didn’t want to talk about it. So you can imagine what’s going round in your head… Didn’t 
want anybody to be worried unnecessarily.” Carol 
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“It’s pointless isn’t it.” Jack 
“Well sometimes it just helps to lighten the load. Just to tell somebody…I mean it were eating 
away at me.” Carol 
“Well it were me really.” Jack 
“Yeah but you didn’t talk to me about it…” Carol 
 
When young children were involved participants tended to ‘tailor’ the level of information, again 
with the intention of avoiding unnecessary upset: 
“My niece and nephew… They haven’t been told it’s the big C because [my niece] is probably 
a bit, she’s starting to understand now… And it would upset her.” Sandra  
 
A similar approach was taken in Ruth’s family, even though her granddaughter was an adult: 
“I don’t really tell her [granddaughter] much because she panics, I just say oh, it’s all right.” 
Ruth 
 
Clearly living with melanoma during the surveillance phase had an ongoing impact on 
‘routines’ and ‘relationships’. In some cases, this caused tension in the ‘relationship’ between 
patients and their family, and often their ‘relationship’ with an HCP took on even greater 
significance.  
 
7.5 HEALTHCARE PROFESSIONALS AS A RESOURCE 
"When you don’t know anything at all about it, you take their advice and listen to what they tell 
you.” Edna 
 
Edna’s comment above captures the vulnerability that many patients and carers still felt at this 
stage, turning to HCPs for information, expertise and reassurance. As we found in the previous 
chapters participants often built a ‘trusting relationship’ usually with one particular HCP at an 
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early stage, HCPs who ‘spent time’ with participants or who ‘went the extra mile’ were 
particularly appreciated. This ‘relationship’ gave HCPs an opportunity to influence patients’ 
and carers’ routines and the best HCPs actively cultivated such interactions;  
“From when you first meet them to say six or 12 months ahead, or three years, you expect the 
relationship to evolve and you know that you can get your patient from severely traumatised 
to reasonably comfortable living life as normal.” Les, CNS 
 
Just as in the initial diagnostic stage, not all participants felt that they had received the type of 
information that they needed. For example after her second surgery Jean did not feel that she 
had been prepared for the true extent of the resulting lesion nor how the surgery would affect 
her daily ‘routines’: 
“So yeah there seems to have been a lack of information to help me understand just how big 
it actually ended up being and how much it was going to affect me.” Jean  
 
In the absence of information from their HCPs some continued to look on the internet but 
many, such as Mark preferred to have a HCP explain information to him rather than looking it 
up on the internet, as did Tony. They had discovered that not all information on the internet 
was to be ‘trusted’ and preferred to talk to someone they did ‘trust’, as Mark said “Sometimes 
it’s easier and better to talk to somebody”.  
 
After completing their initial treatment, patients and carers remained anxious and looked for 
reassurance to mitigate this but understanding the rationale behind the surveillance visits and 
building ongoing relationships with HCPs took time. Seeing the same person at each visit 
helped but as participants often went to multiple departments this could be difficult. This could 
be offset if there was a special ‘relationship’ with a particular HCP. For example, Anne found 
that seeing different doctors was not a problem as the relationship with the CNS felt ‘personal’. 
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“Well all I can say about that is I see [the CNS] every time I go…  I don’t always see the same 
doctor but she’s always there really… and I suppose I feel that if I wanted any personal 
connection I think I would go and talk to her.” Anne  
 
Others found the opportunity to be seen by different doctors as reassuring:  
“If you were to see one person, that one person could be wrong. If you see two or three people, 
somebody’s going to pick up on, you know. So it’s like a second opinion isn’t it.” Jack  
 
For those who had not built a relationship with an HCP, such as Luke, seeing a number of 
different people meant that “There’s been no consistency at all”.  Participants’ experiences of 
surveillance varied considerably, but for many it was nevertheless a reassuring process:   
“And I think it’s a form of support coming up here, being examined, and somebody saying it’s 
fine, we can’t find any problem… Someone who is professional, rather than us talking to each 
other… You feel you can go away for a period of time and literally forget it, and put it to the 
back of your mind.” Alan  
 
As we have noted surveillance often required participants to alter their usual ‘routines’ so that 
these were disrupted as little as possible and help from HCPs to achieve this was valued. For 
instance Helen and Fred’s CNSs did their best to ensure that appointments fitted in with the 
patient’s work demands, as far as possible: 
“And we tried to negotiate around work because she'd missed quite a bit of work already with 
having surgery.  So I was trying to fit it round her shifts at work because she was worried about 
losing her job. So I had her mobile [number] and I kept ringing her when I found slots for her.” 
Chris, CNS   
 
As participants fell into the ‘routine’ of surveillance and became confident that HCPs would 
detect any changes some patients and carers felt they could relax their own ‘monitoring’ 
efforts:  
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“I don't worry so much about having to check him or look for lumps because he's going every 
three months, they're going to see or find anything. So that's my support knowing he is being 
monitored.” Sandra  
 
Sarah was an exception to this as she was diagnosed with melanoma while she was pregnant. 
This meant that her daughter was also being monitored so she had few breaks in the cycle of 
anxiety and relief: 
“I haven’t been sleeping for a bit, to be honest.  If you like with [my daughter] as well, all the 
pressure from her, that kept me awake… because I’m waiting for her results, if not waiting for 
the results from me and it’s been going on quite a few months now.” Sarah 
 
During surveillance the ‘relationship’ forged with HCPs often grew, so that Tony, for example, 
chose to keep his care at his original clinic, even after moving some distance away:   
“I could so easily go to [a nearer hospital] and I thought no, because of the rapport that I’d got 
with [the oncologist], [the CNS], [the dermatologist] and [the surgeon]. Again, if you’ve got a 
slight niggle you know that any one of those will explain things in layman’s terms to you and 
will assist and that is a big thing.” Tony  
 
For many such ‘relationships’ lasted for several years and HCPs ‘recognised’ the value of this 
relationship and the difficulty some patients experienced with discharge: 
“Some of them get upset that you're discharging them because I think they feel reassured by 
coming to see you.  And it's, you've given them as much information as you can over the five 
years about sun exposure and vitamin D, all that sort of thing, and then you can trust them I 
suppose to go off and look after themselves.  They don't need you anymore.” Alex, CNS  
 
But not all relationships were so positive and once lost ‘trust’ could be impossible to regain. 
For example, Jack and Carol changed their GP after their concerns about the initial lesion 
were not recognised and Luke never recovered from the disappointment of the CNS not 
attending his appointments, and therefore navigated his journey alone: 
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“I’ve dealt with it by myself from beginning and I’ve been happy to do it but it’s more the fact 
that [the CNS] let me down. It’s the fact that when you go and she’s not there…  And then next 
time I saw her there were no inkling about why she didn’t come.  And then when I’d mentioned 
my next appointment she went right I’ll see you there.  And then I went to my next appointment, 
she weren’t there.” Luke  
 
However, those with positive relationships with HCPs formed a partnership that was influential 
in shaping their ‘routines and responses’ to melanoma. Even for Ruth who had claimed that 
she did not want to know anything about her melanoma, undertook ‘monitoring’ to please her 
HCP, noting that; ‘I do it every week because they’ve told me to do it’. In addition to 
encouraging ‘monitoring’ HCPs actively sought to change patients’ habits regarding sun 
exposure and protection, whilst also encouraging them to continue to enjoy the benefits of 
safe sun exposure: 
“You work on that… When you first start with them you start from scratch and you're going 
through sun safety, sun awareness, sun protection, vitamin D synthesis.  Some of them avoid 
it altogether, the sun.” Alex, CNS  
 
“Because I always find that patients need some reassurance that they can continue to get 
some sun exposure… encourage him that he still needs to go out and enjoy himself, and it’s 
not going to affect his motorbiking and his holidays and things like that.” Lou, CNS 
 
To be maximally effective many HCPs recognised that they needed to ‘make themselves 
available’ and made every effort to do so.   
“Just to ring up (she said), and you're not frightened to ask her anything either.” Helen  
 
For HCPs to be an effective ‘resource’ during surveillance it was important that there was 
someone that patients and carers could contact easily should they notice any changes. If they 
had concerns patients and carers would contact whomever they had built the best 
‘relationship’ with, be that a consultant, CNS, GP or other HCP. Tom felt that he had been 
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given ‘permission’ to contact his doctors at any time, whereas Matt was reluctant to telephone 
as he had not built a relationship with the person he would be talking to: 
“I have the OK  from both doctors actually, both consultants, that if I see anything I’ve to let 
them know or their secretaries know and they’ll see me.” Tom  
 
“They offered me a phone number like a helpline… I felt like if I did ring somebody, they’d be 
probably speaking off a script if you know what I mean.” Matt  
 
Some participants were reluctant to “trouble” or “bother” an HCP and “waste their time”, 
particularly for anything that might be ‘trivial’: 
“You see things, oh we’ll just keep an eye on that, oh just leave it, if it gets no better.  But 
we’ve not actually thought, I’d probably feel again like I was just wasting their time.  I know 
that’s not right because they just say anything at all you just ring, and I appreciate that.  But 
then I think well if you’re dealing with me you’re probably missing out on somebody who’s 
more important.” Mark  
 
“I’d maybe not have bothered with the nurse as much.  Because I know they’re busy as well, 
nearly as busy as consultants, it’s probably why I wouldn’t.” Jackie  
 
HCPs were aware of this and tried to make sure that participants felt able to contact them for 
information or reassurance, especially during surveillance:  
“….from my point of view it's important they understand that if, that I'm happy to see them at 
any time in the future for whatever reason… the door's always open if they want to come back 
and ask further questions.” Ashley, Surgeon  
 
Some patients were reluctant to contact their doctor with what might be ‘stupid’ questions and 
so turned to their CNS instead:  
 
“Because if it’s only something like minor or something, not stupid but you don’t really want to 
ring a consultant up to ask him… I didn’t mind ringing her (CNS) up.  And then she sorted it 
out from there.” Helen  
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This was not a unique example, with the CNS below describing how she would often see Phil, 
mainly to reassure:  
“We saw him a lot and examined him quite often. At his request he would come outside of 
clinic appointments for an examination, just to be reassured.” Les, CNS 
 
Nurses recognised that they were often seen as being more accessible than doctors and 
consequently would be contacted more readily by patients. However they were also under 
pressures of time and resources which meant that they might not always be free when they 
were needed: 
“….because there’s only two of us we, and we’re spread over three sites, we have to prioritise 
and some patients miss out, don’t they?” Les, CNS 
“You want to give this patient extra time and, but you’ve got three or four patients sitting out 
there waiting, very difficult.” Lou, CNS 
 
Because of this psychological support beyond reassurance was something that the patients 
were more reluctant to ask for, and Jackie would have liked the opportunity for “a bit like a 
counselling session”. This was echoed by others: 
“They’re looking after patients and that and they don’t want to be listening to everybody’s woes 
personally because they are busy aren’t they. So if they had a specialist person, that’s what 
they did, you know I think it would be a good thing.” Jack  
 
However, providing such support was something that HCPs viewed as part of their role: 
“When you first meet patients at diagnosis, and the care that you have to give to get them 
from the diagnosis to a point of being, feeling psychologically and physically healthy again and 
getting on with normal life is, that’s your responsibility.”  Les, CNS 
 
The impact of such support was clear in the data. When Jean was in tears between operations, 
Bob was so worried that he contacted their GP, who spoke to Jean on the telephone. While 
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Jean felt that there was “nothing he could do”, she appreciated him contacting her. Similarly, 
when a CNS gave Sarah an opportunity to talk when she obviously needed it, this enabled 
her to put her concerns to one side:  
“It’s like nurse said to me, she went are you all right, and I said yeah.  And then she went are 
you all right, she could see that I weren’t all right. So it’s like I’m trying to put a brave face on 
but even she knew I weren’t all right.  So then I like sat and I spoke to her for a bit, and she 
just said go away and try and forget about it - which I did.” Sarah  
 
Patients and carers relied on HCPs for their specialist support, drawing on their expertise for 
reassurance but for some people the melanoma did come back. If there was any possibility 
that a melanoma could be removed then patients and carers remained under surveillance, but 
at some point, for some people this was not possible. At this time they were considered to 
have advanced disease and this is the subject of the next chapter.  
 
7.6 SUMMARY  
During surveillance the ‘rollercoaster’ continued to have ‘ups’ and ‘downs’ relating mainly to 
anxiety or concern arising from a variety of sources, such as: 
• Concerns that the melanoma might coming back 
• Monitoring and protective routines  
• Recovery from initial treatment  
• Sun exposure 
• Surveillance visits and scans 
• Removal of suspicious lesions 
 
To counter these concerns patients and carers often took steps such as adopting new 
‘monitoring’ and sun protection routines.  Their anxieties were also mitigated by the expertise, 
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information and reassurance provided by HCPs who built ‘relationships’ with patients and 
carers. Such ‘relationships’ were valued by patients, carers and HCPs and provided a positive 
experience where they were formed. Where they were absent patients and carers negotiated 
their ‘rollercoaster’ without guidance. Where a ‘relationship’ was formed HCPs were able to 
influence patients’ and carers’ sun related behaviours in a positive way and reduce their 
anxiety. The ability to form and maintain these ‘relationships’ depended largely on the HCP 
being accessible to patients and carers. Barriers to access from the perspective of patients 
and carers were the HCP being seen as ‘too busy’, not feeling able to ask their questions for 
fear of appearing ‘stupid’ or physically not being able to make contact if calls were not returned 
or appointments not kept.  
 
‘Relationships’ with family and friends also remained significant and these were often shaped 
by the extent to which both parties either ‘shared’ or ‘hid’ both information and their feelings 
about the melanoma and the ‘ups’ and ‘downs’ they experienced. This chapter has sought to 
capture the dynamics between these various factors. 
 
For some participants surveillance marked the end of their ‘melanoma journey’, others 
however were not so fortunate. 
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8 CHAPTER 8: ADVANCED MELANOMA: THE 
‘BOMBSHELL’ 
As noted in the preceding chapter many patients’ melanoma ‘rollercoaster’ either ended or 
continued in the surveillance phase after the end of data collection. However, for those who 
were deemed to have ‘advanced’ disease this was not the case. It is their stories that we 
consider here. For these individuals their melanoma had spread to distant lymph nodes or 
other organs such as the lungs, liver and brain or the melanoma was not amenable to surgery.  
 
During the study a number of new treatments for advanced melanoma became available (see 
Figure 2.3 in Chapter 2) changing the experience of melanoma patients while data were being 
collected. Whereas, at one time, there were few treatment options available with limited effect, 
towards the end of the study patients could access multiple lines of treatment. The experience 
of patients with advanced disease therefore varied considerably. 
 
I recruited Irene, Sue, John and Esther when their melanoma had already reached the 
advanced stage. Karen’s melanoma progressed quickly during the recruitment process so she 
had advanced disease by the time Laura and herself were first interviewed. Luke, Sarah, Amy, 
Lynn, Phil and Kate experienced melanoma over a longer time from the removal of a mole, 
through surveillance and recurrent disease before experiencing advanced melanoma. This 
chapter seeks to capture their experiences.  
 
8.1 THE BOMBSHELL  
“You know it might come, (but) you don't want it to.” Luke 
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As noted above some patients were initially diagnosed with metastatic disease whereas for 
others, distant spread developed after several surgeries and over some months. Despite this 
variation the discovery of metastatic disease came as a ‘bombshell’ for all the participants, 
and was undoubtedly one of the major ‘downs’ of the ‘rollercoaster’. Even those such as Karen 
who had a clinical background and had undergone treatment for many years had not seriously 
thought about the possibility of progressing to advanced disease:   
“And then again I still had it in my mind ‘it’s fine’, even when obviously I knew it just kept 
spreading and spreading, so they kept chopping bits of my ear away, to the point that they 
had to do the amputation and then the skin graft.  And I kept thinking ‘it’s fine, they’ll get it.’  I 
think the bombshell hit me when it was this is bad news.  And I suppose it’s the realisation 
that it can’t be chopped away and that there’s other things that need to be done now.” Karen 
 
Like Karen, Phil also ‘recognised’ that surgery was not now an option, and that the melanoma 
was not curable as “the iron door has closed”. Finding out that he had advanced disease 
despite numerous surgeries ‘shocked’ Phil, and he also felt disappointed that he had endured 
surgery: 
“I’ve had the operation and through the first scans and things like that they’ve found more 
metastasis. And they’ve said they’re inoperable so the only option is a drug…shock, total 
shock, I mean every time I’ve had an operation it’s gone somewhere else. So it all seems a 
bit pointless. You know, why didn’t I just go on the drug straight away?” Phil 
 
Some participants such as John, as his wife Esther explains below, had initially thought that 
the change in his condition was due to a chest infection, only to be diagnosed with metastatic 
disease immediately: 
“Because you used to say you felt as if you had a weight on your chest, and that’s why I said 
you must go for a chest x-ray, because infection’s the first thing you think, isn’t it?  And that’s 
all you went thinking, when you went for the results.  We both sat there waiting, oh it’s a really 
bad chest infection.” Esther 
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The distress that Sarah felt when she learned that the cancer had returned was compounded 
as her daughter had a mole removed around the same time. This combination of events 
prevented her from sleeping:  
“Devastated. Just not sleeping, I can’t sleep. Why is it coming back there, you know, it’s just 
that same place… I’ve been going through it with [my daughter] as well, my little girl, because 
she had a mole appeared on her bum, same place as mine and it had changed and it was 
going like mine, so she’s had to have surgery and have it removed. Luckily hers has come 
back all right, all clear.” Sarah 
 
When being told that the melanoma was now at an advanced stage patients and carers again 
struggled to understand this information. Phil was in ‘shock’ and Karen just wanted to go home. 
She was not able to ask questions or process information until she returned to clinic the 
following week for a further discussion.  
“But I think that day I was just devastated, I just wanted to go home, I sort of took all the clinical 
trials leaflet stuff and thought I’d just rather go home.  So no, I didn’t ask any questions that 
day, it was the following week when I came back in.  Then it all slots into place, all the things 
that have been happening.” Karen 
 
Mirroring the situation with the initial diagnosis participants were then faced with the decision 
about who to share this information with. 
 
8.2 TO TELL, WHAT TO TELL AND WHO TO TELL: SHARING AND HIDING AS 
PROCESSES IN ADVANCED DISEASE   
“They (family) can support me in the way that I need support, but the whole world doesn’t need 
to know.” Esther 
 
As was the case throughout who participants decided to ‘share’ their news with largely 
depended on their ‘relationship’ with people and whether they considered that they ‘needed 
to know’. The news was therefore most often ‘shared’ with close family or friends. Telling 
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family and friends that the disease was advanced was difficult for everyone, but especially for 
those, such as Irene, Sue, John and Esther who were diagnosed with metastatic disease from 
the outset. Here the ‘shock’ reverberated to everyone and patients had to try and manage the 
‘response’ of family and friends as well as their own. Irene found it a difficult conversation to 
have so tried to ‘lighten the mood’: 
“Well they sympathise and then they say ‘oh but you look so well. They looked shocked… So 
you try and make a joke and say well nobody lives forever.” Irene 
 
Others, such as Luke, took a very stoical view and could not understand why people, even 
HCPs, felt the need to apologise to him when he talked about his advanced melanoma:  
“I said to the nurse who were taking blood, I said well it comes to us eventually don't it?  And 
she looked a bit shocked.  She says I know, but it shouldn't be at your age.”  Luke 
 
Consequently Luke did not really ‘respond’ in the way that people expected, possibly making 
an already difficult conversation more challenging for others. Conversely, Karen, when telling 
her daughters that she now had advanced disease ‘recognised’ the need to help them deal 
with their ‘responses’, and so ‘tailored’ information accordingly. This seemed to make 
subsequent conversations easier, with humour again playing a role:  
“I mean I do cry with them…but we tend to have a talk about it.  And they joke because they 
go ‘God mum, you’ve been poorly for 10 minutes now, it’s really boring, can we do something 
else?’  And that is really nice then because we can go into other things.” Karen 
 
For Karen such a ‘light hearted’ ‘response’ was easier for her to deal with than the way that 
her partner reacted:   
“I have a partner and he’s very supportive, (but) he hates hospitals and medical stuff so it’s 
been quite a challenge for him. He’s been upset, which I understand completely but I do find 
it difficult to cope with…because I just don’t know what to do.” Karen  
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However, not everyone ‘shared’ their diagnosis, even with close family members. Esther 
encouraged John to be more open with their sons as she ‘recognised’ that ‘sharing’ information 
was essential if people were to provide future support, much of which came from family and 
friends.  
“Well (we told) just a handful of close friends, yeah.  They know what’s happening.” John 
“Would you talk more to [our sons], do you think?” Esther 
“Maybe, yeah... because they need to know.  It’s one of those things.” John   
 
The dynamic between ‘sharing’ and ‘hiding’ of both information and feelings was often more 
complex at this stage than it had been previously. For example while Esther and John shared 
information within the family Esther was aware that John was not fully ‘sharing’ his feelings 
with her as he wanted to protect her from his own anxiety. ‘Recognising’ this, she provided 
opportunities for him to share his feelings with the Macmillan nurse as a ‘neutral’ person: 
“Esther spoke with me separately as I was leaving the house…  she actually made a deliberate 
action to go and make a cup of tea to see if John would open up to me but he didn't really say 
anything an awful lot.  But that was trying just to engage him in any conversation, but it was 
more about Esther.” Sam, Macmillan Nurse 
 
This also happened between Karen and Laura, although it was more openly acknowledged 
here, with Laura ‘recognising’ that her Mum ‘sugar coated’ her emotions, and that she had to 
get beyond this if a ‘real conversation’ was to be had:  
“I think I just ask more questions, and I obviously understand it a bit more.  I do think 
sometimes you sugar coat it a little bit though. I can tell when mum’s sugar coating it, and I’ll 
go come on, tell me.  And then we have the real conversation, whereas other people obviously 
just go okay then, and that’s that.” Laura  
 
As with the initial diagnosis the information that was ‘shared’ was sometimes ‘tailored’ 
according to the recipient rather than totally ‘hiding’ it. Sue, for example, tailored the 
information given to her children about their Great Aunty Irene: 
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“They’re (children) kept in the loop because you can’t cosset kids forever.  You know, they’ve 
been talked to in a manner that is appropriate, but they’ve always been told if anybody’s poorly 
and they might die or whatever so they’re now at an age where they can accept it. I mean 
Aunty Irene was in agreement, you know, but they were told what was going on.”  Sue  
 
Phil, however, chose to ‘hide’ his diagnosis from his elderly mother for as long as possible as 
he was concerned that she may not be able to cope with it:  
“I mean she's… 93. To be quite honest if I told her now she'd forget in ten minutes anyway. 
I'm not afraid of telling her, I just think it's pointless at this time. If she was upset too much I 
would always regret telling her. ” Phil  
  
It was only when information was ‘shared’ with family and friends that they could provide any 
support, again highlighting the importance of information as a ‘resource’. But as was the case 
throughout the melanoma ‘journey’ it was family and friends that proved to be the major 
‘resource’.   
 
8.3 FAMILY/FRIENDS AS A SUPPORTIVE RESOURCE:  
Given the often rapid spread of the disease once metastatic, patients became frail quite quickly 
and needed both emotional and practical support. This usually came from close family/friends, 
who were a vital ‘resource’ for participants.  Irene, despite having no children of her own saw 
herself as fortunate to have a caring niece and good neighbours, even if sometimes their 
support was not strictly needed: 
“She's (niece) good. And my neighbour, across the road there, she came in yesterday just at 
my lunchtime, she always comes just then, just wanted to put my dinner in the oven and stays 
for an hour.  And the other one at the bottom of my garden she was going to come with me to 
[the hospital] if necessary. And I have a lady who walks my dog whether I want her to or not…” 
Irene 
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Others also got good support from their neighbours of many years, several of whom had 
experience of cancer themselves:  
“They’ve (neighbours) all been good. Some of them have been through similar scenarios. 
We’ve lived in the same house for 30 years. We know everyone….. He’s got prostate cancer, 
his wife’s got NHL. Another chap had bone cancer because he’s on a trial here.” Phil 
 
It was often carers who needed the most emotional support and this was ‘recognised’ by 
patients who encouraged them to seek whatever help they could: 
“He’s (partner) got a really good supportive network.  We both work (for the same organisation) 
so his work colleagues were my ex work colleagues, so he does have quite a wide group of 
people that know me that he can talk to.  I think most of them (family) do,  I think the only two 
that probably don’t talk to anyone other than family are my twin daughters.”  Karen 
  
Karen’s daughter, Laura, was a mental health nurse, and she considered herself particularly 
lucky to have support, both from colleagues and her friends:   
“…support in my job is amazing, which I think is the perk of working in mental health, a clinical 
psychologist who comes and talks to me quite a lot and we talk a lot about how I feel and 
that’s really helpful.  Then I've got a really good support network of friends that are amazing, 
again they're all mental health nurses.” Laura 
 
However despite such support, having a family member with melanoma could cause 
difficulties in family ‘relationships’. For example we heard earlier that Pam, Sarah’s mother, 
had sought counselling to cope with her daughter’s diagnosis and despite this found it difficult 
to accept things and so slowly withdrew from the family.  
 
As already noted for many the internet became an important ‘resource’, providing valued 
information. But others turned to it for emotional support and in so doing formed new 
‘relationships’ with others in a similar situation. The ‘sharing’ of their stories was in itself a way 
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of fostering hope, but also, as Sarah’s story will show later, it was a way for participants to 
give hope to other melanoma patients.  
 
Both Sarah and Karen felt the need for specific support from others experiencing melanoma 
and they turned to the internet. In doing so they found the Facebook group ‘Melanoma Mates’, 
comprising only of melanoma patients and their carers without any formal moderation useful. 
However, they were also aware that some aspects of discussion need to be taken with a ‘pinch 
of salt’.   
“So yeah, I think information is incredibly important, but it’s also knowing to filter it properly.  
Because you can go online can’t you, and there’s some hideous stories.  But I suppose with 
doing research and assignments and stuff ourselves, we know which is rubbish and which to 
actually read.” Karen  
 
On the whole, though, Sarah and Karen found the group helpful, allowing them to access 
others going through similar experiences. This made them feel less isolated, better informed 
and more ‘normal’: Karen had subsequently met one of her online contacts, who lived close 
by, face-to-face:  
“You can read someone’s post and someone will say ‘oh yes I had that or I had that’, so you 
don’t feel abnormal.   So it is really useful.  I know of three others on the group that are here, 
and one I've actually met today and said hello to her.  It just feels quite nice that there is 
somebody else that has got the same. So it normalises it a bit.  The Melanoma Mates I do find 
quite comforting at times.” Karen   
 
Irrespective of how they met, other patients were an important ‘resource’ for a number of 
participants. For example, Sarah met with a melanoma patient of a similar age via the CNS, 
who had recognized that Sarah needed additional support at that particular point in time.  
“I talk to (to the other patient) a lot, obviously because she’s been through, it’s just getting 
comfort off each other. She’s been there, we understand each other.  And it’s just comfort to 
be honest, it’s someone to talk to who knows, who’s on my level kind of.  I mean I know you’ve 
got your family and everyone, but there’s only so much they can understand.  So yeah, it’s 
just some support but on the outside of family.” Sarah  
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As Sarah continued to interact with other melanoma patients she was able to share her 
experiences more openly than she had done with friends and family. As well as benefiting her 
she found herself helping others in a similar situation. This gave her a sense of satisfaction:  
“It’s like that girl I’m following now. She’s wrote her story and stuff, and she’s scared.  Now at 
one point I wouldn’t tell nobody my story. But I sat and I read through hers, and then I explained 
what I’ve been through in the last four years. And she’s like you’re so inspiring and how do 
you keep going and things like that. So I think me speaking to her because she’s so young, 
I’ve kind of helped her.  And it’s just nice to know that I can actually help someone else.”  Sarah  
 
HCPs ‘realised’ the potential benefit of patients talking to one another at a time when they had 
complex needs but did not always feel able to facilitate this: 
“We’ve had young people recently with metastatic disease that have needed, husband and 
wife and the children, and you think oh I’d just love to put you in a room and you could just 
say actually yes, I know how you feel because I’m going through the same thing.” Les, CNS 
 
The data clearly demonstrated the importance participants accorded to their ‘relationships’ 
with a wide range of people including, family, friends and other people with melanoma. 
Amongst other benefits such ‘relationships’ helped many retain a sense of being ‘normal’. 
HCPs remained an important ‘resource’ at this time and we now consider the role that they 
played, again highlighting the ‘relationships’ between HCPs and participants. 
 
8.4 HEALTHCARE PROFESSIONALS AS RESOURCES   
“Hopefully you gel with the person that’s caring for you, and you have a good relationship. We 
did.” Sue  
 
We have already seen the importance of the ‘relationships’ participants had with HCPs from 
the outset. However as treatment progressed patients and carers experienced changes in 
their ‘relationships’ with HCPs as they were transferred to new services or departments. 
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During such transitions it was most important that HCPs were ‘accessible’ to patients and 
carers but as before participants had both positive and negative experiences at this point too.    
 
Irene, Sue, John and Esther who experienced advanced melanoma from the outset, were 
rapidly seen by several doctors in different specialities and were frustrated by the often poor 
communication within the healthcare system.  In particular Esther felt ‘out of the loop’ and 
would have liked a better understanding of John’s condition, as well as help to deal with her 
own ‘shock’: 
“Just what do I do now? Something you’ve never faced before, you’re in confusion, a lot of 
people are approaching you, nobody’s quite got all the information that you need.  Three 
months, it was so short (especially) if you’re waiting two weeks for each letter and each visit.” 
Esther 
 
Having community based support was an advantage as their Macmillan nurse describes: 
“Because of my role we do community visits… and we're able to spend that little bit extra time 
with the patient and the family and explaining things a little bit better.” Sam, Macmillan Nurse 
 
Conversely, those who had an established ‘relationship’ with a HCP clearly felt the benefit. 
Since getting to know his CNS Phil hadn’t ‘felt quite so alone’. 
HCPs were ‘recognised’ as a different kind of ‘resource’ than friends and family, who 
complemented the efforts of the former by providing differing types of support, including 
information and helping people to use the ‘system’ more effectively, as Esther and Phil 
describe:  
“It’s nice to have the friends, but sometimes you need a professional just to be in there saying 
‘well what would happen if we did take that’, or ‘what would happen if we don’t do that’?”  
Esther  
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“They’ve (HCPs) been so helpful they may even have bent the rules to make the path more 
easy. I mean with appointments, like this week I came to see the surgeon, I’ve got to come 
again to see [the oncologist], got to come again next week for a CT scan… Pick up the 
telephone and hey presto they are all in one day.” Phil 
 
Participants often struggled to understand the information they received (as noted previously) 
and in such circumstances other support was needed. Irene turned to her GP to explain things 
in ‘lay’ terms whereas Sue turned to her cousin, an occupational therapist, when her Aunt 
Irene became ill.   
“They were all very, very busy so they would talk to you, but you had to stand about for ages 
waiting until they’d got 30 seconds to speak to you. But with [my cousin] I could just say what 
I felt and she’d get the gist of what I was saying and not look at me like I’m an idiot, if you 
know what I mean.” Sue  
 
Patients and carers sometimes needed differing types/amounts of information and this was 
also ‘recognised’ by HCPs. Esther and John’s Macmillan nurse noted:  
“I think from the point of view of what Esther wanted to know, the background information of 
the support that's available and how the different services worked.  Whereas John, he was 
engaging in conversation but didn't particularly want to know in-depth information.” Sam, 
Macmillan Nurse 
 
In addition to being a potentially important source of information in the best circumstances 
HCPs also provided much needed emotional support, especially when a good ‘relationship’ 
was established.  For this to happen however participants needed to know who was available. 
This was often not made clear, as Kate, Phil’s carer describes:  
“When we first started there were no information sheets. Then they said get through to your 
cancer nurse. What cancer nurse? We didn’t know [the CNS] then… I mean you can’t fault 
them at all now but in the beginning we didn’t know who they were.”  Kate  
 
As John had treatment from multiple specialties Esther also did not know who to contact: 
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“Who is your point of contact?  I'm not quite sure.  Loads of names there, but who do we 
contact?  I'm still not sure who we contact.” Esther 
 
Fortunately her Macmillan nurse ‘recognised’ this and tried to make sure someone would 
always be available for them, including an out of hours service. 
Similarly Irene’s GP had made a point of being available during the lengthy and complex 
diagnostic period that she experienced. 
“And so I had a series of conversations with her in our branch surgery near her house.  They 
were usually long appointments, sort of 20 minutes, half an hour.   I wanted to make availability 
to me easy.  Which it should be for palliative patients in general, that's our sort of practice 
policy.” Henri, GP 
 
Transfers through the system could disrupt established relationships and starting again with 
a new specialist often took time. Karen, for example, had developed a relationship with her 
surgeon and now knew him so well that she could gauge whether the ‘news’ was likely to be 
‘good’ or ‘bad’ by his non-verbal cues. She felt that she needed to develop the same level of 
understanding with her oncologist if she was to get the most from their ‘relationship’:   
“[The oncologist] has a very different style to [the surgeon], and I suppose because I didn’t 
know him very well it’s gauging what is bad news isn’t it?  [The surgeon] I know completely 
when it’s bad news, but with [the oncologist] I was thinking is this bad news or is this just news 
that you deliver to lots of people who come in here?” Karen 
 
Many HCPs ‘recognised’ situations such as Karen’s and appreciated the need to establish a 
relationship quickly: 
“They may have started off in [other hospitals], so had very close contact with the CNSs there, 
and then we just meet them when things aren’t great really.  And I think sometimes it’s hard 
to try and get a relationship going when you don’t know that patient’s history. I find it quite 
hard to sort of establish any kind of thoughts around a patient.” Sandy, CNS 
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Karen worked on her ‘relationship’ with her oncologist and was so successful that she refused 
to be referred to a hospital closer to home. The need to establish new ‘relationships’ was 
something most participants experienced if they were to move through the hospital ‘system’ 
as smoothly as possible.  
HCPs also felt a sense of satisfaction from their relationships with patients/carers and were 
disappointed when circumstances meant that this did not happen as often as it might: 
“And I'm saddened in a way from my experience about palliative care I didn't have the 
conversation of where would be your preferred place of death.  I didn't have those sort of more 
extended kind of planning palliative conversations with her.  I didn't facilitate her being nursed 
at home or get involved in visiting patients at home, which from a GP looking after a palliative 
care patient can be the most rewarding times. Being completely honest I felt disappointed I 
couldn't try and provide that high level of palliative care right to the end.” Henri, GP 
 
In the face of often unpleasant and invasive treatment participants sought ways in which they 
could maintain some hope. In this sense hope and the desire to keep things as ‘normal’ as 
possible became a ‘resource’. Despite this the melanoma and its ongoing treatment inevitably 
impacted on participants’ daily routines. 
 
8.5 CHANGING ROUTINES  
“Yeah, it’s (the melanoma) just become part of my life.” Luke  
 
Living with advanced melanoma had an impact on participants’ daily ‘routines’ on a number 
of levels. As noted above, new treatments became available during the study which some 
patients were able to access. This meant there was a need to go to hospital for further 
investigations, consultations and (where appropriate) treatment. For many this became the 
new ‘normal’:  
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“So I suppose that’s the whole scary bit of knowing that yes, you start to normalise coming to 
this hospital and knowing that you get a ticket for your bloods or you go up here.  You start to 
know the process; does that make sense? And then it becomes just very normal to you.” Karen 
 
However, probably the greatest impact on patients’ and carers’ ‘routines’ was the need to 
‘monitor’ their melanoma, its associated symptoms and the efficacy and side-effects of 
treatment. Side-effects of treatment were constantly compared to the list of possible side-
effects so having good information was essential. Patients were pleased when they did not 
experience all of the possible side-effects and felt that those that they did experience were 
manageable. This was taken a positive sign, especially if other activities, such as work, could 
be maintained:  
“Just makes me feel lethargic and all my muscles in my back hurt, oh they're really tight, but 
apart from that just normal.  Not had any other side-effects.  God I've got a sheet about that 
long full of side effects, the only ones I seem to have got is my aching muscles, and like I said 
just feeling a bit tired.  But at the same time I've gone back to work full time.” Luke  
 
To manage such side-effects new routines were often needed. Phil, for example, regularly 
applied cream to the blisters on his fingers and Luke, who developed a phobia of needles, 
found strategies to manage this such as concentrating on “gulping coffee” while the needle 
was inserted. 
 
In addition to ‘monitoring’ side-effects participants, both patients and carers, also kept a close 
eye on their symptoms in order to judge how well they were doing. So even with advanced 
disease Karen still ‘monitored’ her moles, feeling that this gave her a ‘sense of control’ as she 
could see when things were changing. She also felt that if she was reporting side-effects to 
HCPs but not being admitted to hospital, she was ‘alright’. 
“So I jot down on a daily basis not everything but just main things. So you do get an idea of I 
wasn’t writing those sorts of things a couple of months ago, but every day I've got the cough 
and breathlessness, whereas a couple of months ago it was fine, I could walk up the stairs 
like anybody else.  So yeah, I know that I monitor.  I feel sometimes I’m a hypochondriac 
because I’m monitoring it so much, but I know I’m not.” Karen  
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Others such as Phil, who had no initial symptoms, found it hard to accept how rapidly his 
melanoma had spread: 
“It’s showing no symptoms whatsoever, I mean they’re telling me I’ve got lumps here, there 
and everywhere. I can’t feel any lumps. Or being affected by anything.” Phil 
 
Family or friends who saw the patient regularly ‘noticed’ subtle changes week-to-week, that 
the patient themselves might not appreciate as Sue describes below:  
“But I did notice that she was more sluggish, she wasn’t as sparkly as she usually was.  When 
we were going places she didn’t walk as fast.  She was just gradually slowing down.” Sue 
 
Others actively sought the help of family. Sarah realized that she found it difficult to assess 
the melanoma on her leg as she looked at it every day, so she shared this task with her family, 
and they would make comparisons: 
“And I showed my dad a few weeks ago and he took a photo of it then.  Because he said he 
can see a change.  But then I’ve not shown him again for weeks.   So he’ll come with me 
Thursday, I’ll show them and I want to see if it’s changed from his photo.” Sarah  
 
As the quote above suggests participants devised a variety of ways of ‘monitoring’ their 
condition but more substantial evidence came from their regular scans and these were a 
further cause of potential concern. Even though hospital visits had become ‘routine’, when the 
results of scans were going to be discussed, this still caused anxiety. Luke describes the sleep 
disturbance he experienced before receiving results and Sarah talks about feeling scared:  
“I just found that the night before I'd come to hospital (for results) I always had restless nights.” 
Luke  
 
“I’m not saying I haven’t had my down days and I haven’t been snappy, because I have, I think 
it’s to do with Thursday (results).  I’m not saying I’m not scared, I’m really scared, but I’m at 
that stage I think, here we go again and whatever it is, it is. I’ll still keep fighting it.” Sarah  
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The psychological impact of living with melanoma is clear from the above but patients still 
often tried to ‘hide’ this from others and keep things to themselves. Carers often became aware 
of this and therefore, as well as ‘monitoring’ physical symptoms, they also assessed the mood 
of the patient to judge how well they seemed to be coping. This could be done covertly so as 
not to worry patients unduly. Lynn, Sarah’s aunt, describes this:  
“It’s like when she’s feeling down, she doesn’t know that I know she’s feeling down.  And she 
doesn’t know that I’m thinking about it. I’ve seen a change in her, especially this last month or 
so.  She’s been more like herself than what she has been, because there’s been times when 
I’ve looked and I’m thinking she’s not herself at all.  But I’ve been really pleased this last 
month.” Lynn 
 
Esther noted John’s mood changing as the metastases spread to his brain and she found this 
the most difficult aspect to deal with as she felt she was losing the person he had been:  
“The brain thing was very disturbing, because that’s the one that really affected him badly in 
the end.  He changed, his whole behaviour changed.  He stopped being the (person) that I 
knew.  He withdrew completely from everybody, everything.” Esther 
 
As noted above both patients and carers did not always ‘share’ their observations/feelings 
with each other and this can be seen as another subtle manifestation of the ‘hiding’ behaviours 
that both could engage in.  
 
In addition to ‘monitoring’ their side-effects, perceived progress and mood, living with 
melanoma also changed other aspects of participants’ daily life, for both patients and carers. 
The latter in particular began to play an increasingly more active role as things developed. 
John experienced difficulty sleeping and so was frequently up during the night. Esther worried 
that he could hurt himself while walking round so she stayed up with him to make sure he was 
safe.  
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“The lack of sleep was quite hard, because he was on the move continually.  I’d say let me 
just sit with you and settle you.  No, leave me alone, leave me alone.  So he’d settle for a bit, 
then he’d go into the other bed. So sometimes I’d sleep in the chair a bit.” Esther  
 
As her aunt became frailer Sue visited her three times a day to help her get up, go to bed and 
cook her meals, varying the dishes to try and accommodate her aunt’s changed sensation of 
taste: 
“Obviously her diet changed because she didn’t feel like eating.  She felt sick with a lot of 
things so I did think about things that were more neutral in flavour because sweet things tasted 
wrong and salty things tasted wrong so I tried to find things that were neutral for her or that 
might just sort of taste a bit.” Sue  
 
As is apparent from the above ‘monitoring’ of various sorts became part of the daily ‘routines’ 
of living with melanoma, as did ‘protecting’, which took a variety of forms. We have already 
seen how both patients and carers often tried to covertly ‘protect’ the other from the impact 
the melanoma was having on them. Another more overt form of ‘protecting’ was apparent with 
regard to sun exposure. For Sarah ‘protecting’ herself and her children from sun exposure 
was part of her regular routine. In addition to sun cream she had bought a canopy to provide 
an area of shade in her garden. She also took care to avoid the sun when out with her friends, 
something that was treated with gentle humour:  
“Been doing more stuff with girls from up at school with their children, just go on park for a 
couple of hours after school and things.  But I have to go and sit over in shade while they’re 
in sun.  I’m like hiya, I am still here.  And the sun, as it’s moving round I move round too, so 
we all laugh and joke about it.” Sarah   
 
Phil was ‘sun aware’ but became more vigilant while on treatment when he developed a rash 
that he attributed to sun exposure:  
“I mean I've got a wide brimmed hat, I've got long sleeved shirts, trousers, that's all I need.  If 
I keep the sun off me then I won't get the (rash) - see I'm blaming the rash last time on the 
sun, I might be wrong.  But it could well be at that time of year that excess sunlight just tipped 
me over onto a, you know, that rash situation.” Phil  
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In addition to the impact of the melanoma on daily routines it also impacted more widely on 
participants’ roles.  
 
8.6 THE IMPACT OF ADVANCED MELANOMA ON ROLES   
“But I've got to think that my time is limited and start planning ahead... before anything happens 
when I can't… it might be years, it might be months, we don't know.” Irene 
 
Patients’ and carers’ roles changed again as the melanoma advanced. As already noted some 
didn’t consider themselves as patients, even when they had advanced disease. The exception 
was Karen who saw herself move into the ‘classic’ patient role, a change in ‘status’ that was 
difficult for her to accept:  
“I suppose it’s the times that I’m spending here (in hospital). I’m here all day today, which I 
suppose in a way gives you a whole new career path doesn’t it.  And sometimes you sit there 
waiting and you think ‘Crikey, is this what I've become?’ You go from being a senior clinical 
manager with lots and lots of responsibilities and running round to like thinking ‘right what’s 
my job now?”  Karen  
 
Other ‘patients’ cited few perceived changes in their role however relatives were far more likely 
to see themselves as moving into a caring role, which often had unexpected impacts. For 
example, Laura recognised the importance of her role as a carer but this caused tension 
between her and others in her life who did not share her view:  
“Like I have got a really good friend support network, they are really understanding, but like 
my partner, me and my partner have split up due to the pressure of me being with my mum 
and working and things like that, and not having enough time for him in his head. And also the 
breakdown in my relationship actually with my sister, with one of them, you know I've got twin 
sisters. One is amazing, but [the other], I just can't even begin to describe that girl. She’s just, 
she hasn’t dealt with it, and instead of dealing with it she has pushed everybody away and 
been very nasty and very volatile, and she’s been quite horrible to mum, and that’s not 
acceptable.” Laura 
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Both Karen and Laura ‘recognised’ the reversal in their roles with Laura now having to look 
after her Mum and at times herself ‘becoming Mum’. Karen also knew that Laura was giving 
up a lot to support her, albeit willingly:  
“So yeah, there’s times when it is quite a role reversal, in a nice way not in a horrible way.  But 
it does make me smile because I think, you know, my gosh. And I think, that you feel guilty if 
you’re not with me or not doing something for me.  And that’s hard for me, because I've always 
tried to be very clear that you’ve still got your own life to live.” Karen 
“Yeah, I don’t go out with my friends as much anymore, because I’d rather be with mum.  I 
worry when I go to work that I’m going to get a phone call or something’s going to happen, like 
mum will need me and I won’t be there.  If I had my way I’d quit my job and I’d just live with 
you all the time.  But I can’t do that because it’s not very realistic, and I’d go a bit stir crazy.” 
Laura 
“Yeah, we’d drive each other mad.” Karen 
 
Sue was also disappointed with the ‘response’ of a family member who did not understand the 
importance that she attached to caring for her Aunt:   
“One of my cousins… Yeah, well, well I can’t do anything I’m working. OK, well I’ve given my 
job up for her so you live with your conscience. And that was it.” Sue 
 
However, as was the case with Karen and Laura the care that Sue, and others, unconditionally 
gave Irene, even though they had other demands, did not go unnoticed:  
“They are there for me when I need them and they do it willingly, not half-heartedly.  I mean 
Sue is always there when I need her.  My friend’s always there, although she’s had a lot of 
trouble because she’s had another friend that’s been poorly, and she’s got another one now 
that’s been taken ill with something like, ovarian cancer.”  Irene  
 
As the melanoma progressed sooner or later participants began to think about what the future 
might hold and ‘recognised’ the need to both change certain roles and to begin ‘putting their 
affairs in order’. 
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In addition to the ‘protecting’ roles described above patients and carers experienced changes 
to their occupational, leisure and family roles at this stage of the melanoma ‘rollercoaster’. 
Despite this they tried to continue to keep things as ‘normal’ as possible by making 
modifications that were necessary. Therefore goals were subtly changed so that they were 
achievable and future planning became more day to day rather than long term.  
 
Most participants in employment experienced changes to their occupational roles. Irene and 
Phil were already retired and Sarah had stopped working when she was diagnosed with early 
stage melanoma.  John’s rapidly deteriorating health meant that he could not continue to work 
as a farmer and Karen also had to reluctantly stop working as a senior clinical manager which 
led to fundamental changes to her identity: 
“And then I’m in that scared bit thinking well I don’t want that to be normal to me, because I've 
still got my bag with my laptop and my notebook and my work clothes in the wardrobe, and 
that’s normal for me.  And I’m having to leave that for a bit for this to be normal for me, which 
is probably where I don’t do patient very well.”  Karen 
 
As with Karen, Luke liked to be busy and work was also a big part of his ‘normal’ identity so 
he negotiated with his employer to keep working for as long as possible:  
“I were off for about two months… Boring.  It were, just pottering round house.  But they didn't 
want to let me back to work, they were scared to death in case owt happened to me.  I says 
I'm all right.  So I ended up building back up to half days, which finished two weeks ago.  I 
didn't bother getting a doctor's note and I just went back full time.  I got a slap on wrist.  So 
they've took two hours off me again, so I finish at three now - can't win.” Luke 
 
Taking on a caring role also impacted on the employment of participants. We have already 
heard how Sue postponed finding a new job after being made redundant so that she could 
care for Irene. Similarly, when Phil was diagnosed with advanced melanoma, Kate decided 
that it was time for her to retire in order to enjoy more time together: 
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“Deep down I’ve been wanting to [retire] for a while but obviously it’s that push. That were that 
when we knew that [Phil had advanced disease]. I said that’s it I’m packing in and I only worked 
a week. That’s out of the way now. Emptying cupboards. We went away with friends and we 
just potter.” Kate 
 
Laura continued to work as she got support from colleagues, but as was noted above always 
felt guilty when she was away from Karen.  Sarah’s sister Amy had reduced her hours at work 
to care for her when she had her initial treatment and now the whole family were involved with 
the exception of her mother who was unable to cope with her daughter’s illness.  
 
For many participants the reduction in working hours meant that they could spend more time 
together and even those reluctant to cut ties with work, such as Karen, recognised the benefits 
of this:  
“And we talk a lot more, that’s changed.  Because obviously we spend a lot more time together, 
I suppose it comes hand in hand doesn’t it?  We’ve had a lot more time together than perhaps 
we would have done if I was working full time and you were doing other things.” Karen 
 
Changes to occupational roles brought with it the need to begin to ‘put affairs in order’ and 
reorganize many aspects of their lives, such as insurance and pensions. This brought further, 
albeit reluctant, ‘recognition’ of the permanent nature of changes: 
“There’s lots of things like pension forms, at work I’m coming up to six months so I’m changing 
from salary to insurance schemes.  I think it’s the amount of letters coming through and contact 
I’m having with people to sort out finances and work that it all, even though really it becomes 
more real that I’m not going back, and that I’m just putting things in place.  It’s like getting your 
affairs in order isn’t it, but not trying to think of it that way.”  Karen  
 
When Karen began to ‘put her affairs in order’, the situation also became more ‘real’ for Laura 
who ‘recognised’ that she would be taking on some of her Mum’s roles after her death: 
“It’s the realisation - I’m going to get upset now and I don’t want to.  Like it’s the realism that 
mum’s not going to be here forever, sorry.  Because of like all the affairs and stuff… Yeah, but 
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I think that just comes from like the sorting out of affairs and stuff like that, that’s quite real, 
that’s scary.” Laura 
 
Others began to plan for an increasingly inevitable future:  
“I’ve been talking to Sue while I was waiting for you about these funeral plans that you can go 
into beforehand.” Irene 
 
Despite the above participants still wanted to maintain an element of normality and to continue 
to enjoy their remaining time so that things like holidays became increasingly important. But 
owing to increased frailty or difficulties in getting holiday insurance changes were necessary 
here too. Differing kinds of holiday, such as visiting family, began to replace more traditional 
breaks, but this type of holiday was still enjoyable and also another manifestation of ‘putting 
things in order’: 
“Yes, my other niece.  I’ve just been for a week’s holiday, well Wednesday to Sunday.  Yeah, 
I went for a holiday to stay with her and her two cats and a dog, yeah.  Yes, we went about 
quite a bit.  A lot more than I thought we would be doing because I thought I wouldn’t be able 
to walk very far, but we did quite well really.” Irene 
 
Conversely, others were frustrated by their newly imposed limitations. For example, Karen’s 
desires to go abroad were thwarted because of the difficulty she had getting insurance, much 
to the disappointment of Laura, who had saved hard for such a treat:   
“My mum really wanted to go to Florida, to go to Disney again, because we went when we 
were younger, and obviously we can't go because insurance either doesn’t cover it or is just 
ridiculous amount of money, and that really upset me, because I've saved up like three grand 
to take her, and I was like continually saving because I really wanted her to go, because it’s 
something she wanted to do.” Laura 
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Others, such as Phil, planned their holidays around their treatment regime and decided to take 
the risk and go without full insurance cover:  
“But I mean I'm perfectly willing to stand the insurance.  I've been open and honest with them, 
all they've said is we're not covering you for any aspect of your illness.  I mean we did Jamaica 
last January, we'd just done Norway on that basis.  And I felt perfectly all right. But I mean 
everything is in four week blocks.  Because like one four week block we've got the scans in 
between, so we can't do it on that block.  So this block is a clear.” Phil  
 
As well as the effect of melanoma on ‘treats’ such as holidays participants also had to restrict 
their usual leisure activities, and sometimes families colluded to ensure this. For example 
Karen’s daughters had hidden her locker keys for the gym so that she did not do too much. 
For Phil the advanced disease meant he was not able to use his new bicycle as much as he 
wanted to and Luke’s gardening was restricted. Irene was able to maintain some of her usual 
activities with the help of Sue. As Sue describes below she was aware of her aunt’s need for 
a degree of closure with friends and was happy to help her achieve this, although it was painful 
for Sue as well:   
“I think she wanted to fill as many blanks in her calendar as she could, you know, get as many 
people visited and just set her world to rights, you know.  And I was quite happy to tag along 
with her, you know.  I don’t think there was any of her friends that I didn’t get along with so it 
was quite nice in a way, although there was always that little note of I wonder when it’s going 
to be in the back of your mind.” Sue 
 
In contrast to the others Sarah began to feel better while she was being treated for advanced 
melanoma and planned to start going back to her usual activities and looked forward to a more 
positive future: 
 
“I feel well in myself, I feel fine.  Like after Christmas I’ve looked into going to the gym and 
getting a personal trainer, and I’ve told them all about my situation and they can help me do 
that.  And they’ll give me support with my leg and stuff.  So I’ve said [this] is going to be my 
year.  I’m going to get my results, I’m going to go to the gym, get healthier and just go from 
there.  It’s like I’ve already made plans, because I feel all right in myself, I don’t feel poorly.” 
Sarah 
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Despite Sarah’s optimism others began to increasingly ‘recognise’ that time was perhaps 
limited and some, such as Irene, began to pass on what might be called their ‘biographical 
legacy’ to the next generation, as Sue recounts below:   
“We were doing a bit of family history storytelling.  She was telling me about who was who, 
people that I’ve not met, obviously they’d passed before I’d been born, but she was telling me 
who they were, who they were related to, little stories about them. We’ve had some good 
days.” Sue 
 
Karen, whilst wanting to spend time with her family, also began to do things that she had 
wanted to, rather than putting them off for another day, knowing that time was of the essence: 
“But latterly however, I have a new folder of things that I've planned to do.  Not a bucket list 
but things that, I’m probably a little bit more impulsive as just booking something. Like we chat 
about doing something, and before we’d talk each other out of it or I’d talk myself out of it and 
think oh we’ll do another day.  But I don’t do that.” Karen  
 
Despite Sarah’s new found optimism she also started to make preparations for her children, 
to enable them to be cared for together should she die: 
“We went to the cancer support centre and I met someone, like a lawyer wise.  Because my 
Dad said he’d always take over all three of them, he’d carry on as normal… That’s the only 
thing what’s not got sorted, something in writing to make sure they’re together.” Sarah  
 
 
The perceived need to “put their affairs in order” occurred throughout the melanoma 
experience with a varying sense of urgency, but this became more pressing when faced with 
the news that treatment was no longer working. The ‘hope’ that patients and carers had sought 
to maintain was reduced and they had to decide how to spend the limited time that they had 
left. Many of the patients were not well enough to take part in interviews by this time, but Karen 
and Laura were interviewed shortly after finding out that Karen’s treatment was not working. 
They both partly expected the news but it was nevertheless a difficult time, described as the 
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‘strangest’ moment in their melanoma experience, which left them both unsure what to do and 
say:  
“When we got the results, we went to [a café].  And it was, it was really quite a surreal moment, 
because everything feels in fast forward around you, and we were just sort of sat there staring 
at each other. And we didn’t quite know what to say to each other…” Karen 
“Which doesn’t happen with me and you, because we just talk about anything and everything, 
it was hard.  It was weird wasn’t it?” Laura 
“It’s been the strangest moment I think in all of this, was just sat eating and trying to talk about 
normal things but thinking oh what’s the point, we’ll just sit here and then that’s it.”  Karen 
“Yeah, first time in a long time I've not known what to say.” Laura 
 
As patients and carers began to “put their affairs in order” there was an increasing ‘recognition’ 
that this was in preparation for saying goodbye to one another. This understandably raised a 
variety of emotions including anger and sadness as Laura and Esther describe below: 
“But I am really angry that she’s had to have this, because she doesn’t deserve it.  And the 
stuff my mum’s been through in her life, like this is just not fair, like she didn’t deserve it.  And 
I don’t think the family deserves it either, like I don’t think I deserve to lose my mum at 22 
years old, that’s not fair.  But that’s quite a selfish way to look at it I guess, but no, I do get 
angry.” Laura  
 
“And I spent so much time telling him how much I loved him.  And when I did he’d look at me 
and then he’d just sort of stroke my arm.  But it was hard losing him before he’d gone really, 
that was hard, because he was a big softie.”  Esther 
 
A number of those left behind decided to continue to contribute to the study and to share their 
experiences with me.  
 
8.7 BEREAVEMENT 
“So again I’ve had to think ahead as to how do I plan my life now because it’s empty.”  Esther  
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John’s wife Esther and Irene’s niece Sue wanted to continue to take part in the study after the 
deaths of their loved ones. Two interviews were conducted with Esther and one with Sue. 
They both also took part in a focus group at the end of the study. It is their experiences of 
bereavement that are explored here, showing how their ‘roles’, ‘routines’ and ‘relationships’ 
continued to change.  
Below both Esther and Sue movingly recall their last moments with their loved ones and it 
seems that these were a time of understandable sadness but were also peaceful and 
reflective:    
“Well only a year ago I was with his father when he died.  I’m not frightened of people dying; I 
think it’s a privilege to be with somebody when they die.  And to be with him was the most 
natural thing in the whole world, and to be able to talk to him.  And I didn’t even ring the bell, I 
could see the breathing, it comes from the diaphragm, I knew what was happening.  And I 
thought I’m not going to call anybody, I don’t want anybody here, I know what’s happening.  
And so I waited until he’d finally breathed his last, and then I rang the bell.  So we had that 
time, but he wasn’t with me, he was on the morphine by that time.  At least he was quiet.” 
Esther  
 
“But she was content, she wasn’t upset or frightened or anything like that, she was quite 
content when I left her.  And I knew that she was going to pass, I just, I don’t know, it’s just a 
sense, you know, I said goodbye, because she was laboured with her breathing a little bit and 
I’d said to her, because she was a tiny bit worried about it and I said if you relax, I said and 
just drift off to sleep you’ll feel better because your body will all relax.  And she closed her 
eyes and I’d kissed her and that and so it did calm down.  But then when I was going I kissed 
her on the forehead and she felt different so I knew that she was going.” Sue  
 
Afterwards the inevitable grief began to have an impact. For Sue this seemed to happen 
almost immediately, whereas Esther, who had lost her life partner, describes how she 
struggled to ‘hide’ her emotions so that they did not overwhelm her:   
“And I went and by the time I got downstairs I think she had probably passed by then because 
I was just overcome and I cried all the way to my car.” Sue  
  
“I mean I’m weeping now, now and again, but I don’t know, it’s also a fear… Of letting go too 
much and not being able to scramble back again.  It’s so deep the grief, I might just lose 
control and not be able to fight my way back.  So my grief has to be measured, and crying at 
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night and sobbing, and then say right come on, pull yourself together, it’s another day, get 
over it.  So it’s all, I mean you can see, I go like I've got to scramble back.” Esther 
 
 
Both Esther and Sue had invested a great deal of themselves in their caring role and they had 
not only lost their loved one but also a role that had played such a prominent part of their lives 
over recent times. However despite all she had done Esther questioned whether she could 
have done more and this added another layer to her grief: 
“I’m not resentful at all of any of the time; I wish I could have given more.  It’s difficult isn’t it, it 
just felt totally normal.  Whatever you had to do you would do for somebody you loved.  You 
do it for your children; you do it for anyone you love…. still the same things going on and on 
in your mind of I should have done this, I should have done that, I should have said this, I 
should have been there for that, all that running through my mind for 10 days just made me 
desperately unhappy.” Esther  
 
Sue, however, had spent a great deal of time with her aunt in the period immediately prior to 
her death and had been able to help her achieve a sense of inner peace.  
“So, in a way I feel privileged that I’ve been able to spend those last few weeks with her, 
because we did talk about so many things and I know she was quite content, she’d put 
everything to rights that she needed to, there was nothing that she wanted to do or no regrets.  
The only thing that she’d said that she wished she’d been a bit less shy, because she was 
when she was younger apparently quite shy and she felt that she could have done more with 
herself, but other than that no regrets.  I think that’s quite nice to be able to look back like that, 
isn’t it?  Not many people get the opportunity.  And it was a lovely funeral as well, as funerals 
go.” Sue 
 
For Esther the loss of John was felt acutely as she began to ‘recognize’ that they were no 
longer an ‘us’ and this is captured below as she describes her on-going ‘relationships’ with 
their children and grandchildren:  
“Suddenly something that I had shared with John that was an ‘us’ thing with our eldest son 
and family out there, suddenly it was just me and there wasn’t some, wasn’t this body next to 
me to share it with, to discuss things.  Even the babysitting type of thing, it’s harder with two 
kids just on your own.” Esther 
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In the midst of this sadness there was however still ‘business’ to complete and Sue, for the 
first time, saw her role as a form of ‘work’ rather than as a labour of love. The ongoing 
emotional impact of this is captured eloquently below:  
“Instead of it (Irene’s house) being a place where I’d go to either socialise, do little jobs, familiar 
type jobs, it became almost a place of work because we’ve been going and emptying 
cupboards, packing stuff up and then we’ve been having to have, because the family is far 
flung, we’ve been photographing and sending pictures of stuff to say, look, these are things 
that are available if anybody wants them, rather than just getting rid of anything and then 
people being, oh where was so-and-so, I wanted that?  So they’ve all had their fair chance, 
so we’ve almost worked there shall we say, off and on, but we’ve not been able to do more 
than a couple of days a week because it’s just so emotional.  You come home and you’re 
absolutely drained.” Sue  
 
For Esther, there was a more urgent need to attend to practical and financial affairs as John 
had deteriorated quickly and there hadn’t been time to do anything beforehand. John’s death 
also had a more immediate impact on Esther as she now had to move out of their home, 
adding another layer of loss:  
“I don’t think I’m anywhere near really being able to get used to the life without him, it’s a totally 
different life it’s going to be.  So it’s something I have to find my way, I have a lot of very big 
practical issues I have to contend with, and that’s what I have to be strong to do.  Moving from 
here. I have to move, it’s too big here, it’s too remote, it’s a huge garden, going out the back 
as well.  Finances, everything, big challenges ahead.  So it’s not just the emotional side of 
getting used to being without him, it’s having to be practical.  Not just with this but there are 
other things as well I have to deal with.”  Esther 
 
Losing her husband also meant that Esther felt that other people saw her in a new role as a 
widow. She noticed this more when completing documents and being asked for her marital 
status. Esther did not want the title and the assumptions that she felt other people made about 
her.  After years of being seen as part of a couple, Esther felt the loss of the ‘relationship’ with 
her husband and began to ‘recognise’ how this had in large part defined who she was: 
“But you do, you’re no longer parents, you’re a parent, I’m a mother, the mother-in-law, little 
old lady on her own, little old widow.  It’s a funny place to be, strange place.” Esther  
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Although grieving, Esther felt that she had to “be strong” for her immediate family. This meant 
‘hiding’ some of her emotions from her children as she did not want them to feel upset. 
However this meant that she had to shoulder much of her grief alone: 
“I feel I have to be strong because I have to survive, and because my children want me to be 
strong.  And they want me there for the grandchildren, and I’m the strong one.  Oh mum, 
you’re so strong.  I think if only they knew I was sobbing in my room.”  Esther 
 
This grief also impacted on her ‘relationship’ with her friends as Esther felt that if she cried too 
much in front of people, it would make them feel awkward and so whilst acknowledging her 
sadness she did not want to burden them with her grief in case this in some way drove them 
away. Esther showed a remarkable degree of insight and sensitivity in the way that she 
‘recognises’ and ‘responds’ to the changing ‘dynamics’ of her ongoing ‘relationships’:   
“And so the dynamics of your life change.  The way people, I wouldn’t say see you, that’s 
slightly different, but you’re very aware of how the dynamics change. You’re no longer a 
couple, that’s the first thing.  Luckily still friends invite me and that’s all fine.  I have invited 
people too.  I had six for dinner on Sunday to try and get them to not be frightened of me in a 
way, and whatever my grief is.  Because I think people are quite nervy about how you are and 
how you’re going to be.  There’s a caution.  I have one friend who as soon as I say John she 
bursts into tears.  Which I then go and say it’s all right, it’s fine, don’t worry about it - because 
she is so soft, so gentle.  But you see people are afraid of their own reactions somehow.  I’ve 
heard stories of people crossing over roads and things, nobody’s done that to me but some 
people have told me that people avoid rather than having to confront.” Esther 
 
It was quite humbling for me to realise that it was only in the context of her participation in the 
study that Esther felt able to share the full extent of her feelings with someone else. This is 
something that will be considered further in the discussion. Neither, Sue or Esther had 
accessed any bereavement support and did not say that any had been offered. However 
during the focus group CNSs recognised that carers may need support during the grieving 
period; that they may have questions that needed answering as they tried to make sense of 
what had happened. 
“And sometimes supporting families after patients have died as well, I think we do that as well. 
So that they, although the patient may no longer be there the carer or partner that’s been 
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coming with them we still, because you’ve had that relationship with them for a few years and 
they still want to talk to you about things. And I think that that’s nice from our point of view to 
be able to be there to support them through that difficult time as well. Fortunately for me it 
doesn’t happen very often.” Pat, CNS 
  
For Sue the process of sorting her Aunt’s possessions meant that she needed to contact wider 
family members, which she found, brought them together: 
“But it was interesting that people that normally wouldn’t have talked a lot to each other, 
because we’ve got quite extreme differences in personality in our family and some of the 
people that wouldn’t normally talk were actually sitting talking, because we’d taken photos, 
she’d sorted photographs out had Auntie Irene and there was a little bundle for each member 
of the family, each of the cousins.  So we’d taken those and given them to people at Christmas 
and so everybody was looking at the photographs and saying, oh, look at this and so on, and 
I think that’s probably why people were talking more.  It was quite good in that respect, but a 
bit sad in another respect, because then all our parents that are now passed they were all in 
these pictures, so everybody was a bit choked and it was very emotional, but we enjoyed it.” 
Sue 
 
The prolific impact of bereavement meant that daily ‘routines’ were altered for both Sue and 
Esther but more so for Esther owing to the nature of her ‘relationship’ with John and the huge 
part it had played in shaping her identity. This was ‘recognised’ by her family who tried to help 
her reshape her life, by making apparently superficial but nevertheless important changes: 
“[My eldest son] was fantastic.  He came and he did very clever things I have to say while he 
was here.  He changed the bedroom completely.  We have two single beds pushed together, 
and he took the one bed away.  He took that single bed and put it into the smaller room.  Took 
a double bed from another room, put it in there, moved the furniture around, and he said you’ll 
use the room now.  And he was right.   I haven’t for a while really because John was so sick.  
But the fact is it’s made it different, so he did that.  He did the garden.  He did all the things 
that I couldn’t do.  And [my youngest son] was helping with the same thing, and he was with 
me one week, and then [my eldest son] was with me another week, so between them they 
really did a lot.  But he had to go back to Australia, and [my youngest son] has to go back to 
work and he’s got a new baby who’s only three months old.  So all this happened with a new 
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8.8 SUMMARY 
As the accounts above have shown the ‘rollercoaster’ continued to have ‘ups’ and ‘downs’ 
after the diagnosis of advanced disease, with such a diagnosis being one of the major ‘downs’ 
that participants experienced. However, new treatments became available during the study 
and this provided a sense of renewed ‘hope’ for some. Responding to these new treatments, 
living with advanced disease and the growing realisation that death was a possibility had 
further significant impacts on participants’ ‘routines’, ‘roles’ and ‘relationships’ both with family 
members and HCPs. ‘Sharing’ and ‘hiding’ continued to play as important role in mediating 
such ‘relationships’ during a time of increasing uncertainty which involved participants trying 
to maintain ‘normal’ activities as far as possible while also preparing to say goodbye to one 
another.  
 
For some the death of the patient meant further changes to the ‘roles’, ‘relationships’ and 
‘routines’ of surviving family members, who could struggle to deal with their grief with minimal 
‘resources’ to do so. This is something that will be considered further in the Discussion chapter 
that follows.  
 
As has been noted at various points the primary aim of the study on which this thesis is based 
was to better understand the experience of living with melanoma from the perspectives of 
patients, their primary carer and the HCP that they identified as being the most influential. It 
was hoped that the insights gained would result in the development of a mid-range substantive 
theory with the potential for practical application in order that the melanoma ‘journey’ could be 
improved for those who might embark on it in the future.  
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Analysis of the extensive volumes of data collected, revealed a complex and multifaceted 
picture, with each ‘journey’ having both shared and unique elements. In developing a theory 
that captured such complexity, but could also be easily understood by multiple audiences, 
some of this individual variation was necessarily lost. At the start of Chapter 6 I provided a 
brief overview of the substantive theory that I, and the participants, believed provided a faithful 
rendering of the major milestones experienced by those living with melanoma and the impact 
that it had on them. It is this that has been elaborated upon in the preceding pages. 
 
Consistent with the temporal approach underlying Grounded Theory this account of the 
‘melanoma journey’ comprised a number of stages captured by the metaphor ‘Riding the 
Rollercoaster’. This reflects the various ‘ups’ and ‘downs’ that participants experienced during 
their ‘journeys’, and whilst the nature of these understandably varied, as did the final outcome 
(for example between participants with fatal metastatic disease and those who achieved cure), 
all those who took part experienced both ‘ups and downs’.  
 
Based on an analysis of their accounts the melanoma experience was described as 
comprising of the following key phases or ‘moments’ :  
• What’s that mole?: Pre-diagnosis   
• The Melanoma journey begins: Diagnosis and early treatment 
• Ups and Downs: Surveillance  
• The ‘Bombshell’: Advanced Melanoma, and for some, death  
 
As has been described not all participants experienced all phases (for example metastatic 
disease and death) but all were experienced by some. In working through these various stages 
participants’ lives underwent a number of changes brought about by the impact of the 
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melanoma, and the nature of the interactions between patients and carers and their contact 
with the health care system. These changes and the processes that accompanied were 
captured in the theory by using an alliteration of ‘R’s, which reflect the impact of the melanoma 
on the participants’:   
• Routines of daily life 
• The Roles that they fulfilled, and 
• Their Relationships with each other and the health care system  
These impacts were mediated by the ways in which participants Recognised and Responded 
to the challenges that they faced and the Resources that they could draw upon in so doing.  
 
The phases of the melanoma rollercoaster are shown in Figure 8.1 along with the transition 
points between these phases where the greatest effect on patients’ and carers’ ‘roles’, 
‘relationships’ and ‘routines’ are seen. While not illustrated on the diagram, there is a further 
transition point for carers upon the death of the patient into bereavement. Throughout the 
rollercoaster patients and carers experience a constant process of re-thinking their ‘roles’, 
‘routines’ and ‘relationships’ as they are presented with new information. New information may 
take many forms such as a new mole or lump, treatment, recovery, the presence or absence 
of side-effects or symptoms, scan results or physical examination findings. Re-thinking ‘roles’, 
‘routines’ and ‘relationships’ involves the key social processes of ‘normalizing’, ‘noticing’, 
‘monitoring’ and ‘protecting’ which underpin ‘routines’ and ‘sharing’, together with ‘hiding’ and 
‘tailoring’ which underpin ‘relationships’ and ‘roles’. There is however, overlap between these 
processes as they do not occur independently of one another.  
 
Of the transition points between phases of the rollercoaster, diagnosis (being told that it is 
melanoma/cancer), advanced disease (that the aim is control rather than cure) and the 
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transition to palliative care (where there is no more treatment available) are key points where 
new information has a profound impact on ‘roles’, ‘routines’ and ‘relationships’ for patients and 
carers. 
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The transition between initial treatment and surveillance is not always obvious as patients with 
small lesions may have their treatment completed before their diagnosis is available as the 
whole lesion is removed to gain the diagnostic information. Other patients, however, may 
require multiple surgeries possibly with other treatments before a more definite progression to 
surveillance at the end of treatment. This transition may therefore be experienced differently 
depending upon physical disease indications.  
 
Prior to diagnosis ‘noticing’, ‘monitoring’, ‘normalising’ and ‘protecting’ were the main 
processes. Where the lesion was obvious, sharing rather than hiding took place as carers or 
family members encouraged patients to seek medical advice.  
 
After diagnosis the process of ‘hiding’, ‘sharing’ or ‘tailoring’ the new information had an effect 
on the resources available. An example of the impact of the ‘hiding/sharing/tailoring’ process 
is the choice made by participants to share or hide their diagnosis from work colleagues. 
Participants were supported in the workplace emotionally or physically but only after ‘sharing’ 
the information. The process of ‘sharing’ was a pre-requisite to gaining supportive 
relationships as a resource to maintain occupational roles. This also applied to family and 
leisure roles where ‘sharing’ information within family and social circles meant that supportive 
relationships were available as a resource to help maintain roles, even if these were modified. 
‘Protecting’ primarily related to sun-protection behaviours which may also impact upon ‘roles’. 
‘Noticing’ and ‘monitoring’ and to an extent, ‘normalizing’ continued but these processes were 
directed towards healing and recovery and the absence or presence of any new symptoms. 
Where suspicious lesions or new melanomas were removed during surveillance, this new 
information was fed into the process of re-thinking ‘roles’, ‘routines’ and ‘relationships’ and 
having surgery may even have become a new routine along with attendance for surveillance 
visits and scans. Diagnosis was a critical point for ‘relationships’ with HCPs to be built and 
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where these occurred, they became a major resource for patients and carers. Diagnosis 
formed the first major ‘down’ of the ‘rollercoaster ride’ as it was perceived as a rapidly 
occurring, negative event. Recovery from this ‘down’ was a ‘slower ride’ as patients and carers 
made changed to ‘roles’, ‘routines’ and ‘relationships’ in light of the melanoma and treatment. 
Surveillance then comprised a number of ‘downs’ and ‘ups’ as patients experienced anxiety 
and relief during scans, examinations and where indicated lesion removal.     
 
Progression to advanced disease was the next major ‘down’ of the riding process as this was 
a further negative event that again meant re-thinking ‘roles’, ‘routines’ and ‘relationships’. 
Sharing facilitated the availability of Resources, but hiding or tailoring were often motivated by 
the desire to protect others. The focus of noticing and monitoring shifted towards the effects 
of treatment and symptoms related to melanoma. Carers’ roles began to take on a noticeable 
change as they undertook more elements of physical caring. Once again the resources 
needed to maintain roles depended largely on information being shared. ‘Relationships’ with 
HCPs again were an important resource as new information was needed. The ‘ups’ of the 
rollercoaster during advanced disease were experienced when the melanoma was controlled 
and roles could be maintained, albeit with modifications. The ‘downs’ came when the 
melanoma was no longer controlled by treatment and impacted on ‘roles’, ‘routines’ and 
‘relationships’. In some instances further recovery and the next ‘up’ of the rollercoaster came 
with new treatment.  
 
When treatment was no longer an option and palliative care became the focus patients and 
carers experienced the next steep ‘down’ in the ‘melanoma rollercoaster’ as this further 
negatively impacted their ‘roles’, ‘routines’ and ‘relationships’ which then required further 
modifications. HCPs were a continued source of emotional support and information. However, 
where good Relationships had been developed, these were difficult to end where a transition 
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to a different service (for example community care) was required. Carers’ Roles continued to 
change as the physical aspects of caring were needed more and they often relied upon other 
Relationships as a Resource to allow them to do this.  
 
The Theory of riding the melanoma rollercoaster is therefore made up of phases with transition 
points, but throughout the rollercoaster patients’ and carers’ Roles, Routines and 
Relationships are mediated by the processes of sharing, hiding and tailoring and noticing, 
monitoring, normalizing and protecting. 
 
The next, and concluding chapter, will consider the extent to which the study’s aims have been 
met and address issues of rigour and reflexivity. The potential contribution of the findings to a 
better understanding of the melanoma journey will be explored and the thesis will conclude 
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9 CHAPTER 9: DISCUSSION & CONCLUSIONS 
Having explored the study results in depth in the preceding chapters, the final chapter seeks 
to; consider whether the theory addressed the initial foreshadowed questions that informed 
the study at the outset, address issues of rigour, reflexivity and the limitations of the research, 
discuss how the study contributes to a better understanding of the melanoma experience, and 
suggest a number of implications for policy, practice, education and further research. 
 
9.1 HOW WELL DID THE STUDY ADDRESS THE FORESHADOWED QUESTIONS? 
The primary aim of this study was to explore the changing experiences and support needs of 
patients with melanoma and their carers throughout the disease pathway. I will discuss the 
ways in which the research contributes to a better understanding of melanoma later in this 
chapter with reference to how melanoma is experienced over time.  Here I consider how well 
the study addressed the initial foreshadowed questions and the ways in which the findings 
reflected (or not) the themes identified as part of the review of existing knowledge as presented 
in Chapter Three.  
 
The initial foreshadowed questions were derived from a distillation of the current 
understanding of the melanoma experience derived from three main sources: patient/carers 
research and personal accounts, the professional and research literature and my own prior 
knowledge. Figure 9.1 below shows which themes generated from this synthesis were 
reflected in the interview data. From this it is clear that only one theme, gender-related 
differences, did not emerge as an influencing factor in the participant data so this was not 
carried forward beyond the review stage. All other themes were represented in the data to 
some extent and influenced to a greater or lesser extent the complex interactions between 
Roles, Routines and Relationships and their underlying processes.  
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Figure 9.1: Themes from the literature review seen in interview data  
 
The ways in which the aspects of ‘roles’, ‘routines’ and ‘relationships’ play a key role in the 
resultant Grounded Theory were illustrated in Figure 8.1. 
 
I now consider how the study addressed each of the foreshadowed questions individually.  
• How do patients and carers experience melanoma, and what impact does it have 
on various aspects of their lives such as QOL, psychological well-being, their 
Themes from patient and carer sources of knowledge
Themes from HCP sources of knowledge
Combined themes
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worries and concerns and their financial situation? 
The study suggested that patients and carers experience melanoma as a ‘rollercoaster’ 
comprising a number of physical and emotional ‘ups’ and ‘downs’ that vary over time. 
Although the impact of living with the disease on patients’/carers’ QOL was not specifically 
discussed there is no doubt that it affected their psychological well-being in a number of 
ways. Many of these were negative, with there being numerous worries and concerns 
about, for example, the effect of the melanoma on: their body image, their ability to 
maintain valued ‘roles’ and activities (including work and consequent financial worries for 
younger patients) and in some cases, worsening ‘relationships’ with family and friends. 
One of the major concerns related to fears that the melanoma would return. These feelings 
capture some of the ‘downs’ of the melanoma ‘rollercoaster’.  However, impacts were by 
no means all negative and some participants described improved ‘relationships’ and an 
enhanced realisation of what matters in life.  
 
For the first time this study made a detailed exploration of the melanoma experience from 
the perspectives of both patients and carers and charted how it impacted on both groups. 
The roles of carers as an essential ‘resource’ supporting patients with melanoma emerged, 
as did the various struggles that they faced throughout the journey. Whilst there was some 
recognition of the challenges carers faced there was often very little tangible support for 
them from the healthcare system. Some of the implications of this will be considered later.   
 
• How do these experiences and impacts vary over time? 
The theory suggested that the melanoma experience can best be understood as 
comprising a number of stages or ‘moments’ beginning with the pre-diagnostic phase, 
through diagnosis and early treatment, surveillance and for some, advanced disease and 
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death. Whilst these stages were not discrete or clear cut they did mark major transition 
points for patients and carers. The ways in which the impact of living with melanoma varied 
over time was described in detail in the preceding chapters which identified impacts on 
‘routines’, ‘roles’ and ‘relationships’ and highlighted how these varied depending upon how 
patients and carers ‘recognised’ the need to act, the ‘responses’ that they evoked and the 
‘resources’ that they could draw upon. Key processes such as the ‘hiding’, ‘sharing’ and 
‘tailoring’ of information; ‘noticing/discounting/normalizing’ and ‘monitoring/protecting’ 
occurred to a greater or lesser extent throughout the melanoma ‘journey’ and helped to 
explain the varying impact that the disease had over time.  However, probably the most 
important factor in shaping individual experiences of melanoma was the nature and quality 
of the ‘relationships’ between patients, carers and HCPs.  
 
• Do patients and carers make changes to their lives as a result of melanoma?  
As described briefly above, and elaborated upon in the findings chapters, patients and 
carers made numerous changes to varying aspects of their lives especially in terms of their 
day to day ‘routines’ and more widely to the ‘roles’ that they saw themselves as fulfilling. 
Such changes could be temporary while the patient recovered from treatment but in many 
cases were more permanent. 
 
The complexity of the treatment regime often meant frequent visits to hospital and this 
inevitably impacted on the daily routines of both patients and carers. Work could be 
disrupted for both patients and carers and in many cases the patients’ ability to undertake 
previously taken-for-granted activities was compromised. Family members in particular 
often had to move into a more noticeable caring role, especially for patients with advanced 
disease. ‘Monitoring’, both overtly and covertly, became an important new ‘routine’ for 
most participants, as did changes in their ‘relationship’ with the sun. This could have a 
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wider impact on previously treasured activities such as taking holidays abroad. For others 
a deterioration in their physical abilities meant restrictions to hobbies and leisure activities. 
 
Melanoma also resulted in more fundamental changes to important roles, including 
occupation, with some having to give up or change their jobs. The taking on of a more 
noticeable caring ‘role’ was identified above.  However, probably the most significant 
change for many participants occurred in their ‘relationships’ with those they were closest 
to. These changes were most often a result of the ‘sharing’ and ‘hiding’ processes 
identified in the theory and these could result in relationships becoming closer or more 
distant.   
 
• Are patient and carer experiences and impacts influenced by factors such as 
gender, information and education, the nature of supportive relationships and the 
support services accessed? What are their experiences of the latter? 
Neither gender nor education, in terms of prior educational achievement, appeared to have 
a major influence on the experience of melanoma. It should be stressed that these aspects 
were not explicitly explored as they were not raised as issues by the participants. Even if 
they had been, it is unlikely that the sample size would have been sufficient to allow a 
detailed consideration of the impact of such factors.    
 
However, the impact of information and education about melanoma was significant for 
both patients and carers. The type of information that was given, the form in which it was 
provided and when it was made available were all important. Some participants felt that 
they had either been given too little information, or that what they had been given was too 
complex. Most struggled to ‘take in’ the information that they were given, especially around 
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the time of diagnosis. Some carers felt that they were better placed to ‘make sense’ of the 
information provided but no information, either about the disease or their own role, was 
specifically given to carers. Paradoxically some patients chose to limit the involvement of 
carers and might ‘hide’ information from them. Consequently the extent to which carers 
were fully involved depended largely on the ‘sharing’ and ‘hiding’ activities that both parties 
could engage in.    
 
Such activities were pivotal as supportive ‘relationships’ were central to the experience of 
patients and carers with most people turning to their existing social networks (including 
family and friends) for support. For those with a limited social support network, interactions 
with HCPs were particularly important, but the supportive role of HCPs was of great 
significance for the vast majority of participants.  HCPs were a key ‘resource’ providing not 
only information and clinical expertise but also emotional support. However, participants’ 
experiences varied. Many established a close ‘relationship’ with a particular HCP, most 
often a CNS, and in the best circumstances this relationship started early and could last 
throughout the melanoma ‘journey’. Participants valued an HCP who was approachable 
and made themselves available, thereby establishing a ‘relationship’ built on trust. 
Unfortunately, some participants had poor initial contact with HCPs, for example if an HCP 
did not deliver on an arranged meeting or telephone call. In such circumstances trust was 
rapidly lost, sometimes never to be regained.    
 
• Do the experiences and perceptions of patients, carers and health care 
professionals vary? 
The theory clearly indicated that many of the experiences of patients and carers were 
‘shared’ and therefore in most instances melanoma could not be understood as a solitary 
‘journey’. Differences in the perceptions of patients and carers did of course emerge and 
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the theory hopefully highlights such differences, often owing to the subtle interactions 
between ‘sharing’ and ‘hiding’ behaviours. 
 
The situation with respect to HCPs was a little different. They primarily viewed the 
melanoma ‘journey’ and their role in it in terms of the care pathways prevalent when the 
study was undertaken. These mainly related to the major treatment milestones. These 
were of course important aspects for patients and carers as well, but their concerns were 
often wider and their need for support was not confined to those periods prescribed by the 
care pathway.  
 
That said the best HCPs were attuned to patients’ needs and sought to address them as 
best they could but their efforts could be constrained by resource and time restrictions. 
Moreover, it must be remembered that the HCPs who took part in the study were, almost 
by definition, providing good support as they had been nominated by patients primarily on 
that basis. Even then a number of HCPs that were nominated did not respond to my 
invitation to take part. The fact that several participants failed to nominate an HCP also 
highlights that good support was by no means universal. In particular the support needs 
of carers was not always explicitly recognised by HCPs who focused primarily on the 
patient.   
• How can the experiences of patients and carers and the impact of melanoma be 
improved? 
This will be considered in detail when the implications of the study are discussed later in this 
chapter. Before attempting this it is essential to establish if the theory arising from the study, 
and the manner in which the study was undertaken, were sufficiently robust.  
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9.2 RIGOUR  
In Chapter Four I considered the possible approaches to judging both the ‘quality’ of a 
Grounded Theory and the extent to which the Constructivist Grounded Theory methods I 
applied in the study ensured meaningful engagement with the participants. Below I explore 
the quality of the Grounded Theory that emerged from the study using the criteria set out by 
Charmaz (2006, 2014), before establishing the extent to which the study engaged with 
participants using the Modified Authenticity Criteria proposed by Nolan et al. (2003).   
 
For Charmaz (2006) the quality of a Grounded Theory is best considered with reference to its 
credibility, originality, resonance and usefulness. I will now consider the extent to which the 
Grounded Theory described in this thesis can be considered to have met these criteria.   
 
9.2.1 CREDIBILITY 
Credibility is established by a combination of the researcher’s familiarity with the subject, 
whether the data support the theory and whether the reader is able to form an independent 
assessment of this.  
 
My familiarity with the setting and subject of melanoma has been transparent throughout the 
research process. Indeed, it was my clinical involvement as a Research Nurse that led me to 
initially explore the experience and support needs of melanoma patients. My prior clinical 
experience meant that I was very familiar with the subject but this could have resulted in me 
making ‘taken for granted assumptions’ about the experience of living with the condition. I 
therefore tried to make the potential influence of my clinical role and other prior experience as 
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transparent as possible in Chapter Three. Further attention will be given to this later in the 
section addressing reflexivity.   
 
In Chapter Four I also tried to demonstrate how the data were co-constructed with participants 
through repeated interviews and diagramming. This enabled a range of data to be collected 
over the course of the study, and the use of longitudinal interviews allowed for an explicit 
exploration of the temporal dimensions of the melanoma experience. I made numerous efforts 
to involve the participants as fully as they wished both in making sense of the data and 
ensuring that they felt that their story had been told. Engaging with participants over time 
enabled me to clarify meanings at subsequent interviews, and allowed categories to be co-
constructed facilitating consensus on the final theory. 
 
The large volume of data supporting the theory cannot be presented in its entirety but the 
excerpts selected for inclusion in the results were chosen to represent a variety of 
observations and ensure the voices of all participants were heard, even though there were 
significantly larger amounts of data from some participants compared to others owing to the 
varying number of interviews conducted with each person.  
 
On this basis I believe that the important tenets of credibility have been met and trust that the 
way in which the results and the theory have been presented will enable the reader to reach 




   
  263 
9.2.2 ORIGINALITY  
To the best of my knowledge at the time of writing this thesis, this work comprises the first 
longitudinal qualitative exploration of the experience and support needs of both patients with 
melanoma and their carers. As highlighted earlier the experiences of carers of people with 
melanoma had hitherto not been systematically explored. Part of my motivation for 
undertaking this study was the lack of ‘evidence’ concerning the support needs of melanoma 
patients and their carers and the overreliance on quantitative methods and standardised 
measures of outcome, as reaffirmed in recent considerations of research relating to melanoma 
(NICE 2015). The very limited attention given to carers’ needs remains a major omission. On 
the basis of the above I feel that the study within this thesis can be said to be original.  
Furthermore, if we consider the additional criteria suggested by Charmaz (2014):  
• Are the categories fresh and do they offer new insights? 
• Does the analysis provide a new conceptual rendering of the data? 
• What is the social and theoretical significance of this work? 
• How does the Grounded Theory challenge and extend current ideas and practices? 
 
 I believe that the categories I generated are fresh and provide new conceptual renderings of 
the data. The social and theoretical significance of the work and the extent to which it 
potentially extends current ideas and practices will be considered later.  
 
9.2.3 RESONANCE 
Resonance is concerned with whether the theory makes sense to participants, captures the 
fullness of their experience, reveals taken-for-granted meanings and draws links between 
institutions and individual lives. As has been described in some detail the theory was ‘checked’ 
with the participants on both an individual and a group level and all agreed that it made sense 
to them. Moreover, whilst it has already been acknowledged that no collective theory can 
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capture every individual nuance, there was also widespread agreement that the theory 
reflected all of the most significant events/experiences of the participants.  
 
It is often not the ‘convention’ to include new data in the discussion section of a thesis but 
being true to the constructivist principles underpinning this thesis I will let some of the 
participants ‘speak for themselves’ in support of the resonance of the theory. I feel that Fred 
does this concisely:  
“Well I mean a lot of this does apply to me, sort of new relationships, which I do share and we 
do trust one another, routines, the noticing and monitoring and protecting that applies to me…” 
Fred 
 
For Carol, certain processes such as ‘hiding’ really resonated:  
… I mean the hiding and everything, that you hide it, you hide it from your relatives, your close 
family to start with don’t you.” Carol 
 
Resonance not only applied to patients but also HCPs. In addition to those who had 
participated in the study, feedback from other HCPs was obtained during the presentation of 
initial results at conferences and meetings. These HCPs identified with many aspects of the 
theory, particularly the importance of building ‘relationships’ with their patients. However the 
need to also build such ‘relationships’ with carers challenged some of the ‘taken-for-granted’ 
assumptions that they had about their role.  
 
During presentation of initial finding to the Yorkshire and Humberside Consumer Research 
Panel, which included members with melanoma but also those who had experienced breast 
cancer and prostate cancer, numerous people identified with several aspects of the theory, 
especially ideas such as the ‘tailoring’ of information. In addition I have presented a number 
of the ‘diagrams’ arising from the study at various conference and meetings (Sheffield 
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Innovation and Research in Oncology Nursing Meeting 2016, Sheffield University Academic 
Unit of Clinical Oncology Study Day 2016, British Association of Skin Cancer Nurse Specialists 
Conference 2018) as well as them being available on the website of the Yorkshire and 
Humberside Consumer Research Panel. These have proved to be a real stimulus for 
discussion amongst both HCPs and consumer representatives, with the idea of a 
‘rollercoaster’ comprising the emotional ‘ups’ and ‘downs’ of the melanoma experience being 
particularly resonant.   
 
9.2.4 USEFULNESS 
Usefulness concerns how the theory may be used by others in their everyday worlds and how 
it has contributed to knowledge and further research. I consider this in greater detail shortly.  
 
Having gauged the ‘quality’ of the theory according to Charmaz’s (2014) criteria, I now 
consider the extent to which participants contributed to the research process in keeping with 
a constructivist approach. The Modified Authenticity Criteria suggested by Nolan et al. (2003) 
which include: Equal Access, Enhanced Awareness, Encouraging Action and Enabling Action 
were applied during the planning of the study, the process of undertaking the work and the 
final product.  As was described in the methods chapter, this framework remains true to the 
principles underpinning the authenticity criteria as originally proposed by Guba and Lincoln 
(1989) but hopefully uses a more accessible language.  
  
9.2.5 EQUAL ACCESS 
Equal access is concerned primarily with the extent to which all participants have the 
opportunity to contribute to the study as fully as they would wish and feel that that their views 
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are listened to and valued. It was originally termed ‘fairness’ by Guba & Lincoln (1989). In 
modifying this criteria Nolan et al. (2003) also considered it important that the results of the 
study are made as widely accessible as possible. This requires that they are made available 
in a wide variety of forms, using a language that is readily understood by a non-
academic/professional audience. This is something that I tried to ensure throughout.   
 
In the planning of this study, I consulted members of the Yorkshire and Humberside 
Consumer Research Panel (YHCRP) who had input into the funding application, project 
design, patient materials and ethics application. In Chapter Four, I noted the advantage of 
incorporating their views into the project so that a ‘user’ voice was integral from the outset. In 
addition when considering the foreshadowed questions I explicitly drew on as wide a range of 
prior knowledge as possible to counter the professional hegemony apparent in the usual 
notions of ‘evidence’.  
I have already described in detail the many ways I sought to fully engage participants during 
the research process, so attention is turned here to the product(s) of the study. To try and 
make the primary product of the study (the theory) as accessible as possible, I sought to 
ensure that it was written in a language and used ideas (concepts) that could be readily 
understood by the participants. I hope I have succeeded in this, and I feel that the 
endorsement provided by my participants gives confidence that I have.    
 
The thesis is itself a further product of the study and it is here that the PhD student faces 
something of a dilemma: the thesis needs to be ‘examined’ by outside ‘experts’ and deemed 
to be worthy of the award of a PhD, whilst at the same being intellectually accessible to any 
participants, and others, who might want to read it.  This is a delicate balance and one that I 
have worked hard to achieve. However to paraphrase a well-known saying ‘The proof of the 
pudding will be in the reading’. 
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Lastly it is important that future dissemination of the work will ensure that it is widely 
accessible. I have already alluded to several public presentations of various aspects of the 
thesis and I intend to ensure that any further outputs are published as widely as possible in a 
variety of media including professional outputs as well as via my Patient and Public 




9.2.6 ENHANCED AWARENESS (OF SELF AND OTHERS) 
Enhanced Awareness of ‘others’ and ‘self’, replaces ontological and educational authenticity 
in the formulation of Guba and Lincoln (1989). It is concerned with the extent to which taking 
part in a study (or vicariously by reading the results) enhances an individual’s understanding 
of their own situation and/or the situation of others (Nolan et al. 2003). In respect of this study 
it primarily refers to patients, carers and HCPs, although as will be considered under reflexivity, 
it may also enhance the researcher’s awareness.  In terms of the chronology of a study, these 
criteria most likely apply to the process of being involved in a study. The data and participants’ 
reactions to their participation suggested that taking part in the study enhanced peoples’ 
awareness of their own situation and that of others.  
During the process of data collection and analysis participants became more aware of their 
own situation and that of others. Jackie, for example, became more aware of her ‘hiding’ 
behaviour, as the following suggests:  
“I wouldn’t say with things like hiding, I don’t hide things.  But then I wouldn’t say I talk enough 
about it probably,  so  maybe that’s classed as hiding.” Jackie 
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Indeed for some participants the interview was the first time that they were enabled to, or had 
let themselves, talk about their feelings and so naturally new insights emerged. In addition 
where joint interviews took place with the patient and carer, each often became more aware 
of each other’s point of view, especially if a degree of ‘hiding’ had been taking place. Although 
I was concerned that this might raise problems in relationships this didn’t seem to be the case 
in most instances.  
 
The interviews also gave HCPs an opportunity to reflect on their interactions with patients and 
carers and to consider how they might do things differently:  
“One of the advantages of you doing something like this is that having it clearer makes us I 
guess look at what we’re doing and how we’re interacting and relating, and how we’re listening 
and what we’re hearing.” Les, CNS 
 
In the context of this study an enhanced awareness was largely a by-product of taking part 
rather than a specific aim. On the other hand as one of my main motivations for completing 
the study was to generate insights that would raise peoples’ awareness of living with 
melanoma then it is to be hoped that the product of the study (theory/thesis/output) will 
resulted in enhanced awareness of those exposed to these outputs.  To begin to achieve this, 
a summary of the results (accessible to all participants) has been sent to patients, carers and 
healthcare professionals who participated in this research (see Appendix 9) and plans for 
future dissemination have already been outlined.   
 
9.2.7 ENCOURAGE ACTION 
Encouraging action (which replaced ‘catalytic authenticity’) is concerned with whether the 
results of the study identify areas for change (Guba & Lincoln 1989, Nolan et al. 2003). When 
planning this study this was at the forefront of my thinking with the aim being to identify areas 
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in which the melanoma ‘journey’ might be improved as informed by the participants’ 
experiences.  
During the research process patients, carers and HCPs reflected on their experiences and 
began to consider improvements.  For example Tom’s surgeon considered how improvements 
could be made to the patient and carer’s experience by everyone working together:  
“I suppose the question is what might help to change? …... maybe health checking and maybe 
talk and sharing. You know, I suppose there’s, what can the patient do, what can healthcare 
do, what can the people around the patient do?” Ashley, Surgeon 
 
Of course the ultimate aim is not only to encourage action but to enable it to happen.  
 
9.2.8 ENABLE ACTION 
Enabling Action (which replaces ‘tactical authenticity’) considers the extent to which taking 
part in a study or being exposed to its results actually facilitates or enables change (Guba & 
Lincoln 1989, Nolan et al. 2003). This study, unlike an action research project, was not intend 
to effect immediate change but it is hoped the results will lead to improvements in the care of 
patients with melanoma and their carers. This will hopefully be a major product of the study 
and in this respect it is closely related to whether there is ‘equal access’ to the results as 
highlighted earlier. Action can only take place if key groups have the information and are aware 
of potential changes that could be made. I consider the potential for the results to encourage 
and enable action in the implications section which follows shortly and have already outlined 
plans to disseminate the results as widely as possible.  
 
Having considered both the ‘quality’ of the theory that emerged from this study and the extent 
to which participants were engaged in a way consistent with a Constructivist approach, 
attention is now turned to reflexivity.    
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9.3 REFLEXIVITY 
As was discussed in Chapter Four reflexivity has, until recently, rarely been fully addressed in 
Grounded Theory. To begin to redress this deficit I decided to use the suggestions of Gentles 
at al. (2014) to frame my consideration of reflexivity. They identified four sets of issues that 
need to be addressed, these being: 
• Types of researcher interactions that may influence the research 
• Researcher influence during all stages of the research process 
• How researcher influence is handled 
• How researcher influence is viewed 
Many of these were given consideration in Chapter Four but some insights are only possible 
when the study has been completed and I turn attention to these now. 
 
Given my clinical background and that fact that participants knew I was a nurse the impact of 
this on the study is an important area of reflexivity. In order not to make ‘automatic’ 
assumptions as to a participant’s meaning I always ‘checked’ these with participants, returning 
to seek extra clarification if meaning remained unclear. The use of a longitudinal design and 
repeated interviews greatly facilitated this. 
 
In many respects the fact that I was a nurse enabled some participants to talk more openly 
about their situation and feelings, for as Sue said, ‘You could talk about it because she would 
understand’.  
This openness came with responsibilities however as a number of participants were surprised 
at how much they had ‘opened up’, especially some of the men:  
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 “Yeah, I don’t know if I should be telling you all of this actually.” Tony  
“I never talk about this, you know, I don't know why I'm talking to you about it.” Tom  
 
I always reassured people as to the anonymity of their stories and gave them the chance to 
have any sensitive issues removed. This option was rarely chosen. 
Taking part in the research also encouraged some participants to talk more openly to each 
other about the melanoma. This had the effect for some of bringing melanoma to the front of 
their minds when they had previously chosen to ignore it, as Sandra explains below:     
“I think we think about it more and talk about it more because you’re here and you’re asking 
questions.  We don’t talk about it, and I carry on my normal life and I don’t worry.  But when 
you’re talking about it, it makes you realise that yeah you do worry, it’s still there.” Sandra 
 
This again required great sensitivity on my part but as they reflected on it participants often 
valued the renewed focus that the interview gave them and the opportunity to talk to a neutral 
but sympathetic person could be seen as therapeutic: 
“I feel like I've got everything off my chest to be honest.  It’s like it bottles up and then finally I 
talk and it’s like everything’s off my chest now.” Sarah  
 
Most patients and carers found being interviewed together beneficial. Esther was pleased that 
John had spoken to ‘someone else’ about his experience and Carol and Jack felt that 
communication between them had improved as a result of the interview. However, during the 
focus group Jean admitted that divulging information during the interviews that she had not 
discussed previously with her partner had caused some tension between them. Clearly great 
care is needed as not all ‘enhanced awareness’ is necessarily beneficial.    
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Taking part in the research was also an opportunity for HCPs to reflect on their practice in a 
way that they may not otherwise have done. Many of them found this was a positive 
experience for them, as Lou notes: ‘It’s been quite good looking back on it really’.  
 
Interestingly, whilst I was very experienced in the field of melanoma, participating in the study 
as a researcher also had an impact on me, especially with regard to future research. Through 
using a Constructivist Grounded Theory method I have become aware of the contribution that 
patients and carers can make to the research process at all stages and now value this 
contribution more than prior to commencing the study. This has led me to consider how I might 
involve patients and carers in future research in a meaningful way. As a result of the study 
and the PhD Fellowship overall I have cemented my belief in the benefit of clinical academic 
roles in nursing and the need to actively involve patients, carers and fellow clinicians in the 
research process.   
 
In addition to reflecting on my influence on the data collection process and its impact on 
participants, I need to make transparent my influence on the analysis of the data and the 
presentation of the findings.  
 
The process of data analysis and the rendering of the ‘results’ in constructivist research relies 
on creating a partnership between the researcher and participants at all stages (Charmaz 
2014). This is something that I aspired to from the outset and I have tried to make this 
transparent throughout. Inevitably however there are some power differentials in evidence. 
For example, together with my supervisors I made the initial decisions regarding the direction 
of the study and the sort of questions I wanted to address. However, in doing so I tried to 
ensure that the patient/carer voice was explicitly included as described in Chapter Two. The 
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efforts I made to ensure patient/carer participation during all phases of the study have already 
been described and I can but hope that these were successful.  
 
I feel in particular that the use of diagramming during data collection was particularly helpful 
in engaging participants. I drew on the work by Keady and colleagues (Keady et al. 2007a, b, 
Williams and Keady 2012) to inform my decision to use diagrams and whilst I did not use them 
within a life story approach they nevertheless proved very useful in helping many participants 
to tell their ‘melanoma story’. Even those participants who could not generate ‘diagrams’ of 
their own responded very positively to the more professional ‘artistic’ representation of the 
‘rollercoaster’, which has also proved very useful in stimulating debate in other arenas such 
as consumer engagement events. This is definitely an approach that merits further 
exploration.  
 
Diagramming was particularly useful in capturing the definition of time and change for 
participants. Saldana (2003) notes that both time and change are contextual and key elements 
of longitudinal research. In this study the element of time is perhaps best captured by the 
metaphor of the ‘rollercoaster’, which seeks to capture change ‘over time’ as it was 
experienced by the participants. The ‘rollercoaster’ seeks to identify the shared ‘moments’ of 
the melanoma journey but at the same time to highlight variation over time depending of each 
participant’s unique set of circumstances. The concepts of time and change were constructed 
by participants and the researcher together through diagramming and analytic processes. The 
‘ups’ and ‘downs’ of the rollercoaster captured the events that marked the phases and 
transitions of participants’ experiences. Where patients and carers drew their own 
rollercoaster and what they thought the other person’s rollercoaster would look like differences 
in perceptions of time and the impact of events were seen. The rollercoaster, represented a 
‘journey’ made up of events that occurred in a linear fashion, but not all participants 
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experienced all events, phases or transitions. Longitudinal interviewing and repeated contact 
made the rollercoaster metaphor possible as it took two or three interviews for it to emerge 
and its significance in the data collection process to become apparent. Using the rollercoaster 
as part of data collection may in itself have influenced the data as it allowed participants to 
reflect on their experience in a particular way. It was during the focus groups that the collective 
experience of time and change emerged more clearly, giving participants access to a wider 
context and timeframe in addition to than their own. Longitudinal interviewing also enabled 
changes to be seen, defined and placed within a temporal context. Without repeated contact, 
the development of the relationships between the various aspects of the final theory would not 
have been seen as they were, nor would the temporary or permanent nature of changes to 
participants’ roles and routines. Diagramming therefore enhanced the individual, and 
collective constructions of time and change within the study. 
 
With regard to the presentation of the thesis, I have already considered my efforts to meet the 
requirements of a PhD whilst also presenting the work in an accessible a form as possible. It 
is for readers to judge the extent to which this has been achieved.  
 
9.4 LIMITATIONS 
Whilst every effort was made to ensure that the study was conducted in a manner consistent 
with the best principles of constructivist work some limitations are inevitable within the time 
and resource constraints of a PhD. The study was limited to the setting of a single teaching 
hospital and surrounding district general hospitals in the north of England. Furthermore 
limitations were apparent with regard to the sample of patients, carers and HCPs that 
participated.  Patients were the primary access route to both carers and HCPs and these were 
largely self-selected in that they were willing to talk about their experiences. Many of the 
patients approached about the study declined to participate due to the time commitment 
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involved but others wanted to forget about the melanoma. This may well mean that the views 
of patients who employed certain types of responses to melanoma were not captured in the 
study.  Carers were only able to take part if patients nominated them. This may well have 
resulted in only dyads who enjoyed a good relationship taking part, thereby excluding those 
whose relationship was fragile. HCPs taking part in the study were similarly limited to those 
nominated by the patients at their six-month interview or as soon thereafter as was possible. 
Interestingly nominations were confined largely to plastic surgeons or CNSs with no 
dermatologists or oncologists being identified. This may be because at the time of nomination 
the majority of contact had been with the two former groups whereas contact with oncologists 
and dermatologists happened at a later point in time. Patients with lower grade melanomas 
did not have contact with oncologists at all. Some patients also felt that they ‘never saw the 
same person twice’ or did not establish a relationship with an HCP so no data were collected 
from HCPs at all. Moreover HCPs were nominated because they had a positive influence on 
the patient’s experience and this may well have resulted in any overly positive picture 
emerging that may not capture the overall contribution of HCPs to the melanoma experience. 
Such issues to do with ‘sampling’ are to an extent inherent within studies of this nature and 
may in part have been overcome if there was time to involve more than one carer or HCP. But 
as ‘representation’ and ‘generalisation’ are not the goals of this type of study such limitations 
should not compromise the integrity of the findings significantly. However, the study is best 
viewed as an initial attempt to provide an in-depth understanding of the melanoma experience 
from the perspectives of the main groups involved. Hopefully it provides a solid platform on 
which to build. Areas for further research will be considered later. 
 
Having now considered issues to do with the rigour of the study consideration is now given to 
its potential contribution to knowledge.    
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9.5 CONTRIBUTION TO KNOWLEDGE 
Given the paucity of prior in-depth qualitative explorations of the melanoma experience it is 
hoped that the present study has provided new insights that prove to be of value, both 
theoretically and practically. This study is the first to consider the experience of melanoma 
patients and their carers longitudinally from pre-diagnosis to death highlighting the temporal 
nature of the experience and the fact that patients’ and carers’ support needs change over 
time. Of particular importance is the period around diagnosis when early patterns of interaction 
between both patients and carers and HCPs are established. I now consider contribution to 
knowledge framed using the temporal stages identified in the study.  
9.5.1 PRE-DIAGNOSIS 
This study captured the ways in which melanoma may be ‘noticed’ but is subsequently often 
‘normalised’ and ‘discounted’. This process could go on for some time and was noted amongst 
HCPs as well as patients and carers. This could result in significant delay in receiving the 
necessary investigations and treatment.  Similar findings have been seen in other studies 
published since my study commenced. For example, Walter et al. (2014) when examining 
reasons for delayed melanoma diagnosis found that initial skin changes and new lesions often 
did not cause concern for patients who would attribute them to other causes or normal skin 
changes rather than seeking help immediately. Also consistent with my findings, Walter et al. 
(2014) found that some patients experienced delays in accessing the healthcare system 
because they had been given ‘false reassurance’ by GPs that skin changes were nothing to 
worry about. To compound matters, they had not been given enough information on 
monitoring the lesion and when further changes warranted a return visit. 
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Walter et al. (2014) suggest that the diagnostic process involves four stages (appraisal, help-
seeking, diagnostic and pre-treatment) with each being affected by factors relating to patient 
and healthcare provider/system interactions. The findings from this study support such 
conclusions but also highlight the longer term impact of the early diagnostic experience on 
future contact with the healthcare system.   
 
The results have shown that throughout all stages of the patient journey, HCPs are a valuable 
‘resource’ to patients and carers. Their expertise is valued as patients and carers seek 
information to navigate their way through the healthcare system. Having personal contact with 
someone who acted as the ‘face’ of the healthcare system improved the experience. If that 
person was then able to deliver the information that the patient and carer needed in a way that 
was understandable this further improved the experience.  
 
Prior to diagnosis, GPs were an important ‘resource’, acting as the gatekeeper to specialist 
care. The 2017 Cancer Patient Experience Survery (Quality Health 2017) suggested that 
patients’ concerns are generally actioned at this point with 69% of patients only seeing their 
GP once before being referred for treatment. 
 
9.5.2 DIAGNOSIS & INITIAL TREATMENT 
During diagnosis and initial treatment, patient and carer experiences varied depending on the 
nature of the further treatment required. This study highlighted the impact of treatment on 
patients’ and carers’ ‘roles’, ‘routines’ and ‘relationships’. Similarly Tan et al. (2014) found that 
patients with stage III melanoma described the impact of treatment on ‘roles’ and ‘routines’ 
including work, socialising, hobbies and activities of daily living related to lymphoedema or 
pain from the site of surgery. They also considered the role of carers, one of the few studies 
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to do so. They found that carers can feel inadequate in their role, believing that they were not 
doing enough to help patients. A particularly interesting finding by Tan et al. (2014) was that 
some patients and carers described ‘putting on a brave face’ to prevent loved ones from 
worrying. This is entirely consistent with the notions of ‘hiding’ and ‘tailoring’ described in detail 
in this study. This is something that I will build upon later. As has already been highlighted few 
prior studies have considered carers’ needs and this remains largely the case.  
 
Patients first turn to the person who may be considered their carer for support and NICE 
(2012b) recommend that family members and carers are involved in patients’ care. It is 
therefore surprising that some carers in our study were not able to form relationships with 
HCPs. Patients and carers then used their existing social networks for support but often 
‘tailored’ information to protect elderly or young family members. This finding has been echoed 
in recent publications involving melanoma. The importance of relationships and social support 
has been found in long-term melanoma survivors (Stamataki et al. 2015) and patients with 
advanced melanoma and their spouses (Engeli et al. 2016). These studies also found that the 
process of telling people about the melanoma to gain their support was difficult and not all 
information was disclosed so as to not overburden family members (Engeli 2016, Stamataki 
et al. 2015). This study however, found that while carers (who were often close family 
members) provided the majority of support for the patient, they themselves also needed 
support and may be drawing on the same wider social network as the patient.  
 
Support from social networks however, can only be gained if information about the melanoma 
diagnosis is shared, something that not all patients in this study were willing to do. The study 
also uncovers the strain that a melanoma diagnosis can put on relationships. Participants in 
this study found that melanoma and its treatment negatively affected some relationships which 
became more distant as a result. Patients and carers may turn to their existing social networks 
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for support, but not all members of these networks are able to fulfil the role. Furthermore some 
people whom the patient would turn to as their main carer are not able to fulfil that role so the 
patient then needs to seek support from their wider network. Support needs to be tailored to 
the individual and a full assessment of a patient’s social network may help HCPs to identify 
their place within that as a source of support. 
 
At diagnosis patients, and to some extent carers, described feelings of ‘shock’. This was also 
echoed in an exploration of the psychosocial impacts of stage III melanoma on patients (Tan 
et al. 2014). These feelings of ‘shock’ can then prevent carers and patients from understanding 
all of the information given to them at that time (Tan et al. 2014, Girgis et al. 2018), something 
that clearly emerged from the present study.  
 
While an unmet need for information has been reported (Palesh et al. 2014, Tan et al. 2014) 
it is also recognised that information provision alone is not enough (Ribi et al. 2018). Patients 
require clarity, quality and availability of information (Stamataki et al. 2015). In this study this 
amounted to personalised information delivered at a pace and using phrases readily 
understood by patients and carers.  
 
Patients have reported difficulties in communicating with their clinical team (Tan et al. 2014) 
which may relate to a lack of clarity, or opportunity. Stamataki et al. (2015) found that patients 
who had the opportunity to discuss their emotional and informational needs with CNSs felt 
that their needs had been met but this was done at a later timepoint whereas patients in our 
study felt they needed that support at diagnosis. Feelings of ‘shock’ combined with the need 
for information makes diagnosis a pivotal time for patients and one where HCPs can contribute 
to their positive experience by providing information in a way that is understandable to them. 
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Given the impact that the ‘shock’ of a diagnosis has on patients’ and carers’ ability to 
understand information, it would seem that more than one information-giving encounter is 
needed. The National Cancer Patient Experience Survey 2017 (Quality Health) found that 
around 70% of patients found it easy to contact their CNS and understood the answers to their 
questions. However, the survey included patients seen as a day case for cancer related 
treatment and discharged, so the results may be biased towards patients receiving day 
surgery for melanoma rather than more complex treatments. HCPs are a valuable source of 
expertise for patients and their families. This study demonstrated that despite attempts by 
HCPs to help patients maintain their usual activities while remaining safe in the sun, some 
patients and carers reduced their outdoor activities. Robinson (2018) also found that 
melanoma survivors reported lower levels of physical activity after being diagnosed with 
melanoma which was possibly related to the need to avoid sun exposure. Information 
provision even after the diagnostic period is therefore important. This study showed that some 
nurses had developed ways to meet these needs by arranging further meetings or telephone 
calls but some patients felt abandoned.  
 
The experience of diagnosis and initial treatment will change further in the coming months as 
adjuvant treatments have been approved for melanoma (NICE 2018a, 2018b, 2018c). The 
lack of structure that Mark and Sandra felt in comparison to Sandra’s experience of breast 
cancer will change in light of this, along with the support needs of patients. Patients and carers 
are likely to be given information about relatively new treatments with unfamiliar side-effects 
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9.5.3 SURVEILLANCE 
One of the major concerns of both patients and carers during the surveillance period was the 
fear of recurrence. This was a significant ‘down’ on the ‘rollercoaster’. Consistent with this 
finding other studies of melanoma patients with local disease have found clinically significant 
levels of fear of recurrence (Bell et al. 2016, Wagner et al. 2018). The present study also 
shows that these concerns are understandably experienced by carers. 
 
The literature review revealed the anxiety felt by melanoma patients from the diagnostic period 
may reduce in intensity but can nevertheless be experienced for years. Research published 
since the original literature review also demonstrated patients’ ongoing worry about melanoma 
recurrence (Beesley et al. 2015, 2017, Kasparian 2013b, Molassiotis et al. 2014, Palesh et al. 
2014). This study reflected this but also demonstrated that these feelings of anxiety and worry 
related to the melanoma were also experienced by carers. The anxiety experienced by carers 
of melanoma patients has not been previously reported.  
After an intensive period of treatment and recovery, survivors can experience a special trust-
based relationship with caregivers such as their oncologist and CNS (Kroon 2017).  In this 
study, the biggest barrier to HCPs providing support was time as they had to “prioritise” 
patients. Where trust was built at diagnosis, this study demonstrated that it lasted as the 
patient’s and carer’s experience progressed. In such circumstances patients/carers felt that 
the clinical team would answer any of their questions with genuine concern and insight. As 
other studies have found, some melanoma patients and carers felt that they were ‘abandoned’ 
by the clinical team, this was especially prevalent amongst carers who felt that the patient was 
the priority (Tan et al. 2014, Kroon 2017). This study demonstrated that patients used HCPs 
responses to their needs as a measure of the quality of their relationship. Where expectations 
were met, such as telephone calls or appointments being kept as promised, trust was 
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reaffirmed but if planned contact was not forthcoming, the trust within the relationship was 
usually lost and proved very difficult to regain.   
 
Interviews and the focus group with HCPs demonstrated that the patient was the priority, with 
varying recognition of the need to support carers or the wider social support network. It may 
therefore be harder for carers of melanoma patients to be recognised.  Melanoma patients, 
until recently, have not received anti-cancer treatments until the advanced stages of disease. 
Carers provide valuable support to patients and, as this study shows, the melanoma diagnosis 
affects them as well. It is therefore short-sighted not to include them in the patient’s care. This 
is particularly relevant as carers are the main support for patients at home and often prompt 
further contact with HCPs by contributing to patients’ ‘monitoring’ routines. Consequently 
carers, as well as patients, need to feel that their concerns are recognised and that HCPs are 
available to them, particularly when the patient does not feel able to ask for help themselves.  
 
There is a lack of evidence based interventions to support HCPs caring for melanoma patients. 
One recent study reporting on a psychoeducational intervention to reduce fear of recurrence 
in patients at high risk of another melanoma found that while HCPs (CNSs in particular) aimed 
to reduce melanoma worry in patients, they did not use any specific interventions (Dieng et al. 
2016). The authors therefore developed a psychoeducational intervention that was found to 
reduce fear of recurrence. This is an area that merits further study.    
 
9.5.4 ADVANCED MELANOMA 
The experience of patients and carers changed further as patients developed advanced 
disease. Carers took on more physical aspects of caring as patients experienced side-effects 
of their treatment and further symptoms developed. Patients in our study receiving treatment 
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spoke of positive experiences with HCPs but they and carers voiced concerns about who to 
contact when they needed help as they transitioned from one setting to another.  Once new 
relationships were established patients felt supported and family members were better able to 
continue in their more demanding caring role.  
 
Patient and carer experiences also changed during the study as new treatments for melanoma 
were approved. Further work is needed to explore the experience of melanoma patients 
receiving these new therapies, which can enable patients to have long periods of stable 
disease during the advanced stage. When reviewing the literature regarding nursing 
interventions to support melanoma patients receiving targeted therapies, Koldenhof et al. 
(2018) found that the majority of these were focussed on adherence to treatment. The authors 
suggest that future nursing interventions should also focus on QOL and quality of dying, with 
respect to the patient’s needs and wishes. Kroon (2017) explored the experience of melanoma 
patients surviving two years after ipilimumab immunotherapy for advanced melanoma, finding 
that patients experienced anxiety about the future and physical problems that limited their 
usual activities.  Their experience was improved by the presence of a social network and 
engaging in normal activities. They trusted HCPs to care for them but medical follow up 
decreased when the melanoma was stable leaving patients with support issues that weren’t 
addressed. During this study patients experienced relatively short periods of stable disease 
but their expectations of treatment and support needs changed. Whereas patients would at 
one time progress fairly predictably to palliative care and terminal illness, after multiple lines 
of treatment for advanced melanoma they deteriorated quickly. This made the transition to 
palliative care more difficult as patients with advanced disease towards the end of the study 
quickly progressed from having active treatment to terminal illness often without much time to 
establish relationships with palliative care teams.  
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The benefit of ‘relationships’ and social networks as a ‘resource’ was evident at all stages but 
some patients also valued the opportunity to make contact with other melanoma patients.  
Melanoma patients in this study did not have treatment visits until they had advanced disease 
so opportunities to meet other patients were restricted to people within their existing social 
networks who had experienced a cancer diagnosis. To meet this need, some patients in this 
study sought peer support from the internet, reporting use of a closed Facebook group, which 
is only available to melanoma patients and their carers and not moderated by HCPs.  The use 
of social media and online forums has shown benefit for patients. However there are no 
moderated forums for melanoma. Participants in this study reported caution when interacting 
with the Facebook group and the only other support groups available online provided by 
OcuMelUK (a charity providing support for patients with ocular melanoma) are also closed 
groups run via Facebook (OcuMelUK 2018). Spaces that are not moderated are less 
trustworthy as there is no one checking the accuracy of posts (Hargreaves et al. 2018a), so 
the opportunities for melanoma patients to interact online are currently limited. Social media 
is not easily available to all cancer patients but melanoma is prevalent in younger, working 
age adults so online support may be more readily used by this group and is an area for further 
investigation. 
 
For some, taking part in the research also helped patients and carers to reflect on their 
experiences. This seemed especially important during disease and reinforces the potential 
benefits of being enabled to reflect on their melanoma experience with an interested but 
‘neutral’ listener.     
 
Having considered potential additions to knowledge regarding melanoma, attention is now 
turned to how the theory might be developed further.   
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9.5.5 FURTHER THEORETICAL DEVELOPMENTS: MOVING FROM SUBSTANTIVE TO 
FORMAL THEORY 
As with all initial Grounded Theory studies the primary aim of my work was to develop a 
substantive theory of the experience and support needs of melanoma patients and their 
carers. A substantive theory is one that addresses a given phenomenon in a certain context, 
in my case melanoma. However, one of the key characteristics of a Grounded Theory is that 
of ‘modifiability’: the ability to accommodate new data in a related but somewhat different 
context and to expand and develop as a consequence (Glaser & Strauss 1967). In so doing 
the theory accounts for a growing number of phenomena in differing contexts and moves from 
a substantive to a formal theory (Glaser and Strauss 1967).  
 
Elements of the substantive theory relate to the wider cancer literature, suggesting application 
beyond melanoma. Carers of patients receiving treatment for other types of cancer have 
reported ‘monitoring’ symptoms (Ream et al. 2013, Ullgren et al. 2018) but it is not explored 
whether this is done in an overt or covert way as part of ‘hiding’, ‘sharing’ and ‘tailoring’ 
processes as in this study. Investigations regarding wider cancer groups have found that 
patients and carers rely on their existing social networks for support. A large social network 
may prove beneficial (Kroon 2017, Ream et al. 2013, Drury 2018, Lynalla 2017, Howard-Jones 
2018) but a limited social network can result in unmet support needs (Ream et al. 2013). The 
involvement of a social network for support suggests that patients and carers engage in 
‘sharing’ processes but this has not been explicitly explored and warrants further investigation. 
The use of peer support is growing in the general cancer literature, again with some benefits 
noted (Lynalla 2017, Drury 2018, Walshe et al. 2017). As the use of technology has increased 
there is interest in the use of online peer support forums (Benetoli et al. 2018, Chiu & Hsieh 
2013, Hargreaves et al. 2018b). Peer support begins with a degree of ‘sharing’ but Hargreaves 
et al. (2018b) describe instances of ‘sharing’, ‘hiding’ and ‘tailoring’. Their work suggests that 
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these elements are applicable to other cancer sites but as they also included patients with 
Motor Neurone Disease there is evidence within the wider context of chronic disease. 
 
When exploring death and dying in acute hospitals in the first ever Grounded Theory study 
Glaser and Strauss (1967) identified a core category that they termed ‘awareness contexts’. 
This explained the varying levels of awareness amongst patients, family and staff of the 
likelihood of death. At the time the study was completed patients were not usually informed 
that they were dying and so they had a ‘closed awareness context’. On the other hand staff 
and families often knew of the impending death (open awareness) but tried to ‘hide’ this from 
the patient. To do so they engaged in subterfuge and this could cause difficulties in family 
relationships. Since the 1960s the idea of awareness contexts has been developed and 
applied to other conditions that have been, or still are, kept ‘hidden’ from patients, such as 
dementia (Hellstrom et al. 2005). There has therefore been a move from substantive to formal 
theory. 
A number of the processes identified in my work have previously been described in other 
studies, these are: ‘noticing, normalising and discounting’ (Keady et al. 2003) in relation to 
dementia; and ‘hiding, sharing and tailoring’ (Wang and Nolan 2016) in acute stroke.  None of 
these processes were imposed on my theory but rather ‘earned’ their way in because of their 
potential to illuminate important parts of the melanoma ‘journey’.   
 
In exploring the interactions between people with early dementia and their close family Keady 
and Nolan (2003) described how the early symptoms (such as forgetfulness) were often 
‘noticed’ but then ‘normalised’  (I’m getting old or I have the flu)  and then ‘discounted’ . Both 
people with early dementia and their family could do this (often ‘hiding’ this activity from each 
other) for many months or even years before seeking help. Unfortunately GPs would then 
often do the same thing resulting in extensive delays before formal assessment was made. 
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During this period the relationships between people with dementia and their family could subtly 
deteriorate resulting in them ‘working apart’, a pattern of behaviour that could become 
embedded.    
 
Wang and Nolan (2016) studied the experience of acute stroke in mainland China and 
described many examples of ‘hiding’ behaviours. For example family and professionals would 
collude to ‘hide’ any serious news from the patient believing that if they knew this would create 
a negative mental state and make any recovery unlikely. Some information was ‘shared’ but 
any that was given was usually ‘tailored’ to present a more positive picture. This effectively 
excluded the person with stroke from taking an active role in decisions about treatment and 
further care and could have a detrimental effect on relationships.  
 
The addition of my own accounts of ‘noticing/normalising/discounting’ and of 
‘hiding/sharing/tailoring’ suggest the potential for the incorporation of these processes into a 
more ‘formal’ theory and other researchers might want to consider exploring these ideas 
further in other contexts.   
 
Having considered contribution to the knowledge of melanoma and possibility for further 
theoretical developments, I now consider how the experience of melanoma patients and their 
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9.5.6 WHAT IMPROVES OR HINDERS THE EXPERIENCE OF PATIENTS AND 
CARERS AND HOW CAN IT BE IMPROVED FURTHER?  
Our study has shown that patients and carers experience a ‘rollercoaster’ of emotions and 
events during the melanoma experience. Factors that seemed to improve their experience 
include:  
• Access to social networks: Patients and carers obtained much of their support from 
their existing social networks including family and friends. Limited social networks 
seemed to make the experience harder. Where participants sought out peer 
relationships with other cancer patients, this also improved their experience. If HCPs 
recognise the resources available to patients including existing relationships, they may 
then be able to identify where further support is needed.  It would also be beneficial for 
HCPs to recognise where appropriate peer relationships may be helpful and facilitate 
these where possible.  
 
• The formation of trusting relationships with HCPs: Where HCPs actively forged 
relationships with patients and carers and represented the ‘human face’ of the 
healthcare system they became a powerful and valued resource for patients (and 
occasionally carers). Many HCPs already recognise the important time points in the 
‘rollercoaster’ experienced by patients and carers and seek to provide support when it 
is most needed. Their efforts can be thwarted by time and other constraints.  Lack of 
access to HCPs can leave patients feeling isolated and limit the availability of reliable, 
personalised information.  It is important that HCPs recognise the importance of being 
the ‘human face’ of the healthcare system and make efforts to establish a relationship 
of trust at the earliest possible moment.  
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• Active and explicit support for carers: It is essential that the role of the carer is 
recognised at all stages of the melanoma ‘rollercoaster’. They are the main support for 
the patient and play a key part in their physical and psychological care. Carers also 
have their own support needs, particularly as melanoma may affect the wider family in 
numerous ways. It is therefore important that HCPs involve carers in consultations 
wherever possible, but also explicitly recognise their own need for support.  
 
• Access to easy to understand information: Currently much of the information given to 
patients/carers is provided whilst they are still coming to terms with their diagnosis and 
are experiencing considerable ‘shock’. This makes it difficult for them to understand 
any information they are given, particularly if complex treatments are being explained 
to them. Without further opportunities for discussion and questions it may be difficult 
for patients and carers to fully understand what they are being told. This has 
implications for the informed consent process. Where information about melanoma 
and treatment is provided in a personalised way, that is, at a pace that patients and 
carers can understand and with opportunities made available for them to ask questions 
then the experience can be improved.  Without opportunities to clarify issues patients 
may have regrets after treatment and feel that they were not fully informed. This may 
be difficult where treatment needs to be delivered in a timely manner, particularly within 
national target times, so the MDT need to work together to provide opportunities for 
patients and carers to explore issues fully.  The use of patient generated questions 
may also improve the experience as some participants stated that they didn’t know 
which questions to ask. 
All of the above have a number of implications across a range of fronts. These are considered 
below.  
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9.6 IMPLICATIONS 
9.6.1 PRACTICE & POLICY  
Improvements to the experience of melanoma patients and carers can be made by assessing 
the extent of their support network and recognising the role of the carer as it may be the carer 
that needs the most support. Even where the patient is not receiving complex treatment, the 
carer may be providing significant psychological support. Assessment of the patient and 
carers’ support network can identify those in need of additional support. This may not require 
formal evaluation if included in existing holistic needs assessments.  
 
Information provision has received much attention in the cancer population in general but there 
are still improvements to be made. Providing information over multiple occasions rather than 
a single visit is beneficial with opportunities to ask questions after information has been 
assimilated. Where patients do not know which questions to ask, it may be beneficial to have 
a resource where questions generated by previous patients can help to guide the 
conversation.  
One of the main barriers to HCPs providing support to patients and carers was them being 
perceived to be inaccessible because they were too busy. HCPs, CNSs in particular, 
recognised that they prioritised certain patients owing to workload pressures suggesting that 
access to support via CNSs is not equitable for all patients. The HCPs taking part in this study 
were nominated because of their positive influence on the patient’s experience. However, 
there were still a number of patients who did not feel able to nominate a HCP. To provide 
adequate support to all patients rather than only those who ask for it or that HCPs judge in 
greatest need, staffing levels need to be adequate to facilitate this. An increase in staffing 
levels, particularly of CNSs, may therefore be required. A recent report by MCS (2017) citing 
the average caseload of CNSs in England found that Skin Cancer CNSs had a comparable 
caseload compared to CNSs in other disease sites. However, the figures only included 
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melanoma and not any other skin cancers, even though a large part of the workload includes 
non-melanoma skin cancers. The availability of Skin Cancer CNSs as a resource is therefore 
less than that of other cancer sites demonstrating a need for greater investment.  
 
HCPs need to be aware of the extent to which carers provide support to patients with 
melanoma at all disease stages and that the pathological stage of the melanoma does not 
necessarily reflect the patient’s or carer’s assessment of the situation or their reaction. 
Identification of the involvement of carers in the care of melanoma patients is therefore 
required, but this goes beyond the NICE (2015) recommendation of encouraging patients to 
bring a companion to consultations. The needs of carers are not currently accounted for in 
national policy for melanoma (NICE 2015). There may therefore be a need to evaluate roles 
within the MDT to ascertain who should take responsibility of assessing and meeting the needs 
of carers. 
 
The fact that many of the patients and carers who took part in the study did not know what 
melanoma was prior to their diagnosis suggests that there is a lack of public awareness 
regarding melanoma. In Australia the success of mass media campaigns such as the ‘slip slap 
slop’ campaign have achieved success through the backing of policies, supportive 
environments (such as the availability of shade) and the availability of quality sun-protection 
products governed by national standards (Innacone & Green 2014). In the UK there has been 
limited success of such campaigns (Diffey & Norridge 2009, Butler et al 2013) but many of 
these are run by charities rather than the government so do not have equivalent backing. 
Given the rising incidence of melanoma and the costs of treatment government investment in 
public awareness campaigns for skin cancer may be cost-effective.  
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9.6.2 EDUCATION 
Patients and carers experienced difficulty understanding information provided to them at 
diagnosis. Further education for HCPs is therefore required regarding the delivery of 
information, particularly when the patient has received bad news and this is in keeping with 
recommendations by NICE (2015) for the care of melanoma patients. The lack of information 
to date on the experience of patients with melanoma and their carers brings with it a lack of 
education regarding how to meet their support needs and the ways in which they meet these 
needs themselves. The difficulty that patients talked about in understanding information while 
coping with the ‘shock’ of diagnosis is likely to be compounded by the addition of adjuvant 
treatment. Patients will now be given information about treatment with life-threatening side-
effects at a time when they are coming to terms with their diagnosis. It is therefore important 
that employing organisations provide HCPs with educational opportunities regarding ways to 
deliver information at such an emotional time so as to provide important information about 
treatments in a way that patients and carers can understand it. Not providing these educational 
opportunities may have consequences for the informed consent process and therefore legal 
ramifications for healthcare trusts. HCPs will also need educational opportunities regarding 
the side-effects of new adjuvant therapies so that they may in turn educate patients and carers.  
 
We have seen that patients use their social support network as a resource throughout the 
melanoma ‘rollercoaster’ but HCPs need to be aware of how patients and carers hide and 
share information to identify the amount of support available to the patient and recognise the 
role that they need to play in that network. In the digital age more patients are seeking the 
internet as a source of support as well as information. HCPs therefore need to be aware of 
available resources so that they can direct patients to credible sites and educate patients in 
the risks and benefits of online peer support.  
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The difficulty experienced by some patients and carers in the pre-diagnostic period suggests 
that awareness of melanoma needs to be raised within healthcare professions at an 
undergraduate level as well as for those specialising in primary care. The majority of patients 
presented to their GP but as nurses take on more advanced roles within the wider healthcare 
system they may also be involved in the diagnostic pathway. It is therefore essential that the 
possible presentations of melanoma are covered within the educational curriculum of HCPs 
within primary care.  
 
9.6.3 RESEARCH  
Relationships are key to the experience of melanoma patients and carers, but the use of 
support networks by melanoma patients has not been explored and warrants further work. 
The use of peer support, particularly the use of internet forums that cross geographical 
boundaries requires exploration as patients are seeking these out but the evidence base is 
not yet thoroughly developed. Whether the advantages of peer support extends to carers 
should also be considered.  
 
The changing nature of melanoma treatment means that there is a need to explore the 
experience as it unfolds over time, particularly the experience of patients receiving targeted 
or immunotherapies for advanced melanoma and the experience of patients receiving 
adjuvant treatment for surgically resected melanoma to reduce the risk of recurrence. A recent 
study I have been involved in had explored the experience of patients receiving targeted and 
immunotherapies for advanced melanoma (Smedley et al. 2018) indicating that patients 
commence cancer treatment with preconceptions about chemotherapy that may prevent them 
from reporting side-effects from newer treatments appropriately. As adjuvant therapy is aimed 
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at curing melanoma patients, they may live for years or the rest of their lives with ongoing 
effects of their treatment. There is therefore a need to investigate the incidence of long-term 
side-effects, the experience of living with these and how they might impact the daily lives of 
patients and carers and if indicated, design supportive interventions. To understand how 
patients and carers will be affected by these changes in treatment, research must be 
conducted in partnership with them. The advantage of constructivist research is that the 
process of clarifying meanings with participants can reveal new insights that a healthcare 
professional could not conceive from their perspective. The addition of diagramming or using 
visual representations means that for those patients that are able, they can convey very 
powerful emotions that may be difficult to otherwise describe. This is particularly helpful in 
cancer research where the patient and carer may begin to prepare for death and saying 
goodbye. It can also be a way for patients and carers to see the experience from the point of 
view of the other.  
 
The study provided the opportunity for initial exploration of the experience of carers after the 
death of the patient and the profound effects on their lives. However, this was only a small 
part of the study and not all carers felt able to continue participation at that time. It may be that 
those who did not participate had unmet needs that were not captured. Therefore, there is a 
need to further explore the transition that carers experience after the death of the patient and 
how the relationships built with HCPs are brought to a close.  
 
9.7 CONCLUSIONS 
The theory described in this thesis has captured the ‘rollercoaster’ of changing ‘roles, routines 
and relationships’ experienced by patients and carers as a result of a melanoma diagnosis. 
Even when melanoma is easily treated it can have significant effects and for those with more 
serious disease the consequences can be life-changing, profound and prolonged. The role of 
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HCPs in providing information, expertise and emotional support in an accessible way has been 
shown to be a vital resource. HCPs are aware of the key timepoints in the patient pathway 
where support is required but an increasing workload can prevent this support from being 
provided.   
 
Patients and carers turn to their existing networks for support so assessment of the extent of 
this network as part of an holistic needs assessment may provide an indication of how much 
additional support is required from HCPs and peers.  
 
The rapidly changing treatment pathway for melanoma means that the experience of patients, 
carers and HCPs is changing at the same rate. Incidence of melanoma continues to rise but 
with treatments now available there are more patients and carers requiring support for a 
greater length of time. It is essential that future research regarding the experience and support 
needs of melanoma patients keep pace with the ever-changing treatment landscape to ensure 
that evidence-based care is provided.  
 
As noted at numerous points my primary aim in undertaking this study was to provide new 
insights that might have the potential to improve the melanoma experience. This study has 
led to ways that improvements might be made but this can only be achieved if they are put 
into practice. Work is being carried out locally to ensure that this is carried out. On a national 
level this depends on the published results being considered when the NICE guideline is next 
revised.  
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11 APPENDICES 
11.1 APPENDIX 1: EXAMPLES OF MELANOMA PATIENT INFORMATION LEAFLETS 
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11.2 APPENDIX 2: DESCRIPTION OF WEBSITES INCLUDED IN THE SEARCH 








USA Not for profit/ 
Charitable 
International melanoma 
organisation focused on research, 
education, legislation, and 
awareness. Formed by merging 
two foundations created by the 
families of melanoma patients.  
Information about melanoma risk, 
diagnosis, research and living with 
melanoma. Provides information on US 
based support groups and the option to 






USA Not for profit/ 
Charitable 
A nationwide, community-based 
voluntary health organisation 
dedicated to eliminating cancer as 
a major health problem. 
Provides information about what 
melanoma is, prevention. Treatment, 
support, research, related news articles, 
online support community, stories of hope. 






UK specific, GP reviewed health 
information.  
Provides information about sun exposure, 
causes, risks, symptoms & types, 
diagnosis & tests, treatment & care, living 
& managing which includes a list of 
questions that patients may want to ask 










Information leaflets produced for 
each stage of melanoma. 
Information on staging, diagnosis, 







UK Not for profit/ 
Charitable 
Charitable organisation who aim 
to raise money and fund research 
to find cures for skin disease and 
cancer 
Information about melanoma, symptoms 
and diagnosis.  
David Cornfield 
Melanoma Fund 
http://dcmf.ca/melanoma Canada Not for profit/ 
Charitable 
The DCMF is devoted to saving 
lives from melanoma through 
prevention and research. 
Information about melanoma and patient 
stories.  
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Ireland Not for profit/ 
Charitable 
Cancer support and information Provides information about melanoma, 
symptoms and diagnosis, causes and 
prevention, treatment, living with 
melanoma (support group contacts), 
access to online cancer community and 









Information about melanoma, 
identification, prevention, sun exposure, 







USA Not for profit/ 
Charitable 
Aims to promote awareness of 
melanoma and early detection. 
Developed from Dan's father's 
website tribute to his son.  
Information about detection, what 
melanoma is, how it develops, prevention, 







USA Not for profit/ 
Charitable 
Aims to develop personalised 
strategies with patients so they 
may live longer, better lives. 
Website for educational 
purposes.  
Information about melanoma, pathology, 
sunscreen, prevention, staging, skin 
examination, details of helplines and 






Healthcare provider information 
related to melanoma and 
available NHS services.  
Overview of melanoma, symptoms, 






Commercially sponsored health 
information site.  
Information about melanoma, prevention 
and treatments, links to clinical trials, links 








Reviews of clinical effectiveness 
research, with easy-to-read 
summaries for consumers 
Information about melanoma, symptoms, 
tests, treatments and prevention.  
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USA Not for profit/ 
Charitable 
Aims to set the standard for 
educating the public and the 
medical profession about skin 
cancer. 
Provides information about causes, risk 
factors, prevention, treatments, staging 
and sub-types of melanoma. Links to true 
stories including Eric Sizemore's video 
diary & Vivian Bucay's story. 
Teens Health http://kidshealth.org/en/tee
ns/melanoma.html 
USA Not for profit/ 
Charitable 







Encyclopedia Information - sources unknown Definition of lentigo maligna melanoma (a 
specific type of melanoma) 







Dermatology information videos Shows surgery to remove a melanoma 
including the size of the surgery needed 
for a wide local excision.  
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11.3 APPENDIX 3: DATABASES AND SEARCH TERMS USED FOR THE 
PROFESSIONAL LITERATURE SEARCH 
Searches were conducted to identify published and unpublished literature conforming to the 
selection criteria. 
 
11.3.1 ELECTRONIC SEARCHES 
In order to find papers regarding the needs and experiences of patients with melanoma the 
following databases were searched between January 2005 (published following papers 
included in the NICE review) and June 2013 (commencement of the study):  
• AMED 





• Cochrane Library 
• ASSIA for Health  
• National Research Register 
The databases were selected to encompass literature from the fields of nursing, medicine, 
psychology and social sciences that may relate to melanoma.  
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For patient related literature the term ‘melanoma’ was used in each database. This was not 
limited by combining with any other terms so as not to miss any important papers. The term 
skin cancer was not used as this covers multiple diseases and only papers relating to 
melanoma were required. The search was limited to papers published between 2005 (those 
published following the NICE review, 2006b) and the start of the study in June 2013.  
 
The following search terms and combinations were used to find literature related to the needs 
of carers of melanoma patients: 
 1. caregivers.mp. or Caregivers/ or Social Support/  
 2. cancer.mp. or Neoplasms/  
 3. Melanoma/ or melanoma.mp.  
 4. 1 and 3  
 5. 1 and 2  
The search for melanoma-specific papers produced limited results therefore the search was 
widened to include all cancers and papers then scanned for those that included melanoma 
patients. The searches were limited to papers published after 2005. 
 
11.3.2 GREY LITERATURE 
Conference proceedings and other unpublished works were sought through correspondence 
with CNSs and research nurses currently treating melanoma in the United Kingdom. Current 
research and trials registers were also searched. The contents lists of relevant textbooks were 
also searched for chapters relating to psycho-social needs. Guidance regarding the care of 
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melanoma patients was also included where the patient experience or support needs were 
considered. 
 
11.3.3 HAND SEARCHING 
Hand searches of key journals likely to publish papers about melanoma or the needs of cancer 
patients were performed to identify articles not found through electronic searches. The 
following subject specific journals were hand searched: 
• British Journal of Dermatology 
• European Journal of Cancer Care 
• Supportive Care in Cancer  
• Psycho-Oncology 
 
11.3.4 REFERENCE LISTS 
Reference lists from texts relating to the treatment of melanoma were examined for any 
additional material. The personal manuscript collections of colleagues involved in melanoma 
care were also accessed to retrieve relevant information. 
 
11.3.5 WORLD WIDE WEB 
Sources of information published via the World Wide Web were identified via the Google 
search engine (www.google.co.uk – set to retrieve international results). The Google search 
engine was chosen as its database catalogues the greatest number of web pages of any of 
the freely available search engines. It also enables the retrieval of information generally or 
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specifically as academic papers or books with limitations placed on the date of publication. 
The same search terms were used to retrieve papers via electronic databases. 
 
11.3.6 CORRESPONDENCE 
Experts and organisations contacted in order to retrieve other information sources for review 
included the British Association of Skin Cancer Specialist Nurses. 
 
11.3.7 SEARCH TERMS 
Owing to the relatively small number of published papers on the subject melanoma could be 
used as a keyword search and mapped to subject headings where possible. The remaining 
papers could be quickly searched by title. All papers were considered in terms of patient, carer 
and healthcare professionals’ experience of melanoma. 
 
11.3.8 SEARCH COMPLETION 
The search was considered complete when no new papers were found. 
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11.4 APPENDIX 4: SELECTION CRITERIA FOR PROFESSIONAL LITERATURE 
INCLUDED IN THE REVIEW 
 
Professional literature was selected according to the criteria below: 
 
11.4.1 TYPES OF STUDIES 
Owing to the lack of evidence found during the review conducted by NICE (2006a) it was 
anticipated that the amount of available literature would be limited. Studies may have used 
quantitative or qualitative methods to address related aims but in either case would be likely 
to be relatively small scale. Broad criteria were set for the types of studies and included: 
• Randomised Controlled Trials 
• Systematic Reviews 
• Meta-analyses 
• Non-randomised experimental designs 
• Cohort studies 
• Interview and questionnaire studies 
• Observational studies 
• Case Studies 
• Anecdotal/opinion papers 
• Letters 
• Papers not peer reviewed 
• Guidance and policy documents 
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11.4.2 TYPES OF PARTICIPANTS 
Patients with melanoma of any histological sub-type, age, sex or setting were included. Carers 
or family of melanoma patients were included without restriction. Healthcare professionals of 
any discipline were included.  
 
11.4.3 TYPES OF INTERVENTIONS  
Interventions affecting the patient experience were not restricted and included surgery, 
chemotherapy, immunotherapy, radiotherapy, physical examination, skin surveillance, 
palliative care, counselling and complex interventions relevant to the study population.  
 
11.4.4 TYPES OF OUTCOME MEASURES 
Outcomes were included if they related to patient or carer experience, Quality of Life, anxiety, 
satisfaction with treatment and care or side-effects of treatment. Other outcomes deemed 
relevant to the study population were considered including qualitative findings.   
 
11.4.5 OUT OF SCOPE OF THE REVIEW 
Studies were not considered to fall within the scope of the review where melanoma patients 
and their carers were included but outcomes were not separated from those of other patients 
or carers. Papers were excluded if they did not focus on melanoma or had a focus on 
outcomes that did not include the experience of having melanoma such as: 
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• Perceived risk of melanoma in the general population or perceptions of sun 
exposure prior to diagnosis 
• The role of sentinel lymph node biopsy 
• The evaluation of Patient Reported Outcome or Quality of Life tools 
• The evaluation of Quality of Life reported as part of a clinical trial of a new 
intervention rather than the focus of the paper  
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11.5 APPENDIX 5: CHARACTERISTICS OF STUDIES INCLUDED IN THE LITERATURE REVIEW 
Author(s), Year & 
Title 
Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Mancini J, 
Baumstarck-Barrau 
K, Simeoni MC et al. 
(2011) Quality of life 
in a heterogeneous 
sample of caregivers 
of cancer patients: 
an in-depth interview 
study. 
Cross-sectional study. 
Qualitative interviews with 
thematic analysis 
(quantitative & narrative). 
To identify the main 
domains of QoL in 
terms of their impact 
on caregivers. 
Carers of patients with 
melanoma accounted 
for 17 patients in the 
total group of 77.                                     
Caregivers of melanoma patients in particular 
reported a decrease in sun-related activities. 
The caregiver–patient relationship influenced 
the domains of the caregivers’ lives that were 
impacted by cancer. 
Only 17 of 77 participants 
cared for melanoma patients.  
Al-Shakhli H, 
Harcourt D & 
















process in an 
outpatient 
pigmented lesion 
clinic    .                                               
Patients with 
suspected malignant 
skin lesions who had 
been booked for a 
new appointment, with 
the exclusion 
of those under 18 
years old, elderly, 
infirm and non-English 
speaking. 324 of 463 
eligible patients took 
part. 
Women reported more anxiety than men. 
Patient’s quality of life prior to diagnosis was 
excellent, but emotional functioning, insomnia 
and global health status deteriorated 
throughout the diagnostic process for those 
patients who were finally diagnosed as having 
malignant melanoma. Patients reported high 
levels of satisfaction with clinic attendance and 
treatment but a need for further information 
was identified. 
129 did not complete all time 
points required for analysis. 
The conclusions presume 
that the CNS is involved pre-
diagnosis which does not 
reflect my clinical experience 
where the CNS is involved at 
diagnosis.  
Burdon-Jones D, 
Thomas P & Baker 
R (2010) Quality of 




questionnaire with thematic 
analysis and comparison 
between groups using 
frequency count and 
Fischer's exact test.  
To determine the 
impact of non-
metastatic skin 
cancer on patients’ 
QOL by asking such 
patients for their 
opinions. 
50 patients with 
melanoma and 50 
patients with Non-
melanoma skin cancer 
at diagnosis of primary 
lesion. 
10 main themes were identified:  Avoiding 
excess sun exposure, concern that skin cancer 
could spread, concern about the public’s lack 
of understanding of skin cancer, a sense of 
relief/gratitude following treatment, feelings of 
anxiety/depression/guilt/stress, concern 
regarding possible scarring/disfigurement, 
initial shock at diagnosis of skin cancer, 
inconvenience/discomfort of surgery; fear of 
hospitals, realization of one’s 
mortality,sStrengthening of emotional 
relationships. 
Recruitment of a convenience 
sample. The study was 
performed to develop a Skin 
Cancer QOL measure for use 
in both non-metastatic MM 
and non-metastatic NMSC 
which the authors report as 
being under way.  
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Author(s), Year & 
Title 
Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Clarke SA, Booth L, 




Cancer Patients in 
the United Kingdom. 
Cross-sectional qualitative 
study using semi-structured 
interviews and thematic 
analysis. 
It aims first to 
explore perceptions 
of available support 
services, second: 
preferences for 
source and type of 




11 melanoma patients 
receiving observation 
or adjuvant trial 




surgery for first 
relapse.  
Men tended to access support for information 
and perceived the staff’s provision of 
information as emotional support. Men 
perceived every day pleasantries to represent 
emotional support. Women had less flexible 
perceptions of emotional support and 
perceived intimate and lengthy chats, inquiries 
about their emotions, and reassurance to 
constitute support.  
All authors were female. 
Given the gender specific 
investigation, this may have 
influenced the results.  
Findings were validated via 
oncology medical 
professionals rather than 
participants.  
Constantinidou A, 
Afuwape SA, Linsell 
L et al. (2009) 
Informational needs 
of patients 
with melanoma and 
their views on the 
utility of investigative 
tests.  
Cross-sectional survey 
using a face-to-face semi-
structured questionnaire. 
To identify the 
informational needs 
of patients with 
melanoma on 
disease status and 
prognosis, and to 
ascertain their views 
on the utility of 
positron emission 
tomography (PET) 
and sentinel node 
biopsy (SNB). 
106 English speaking 
patients with 
melanoma diagnosed 
within the previous 4 
months. Metastatic: 
17%, Disease free: 
83%,Time since 
diagnosis (years): 
Median (range) 3 
(0.3–17). 
The vast majority (88%) reported that they 
wanted to know everything about their disease 
and over 90% would like to be informed about 
the spread of their disease and their chances 
of cure. Around 85% wished to know the length 
of time to live (with and without symptoms), 
and 97% wanted to know about the palliative 
care input available. Most patients wanted to 
discuss prognosis and palliative care support 
as soon as their disease became metastatic, 
and over 50% expected the doctor to impart 
the information without negotiation. 
High response rate. The 
authors note that the sample 
was derived from one area in 
London that may not be 
representative of the UK as a 
whole. 
Cornish D, 
Holterhues C, van 
de Poll-Franse LV et 
al. (2009) A 
systematic review of 
health-related 







discuss the available 
literature concerning 
HRQOL in patients 
with cutaneous 
melanoma. 
44 full articles on 
melanoma were 
considered, but only 
13 were eligible for 
this review. The 
tumour stages varied, 
but most studies 
focused on localised 
disease, and only a 
few focused on 
metastatic melanoma. 
20 different instruments were used in 13 
studies. The results indicated that there are 
three distinct periods of HRQOL impact: 
diagnosis, treatment and follow-up. The 
immediate period following diagnosis was often 
associated with high levels of HRQOL 
impairment. Extended survival is dominated 
more by fears of recurrence and less by 
physical limitations. In the follow-up phase, 
psychological distress can interfere with 
screening recommendations and preventive 
behaviours. The proportion of patients with 
melanoma who report high levels of HRQOL 
impairment is comparable to that observed in 
other cancers. 
The authors note that patients 
participating in the clinical 
trials for interferon may be 
more motivated and optimistic 
so may rate their HRQOL 
higher. 
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Author(s), Year & 
Title 
Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Hamama-Raz Y, 
Soloman Z, 
Schachter et al. 
(2007) Objective 
and subjective 
stressors and the 
psychological 
adjustment of 








and their objective 
and subjective 
stress. 
300 survivors of 
malignant melanoma 
(182 women and 118 
men). Stage IA, IB, 
IIA, or IIB, and having 
been in oncological 
follow-up for at least a 
year with no signs of 
recurrent cancer or of 
other chronic illness. 
Mean distress and wellbeing scores were 
similar to scores among a normative Israeli 
sample. All the correlations were weak, 
however, none of them accounting for more 
than 5% of the shared variance. A small 
correlation suggested that the more children 
the survivors had, the better their psychological 
well-being and the lower their distress. Married 
survivors had greater wellbeing and less 
distress. Neither stage or time since diagnoses 
proved significant predictors of well-being or 
distress. 
 Same study as Hamama-
Raz (2012) & Hamama-Raz & 
Solomon (2006). Kessler's 
scale was translated and 
modified for use in the study 
but details of the pilot are 
brief and not reported in full 
elsewhere. The cross-
sectional nature of the study 
makes it impossible to know 
with any certainty how much 
the survivors’ appraisal 
contributed to their 
adjustment and how much 
was the product of their 
adjustment. 
Mols F, Holterhues 
C, Nijsten T et al. 
(2010) Personality is 
associated with 
health status and 





To investigate the 
prevalence of Type 
D personality (the 
conjoint effects of 
negative affectivity 
and social inhibition) 
among melanoma 
survivors and to 
obtain insight into its 
effects on health 
status, impact of 




melanoma between 1 
January 1998 and 1 
August 2007.  Mean 
years since diagnosis 
4.6. Stage I to III. 
22% of melanoma patients were classified as 
having a Type D personality.  
Type D patients reported statistically significant 
lower scores on clinically relevant subscales 
for general health, vitality, social functioning, 
role limitations, emotional and mental health. 
Type D patients reported statistically significant 
and clinically relevant differences for the 
subscales body changes, negative self-
evaluation, negative life outlooks, life 
interferences, health worry and higher order 
negative scale. Type D patients more often 
reported more sun avoidance. 
Same study as Husson et al 
(2010). The authors note that 
the reasons for declining to 
participate remain unknown 
and although Type D 
personality is a stable 
construct, the cross-sectional 
design of the study limits the 
determination of causal 
association between Type D 
personality, health status and 
impact of cancer. 
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Author(s), Year & 
Title 
Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Murchie P, Delaney 
EK, Campbell NC et 
al. (2010) GP-led 
melanoma follow-up: 
views and feelings 
of patient recipients. 
Semi-structured audio-
taped telephone interviews     
thematically analysed. 
To explore the 
practical 
experiences and 






from their general 
practitioner (GP) as 
an alternative to 
traditional hospital-
based follow-up.  
18 patients 
randomised to receive 
GP led follow up for 
malignant melanoma 
as part of a clinical 
trial. All patients had 
been treated solely by 
potentially curative 
surgical excision for 
primary cutaneous 
melanoma and were 
recurrence free. 
Almost all patients were happy that they knew 
what to do and who to contact if they became 
worried between GP-led melanoma follow-up 
appointments. When comparing GP with 
hospital follow-up, the most frequent 
advantage stated was convenience. Seeing a 
GP who knew them well was seen as an 
advantage. The main benefit of attending the 
hospital for melanoma follow-up was being 
seen by a specialist and having an immediate 
diagnosis about any concerns. A disadvantage 
of the hospital system was a lack of continuity. 
Patients went through a process of adjustment 
following their diagnosis, becoming less 
anxious as time went by. 
 Same study as Murchie et al. 
(2009). The authors note that 
the data were collected and 
analysed by PM (a GP) 
meant that there is a 
possibility that patients may 
have felt restricted in voicing 
negative views of the study. 
The study does not take 
funding arrangements into 
account which differ in 
Scotland to the rest of the UK 
and may affect the feasibility 
to run this study elsewhere.  
Banks E, Byles J E, 
Gibson R E et al. 
(2010) Is 
psychological 
distress in people 
living with cancer 
related to the fact of 
diagnosis, current 
treatment or level of 
disability? Findings 
from a large 
Australian study. 
Self-reported questionnaire 
data on demographic, 
health and lifestyle factors 






distress in cancer 
survivors relate 
specifically to 
aspects of cancer 
diagnosis, to 
treatment or to 
disability. 
89,574 patients with 
cancer in total of which 
2337 had melanoma. 
Over 45 years of age. 
Self-reported cancer 
diagnosis.  
A similar pattern of increasing psychological 
distress with increasing degree of functional 
limitation was seen, independent of the 
diagnosis of cancer.  Psychological distress 
related much more strongly to disability than to 
site-specific cancer diagnosis. 
The authors note that the 
measure of disability does not 
specify the cause of the 
disability and therefore 
includes disability resulting 
from mental health problems. 
Activity changes such as sun 
avoidance were not 
measured here and may have 
changed the results if the 
study was specifically 
focussed on melanoma. 
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Author(s), Year & 
Title 
Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Husson O, 
Holterhues C, Mols 
F, et al. (2010) 
Melanoma survivors 








To measure the 







melanoma between 1 
January 1998 and 1 
August 2007.  Mean 
years since diagnosis 
4.6. Stage I to III. 
A large percentage of patients indicated the 
absence of information about different aspects 
of melanoma, treatment and aftercare. None of 
the patient characteristics were significantly 
associated with perceived information provision 
about the disease. More information about 
medical tests was associated with shorter time 
since diagnosis and a higher stage melanoma. 
More perceived information provision about 
treatment was significantly independently 
associated with younger age, higher stage of 
disease and higher educational level. 
Satisfaction with information was 
independently associated with high educational 
level and less frequent use of the internet for 
additional information. 
Same study as Mols et al. 
(2010) The questionnaire 
does not detail the format of 
the information or whether it 
was discussed.  
Noorda E M, van 
Kreij R H J, 
Vrouenraets B C et 
al. (2007) The 
health-related 
quality of life of long-
term survivors of 
melanoma treated 




To assess the long-
term Health Related 
Quality of Life 
(HRQOL) of 
melanoma survivors 
who had undergone 
Isolated Limb 
Perfusion (ILP) of 
the extremities and 
to identify the 
patient, tumour and 
ILP-related factors 
associated most 
strongly with the 
patients' self-
reported HRQOL.  
51 Patients who had 
undergone ILP 
between 1978 and 
2001 who were alive 
and disease free for a 
minimum of 6 months 
prior to recruitment. 
Stage I-IV. Median 
follow-up after ILP = 
14 years (range 3-25 
years). 
Overall, the self-reported HRQOL was better 
than that of the age and gender matched 
comparison group. 49-55% of the patients 
reported physical symptoms including oedema, 
stinging sensations or limb stiffness. 72-82% of 
those who experienced any degree of physical 
symptoms indicated that those symptoms 
resulted in some impairment in their daily 
activities. 61-69% of the patients with a 
cosmetic problem (including oedema) were 
bothered by it. 63-77% reported fear of local or 
distant disease recurrence. 55% frequently 
checked their limb for new recurrences. Some 
patients also reported financial consequences 
of their diagnosis and treatment. 
The authors note the 
limitations of having a small 
sample size, a single centre, 
lack of an adequate control 
group and variation in the 
time since ILP. Validity and 
reliability of the ILP-specific 
tool are not reported or 
referred to. 
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Author(s), Year & 
Title 
Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Trapp M, Trapp EM, 







To assess possible 
differences in coping 
patterns of patients 
with MM compared 
with those of a 
control group of 
patients with benign 
dermatological 
diseases, such as 
varicosis, leg ulcers, 
and keloids.  
46 patients having 
planned excision 
biopsy or wide local 
excision the following 
day. Stage not defined 
but no evidence of 
metastasis prior to 
surgery. Patients with 
a history of melanoma 
or non-melanoma skin 
cancer were excluded. 
This study shows that chosen coping strategies 
allow prediction with statistical significance of 
the diagnosis of MM vs. benign dermatological 
disease, thus suggesting the existence of 
some differences in coping strategies in 
patients with MM compared with a control 
group. Low scores for situation control indicate 
that stressful situations are not adequately 
analysed and, consequently, few attempts are 
made to control the stressor and the stress-
reaction. High scores in the subtest resignation 
indicate the tendency to give up quickly in a 
stressful situation (type C behaviour), which 
may produce feelings of helplessness and 
hopelessness. 
The analysis is based on 
clinical rather than 
histological information as 
data was collected prior to 
surgery. The authors note 
that she assessment provided 
information on “original” traits 
and not on states that might 
have “become chronic” as a 




Cornish D, van de 
Poll-Franse LV et al. 




survivors: a Dutch 
population-based 
study. 
A cross-sectional Dutch 
population-based postal 
survey. 
To assess the 
impact of melanoma 
on the health-related 
quality of life of 
patients from the 
general population 
up to 10 years after 
diagnosis and its 
determinants. 
562 patients 
diagnosed as having 
melanoma from 
January 1, 1998, to 
August 1, 2007 
returned the 
questionnaire. Any 
stage at diagnosis. 
Time since diagnosis 
was 6 months to 10 
years. Patients older 
than 85 were 
excluded.  
Melanoma survivors did not report impaired 
HRQoL compared with an age- and sex-
matched sample. IOC scores implied that for 
every year further from diagnosis the patient 
may be less negatively influenced by their 
cancer. This observation suggests that generic 
and even cancer-specific HRQoL 
questionnaires might not be sensitive enough 
for patients with predominantly low stages of 
melanoma. UV related aspects of patients’ 
lives were affected and a diagnosis of 
melanoma had practical implications for their 
daily life (eg, getting a mortgage, health 
insurance or life insurance). 
The SF36 and IOC are 
validated measurement 
scales but the authors note 
that they had not been 
formally tested in melanoma 
patients. Additional questions 
were based on expert opinion 
so may not have been 
interpreted as intended by 
participants. Validity of the 
additional questions is not 
addressed.  
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in tertiary care. 
Retrospective cross-
sectional data collection of 
referral data. Descriptive 
and inferential statistics 
were employed to compare 
patients with melanomas 
and patients with other 
dermatological diseases. 









CLS provided within 
a comprehensive 
clinical care 
approach at the 
general hospital. 
All patients (3658) 




service (CLS) between 
2005 and 2008. 49 
had melanoma and 
262 had non-
melanoma skin 
cancer. Details of the 
melanoma diagnosis 
are not reported.  
Melanoma patients were referred to the service 
more often and required more interventions 
than patients with dermatological conditions 
but less frequently than patients with other 
cancers. The most common reasons for 
referring melanoma patients were: ‘‘coping 
issues’’ (57%) and acute psychological 
symptoms (39%) (anxieties or depressive 
symptoms). Both groups had some mild 
symptoms difficulty in social, occupational or 
school functioning but were generally 
functioning quite well and had some 
meaningful interpersonal relationships. 
Descriptive study confirming 
that some melanoma patients 
require psychosomatic 
therapy but only includes 
those referred to the service.  
Rychetnik L, 
McCaffery K, Morton 




for stage I/II 
melanoma: a 










treatment of stage I 




The review included all 
(15) empirical studies 
that considered 
psychosocial factors 
as anticipated or 
experienced outcomes 
of routine follow-up 
after treatment of 
stage I/II primary 
cutaneous melanoma 
and as reported by 
patients or clinicians. 
Articles published in 
languages other than 
English but catalogued 
with an English 
abstract were 
included. 
Over half of the patients were interested in 
professional emotional support, and the 
majority preferred to get this from their doctor 
than from a psychiatrist or psychologist. 
Overall satisfaction with hospital-based follow-
up was high with patients finding it worthwhile 
and useful because they felt reassured and 
were able to ask questions. Disadvantages 
related to transport, parking and associated 
costs, anxiety associated with attending follow-
up appointments (which could begin over 24 h 
prior to their appointment and may include 
physical symptoms such as diarrhoea, nausea 
and sleeplessness). Follow-up was also an 
important source of reassurance and 
information. Around three quarters of patients 
also conducted skin self-examination. Around 
half of surveyed patients participated in 
melanoma follow-up in accordance with 
recommended schedules. 
Covers papers also reviewed 
separately: Murchie et al. 
(2009) & Murchie et al. 
(2010). The findings related 
to these studies were easily 
identified and have not been 
included here to prevent over-
reporting.   
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Winzer A, Hoppe A, 
Altenhoff J et al. 






relation to their 
need: which patients 




structured interviews with 
standardised 
questionnaires.  
To determine the 
perceived and the 
normative need of 
psychosocial 
support and the 
interest for a 
psycho-educational 
group intervention 
among patients with 
malignant 
melanoma.  
144 patients with 
stage I-IV melanoma, 
had an appointment 
for their next control 
visit in the outpatient 
clinic, and were able 
to communicate in 
German. Exclusion 
criteria were 
melanomas in the eye 
or the mucous 
membranes, diagnosis 
of cancer at another 
site, and a history of 
psychiatric illness. 
The two main reasons melanoma patients 
stated for participating in the intervention were 
to gain information about the disease (n=42) 
and to meet other people with whom they could 
share experiences (n=24). There were slightly 
more patients in the non-interested group than 
in the potentially interested group who stated 
‘they don’t want to be reminded of their illness’. 
Older people, those not in employment, those 
with higher cognitive avoidance scores and 
those with less health behaviour knowledge 
were less interested in a support programme. 
Patients who were younger, male, had no 
partner and had lower scores on the cognitive 
avoidance scale were more likely to be 
interested in the intervention. Medical variables 
were not predictive of an interest in the support 
programme. 
The authors discuss the self-
perceived need for support 
compared to professionally 
determined need for support 
or intervention, but this is 
limited to the expert-defined 
cut off on the HQ and testing 
the benefit of an intervention 




Raab A, Hein R et 
al. (2013) Quality of 









To examine the 
influence of 
additional chronic 







644 patients with 
malignant melanoma 
but without distant 
metastasis 21–24 
months prior to the 
start of the study, the 
absence of disease 
progression at the time 
of questionnaire 
administration, and the 
ability to read German. 
Stage 0-IIIc.  
Two years after initial diagnosis, disease-free 
patients with localised malignant melanoma 
are able to experience a QoL similar to that 
enjoyed by the general population. In this 
survey of melanoma patients, the results 
indicate that other chronic diseases have 
strong influences on QoL, irrespective of a 
patient’s malignant disease. Therefore, 
localised malignant melanoma per se is not 
associated with reduced QoL.  
Same study as Schlasinger-
Raab et al. (2010). 
QLQ-C30 Questionnaire is a 
recognized and validated QoL 
evaluation tool. Other items 
are not clearly validated or 
drawn from other tools. Parts 
of questionnaires may not be 
valid on their own. It is not 
evident that the original tools 
were developed in German or 
any processes used for 
translation.  
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Ludgate MW, Sabel 
MS, Fullen DR et al. 
(2011) Internet use 





Prospective survey. To compare the 
patterns of Internet 
use of people with 
skin cancer with 
previous findings by 
including people 
with nonmelanoma 
skin cancer (NMSC) 
using a 
comprehensive 
survey. To evaluate 
perceived anxiety 
levels and overall 
satisfaction after 
searching the 
Internet of people 
with skin cancer. 
Patients diagnosed 
with Melanoma (395), 
BCC (290) or SCC 
(108) attending an 
initial consultation. 
Individuals younger 
than 18 or who had 
previously been seen 
in the Multidisciplinary 
Melanoma Clinic were 
excluded. 
Participants without Internet access were 
significantly older than those with access. 
Regardless of their type of skin cancer, the 
majority of participants were satisfied with the 
amount of information provided by their 
referring physician. Despite this, a large 
number of participants sought additional 
information regarding their diagnosis on the 
Internet. Participants with skin cancer who  
searched the Internet themselves for 
information related to their diagnosis were 
more likely to be younger, female, diagnosed 
with melanoma, and more-highly educated. 
More than half of all study participants reported 
that they trusted only some of the information 
they found on the Internet. One-third reported 
that their search had made them more anxious, 
one-third felt less anxious, and one-third felt 
neutral. 
Descriptive data, no causal 
relationships. The majority of 
websites visited were 
american cancer societies as 
the study was conducted in 
the U.S. This may differ for a 
UK population.  
Bowen D, Jabson J, 
Haddock N et al. 









recruited through a 
population-based 








survivors aged 18 
years or older with 
internet access and a 
relative who was a 
parent of a child 18 
years and younger. 
Stage 0-IV. Average 
survival since 
diagnosis was 5 years.  
59% were compliant with wearing a long-
sleeved shirt, 80% wore long pants or skirts, 
45% used sunscreen with SPF 15+, 35% wore 
something to cover their head, 16% wore a hat 
with a brim of 2.5 inches around, 46% wore 
sunglasses, 36% stayed in available shade, 
and 20% avoided the outdoors when the sun is 
strongest. 74% believed their chances of 
getting melanoma again are ‘a little higher than 
average’ or ‘much higher than average’. Men 
reported nearly seven times more usage of 
hats, caps, or scarves than women. 12% were 
considered to have a ‘high cancer worry’. 22% 
believed they ‘conducted a thorough skin 
examination’. 
The authors caution that the 
results are specific to the 
population of the Pacific 
Northwest region of the USA. 
More of the population hold 
college degrees that other 
regions and skin protection 
and screening behaviours 
could vary because of the sun 
exposure specific to the area. 
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Oliveria S A, Shuk 






factors, and family 
concerns. 











using focus groups. 
48 participants in 8 
focus groups, ≥18 




stages I–III, and 1–10 
years since diagnosis 
treated during 1996–
2005. Patients who 
had prior 
malignancies, did not 
speak English or lived 
more than 2 hours 
from the centre were 
excluded. 
Receiving good news from physician 
screenings was psychologically reassuring for 
survivors. Melanoma diagnosis prompted many 
survivors to assess and reprioritise life values 
and develop a more positive life outlook. 
Receiving a melanoma diagnosis served to 
either strengthen or place stress on survivors’ 
relationships with romantic partners. 
Survivors became more conscious of sun 
exposure and expanded use of sun protection 
measures following diagnosis. Seeing a 
dermatologist was seen as an effective 
strategy to ensure new melanomas would be 
identified early. Skin self-examination varied 
significantly across the sample but most did not 
conduct skin self-examinations on a regular 
basis. Lack of confidence in ability to identify a 
suspicious mole was cited as a barrier to 
conducting skin self-examination, and some 
survivors preferred to off-load the responsibility 
to the doctor. 
The authors state that the 
focus groups served as a pilot 
study to inform a larger scale 
survey study currently 
underway so the cohort 
reflects a convenience 
sample.  
McLoone J, Watts K, 
Menzies S et al. 
(2012) When the 




at High Risk of 
Developing New 
Primary Disease. 
Qualitative interviews with 
framework analysis. 




coping responses of 
melanoma survivors 
known to be at high 
risk of developing 
new disease. 
20 participants 
attending a High-Risk 
Clinic (HRC) and had 
attended a minimum of 
at least three clinical 
skin examinations 
(CSEs), spoke English 
and over 18 years of 
age were included. 
Individuals receiving 
active treatment for 
locally advanced or 
metastatic melanoma 
were not included.  
Participants perceived melanoma as potentially 
terminal and reported persistent worries about 
the possibility of developing new or metastatic 
disease. Fear of developing a new melanoma 
endured for years after treatment.  A 
substantial proportion reported concurrent and 
persistent uncertainty, anxiety, and fears 
regarding recurrence. Not a single participant 
in the current study reported seeking or 
receiving professional emotional support, 
despite a desire for such support on the part of 
some individuals. Belief in the benefits of early 
intervention, including self- and clinical skin 
examination, provided a sense of control. The 
expertise of physicians was perceived as 
instrumental in creating a sense of 
reassurance. 
Same study as McLoone et 
al. (2013). Codes were 
inductively derived from the 
data. Discrepancies in coding 
were discussed with the team 
until a consensus was 
reached.  
   
  346 
Author(s), Year & 
Title 
Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Kasparian N A, 
Branstrom R, Chang 
Y M et al. (2012a) 
Skin examination 
behaviour: the role 
of melanoma 
history, skin type, 
psychosocial 
factors, and region 






To examine the 
frequency and 
correlates of skin 
examination 
behaviours in an 
international sample 
of individuals at 
varying risk of 
developing 
melanoma. 
Participants may have 
no history of 
melanoma, a family 
history of melanoma or 
a personal history of 
melanoma.  
Frequency of skin examination was strongly 
associated with melanoma history. Participants 
with a personal history of melanoma reported 
the highest frequency of examination. Skin 
examination frequency was lower in Northern 
Europe than Central Europe, Southern Europe, 
Australia or the US. For participants with a 
personal history of melanoma, frequency of 
examination increased only with perceived 
benefit, not perceived risk or skin cancer-worry. 
Much of the raw data is 
reported elsewhere. The 
online method of 
administration limited the 
sample to those with internet 
access and the skill to access 
and complete the survey.  
Campolmi E, 
Mugnai F, Riccio M 







Pilot study. Cross-sectional 
quantitative survey. 
To investigate the 
efficacy of a 'take in 
charge' model of 
advanced stage 
melanoma patients 
by a multidisciplinary 
team and highlight 
the psychological 
patterns of the 
disease compared 
to a traditional pre-
terminal end of life 
care model. 
44 patients with 
unresectable 
advanced melanoma 
(stage IIIb -IV). 
Both men and women demonstrated low 
mental and physical scores. Patients have a 
low mental score and do need a structured and 
professional psychological support. This 
appeared to be worse for patients with skin 
rather than visceral disease.  
The clinical relevance of the 
data is not clear. The 
methods talk about an 
intervention and semi-
structured interviews but only 
baseline data for the SF12 in 
patients with advanced 
melanoma is presented. 
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Hetz S P & 
Tomasone J R 
(2012) Supportive 






To determine the 
support needs for 
melanoma patients 
in Canada in order 
to help direct future 
support services and 
research. In addition 
the study attempted 
to examine how 
level of education 
may affect these 
support needs.  
31 patients with a 
current or past 
diagnosis of 
melanoma. Stage I-IV. 
Mean years since 
diagnosis was 5.  
The highest reported supportive needs were: 
access to a second opinion, information about 
non-surgical treatment, information about how 
and when to check for skin changes, 
information about side-effects of surgical 
treatment, skin soreness and lymphoedema. 
Individuals without post-secondary education 
had a higher information need. Additional 
information needs included: information at 
diagnosis, treatment options, diagnosis and 
prognosis. The majority of patients felt 
comfortable asking questions to their medical 
team but those with less than secondary 
education felt less comfortable and reported 
conducting less regular SSE.  
 
  
The prescriptive responses 
did not allow for patients to 
express additional concerns. 
Not all participants completed 
all items. The authors 
cautioned that the 
questionnaire asked about 
current needs/within the last 
month and it is likely that 










Are there gender 










patients (182 women 
and 118 men). Age 
(25–60), no other 
chronic illness, 
Hebrew speaking, 
stage of illness IA, IB, 
IIA or IIB, and having 
been in oncological 
follow-up for at least a 
year with no signs of 
recurrent cancer. 
  
Distress was found to be significantly higher 
among women than men. Mental distress and 
wellbeing of melanoma survivors is by far 
better predicted by their attachment style than 
by other variables. Avoidant or anxious 
attachment reduced well-being and increased 
distress. This highlights the importance of 
social relations in the adjustment of cancer 
survivors. 
Same study as Hamama-Raz 
et al. (2007) & Hamama-Raz 
& Solomon (2006). In modern 
society gender roles are 
changing so the interpretation 
of gender specific differences 
must be considered with 
caution. It may be preferable 
to consider personality traits 
that apply to all genders to 
facilitate person centred care. 
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Passalacqua S, di 
Rocco Z C, Di Pietro 
C et al. (2012) 
Information Needs 





To evaluate the 
information, 
psychological, social 
and practical needs 
of patients with 
melanoma and to 
compare such 
needs with those of 
patients with other 
malignancies. 
35 melanoma patients 
and 186 with other 
cancers. Aged 18 
years or older, Italian 
speaking, without 
psychiatric disorder or 
cognitive impairments, 
cancer stage 0-IV, 
time since diagnosis 
between 0 and 18+ 
months.  
Patients with melanoma had a higher 
frequency of information needs compared to 
patients with other cancers. They showed 
significantly higher frequencies for "better 
dialogue with clinicians" and "more sincerity". 
They had consistently lower median symptom 
scores than all other cancers combined and as 
such were statistically significant for pain, 
depression, anxiety, wellbeing and breathing.   
Among patients with a non-metastatic stage, 
those with melanoma needed to be more 
involved in therapeutic choices, wanted nurses 
and physicians to give more comprehensible 
information, wanted clinicians to be more 
sincere, and expressed more information 
needs compared to those with other cancers. 
  
To compare melanoma to 
other cancers a generic, 
rather than specific measure 
was required. Tumour 
specific issues may not be 
easily compared. The authors 
caution that the NEQ has 
been validated previously and 
used in studies on patients 
with liver, breast, colorectal, 
head & neck and other 
cancers but never for 
melanoma. 
Cashin R P, Lui P, 











To examine all of 
the information 
published so far on 
the impact of 
interventions on 





The patients of 
interest were adults 
with metastatic 
disease. Studies were 
excluded from this 
analysis if the 
intervention studied 
involved surgery, 
resectable disease, or 
radiation therapy. 
Studies that grouped 
different types of 
cancers together 
where subjects with 
MM could not be 
separated from others 
were also excluded. 
13 articles were reviewed. There were six 
studies that used survey methods to obtain 
longitudinal data from patients and seven that 
were based on clinical trials. Four of the six 
survey-based articles concerned the same 
study. Physician-rated outcome variables did 
not correspond to the patients’ measured QoL. 
There were no statistical differences between 
the responses of the patients and those of the 
relatives. Nurses more often underestimated 
patients’ fatigue and difficulty in concentrating 
and overestimated the degree of nausea and 
vomiting as well as the patients’ global QoL. 
Only QOL results are 
considered here as economic 
analysis is outside of the 
remit of this review. 
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Zucca A C, Boyes A 
W, Linden W et al. 
(2012) All's Well 
That Ends Well? 








To assess QoL and 
the clustering of 
patient-reported 
symptoms by cancer 
type in a large-scale 
population-based 
sample of long-term 
cancer survivors five 
to six years post-
diagnosis. 
864 patients with a 
new histologically 
confirmed cancer 
(local or metastatic) 
five to six years ago, 
aged between 18 and 
75 years at the time of 
diagnosis, able to read 
and understand 
English. 131 patients 
with melanoma were 
included.  
One-fifth of breast (21.1%), prostate (20.2%), 
and colorectal (19.0%) cancer survivors 
reported two or more symptoms, compared 
with only 4% of melanoma survivors. No 
unique physical symptom clusters by cancer 
type were found in long-term survivors 
diagnosed with either breast, prostate, or 
colorectal cancer or melanoma. This suggests 
that by five to six years post-diagnosis, long-
term cancer survivors’ experience of clusters of 
generic physical symptoms are similar to one 
another, regardless of their primary diagnosis.  
Melanoma patients were found to have 
moderately better global QoL compared to a 
normative data set for cancer patients pre-
treatment.   
Differences may not have 
been detected because 
generic, rather than cancer 
specific measures were used. 
The authors caution that the 
comparison data were not 
directly matched to the 
sample and were primarily 
from European countries, 




A, Karow  A et al. 
(2006) The Impact 










To test the 
hypothesis that (a) 
diagnosis and 
treatment of MCM 
lead to QOL 
impairment 
compared with 
healthy controls, and 
patients with a 
different oncological 
or ophthalmologic 
diagnosis, and (b) 
plaque radiotherapy 
treatment leads to a 
decline in QOL. 
  
All 35 patients with 
Malignant Choroidal 
Melanoma (MCM) 
admitted to the centre 
for ophthalmology for 
plaque radiotherapy 





participation in the 
study was 12 days (+/-
7.1). 
Out of the 51 patients participating at t0, 35 
(68.6%) took part in the survey at t1. 16 
patients (45.7%) suffered from one or more 
complication postoperatively.The MCM 
diagnosis compromises QOL, which is 
additionally impaired by radiotherapy. Regular 
QOL assessment can help to identify patients 
at risk. 
Psychometric properties of all 
tools are addressed but the 
internal consistency of one 
was limited to medical 
students; student nurses; and 
patients with an 
immunodeficiency syndrome. 
Administration of the 
questionnaires is not 
reported.  Visual impairment 
may have affected 
participants ability to 
complete them and carers 
may have helped. 
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Mujumdar U J, Hay 
J L, Monroe-Hinds Y 
C et al. (2009) Sun 





This study examined 
performance of Skin 
Self-Examination 





from the general 
population. 
115 individuals with a 
first primary 
melanoma. 
115 (response rate 78%) patients participated. 
20 individuals (17%) conducted deliberate and 
systematic SSE as defined as ‘always or nearly 
always’ examining all but one body parts. 23% 
met the criterion for regularly conducting all but 
one sun protection practice and this includes 
the 12 participants (10%), who ‘never went out 
in the sun,’ thus were classified as practicing 
full sun protection. Individuals who reported 
having moles, as compared with those 
reporting no moles, were more likely to report 
conducting comprehensive SSE.  
Significant predictors of regular sun protection 
strategies included older age, being female 
and higher sun protection self-efficacy. 
Participants were also asked 
about family discussions 
about melanoma risk, and 
these results are reported 
elsewhere. The sample are 
recruited from a research 
active population so they may 
be more motivated to take 
part in melanoma prevention 
strategies.  
Kasparian N A, 
McLoone J K & 




among patients with 
malignant 
melanoma: a 





review the body of 






The review was 
concerned with the 
psychological 
responses of patients 
with melanoma. All 
stages were included. 
Time since diagnosis 
ranged from diagnosis 
to 108 months 
afterwards. The 
number of participants 
in each study ranged 
from 44 - 427.  
43 studies remained after applying exclusion 
criteria. Approximately 30% of all patients with 
melanoma report clinically relevant 
psychological distress but their psychosocial 
needs frequently go undetected and unmet. 
Demographic factors associated with adverse 
psychological outcomes in patients with 
melanoma include: female gender, younger 
age, absence of a spouse or partner, lower 
education, and economic adversity. The 
association between clinical factors and 
psychological distress is unclear. Patients with 
melanoma who form positive or meaningful 
appraisals of their cancer experience, have an 
active-cognitive coping style, and/or greater 
social support are more likely to demonstrate 
healthy psychological adjustment. 
The authors suggest the use 
of validated tools such as the 
IES but do not discuss the 
merits and validity of the 
many tools found in their 
review. The review covers 
some of the papers also 
included here.  
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Schlesinger-Raab A, 
Schubert-Fritschle 
G, Hein R et al. 






To present QoL data 
from a population-
based cohort of 
melanoma patients 
after treatment with 
curative intent and 
the cessation of 
treatment-related 
acute side-effects. 
664 patients with an 
initial diagnosis of 
melanoma without 
distant metastasis 21–
24 months before the 
study, the absence of 
disease progression at 
time of questionnaire 
administration and the 
ability to read German. 
Stage 0-III disease. 
QLQ-C30: women had lower emotional and 
sexual functioning scores and higher symptom 
scores of insomnia and constipation and men 
had higher diarrhoea scores. Younger age 
correlated overall with better functioning and 
symptom scores.  
More than 50% of the participants felt 
incompletely informed about their illness. 
Almost half of all study participants (47%) 
indicated that their doctors did not ask about 
their ability to cope with their disease. Women 
felt significantly more supported by their 
friends, while men felt supported by their 
family. 42% worried about a relapse. A greater 
number of comorbidities was related to worse 
physical and mental functioning scores.  
Same study as Schubert-
Fritschle (2013).  
QLQ-C30 Questionnaire is a 
recognised and validated QoL 
evaluation tool. Other items 
are not clearly validated or 
drawn from other tools. Parts 
of questionnaires may not be 
valid on their own. It is not 
evident that the original tools 
were developed in German or 
any processes used for 
translation. 
McLoone J K, Watts 
K J, Menzies S W, 
et al. (2013) 
Melanoma survivors 
at high risk of 
developing new 
primary disease: a 
qualitative 
examination of the 
factors that 




with framework analysis.  
To investigate 
satisfaction with 
clinical care among 
individuals at high 




care at a highly 
specialised 
melanoma clinic. 
20 patients who had 
attended a minimum of 
three consultations at 
the High-Risk Clinic. 
Participants were at 
least 18 years of age 
and English speaking. 
Patients on current 
active treatment for 
locally advanced or 
metastatic melanoma, 
those with a strong 
family history or 
carrying a p16 
mutation were 
excluded from the 
study.  
Counselling to aid the adoption of positive 
coping skills relating to fears about the 
possibility of recurrence was not addressed. 
This left many participants expressing ongoing 
emotional challenges. The majority of 
participants reported receiving sufficient 
information about melanoma. The most 
frequently reported source of melanoma-
related information was the internet (8/20). 
Several participants (6/20) felt insufficiently 
trained in how to perform skin self-
examinations. 
Same study as McLoone et 
al. (2012) All participants had 
thin melanomas. The model 
of care may be specific to a 
large centre that can identify 
a sub-popuation of high risk 
individuals.  
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Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Hamama-Raz Y & 















style, appraisal of 
one’s situation as a 
challenge, and a 
high subjective 
sense of one’s 
ability to cope will all 




300 patients with 
melanoma from 400 
potential subjects 
aged 25–60, Hebrew 
speaking, stage of 
illness IA, IB, IIA, or 
IIB and having been in 
oncological follow-up 
for at least a year with 
no signs of recurrent 
cancer or of other 
chronic illness. 
Findings support the view that inner resources 
contribute to the psychological adjustment of 
melanoma survivors. They also suggest that, 
for the most part, melanoma survivors do not 
differ substantially from other cancer patients 
or healthy populations in the role that inner 
resources play in their psychological 
adjustment.  
 Same study as Hamama-
Raz et al. (2007) & Hamama-
Raz (2012). 
The translation of tools & 
modification may affect their 
validity. The authors note that 
the study does not examine 
the day to day functioning of 
patients or include any of the 
residuals of melanoma and 
associated treatment. 
Boesen E H, Ross 









Randomised controlled trial 
of a psychoeducational 
intervention. 
To test the 
hypothesis that 
psychoeducation 
among a group of 





distress and improve 
active coping 
methods and health 
behaviour. 
  
259 patients, 18 to 70 
years of age with 
cutaneous malignant 
melanoma stage IIA-
IIB, 3-12 weeks after 
surgery. 
The beneficial effect of the intervention was 
larger for patients with higher baseline values 
for total mood disturbance (TMD). The 
intervention group used significantly more 
active-behavioural coping and active cognitive 
coping than the control group at 6-months. No 
differences were seen at 12-month follow-up. 
No significant differences between the two 
groups were observed for avoidance coping. 
Levels for clinical relevance 
were not discussed in the 
study. The revision of the 
intervention and lack of 
validation of the DWI-R mean 
that no judgement can be 
made as to the clinical 
relevance of the intervention 
in this population.  
Vurnek M, Buljan M 
& Situm M (2008) 
Psychological Status 
and Coping with 
Illness in Patients 
with Malignant 
Melanoma. 
Cross-sectional survey. The aim of this 
paper was to 
investigate the 
quality of life (QoL), 
emotional status and 
coping styles in 
patients with 
melanoma. 





the study period. 
Diagnosed 1 to 14 
years previously. 
Melanoma had a minimal impact on QOL.  
Beck Depression Inventory scores indicated 
that 4 patients had mild or moderate 
depression and two had severe depressive 
symptoms. Women were significantly more 
depressed than men. The higher the number of 
depressive symptoms, the more influence 
melanoma has on QoL. The more patients use 
avoidance the less impact melanoma has on 
the quality of their life.  
The use of a small, 
convenience sample limits 
the results. Validation of 
Croatian versions of the 
measurement tools used is 
not reported so the results 
need to be interpreted 
cautiously.   
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Sample Key findings Limitations/comments 
Lehto U-S, Ojanen 
M & Kellokumpu-
Lehtinen P (2005) 
Predictors of quality 





Cross-sectional survey. To evaluate 
psychosocial factors 















72 melanoma and 103 
breast cancer patients, 
28–71 years of age 
with localised disease 
who were newly 
diagnosed and 
admitted for treatment 
and/or follow-up to the 
Oncology Clinic during 
the study period. 




Social support was the major distinguishing 
factor in the sample, the division occurring 
between melanoma and breast cancer. 
Comparison between treatment modality 
groups within the total sample indicated a 
possible support-increasing effect of adjuvant 
cancer treatment. If adjuvant medical cancer 
treatment has the additional effect of resulting 
in more social support, which in turn affects the 
psychological stress processes and QoL, those 
patients not undergoing these treatments also 
receive something less in the psychosocial 
sense. The highest amount of support was 
received from the spouse or partner and, rather 
unexpectedly, from physicians and nurses. 
Breast cancer patients received more support 
than melanoma patients. The younger the 
melanoma patients, the more likely they had 
psychological symptoms and depression.    
The authors note that a 
disadvantage of this study 
was that the subgroups were 
relatively small. A disease-
specific measure was used 
for breast cancer patients but 
not melanoma patients. 
Melanoma-specific findings 
are therefore limited.  
Lichtenthal W G, 
Cruess D G, Clark V 
L et al. (2005) 
Investment in body 
image among 
patients diagnosed 
with or at risk for 
malignant 
melanoma. 
Cross-sectional survey. To assess whether 
or not there are 
gender differences 




melanoma (MM) and 
benign lesions.  
New patients 
diagnosed with either 
Malignant Melanoma 
(MM) or Dysplastic 
Naevus (DN), at first 
or second visit to the 
clinic, aged 21 to 60 
years inclusive. 
Melanoma stage 0-III. 
Median time since 
diagnosis was 277 
days. 
No significant interactions were found with 
regard to gender although women reported 
significantly greater investment in their 
appearances than men. With regard to fatigue, 
perceived stress, and depressive symptoms, in 
the total sample, concerns about physical 
appearance were significantly associated with 
mean level of fatigue. 
Many of the tools were 
validated in general 
populations or student 
populations. The authors 
state that the study also lacks 
a healthy comparison group 
to determine how the 
investment in body image of 
this patient group compares 
to the general population and 
that statistical power was 
reduced because of the 
relatively small sample size. 
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Study Design Aim/Objectives of 
the study 
Sample Key findings Limitations/comments 
Lehto U-S, Ojanenb 
M, Dybac T, et al. 
(2007) Baseline 
psychosocial 
predictors of survival 
in localized 
melanoma. 
Cross-sectional survey To investigate the 







social support, NE 
(anger), non-cancer 
life stresses, and 
domains of QOL on 
survival time in 
primary localised 
melanoma. 
59 newly diagnosed 
28 - 70-year-old 
melanoma patients 
with localised disease 
who attended the 
oncology clinic for 
treatment and/or 
follow-up during the 
study period. One 
patient was excluded 
owing to a prior cancer 
diagnosis.  
A shorter survival time was predicted by male 
gender, anger-in trait (repression of angry 
feelings), the existence of feelings of 
hopelessness, and better single-item reported 
QOL at baseline.  When the variables of the 
final model were tested one by one with the 
adjustment variables, only the Cognitive 
Avoidance coping was significant. Responding 
to the cancer diagnosis by denying the disease 
or its seriousness improved survival. 
Same study as Lehto et al. 
(2005). 
McLoone J, Menzies 





a systematic review. 
Systematic literature 
review. 
To critically evaluate 
both the 
effectiveness and 






people affected by 
melanoma. 
Abstracts of identified 
articles were screened 
and included studies 
involving: 
development and 
evaluation of an 




to melanoma patients, 
case studies, 
published in English 
between January 1980 
and December 2010. 
Educational interventions aimed to increase 
melanoma knowledge had mixed results with 
some, but not all studies reporting increases in 
melanoma related knowledge, SSE, adherence 
and self-confidence in SSE. No significant 
changes were reported in anxiety, depression 
or psychosomatic symptoms after education or 
6 months later. Of 4 psychological 
interventions studies, 4 were CBT based. One 
reported a reduction in anxiety in the 
intervention group at 2 and 6 months follow up, 
one reported a reduction in distress and 
another reported no reduction in distress. 
The authors state that there 
was an absence of 
educational interventions that 
addressed sun protection 
attitudes and behaviours in 
the studies reviewed and 
variations in what constitutes 
a ‘session’ in terms of 
content, duration, and 
facilitator rapport as well as 
inconsistent reporting limited 
comparison between studies.  
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Sample Key findings Limitations/comments 
Kasparian N A, 
McLoone J K, 
Meiser B, et al. 
(2012b) ‘Living 
beneath the sword 
of Damocles’: 
perceptions of risk 




at high or moderate 





To examine risk 







survivors at high or 
moderate risk of 
new primary 
disease. 
310 individuals at high  
or moderate risk of 
recurrent melanoma.  
Clinically-relevant levels of anxiety and 
depression, as measured by the HADS, were 
reported by 25% and 9% of participants, 
respectively. 73% of participants reported 
clinically-relevant levels of fear of cancer 
recurrence, with mean scores similar between 
groups. Participants reported high levels of 
satisfaction with melanoma care. 
Poster abstract only.  
Lehto U-S, Ojanen 
M, Dyba T, et al. 
(2012) Impact of life 
events on survival of 
patients with 
localized melanoma. 
Longitudinal questionnaire. To investigate the 
effect of life events 
evaluated 
cumulatively over 4 
years on survival of 
patients with 
localised melanoma.  
59 patients diagnosed 
with Clark level II-IV 
(Breslow I-II) 
melanoma.  
Life events demonstrated an impact on survival 
when evaluated with stress mediators such as 
coping mechanisms and evaluated 
cumulatively over time. This supports the idea 
that psychological stress has a slow but 
cumulative effect on cancer survival.  
Same study as Lehto et al. 
(2005) & Lehto et al. (2007), 
but with longitudinal data.  
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Grichnik J M (2011) 
Unrecognized sex-





Letter to the editor. Comment on 
Holterhues at al. 
(2011) 
N/A The study by Holterhues reveals differences in 
the way that men and women respond to their 
melanoma diagnosis. This may represent a 
practice gap for dermatologists who do not 
modify their counselling to account for sex-
specific patient needs. The effect was more 
extreme for women both positively and 
negatively. Improved sun-protection is 
beneficial but increased anxiety can impair 
QOL. The reason for this gap is not clear and 
further examination of possible causes, such 
as information seeking behaviour and social 
networks should be conducted.  
N/A 
McArdle C (2012) 
Patients with 
melanoma are 
avoiding follow-up to 
get insurance. 
Personal View. N/A N/A The author notes that in their plastic surgery 
unit they have seen an alarming rise in the 
number of patients electing to withdraw from 
regular review because of difficulties in trying 
to secure insurance, particularly referring to 
patients with stage I and II disease. Upon 
investigation the author found that 7 of 10 
leading insurance companies would decline an 
application for insurance within 5 years of 
diagnosis and two others would decline 
insurance within 5 years of diagnosis, 
treatment or follow-up (which they class as 
ongoing care or treatment). After 5 years 
patients faced an increased premium. The 
stage of melanoma was considered irrelevant 
but the author argues that this penalises 
otherwise healthy individuals.  
Personal view. Not peer 
reviewed. The purpose of the 
insurance is unclear. Life 
insurance may be taken up 
by fewer patients than travel 
insurance and the cost of 
insurance excluding 
melanoma is not discussed.  
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the study 
Sample Key findings Limitations/comments 
Griffin K (2011) 
"Everyday I'm alive, 
it's a miracle". 
Magazine article. N/A N/A The author tells the story of Maggie Barbieri 
who was diagnosed with stage III melanoma 
and then metastatic disease. Maggie describes 
how important it was to be there for her family, 
to continue to look after her children and how 
her job as a writer helped her to cope with 
treatment. She didn't want to "just be a cancer 
patient". Having a complete response to an 
experimental treatment Maggie sees being 
alive as a "miracle".  Her husband is mentioned 
once as he didn't cry when they were told that 
the melanoma had come back but telling his 
mother made it real and he couldn't stop 
crying. Maggie also talked about comforting 
her 11-year-old daughter.  
The magazine article has 
selected quotes from Maggie 
which present an edited 
version of the interview. The 
quotes were used as the 
information source rather 
than the journalist's 
interpretations.  
Kasparian N A 
(2013a) 
Psychological stress 
and melanoma: are 




Discussion paper. N/A Covers all stages. The psychological and emotional needs of 
patients are often overlooked. The reasons for 
this vary and may include under-recognition of 
the need for psychological care by the 
treatment team, difficulties in doctor-patient 
communication about psychosocial issues, an 
absence of clear referral pathways, inadequate 
funding and resources, difficulties experienced 
by patients attempting to access support, and 
the perceived stigma associated with uptake of 
psychological services. 
The evidence rating system 
of the National Health and 
Medical Research Council of 
Australia was used to select 
the intervention studies 
discussed.  
Korner A, Coroiu A, 
Martins C et al. 




after a melanoma 
diagnosis: the role of 
medical advice and 
patient’s level of 
education. 
Questionnaire. To examine the 
predictors of Skin 
Self-Examination 
(SSE). 
47 Patients with stage 
I-III cutaneous 
melanoma. 
Most melanomas were first detected by 
patients themselves, partners/spouses and 
other laypersons. Higher education was 
associated with an increased likelihood of a) 
having ever self-examined the skin for 
suspicious lesions at pre-diagnosis, b) having 
used a melanoma picture to assist with SSE 
post-diagnosis and c) having been advised to 
perform SSE by a health care professional at 
post-diagnosis.  
Age and gender were not significantly related 
to any of the four SSE-related behaviours. 
Convenience sample but only 
a pilot study.  
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Manne S & Lessin S 
(2006) Prevalence 
and Correlates of Sun 







To examine engagement 
in and stage of adoption 
of sun protection 








than 18 years of age 
and English speaking. 
Stage 0-IV disease. 
1.5 - 2.2 years since 
diagnosis. 16 (7%) 
had recurrent disease.  
Male melanoma survivors were less likely to 
engage in SSE and sun protection. Reducing 
reliance on the beliefs of friends and the 
general population regarding sun protection, 
reducing perceived barriers to sun protection, 
and bolstering confidence in sunscreen use 
may improve sun protection. It is important that 
dermatologists and other HCPs educate 
survivors about correct SSE performance and 
the importance of sun protection. 
The IES was the only 
measurement tool used in it's 
original form. All other 
measures were adapted for 
use with the population. 
Smith R (2012) Living 
with familial 
melanoma syndrome: 
coping with the 
anxiety of three 
melanomas. 
Personal account of 
having melanoma. 
N/A N/A Rebecca was diagnosed with three stage I 
melanomas within a six-month period. Having 
lots of irregular moles, they didn't look out of 
the ordinary and Rebeca was afraid that she 
would not be able to identify another 
melanoma until it was too late and reached 
stage IV. She was 'consumed by anxiety' that 
she whould not see her daughter's wedding the 
following year. Over the next 4 years Rebecca 
had 120 moles removed which were atypical or 
benign. This aggressive treatment plan gave 
her hope and reduced her fear. Rebecca talks 
about hope and anxiety, almost as 
counterbalances. Continuity of care and 
collaboration were also important. 
Rebecca was working as an 
oncology nurse when her first 
mole was removed and had 
an oncology position at the 
time of publication. Her 
awareness of melanoma from 
a professional perspective 
means that she may not 
represent a typical melanoma 
patient.  
White K, D’Abrew N, 




needs of cancer 




To describe the 
prevalence of cancer 
patients’ unmet needs 
and explore how these 
needs vary across the 
five most common 
cancers in Australia 
(prostate cancer, 
colorectal cancer, breast 
cancer, melanoma of the 
skin and lung cancer). 
90 patients with 
melanoma out of 786 
patients diagnosed 
with cancer between 6 
months and 2 years 
ago. 
The two most common needs expressed by all 
patients were: Fears about the cancer 
returning and fears about the cancer 
spreading. When tumour groups were 
considered separately this was also true for 
melanoma patients. Unlike other cancer 
subgroups, participants with melanoma did not 
rate any items from the physical & daily living 
domain highly but a significant minority (41%) 
reported unmet needs from the health system 
& information domain. Unmet information 
needs were higher in melanoma patients. 
The authors note that during 
the study, the research 
assistant received calls from 
potential participants who 
wondered why they had been 
sent the survey as they had 
not had cancer despite 
diagnosis and treatment for 
melanoma. This perception 
may influence the 
respondents’ perceived 
unmet needs.  
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McLoone J K, 
Kasparian N, Meiser 
B, et al. (2011) 
Melanoma risk, 
clinical care and 
patients’ fears of 
melanoma 
recurrence: what is 




To investigate the 
prevalence of Fear Of 
Recurrence (FoR) 
among moderate and 
high risk melanoma 
survivors and explores 
the psychological 
mechanisms which may 
moderate the 
relationship between risk 
and fear. 
306 melanoma 
patients with high 
(54%) or moderate 
(46%) risk of 
recurrence.  
Participants reported clinically-relevant levels 
of Fear Of Recurrence (74%), which did not 
differ significantly between risk groups. 
However, high-risk (HR) participants did report 
significantly greater perceived risk of 
developing a melanoma in the future, 
compared to moderate-risk participants. They 
also reported significantly greater satisfaction 
with clinical care and a greater percentage 
reported that their doctor had provided 
education regarding sun protection. 
Same study as Kasparian et 
al. (2012). 
Boesen E H, Boesen 
S H, Frederiksen K, 









controlled trial of a 
psychoeducational 
intervention. 
To report the effect of 
the intervention on 
disease recurrence and 
mortality up to 5 years 
after primary surgery. 
Results for patients who 
refused to participate in 
the randomised study 
are also reported. 
262 (128 intervention, 
130 control) patients 
with cutaneous 
malignant melanoma, 
18-70 years old, stage 
IIA-IIB, 3-12 weeks 
after surgery. 
The cumulative disease-free and survival rates 
of the groups indicate that non-participants 
survived for a shorter time than the intervention 
and control groups, for which there was no 
difference in survival. No difference in time to 
recurrence was observed among the three 
patient groups. Breslow depth and lymph node 
status were significant prognostic factors for 
time to recurrence and length of survival. None 
of the scores for profile of mood and dealing 
with illness predicted time to recurrence or 
death. 
The authors state that the 
participants overall had low 
levels of distress. To identify 
a survival benefit among 
patients with low rates of 
distress, a substantially larger 
sample size would be 
needed. 
Murchie P, Delaney E 
K, Campbell N C et 
al. (2009) GP-led 
melanoma follow-up: 
the practical 




with GPs delivering 
the intervention. 
To explore how GP-led 
melanoma follow-up had 
worked from the 
perspective of GPs by 
exploring in detail the 
practical experience of 
GPs running the 
programme. 
17 GPs from rural, 
suburban or urban 
areas taking part in a 
GP-led follow-up 
programme as an 
alternative to 
traditional hospital-
based follow-up. All 17 
GPs who received 
training and delivered 
melanoma follow-up 
during the study year 
took part in interviews. 
GP-led melanoma follow-up worked well from 
the perspectives of GPs. They felt that they 
were well equipped and supported in 
undertaking the follow-up consultations and 
that patients appreciated 
the convenience. The GPs felt that a robust 
recall system, initial training with regular 
refreshers and effective consultant backup 
were vital components of a successful long-
term programme. 
Same study as Murchie et al. 
(2010). 
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11.6 APPENDIX 6: EXAMPLE OF CODING, CATEGORY AND THEORY DEVELOPMENT FROM AN INITIAL TO LATER INTERVIEW 
Transcript Open Coding Focussed Coding 
Sarah:  Yeah, it started when, well I've always had a mole on me bum, and when I 
were pregnant with Eva, there were some changes going off in it, mainly towards 
the end, where it started itching, it had grown outwards.  And then when I'd had, I 
went for me six weeks’ check, and I were just going to walk out of the doctors to 
be honest.  I'd had me check in, something just like told me just to get it checked.  
So I asked if they'd check it, mean I just told them the symptoms, what had 
changed in it and stuff, and they sent it off.  They told me it were probably nowt, it 
looks fine, probably nowt, and I went to see somebody.  They said it’d be nowt, 
and then it come back, they took something from it, and it come back it were 
melanoma, in the second stage of it.  So then I started to have, I had to have an 
operation on it, have it all removed and things.  And then obviously I had to have 
follow ups at hospital, where having all me moles constantly checked.   
I had to have a couple more removed on me belly, one had changed, one were 
changing, so they took them off, a precaution.  And then obviously I've seen them 
like check me groins and stuff like that, and I missed an appointment in, I think it 
Seeing mole change 
Feeling mole itch 
Seeing mole growing outwards  - 
Noticing changes 
Delayed seeking help. 
Deciding to get it checked while at 
the doctors/seeking help. 
Telling the doctor what had 
changed 
Being told by the doctor it was 
probably nothing. Reassured. 
Trusted the doctor. 
Being told it was melanoma. 
?Loss of trust in doctor. 
Needing an operation 
Constantly checking moles.  
 


















Treatment as part 
of monitoring 
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were July last year, completely forgot all about it, so I chased it up and they got 
me in in November.  Well the week before I were due to go, I'd like been checking 
me groins and I'd found a lump.  There were three.  There were one on me leg, 
there were two other ones, but one hurt, that’s why I realised it.  So I booked 
straight back into the doctors.  It had been there for two weeks, so they said they’ll 
transfer me back up to hospital.  But I'd already had appointment coming up so 
they left it at that, and then they got, they checked it all and stuff and did some 
tests, I had to have a biopsy and everything, and it came back as lymph nodes.   
 
It were lymph nodes, and when I were sat in the room with me friend, I could tell 
on their faces, from the last time I got diagnosed with it.  It’s like for a second time 
you're like [sighs].  And me friend said to me why are we sat in this room?  I said 
because they're going to tell me it’s bad news.  She said no, no, it’s not.  I said 
they are, I've got a feeling.  The one lump what hurt had gone, but the other two 
had like joined together and got bigger.  So I knew myself, and then they come in 
and I looked at me friend and she looked at me, and I nodded to her because I 
Checking groins 
Recognising appointments as 
important 
Checking my groins 
Finding a lump that hurt 
Finding two other lumps that 
didn’t hurt 
Delaying seeking help from GP 
Waiting until routine appointment 
 
 
Getting bad news 
Being able to tell [that it was bad 
news] from their faces 
Knowing from last time 
 
Expecting bad news from the 
room that we were in. 
Having a feeling that it would be 
bad news. Checking lumps. 
Seeing the lumps change/grow so 
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just, I saw their faces.  And then the doctor sat down and told me, and just like, 
you think not again, really.  I'm 28 year old, I've got three young children, why me, 
what have I, you know, it’s not fair on nobody but you think.   
 
And then it had been, the doctor had told me from when I had me first operation 
with the mole on me bum, some had broke off, so that’s been travelling around 
me body for over a year and a half.  So, because it’s gone to me lymph nodes 
there, they're thinking has it gone anywhere else, has it gone to me brain, 
because it’s been over a year and a half?  So I had to have all the scans done, 
and you're just like, you know, just scared really.  There were some results 
coming back to see if, because I'd already had a brain scan to see if it had gone 
up to me brain and everything, so we had to wait about in hospital.  We went back 
up, and me dad had asked before I'd even like looked, and he said it’s alright, so it 
were like a relief.  When he took me back into the room and told me, it were like, 
you know, it had not gone up to me brain but they found some more, like in me 
belly a bit up.  They said they don’t, they're not cancerous but they're still there, so 
Knowing that it was bad news 
from their expressions 
Thinking why me. Thinking that 
it’s not fair 
 
 
Being told that it has travelled 
around my body 
 





Being scared while waiting for 
results (of cancer/consequences 
of cancer) 
 
Feeling relieved that the scan was 
alright  
 
Finding things that weren’t cancer 
Trusting (non-
verbal) 
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they were going to take them away, so it were like basically what, he talked 
through one operation had now turned into two in one.   
 
I just, I were relieved it had not gone nowhere else, but in another way like it’s still 
something else what’s happened and stuff.  It were all near Christmas time, new 
year time.  They'd given me me operation date for 6
th
 January, so I just had to, for 
them few weeks, just put a brave face on for me three children, they didn’t want to 
know, and then after that I actually sat down and told them.  I'd brought me two 
boys into the hospital to see the CNS.  She spoke to the boys with me and took 
them up to the ward actually where I'd be staying, to tell them that I'd be alright 
and be in for a few days.  They were alright about it.  They’ve been good, haven't 
they, they’ve been supportive. 
 
Mum: Yeah, they have, they’ve done really well to say, you know.  
 




Feeling relieved that it hadn’t 
gone anywhere else 
Feeling as though it’s another 
thing to worry about 
 
Putting a brave face on for the 
children 
Telling the children 
Taking the boys to the hospital to 
see the CNS and where I would 
be staying. 
Telling the boy that I’ll be alright.  
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Sarah:  You see, they think I’m, I tell them I'm poorly, I'm not well, but they look at 
me and think, you know, mum, I've played that act, I'm poorly but I'm not.  
 
Mum: It’s not so much the older one, it’s the younger one, isn’t it, and he gets 
really emotional.  He looks at his mum and thinks, you know, and then he like 
goes to her and hugs her and, so he knows, he’s a very emotional little boy. 
 
Sarah:  Yeah, they realised I were poorly when I come out of hospital and when I 
had to have the bag, the tube thing what I had to come out with.  Then they 
realised like yeah, mummy’s poorly.  And then once that had gone, they think I'm 
alright again.  I've just like told them now I have to go to hospital every day while 
you're at school.  And I've shown them and stuff, because I've had changes in me 
body, so I've told them this is, I've got three big scars, this is what’s happened, 
this is, mummy’s poorly, she just had to have some lumps took away.  And then 
like such as yesterday, I got out the bath and Josh went mum, what’s that on your 
leg, and seen me scar, because it’s all been getting a bit more red and stuff now.  
Not looking poorly. 




Dealing with the reactions of the 
children 
Recognising that the youngest 
son is upset when he hugs Sarah 
more 
 
Looking poorly when I came out 
of hospital 
Tubes and bags make me look 
poorly 
Looking better because the tubes 
have gone 
The boys think I’m better because 
they can’t see anything. 
Showing the scars to the boys to 
help them understand what has 
happened. 
Having three big scars. 
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And I just say that’s where mummy’s poorly, and it’s what mummy has to go to 
hospital for, to make it better.   
 
So they understand, but it’s just hard me being - I get support through the day, me 
mum’s there, me sister’s there, but it’s just at night, do you know, like they 
sometimes ask questions and it’s like are you going to be alright mummy, and 
you're never going to leave me, or you haven't, you know, and you think you’re 
eight year old, you know, you're eight, you're six, this shouldn’t be happening.  But 
getting there, I've got me head round it and stuff.  I just have all me check-ups and 
hopefully once this is done with, hopefully I’ll be alright in the end.  This will sort 
me out and fingers crossed, they’ll be no more.  I don’t know really.  




Having support during the day 
from sister or Mum 
[providing distraction] 
Being asked if I am going to be 
alright 
Dealing with the children’s 
reactions 
Finding it difficult to have the boys 
ask if I’m going to leave them, 
that they are thinking about death. 
Getting my head around it 
Having check-ups (to reassure?) 
Hoping that I’ll be alright. Hoping 
that there won’t be any more 
melanoma 
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Beginning the rollercoaster: Categories and time points shared with Sarah and Lynn during one of the interviews to begin to develop their 
rollercoaster including a short summary of how the categories fit their experience. This was used to generate discussion during the interview.  
 
P05 & C05 Rollercoaster intro 
July 2015 
Important time points Roles Relationships Routines Resources Reasoning & Reactions 
Before noticing anything Being a Mum Kids Noticing Family Why 
Noticing Being normal Aunt Monitoring Healthcare professionals Worry about it coming back 
Diagnosis  Sister Protecting  Worry about treatment 
Finding something new  Mum   Hoping it will be ok 
Surgery  Healthcare 
professionals 
   
Radiotherapy  Self    
New moles      
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P05 & C05 Rollercoaster intro 
July 2015 
ROLES 
BEING A MUM 
This is the most important thing to you. You have maintained the role as much as possible but accepted help from family members when they have offered it. Help has been 
needed more so during surgery or treatment. Your role as a Mum is limited by tiredness, awareness of the sun on nice days and the need to attend hospital appointments.  
Your daughter needed to have a mole removed, which caused worry. You have also been thinking about what might happen if you can’t be a Mum anymore – will the kids stay 
together? 
BEING A CARER  
Your Mum and Auntie have taken on the role of carer at different times, but in different ways. Your expectations of the kind of support you need are similar to your Aunt’s 
expectations and different to your Mums. Your Auntie has been more successful in meeting your needs and expectations, with the help of other family members. 
ROUTINES 
PROTECTING 
Since the first surgery you are more cautious in the Sun and have always been careful to protect your kids. Your awareness of sun protections may have started before you 
got the first mole. You are aware that protecting yourself from the sun can interfere with playing with the kids in good weather.  
NOTICING AND MONITORING 
This started when you noticed the first mole – or were you monitoring your skin before? Since then you monitored your body and found the second lump. While looking for 
changes, the surgeon noticed when the melanoma came back a third time. You have also started to notice and monitor symptoms such as levels of tiredness since the 
radiotherapy. 
RESOURCES 
 Your main resource has been your family, although your Mum has taken a back seat and your Auntie has provided more support recently. One the melanoma came back a 
third time, you felt that you needed more help from professionals, such as the Nurse Specialist and allowed yourself to use the help that was offered. You didn’t seek help for 
yourself at any point, from family or nurses until it was offered.  
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You hide a lot of information about your melanoma from people and select who it is shared with. You have sometimes tried to hide from it yourself, but are more accepting of it 
now that it has come back a third time. You open up more when relaxing with a drink at the weekend with friends or family. Your relationship with your Mum has become more 
distant as she is unable to provide the support you need, but your Auntie and Sister have been there. Your Dad has been there although he has also been ill.  
Your relationship with yourself has been difficult as you struggle to accept the limits of what you can do and how your leg looks after the radiotherapy. Your body image has 
changed and you have been trying to accept that.  
You have tried to hide how ill you are from the kids but have noticed that they are more clingy and may know more than they let on.  
 
REASONING AND REACTIONS 
This is mostly concerned with thinking about why you got the melanoma in the first place and then why it came back. You worried about it coming back until it did and then 
when faced with treatment your worry changed to being about the effects of treatment. You take things a step at a time and create milestones for yourself to get to.  
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11.7 APPENDIX 7: EXAMPLE OF A THEORETICAL MEMO USED IN THE STUDY 
The Memo below shows in part how the process of ‘hiding’ was developed from interview 
data and elaborated upon during the analysis process. It illustrates a number of reflective 
‘questions’ that I posed to myself and subsequently explored in the data. Through posing 
these reflective questions, links between the processes of ‘hiding’ and ‘sharing’ became 
apparent along with a further link to ‘relationships’.  
 
Hiding (not sharing) 
A number of patients describe ‘putting on a brave face’. They feel that they don’t want to 
burden others with their worries or concerns. Others describe ‘choosing’ to tell certain 
amounts of information to others. Sharing may be delayed to a point where the information 
feels complete enough to be shared as there would be fewer questions surrounding the 
information and therefore less to worry others about. This raises a number of questions that I 
reflected upon such as:  
• How do patients and carers decide whom to share information with, when they share 
it and how much of it is shared? 
• Does this relate to age/stage in the lifecycle? Older patients and carers talk more 
freely about melanoma and what is happening to them but do not always share how 
they are feeling with others.  
 
It seems that ‘hiding’ is usually purposeful, often serving a protective purpose. Does ‘sharing’ 
also have a separate purpose of warning others about the dangers of melanoma specifically 
or cancer more generally? Or where the effect of not sharing would be seen to be more 
detrimental (family members who would be more upset to be excluded than by the 
information or HCPs where not sharing could be detrimental to treatment/recovery)?  
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Hiding seems to occur throughout the melanoma experience and I wonder if it is a constant 
process depending upon new information being available to hide or share? This raises the 
possibility of further questions, such as:  
 
How do patients and carers choose who information is hidden from/shared with? 
There also seems to be a variation in who participants want to protect – For example is 
protective behaviour towards young children or older adults based on an assessment of 
comprehension or understanding?  
 
Also it is important to consider when information is hidden or shared. From the data it seems 
that this may be: 
 
• Immediate – to gain support. Family/friends are a resource. Information must be 
shared with HCPs to gain support (but only if HCP is available and forming a 
relationship is required for ongoing sharing).  
• Delayed – trying not to worry people until it is known that there is something to worry 
about. This may also depend on how obvious any treatment is (surgery to the head 
or neck is usually obvious). Not wanting to ‘bother’ HCPs if perceived as busy.  
• Never – Distant relationship e.g. work colleagues, or more distant family or friends. 
 
Questions also arose in my mind about the amount of information that may be hidden 
What information is hidden? 
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• All – distant relationship with the other person, it won’t affect them. 
• Some – assessment of the relationship or person means that they need to know 
some information but not all. Hiding everything may be more detrimental.  
• None – usually an existing close relationship where sharing is needed to gain 
emotional support.  
 
So far the data seem to be indicating that ‘hiding’ or ‘putting on a brave face’ depends on 
assessment of the relationship and person with whom the information is to be hidden from. 
Most effort is put into the situation where some, but not all information is shared, or where 
information is shared. The data would suggest that this assessment includes a consideration 
of the:  
• Nature of any existing relationship 
• How much the information would affect the other person 
• Ability of the other person to understand the information  
• Ability of the other person to deal with the information  
• Perceived benefit of hiding the information/perceived disadvantage of sharing 
• Perceived advantage to hiding immediately but sharing at a later time.  
 
This suggested the following type of interactions: 
‘Putting on a brave face’ is part of ‘hiding’.        ‘Hiding’ cannot be considered without sharing 
as they are two points on a continuum.       ‘Hiding’ depends on an assessment of a 
relationship but the action decided upon can then affect that relationship.  
 
If patients are ‘putting on a brave face’ or ‘hiding’ some information from some people, but 
talking about this in the interview then that suggests that they do not feel the need to hide 
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any information from me. Reasons for this disclosure could include: the situation of the 
research interview, my role as a researcher, early development of the research relationship, 
knowledge of my role as a nurse, that I am seen as being removed from the situation so not 
affected by the information in the way that friends or family would be. If the research 
situation allows participants to talk more freely it begs the question – do participants ever 
hide any information or feel that they have to ‘put on a brave face’ for HCPs? If so, why and 
what, if any are the barriers to sharing information with HCPS?   
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11.8 APPENDIX 8: DOCUMENTATION OF ETHICAL APPROVAL 
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RISK ASSESSMENT FORM 
 
 
To be completed for all newly identified risks 
For further guidance on completing this form please refer to Guidelines for Completing a Risk 
Assessment Form (available on the Trust’s intranet) or contact your directorate Risk Lead 
 
Department / Directorate Cancer Clinical Trials Centre 
Description of risk Loss or breakdown of laptop containing patient, carer and healthcare professional interviews for STH 17039 research study.  
Existing controls in place 
when risk was identified 
Laptop is encrypted so data would not be accessible to others if 
found.  
Data is backed up weekly to University server to reduce the likelihood 
of loss of all data. University server is covered by university backup 
policies.  If loss were to occur a maxium of 2 interviews would be lost. 
This would not be detrimental to the study as interviews are repeated 
throughout the study and data revisited. It is therefore unlikely that 
important data were not re-visited at a later interview.   
Initial Risk Score i.e. with existing controls in place 
Consequence (1-5) 1 
Likelihood (1–5) 2 
Risk Score (1 – 25) 2 
Action Plan to reduce the risk to an acceptable level 
Description of actions  Cost Responsibility (Job title) 
Completion 
Date 
Register risk on DATIX (for all risks > 3) nil   
    
    
    
    
Target Risk Score i.e. after full implementation of action 
plan 
Consequence (1-5)  
Likelihood (1–5)  
Risk Score (1 – 25)  
Date for completion  








assessment  21/06/2013 Date of next review 21/06/2014 
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A Research Ethics Committee established by the Health Research Authority 
 
 
NRES Committee Yorkshire & The Humber - South Yorkshire 
North East REC Centre 
Unit 002, TEDCO Business Centre 
Rolling Mill Road 
Jarrow 
Tyne and Wear 
NE32 3DT 
 
Tel: 0191 428 3561 
 
03 March 2014 
 
Miss Joanne Bird 
NIHR Research Fellow 
University of Sheffield 
Academic Unit of Clinical Oncology 





Dear Miss Bird 
 
Study title: Understanding the experiences and support needs of 
patients with melanoma and their carers: Charting 
changes over time 
REC reference: 13/YH/0212 
Protocol number: STH17039 
Amendment number: Substantial Amendment 1 
Amendment date: 05 February 2014 
IRAS project ID: 126810 
 




The members of the Committee taking part in the review gave a favourable ethical opinion 





The documents reviewed and approved at the meeting were: 
 
 Document  Version  Date  
Notice of Substantial Amendment (non-CTIMPs)  Substantial Amendment 1  05 February 2014  
Covering Letter  Letter from Joanne Bird  05 February 2014  
Summary of Changes    14 January 2014  
Protocol  Version 2.2  14 January 2014  
  
A Research Ethics Committee established by the Health Research Authority 
 
Membership of the Committee 
 





All investigators and research collaborators in the NHS should notify the R&D office for the 
relevant NHS care organisation of this amendment and check whether it affects R&D 
approval of the research. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating Procedures for 
Research Ethics Committees in the UK. 
 
We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/  
 














Enclosures: List of names and professions of members who took part in the 
review 
 
Copy to: Miss Clare Hockley, Sheffield Teaching Hospitals NHS Foundation 
Trust 
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A Research Ethics Committee established by the Health Research Authority 
 
NRES Committee Yorkshire & The Humber - South Yorkshire 
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Ms Helen Barlow  Knowledge Service Manager  Lay Plus  
Miss Kerry Dunbar  Assistant Coordinator  None  
Mr Neil Marsden  Police Staff  Lay Plus  
 
 











 Understanding the experiences and support Needs of 
patIents with melanoma and their carers: charting changes 
over TIme (UNITI) 
 
Information Sheet for Patients 
 
We would like to invite you to take part in our research study. Before you 
decide we would like you to understand why the research is being done and 
what it would involve for you. One of our team will go through the information 
sheet with you and answer any questions you have. Please take time to read 
the following information carefully and discuss it with others if you wish. Ask 
us if there is anything that is not clear or if you would like more information - 
contact details can be found at the end of this sheet. Take time to decide 
whether or not you wish to take part. 
Thank you for reading this. 
 
What is the purpose of the study? 
The purpose of this study is to consider the experiences of both patients with 
melanoma and their carers and the kind of support that they need. The type of 
support has been shown to be an important part of care for cancer patients in 
general. This study is looking at what patients and carers feel they need.  
 
 
Why have I been invited? 
You have been invited because you have been diagnosed with melanoma 
and we are interested in your experience and your views about the care you 
received. We will be asking people to help us who, like yourself, have had 
treatment, or are currently having treatment, for melanoma.  
 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take 
part you will be given this information sheet and asked to sign a consent form. 
If you change your mind and want to withdraw you can do so at any time 
without giving a reason. If you do not want to take part or withdraw from the 
study, it will not affect you or the care you receive in any way. If you withdraw 
from the study, any information that can still be identified as yours will be 





Academic Unit of Clinical Oncology 
Head, Prof P J Woll 
Cancer Clinical Trials Centre 
Weston Park Hospital 
Whitham Road, Sheffield S10 2SJ 
 
Tel: 0114 226 5000/5208     Fax: 0114 226 5678 
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What will be involved if I agree to take part? 
If you would like to take part we would like you to be involved in a series of 
interviews over three years. These can take place somewhere that is 
convenient for you, which could be your home or at the Cancer Clinical Trials 
Centre, Weston Park Hospital. We would like to ask you about your 
experience of being treated for melanoma and how it has affected you. If you 
agree, we would like to audio-record the interviews to help us to remember 
the things you have said. The interviews should take about an hour. 
Interviews will take place at different time points over the three years to look 
at how things have changed for you. This would be an initial interview 
followed by further interviews at 3, 6 and 12 months then 6 monthly 
interviews. If you have any further treatment for melanoma we would ask to 
do another interview at that time.  
 
If you agree, we may contact you after the interviews to ask if you would like 
to help us to create recommendations for the care of future melanoma 
patients. This is optional and you may choose not to take part at that point. 
 
We are also inviting carers to take part and with your permission would invite 
whoever is most involved in your care at home to take part. This could be a 
relative, friend or someone else. We will provide them with a separate 
information sheet and ask them to complete a consent form if they would like 
to participate. If your carer decides to take part, you may choose to be 
interviewed together or separately. 
 
Healthcare professionals are being included in this study and if you would like 
to take part, at the 6 month interview we would like to ask you to nominate a 
healthcare professional who you think has been helpful during your care. This 
could be nurses, doctors, complementary therapists or other professionals 
from the community, hospital or charitable teams.  
 
We will also ask for your permission to look at your medical notes to obtain 
information about your diagnosis and treatment.  
 
At the end of the study we will create guidelines for the care of patients with 
melanoma based upon the findings of the study. You will have the opportunity 
to take part in this if you wish to and this may be done individually or as a 
group.  
 
What are the possible disadvantages and risks of taking part? 
We will be asking you to spend an hour of your time with us to talk about your 
experience of being treated for melanoma on 8 to 10 occasions. Your 
healthcare will not be affected in any way by taking part in this study but 
talking about some experiences may be upsetting.  
 
What are the possible benefits of taking part? 
There is no intended clinical benefit to you from taking part in this study 
although some people find it helpful to talk about what has happened to them. 
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The information we gain may help improve the experience of people who are 
treated for melanoma and their carers in the future. 
 
What if I experience distress as a result of taking part in this study? 
The researcher, Joanne Bird, will be happy to answer any questions you may 
have as a result of taking part in this study and can be contacted on 0114 
2265208.  
 
The Skin Cancer Clinical Nurse Specialist team can also be contacted if you 
wish to discuss your participation in this study or have any questions about 
your care. They are independent of the research team and will not have 
access to any information you provide as part of this study. 
 
Claire Powell: 0114 2713014 
Marion Page: 01226 435311 
 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will 
be handled in confidence. 
 
Anything you tell us in the interview will be kept strictly confidential. We will 
not tell anyone else of your involvement in the study or of anything that you 
may say to us without your permission. Only members of the research team 
will have access to the audio recordings and the written transcripts obtained 
from the audio recording. The transcripts will not identify you personally or 
anyone who you may have talked about. The audio recordings of the 
interviews will be kept in a locked cupboard for the duration of the study, and 
destroyed afterwards. The reports and publications arising from the study will 
not identify anyone who has participated.  
 
If your carer or nominated healthcare professional takes part in the study and 
the interview takes place separately, then we will not discuss what you have 
said in these associated interviews.  
 
With your permission, we will write to your GP to let them know of your 
participation in this study and what it involves, but they will not have access to 
any of the information that you provide in the interview.  
 
What will happen to the results of the research study? 
The findings from the study will be published in medical journals. No-one will 
be identifiable. 
 
Who is organising and funding the research? 
The study is being undertaken by researchers from the Department of Clinical 
Oncology and School of Nursing & Midwifery at the University of Sheffield. 
The research is funded by a grant from the National Institute of Health 
Research.  
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Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, 
called a Research Ethics Committee, to protect your interests. This study has 
been reviewed and given a favourable opinion by South Yorkshire Research 
Ethics Committee. 
 
Who can I contact for independent advice about participating in this 
study?  
If you would like independent advice about taking part in the study, you may 
wish to contact: 
 
Patients Services Team 
Tel: 0114 271 2400 
Email: PST@sth.nhs.uk 
 
What if something goes wrong? 
If you have a concern about any aspect of this study, you should ask to speak 
to the researchers listed below who will do their best to answer your 
questions. If you remain unhappy and wish to complain formally, you can do 
this through the NHS Complaints Procedure by contacting the following 
person: 
 
Simon Heller, Research Department, Sheffield Teaching Hospitals NHS 
Foundation Trust.  
Telephone: 0114 2265934 
 
There are no special compensation arrangements for patients harmed by 
taking part in this research project. In the event that something does go wrong 
and you are harmed during the research and this is due to someone’s 
negligence then you may have grounds for legal action for compensation 
against Sheffield Teaching Hospitals NHS Trust but you may have to pay your 
legal costs. The normal National Health Service complaints mechanisms will 
still be available to you. 
 
Further information and contact details 
If you would like more information about the study, would like to talk about 
taking part or are have any concerns about the study please contact: 
 
Joanne Bird 
NIHR Research Fellow 
 
Tel: 0114 2265208 
Email: joanne.bird@sheffield.ac.uk 
 
Dr Sarah Danson 
Consultant in Medical Oncology 
Tel: 0114 2265235 
Cancer Clinical Trials Centre 





Thank you for reading this and for taking an interest in this research 
study.  










 Understanding the experiences and support Needs of patIents with 
melanoma and their carers: charting changes over TIme (UNITI) 
 
CONSENT FORM  - PATIENTS 
 
Please  
Participant Identification Number for this study: ………..           initial box 
 
1. I confirm that I have read and understand the information sheet dated 
…………….. (version ………) for the above study.  
 
2. I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
 
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my medical 
care or legal rights being affected. 
 
4. I understand that relevant sections of my medical notes and data 
collected during the study, may be looked at by individuals from the 
University of Sheffield, from regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my records. 
 
5. I agree to my GP being informed of my participation in the study. 
 
 
6. I agree to the use of audio-taping, with possible use of anonymised 
verbatim quotation. 
 





    




    
Name of Person Taking consent  Date  Signature 





Academic Unit of Clinical Oncology 
Head, Prof P J Woll 
Cancer Clinical Trials Centre 
Weston Park Hospital 
Whitham Road, Sheffield S10 2SJ 
 
Tel: 0114 226 5000/5208     Fax: 0114 226 5678 
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 Understanding the experiences and support Needs of 
patIents with melanoma and their carers: charting changes 
over TIme (UNITI) 
 
Information Sheet for Carers 
 
We would like to invite you to take part in our research study. Before you 
decide we would like you to understand why the research is being done and 
what it would involve for you. One of our team will go through the information 
sheet with you and answer any questions you have. Please take time to read 
the following information carefully and discuss it with others if you wish. Ask 
us if there is anything that is not clear or if you would like more information - 
contact details can be found at the end of this sheet. Take time to decide 
whether or not you wish to take part. 
Thank you for reading this. 
 
What is the purpose of the study? 
The purpose of this study is to consider the experiences of both patients with 
melanoma and their carers and the kind of support that they need. The type of 
support has been shown to be an important part of care for cancer patients in 
general. This study is looking at what patients and carers feel they need.  
 
 
Why have I been invited? 
You have been invited because you care for someone who has been 
diagnosed with melanoma and we are interested in your experience and your 
views about how this has affected you. We are asking people who care for 




Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take 
part you will be given this information sheet and asked to sign a consent form. 
If you change your mind and want to withdraw you can do so at any time 
without giving a reason. If you do not want to take part or withdraw from the 





Academic Unit of Clinical Oncology 
Head, Prof P J Woll 
Cancer Clinical Trials Centre 
Weston Park Hospital 
Whitham Road, Sheffield S10 2SJ 
 
Tel: 0114 226 5000/5208     Fax: 0114 226 5678 
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any way. If you withdraw from the study any information that can still be 
identified as yours will be destroyed if you wish. 
 
 
What will be involved if I agree to take part? 
You will only be able to take part if the person you care for also wishes to take 
part as we would like to look at how patient and carers are affected by the 
same experience. If you would both like to take part we would like you to be 
involved in a series of interviews over three years. These can take place 
somewhere that is convenient for you, which could be your home or at the 
Cancer Clinical Trials Centre, Weston Park Hospital. We would like to ask you 
about your experience of caring for someone being treated for melanoma and 
how it has affected you both. If you agree, we would like to audio-record the 
interviews to help us to remember the things you have said. The interviews 
should take about an hour. Interviews will take place at different time points 
over the three years to look at how things have changed for you. This would 
be an initial interview followed by further interviews at 3, 6 and 12 months 
then 6 monthly interviews. If the person you care for has any further treatment 
for melanoma we would ask to do another interview at that time. You may be 
interviewed with the person you care for or separately if you wish.  
 
If you agree, we may contact you after the interviews to ask if you would like 
to help us to create recommendations for the care of future melanoma 
patients. This is optional and you may choose not to take part at that point. 
 
Healthcare professionals are being included in this study and if the person 
you care for chooses to take part, at the 6 month interview we ask them to 
nominate a healthcare professional who they think has been helpful during 
their care to be interviewed. This could be nurses, doctors, complementary 
therapists or other professionals from the community, hospital or charitable 
teams.  
 
At the end of the study we will create guidelines for the care of patients with 
melanoma based upon the findings of the study. You will have the opportunity 
to take part in this if you wish to and this may be done individually or as a 
group.  
 
What are the possible disadvantages and risks of taking part? 
We will be asking you to spend an hour of your time with us to talk about your 
experience of caring for someone being treated for melanoma on 8 to 10 
occasions. The healthcare of the person you care for will not be affected in 
anyway by taking part in this study but you may find that talking about some 
experiences is upsetting.  
 
 
What are the possible benefits of taking part? 
There is no intended clinical benefit to you or the person you care for from 
taking part in this study although some people find it helpful to talk about what 
has happened to them. The information we gain may help improve the 
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What if I experience distress as a result of taking part in this study? 
The researcher, Joanne Bird, will be happy to answer any questions you may 
have as a result of taking part in this study and can be contacted on 0114 
2265208.  
 
The Skin Cancer Clinical Nurse Specialist team can also be contacted if you 
wish to discuss your participation in this study or have any questions about 
melanoma care. They are independent of the research team and will not have 
access to any information you provide as part of this study. 
 
Claire Powell: 0114 2713014 
Marion Page: 01226 435311 
 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will 
be handled in confidence. 
 
Anything you tell us in the interview will be kept strictly confidential. We will 
not tell anyone else of your involvement in the study or of anything that you 
may say to us. Only members of the research team will have access to the 
audio recordings and the written transcripts obtained from the audio 
recording. The transcripts will not identify you personally or anyone who you 
may have talked about. The audio recordings of the interviews will be kept in 
a locked cupboard for the duration of the study, and destroyed afterwards. 
The reports and publications arising from the study will not identify anyone 
who has participated.  
 
If your interview takes place separately from the person you care for, then we 
will not discuss what you have said with them.  
 
 
What will happen to the results of the research study? 
The findings from the study will be published in medical journals. No names or 
details of individual patients will be included. 
 
Who is organising and funding the research? 
The study is being undertaken by researchers from the Department of Clinical 
Oncology and School of Nursing & Midwifery at the University of Sheffield. 




Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, 
called a Research Ethics Committee, to protect your interests. This study has 
UNITI PIS-C Version 2.1 (28 May 2013)   4    
been reviewed and given a favourable opinion by South Yorkshire Research 
Ethics Committee. 
 
Who can I contact for independent advice about participating in this 
study?  
If you would like independent advice about taking part in the study, you may 
wish to contact: 
 
Patients Services Team 




What if something goes wrong? 
If you have a concern about any aspect of this study, you should ask to speak 
to the researchers listed below who will do their best to answer your 
questions. If you remain unhappy and wish to complain formally, you can do 
this through the NHS Complaints Procedure by contacting the following 
person: 
 
Simon Heller, Research Department, Sheffield Teaching Hospitals NHS 
Foundation Trust.  
Telephone: 0114 2265934 
 
There are no special compensation arrangements for patients harmed by 
taking part in this research project. In the event that something does go wrong 
and you are harmed during the research and this is due to someone’s 
negligence then you may have grounds for legal action for compensation 
against Sheffield Teaching Hospitals NHS Trust but you may have to pay your 
legal costs. The normal National Health Service complaints mechanisms will 
still be available to you. 
 
 
Further information and contact details 
If you would like more information about the study, would like to talk about 
taking part or are have any concerns about the study please contact: 
 
Joanne Bird 
NIHR Research Fellow 
 
Tel: 0114 2265208 
Email: joanne.bird@sheffield.ac.uk 
 
Dr Sarah Danson 
Consultant in Medical Oncology 
 
Tel: 0114 2265000 
Cancer Clinical Trials Centre 





Thank you for reading this and for taking an interest in this research 
study.  
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melanoma and their carers: charting changes over TIme (UNITI) 
 
CONSENT FORM  - CARERS 
 
Please  
Participant Identification Number for this study: ………..           initial box 
 
1. I confirm that I have read and understand the information sheet dated 
…………….. (version ………) for the above study.  
 
 
2. I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
 
 
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason. 
 









    




    
Name of Person Taking consent  Date  Signature 






Academic Unit of Clinical Oncology 
Head, Prof P J Woll 
Cancer Clinical Trials Centre 
Weston Park Hospital 
Whitham Road, Sheffield S10 2SJ 
 
Tel: 0114 226 5000/5208     Fax: 0114 226 5678 
 











Understanding the experiences and support Needs of patIents 
with melanoma and their carers: charting changes over TIme 
(UNITI) 
 
Information Sheet for Healthcare Professionals 
 
We would like to invite you to take part in our research study. Before you 
decide we would like you to understand why the research is being done and 
what it would involve for you. One of our team will go through the information 
sheet with you and answer any questions you have. Please take time to read 
the following information carefully and discuss it with others if you wish. Ask 
us if there is anything that is not clear or if you would like more information - 
contact details can be found at the end of this sheet. Take time to decide 
whether or not you wish to take part. 
Thank you for reading this. 
 
What is the purpose of the study? 
The purpose of this study is to consider the experiences of both patients with 
melanoma and their carers and the kind of support that they need. The type of 
support has been shown to be an important part of care for cancer patients in 
general. This study is looking at what patients and carers feel they need.  
 
 
Why have I been invited? 
You have been invited because one of your patients is taking part in our study 
and they have nominated you as a Healthcare Professional who has 




Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take 
part you will be given this information sheet and asked to sign a consent form. 
If you change your mind and want to withdraw you can do so at any time 
without giving a reason. If you do not want to take part or withdraw from the 
study, it will not affect you, the person you care for or the care they receive in 
any way. If you withdraw from the study, any information that can still be 





Academic Unit of Clinical Oncology 
Head, Prof P J Woll 
Cancer Clinical Trials Centre 
Weston Park Hospital 
Whitham Road, Sheffield S10 2SJ 
 
Tel: 0114 226 5000/5208     Fax: 0114 226 5678 
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What will be involved if I agree to take part? 
If you would like to take part we would like you to be interviewed twice during 
the study, once now and again at the end of your patient’s participation. The 
second interview could take place at any time in the next two years if you wish 
to participate in a further interview. Interviews can take place somewhere that 
is convenient for you, which could be your home, place of work or at the 
Cancer Clinical Trials Centre, Weston Park Hospital. We would like to ask you 
about your experience of providing healthcare for someone with melanoma 
and how you think it has affected them. If you agree, we would like to audio-
record the interviews to help us to remember the things you have said. The 
interviews should take about an hour.  
 
At the end of the study we will create guidelines for the care of patients with 
melanoma based upon the findings of the study. You will have the opportunity 




What are the possible disadvantages and risks of taking part? 
We will be asking you to spend an hour of your time to talk about your 
experience of providing healthcare for someone being treated for melanoma 
on 1 to 2 occasions. The healthcare of the person you care for will not be 
affected in any way by taking part in this study. 
 
 
What are the possible benefits of taking part? 
There is no intended benefit to you or your patient from taking part in this 
study although some patients find it helpful to talk about what has happened 
to them. The information we gain may help improve the experience of 
melanoma patients and their carers in the future. 
 
 
What if I have concerns as a result of taking part in this study? 
The researcher, Joanne Bird, will be happy to answer any questions you may 
have as a result of taking part in this study and can be contacted on 0114 
2265208.  
 
The Skin Cancer Clinical Nurse Specialist team can also be contacted if you 
wish to discuss your participation in this study or have any questions about 
melanoma care. They are independent of the research team and will not have 
access to any information you provide as part of this study. 
 
Claire Powell: 0114 2713014 
Marion Page: 01226 435311 
 
 
Will my taking part in the study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will 
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be handled in confidence. 
 
Anything you tell us in the interview will be kept strictly confidential. We will 
not tell anyone else of your involvement in the study or of anything that you 
may say to us. Only members of the research team will have access to the 
audio recordings and the written transcripts obtained from the tape recording. 
The transcripts will not identify you personally or anyone who you may have 
talked about. The tape recordings of the interviews will be kept in a locked 
cupboard for the duration of the study, and destroyed afterwards. The reports 




What will happen to the results of the research study? 
The findings from the study will be published in medical journals. No-one will 
be identifiable. 
 
Who is organising and funding the research? 
The study is being undertaken by researchers from the Department of Clinical 
Oncology and School of Nursing & Midwifery at the University of Sheffield. 




Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been 




Who can I contact for independent advice about participating in this 
study?  
If you would like independent advice about taking part in the study, you may 
wish to contact: 
 
Patients Services Team 




What if something goes wrong? 
If you have a concern about any aspect of this study, you should ask to speak 
to the researchers listed below who will do their best to answer your 
questions. If you remain unhappy and wish to complain formally, you can do 
this through the NHS Complaints Procedure by contacting the following 
person: 
 
Simon Heller, Research Department, Sheffield Teaching Hospitals NHS 
Foundation Trust.  
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Telephone: 0114 2265934 
Further information and contact details 
If you would like more information about the study, would like to talk about 
taking part or are have any concerns about the study please contact: 
 
Joanne Bird 
NIHR Research Fellow 
 
Tel: 0114 2265208 
Email: joanne.bird@sheffield.ac.uk 
 
Dr Sarah Danson 
Consultant in Medical Oncology 
 
Tel: 0114 2265000 
Cancer Clinical Trials Centre 
























 Understanding the experiences and support Needs of patIents with 
melanoma and their carers: charting changes over TIme (UNITI) 
 
CONSENT FORM  - HEALTHCARE PROFESSIONALS 
 
Please  
Participant Identification Number for this study: ………..           initial box 
 
 
1. I confirm that I have read and understand the information sheet dated 
…………….. (version ………) for the above study.  
 
 
2. I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
 
 
3. I understand that my participation is voluntary and that I am free to 















    




    
Name of Person Taking consent  Date  Signature 






Academic Unit of Clinical Oncology 
Head, Prof P J Woll 
Cancer Clinical Trials Centre 
Weston Park Hospital 
Whitham Road, Sheffield S10 2SJ 
 
Tel: 0114 226 5000/5208     Fax: 0114 226 5678 
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Understanding the experiences and support Needs of patIents with 
melanoma and their carers: charting changes over TIme (UNITI) 
 
Summary of Results for Patients, Carers and Healthcare Professionals 
 
Thank you for taking the time to participate in this study. We hope you will find the final results of the 
study interesting and that they reflect your experience.  
 
What was the purpose of the study? 
This research aimed to explore the changing experiences and support needs of patients with melanoma 
and their carers throughout the disease process.  
 
What happened during the study?  
Patients, carers and healthcare professionals were interviewed up to six times over a two-year period. 
Interviews were transcribed and key events identified. Diagrams were also drawn to visually represent 
the experience of having melanoma.  
 
What were the main findings of the study?  
Interviews with patients, carers and healthcare professionals identified four important stages of the 
melanoma experience, these were: 
 
• Before diagnosis 
• At diagnosis 
• During observation 
• Living with advanced disease 
 
The overall experience was described as being like ‘Riding a Rollercoaster’ with melanoma causing both 
‘ups’ and ‘downs’ for patients and carers as changes had to be made to their roles, routines and 
relationships.  
 
Before diagnosis patients and carers usually ‘noticed’ some unusual change to their skin, but this was 
often seen as nothing to worry about and could be forgotten until it further changes caused greater 
concern. It was only then that professional help was sought. This would usually be from the patient’s GP 
who would either give reassurance and advise the patient to monitor any further changes or refer them 
to a specialist.  
 
Patients then underwent investigations and when they were given a diagnosis of melanoma they talked 
about being in a state of “shock”. This often made it difficult for information about melanoma and any 
related treatments to be fully understood. In the best circumstances patients (but rarely their carers) 
were well supported by a healthcare professional and developed a trusting relationship, often with the 
same person. This relationship frequently lasted throughout their whole experience. However, not 
everyone was well supported and carers needs in particular were often not recognised.  
 
Co-Directors:  
Dr Jon Wadsley, Prof Janet Brown 
 
Cancer Clinical Trials Centre 
Weston Park Hospital 
Whitham Road, Sheffield  S10 2SJ 
Telephone: +44 (0) 114 226 5208 
Fax: +44 (0) 114 226 5678 
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During initial treatment, patients tried to continue with their normal work, family and leisure routines but 
these were often affected due to their treatment. These changes could be temporary but some were long 
lasting. Patients and carers usually turned to their family and friends for support at this time, but to 
provide the support needed family/friends had to have information about the melanoma. Not all patients 
shared their diagnosis with everyone, and sometimes they ‘hid’ it so as to prevent people from worrying. 
This could have a negative impact on patients’ relationships with family and friends.   
 
At all stages healthcare professionals were an important resource providing information, clinical 
expertise and emotional support. It was therefore essential that healthcare professionals were accessible 
to patients and carers and could be easily contacted if help was needed. However, if healthcare 
professionals made promises that they did not keep, such as failing to return telephone calls, patients 
and carers lost trust in them and felt abandoned.  
 
While recovering from treatment patients and carers remained under close observation requiring 
frequent visits to clinics. During this time, scans, examinations and if needed the removal of any 
suspicious lesions could be reassuring or a cause of major worry. Feelings of uncertainty were some of 
the major ups and downs of ‘riding the rollercoaster’. In between clinical visits patients and carers would 
keep a close eye on any changes to their condition (‘monitoring’). Sometimes patients and carers would 
do this together but at other times carers would ‘keep an eye’ on their relative but not tell them so that 
the patient wouldn’t worry. In addition patients and carers often developed new sun protection routines 
such as applying sun cream or wearing more clothing in sunny weather.   
 
Some patients developed advanced melanoma and at this stage monitoring for any side effects of 
treatment and the symptoms of melanoma became even more important. Family members also often 
had to take on more caring responsibilities, especially if the patients’ condition worsened. Therefore 
relationships with family and friends became increasingly important as people prepared to say goodbye.  
 
At this stage it was very important to have a healthcare professional to contact for advice. However, as 
patients often received treatment from a number of differing departments maintaining a close relationship 
with a trusted healthcare professional could be difficult. The quality of the overall experience of patients 
with melanoma and their carers is largely determined by their interactions with healthcare professionals 
which can have a positive effect, especially where a trusting relationship has been built. Unfortunately, at 
times too many healthcare professionals were involved and patients and carers did not know who to 
contact. 
  
What will happen to the results of the research study? 
The findings from the study have been presented at conferences and will be published in medical 
journals. They will also be made available via the websites of the Yorkshire and Humberside Consumer 
Research Panel and Cancer Research UK. It is hoped that the findings will be used to improve the 
experience of patients and carers living with melanoma in the future. No participants will be identifiable. 
Pictures created during the study can be seen on the website of the Yorkshire and Humberside 
Consumer Research Panel:  
http://www.yhcrp.org.uk/?page_id=890 
 
Further information and contact details 
If you would like more information about the study or results please contact: 
 
Joanne Bird 
NIHR Research Fellow 
 
Tel: 0114 2265208 
Email: joanne.bird@sheffield.ac.uk 
 
Professor Sarah Danson 
Consultant in Medical Oncology 
 
Tel: 0114 226 5221 
 
Cancer Clinical Trials Centre 
Weston Park Hospital  
Whitham Road 
Sheffield  
S10 2SJ 
 
